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ABSTRACT 
Nurse Practitioners (NPs) are frequently integrated into interprofessional teams to improve 
quality and efficiency of healthcare delivery, especially in complex systems. Research on the 
NP role has grown dramatically, yet an aggregate analysis had never been performed. The 
purpose of this review was to systematically describe the nature and impact of NP 
interventions in healthcare settings, to establish a comprehensive understanding of NPs with 
respect to healthcare delivery, including discovery of information gaps. The specific 
objectives of the study were to describe the types of: 1) intervention activities that NPs have 
performed in randomised controlled trials (RCTs); 2) quantitative study endpoints measured 
in RCTs; and 3) impact of NPs on all quantitative patient outcomes in four settings: primary 
health care, long term care, outpatient care, and acute care, conducting meta-analysis where 
possible. Eligible studies included low risk of bias RCTs that tested NP interventions on 
quantitative endpoints in healthcare settings; data sources included peer reviewed or grey 
literature in   English, from the year 2000 forth. The literature search performed by a 
professional librarian (MH) yielded 1,188 unique citations. Screening for relevance and risk 
of bias by two independent reviewers (LT and NL) resulted in a set of included studies 
comprised of 39 articles (29 different RCTs). Data extraction by LT was cross-checked by 
the second independent reviewer NL. Findings were systematically summarized according to 
pre-specified protocol. Out of 89 classes of endpoint-outcomes, results for 43 patient outcome 
classes (43/89; 48%) were statistically significant, associated with 26/29 (90%) interventions. 
Meta-analysis was conducted to compare the proportion of hospitalizations between 
intervention and control groups of two homogenous studies, systematically completing the 
review’s data analysis. Transparent data presentation within an explicit, reproducible 
methodology minimizes bias, resulting in reliable findings that were organized, synthesized 
and summarized in a clear and comprehensive fashion. To the extent of its findings, this 
systematic review may support improvements in access to quality healthcare, and may 
provide insight into long term strategies that have potential to contribute toward enhanced 
balance within the healthcare continuum, from delivery of preventive primary health care 
services to treatment in acute care.  
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GLOSSARY 
Nurse Practitioner (NP) - Registered Nurse (RN) with additional educational preparation 
and experience who possesses and demonstrates the competencies to autonomously diagnose, 
order and interpret diagnostic tests, prescribe pharmaceuticals and perform specific 
procedures within their legislated scope of practice.
2
 
 
Primary Health Care (PHC) - a basic level of health care that includes programs directed at 
the promotion of health, prevention of disease, and early diagnosis of disease or disability, 
provided in an ambulatory facility to people often living in a particular geographic area; 
3
 
essential health care made universally accessible to individuals and families through their full 
participation, at a cost their community and country can afford; includes broad determinants 
of health (e.g. food security, environment, housing, education, socioeconomic status, social 
support networks, integrated health services) and the principle of appropriate technology: 
modes of care that are appropriately adapted to the community’s social, economic and 
cultural development, as alternatives to high technology, high cost services, through 
innovative models of health care that disseminate research results.
4
   
 
Primary Care - first contact care that leads to a course of action to resolve the health 
problem; illness oriented, and may include preventive, curative, and rehabilitative care; 
focuses on health care services often provided by a physician, may be provided by a nurse, 
and may include emergency room visits; a narrow component of the broader concept of 
primary health care.
3,4
  
 
Long Term Care - provision of medical, social, and personal care services on a recurring or 
continuing basis to persons with chronic physical or mental disorders, in environments 
ranging from institutions to private homes, for patients of all age groups.
3
  
 
Outpatient / Specialized Referral Care - treatment of a patient not admitted overnight to 
hospital, in an office, clinic or other ambulatory care facility.
3
  
 
Emergency Department (ED) / Acute Inpatient Care - treatment in a hospital, where 
inpatient care requires admission to a hospital or other healthcare facility for at least an 
overnight stay.
3
  
 
Interprofessional Team (IPT) mode of NP implementation - the NP practices with at least 
one other health care provider to deliver patient / client care.  
 
Role Substitution (RS) mode of NP implementation - the NP acts as a replacement for 
another health care provider, and is delegated the responsibilities of diagnosing, prescribing, 
and overseeing patient care; relates to the formal origin of the NP role in Canada in 1973 to 
create alternative health care services where / when physician shortages were being 
experienced.
5
  
 
IPT Study - mutually exclusive to a role substitution (RS) study.  
 
 xii 
 
Program Study – tests an intervention program delivered by the NP(s) or a team of health 
professionals that may include a NP.  
 E.g. Web-based program study (IPT study) tests the effectiveness of a web-based 
 platform on the management of diabetes, rather than NP care provision per se.
6,7
 
 E.g. PALSA (Practical Approach to Lung health in South Africa) program study (IPT 
 study) tests the effectiveness of educational outreach in the case management of 
 priority respiratory diseases, delivered by NPs.
8
  
 
Diagnosis - the identification of a disease or condition by a scientific evaluation of physical 
signs, symptoms, history, lab test results and procedures.
3
  
 Open diagnosis - detection and management of any type of condition, disease, or risk 
 factor for disease.  
 Limited diagnosis - detection and management of various types of conditions, 
 diseases, or risk factors for disease, based on assessment of data limited by inclusion 
 criteria and / or protocol.  
 Diagnosis of disease status - restricted to the detection or risk stratification of 
 specific conditions / status of disease, often guided by protocols or algorithms 
 forming the basis of the intervention.  
 Wellness Diagnosis - focuses on strengths that reflect an individual’s transition to 
 higher  levels of wellness, where ‘wellness’ is a dynamic process of progress toward 
 maximizing an individual’s potential. Wellness diagnoses detect progression from 
 one level of wellness to a higher level of wellness, by facilitating healthy responses 
 for attainment of higher levels of health oriented goals.
9
  
 E.g. of wellness diagnosis = ‘Health-seeking behaviour regarding weight-loss diet’  
 Health-seeking behaviors - active seeking of ways to alter personal health habits 
 and/or  the environment, by a person in ‘stable health’, in order to move toward a 
 higher level of health.
10
 
 Stable health - achievement of age-appropriate illness-prevention measures; client 
 reports good or excellent health, and signs and symptoms of disease, if present, are 
 controlled.
10
  
 
Prescribing Pharmaceuticals - to write an order for a drug or treatment.
3
  
 Open prescribing - conducted for the purpose of managing any type of condition, 
 disease, or risk factor for disease. 
 Limited prescribing - conducted for the purpose of managing various types of 
 specific conditions, diseases, or risk factors for disease based on data limited by 
 inclusion criteria and / or protocol. 
 
Procedures - the sequence of steps to be followed in establishing some course of action.
3
 
 
Education - intellectual, moral and social instruction, giving information on a particular 
subject.
11
  
 
Strategies for Behaviour Change - an interactive helping process focusing on the needs, 
problems, or feelings of the patient and significant others, to enhance or support coping, 
 xiii 
 
problem-solving, behaviour change and interpersonal relationships, including relationships 
with the health care team.
3
 E.g. ‘Motivational interviewing’ increases patients’ awareness of 
‘readiness to change,’ to subsequently create attainable goals toward a healthier lifestyle.12 
 
Care Coordination - activities delivered from a remote site via telephone or email, often 
requiring patient referrals to appropriate services based on a limited assessment; not 
completely classified within the traditional categories of diagnosis, prescribing, clinical 
procedures, or strategies for behaviour change / education.  
 
Preventive Healthcare - to hinder the occurrence of an illness or to decrease the incidence of 
a disease;
3
 reducing risks or threats to health.
13
  
 Primary (1
0
) Prevention - aims to prevent disease or injury before it ever occurs, by 
 preventing exposures to hazards that cause disease or injury, altering unhealthy or 
 unsafe  behaviours that can lead to disease or injury, and increasing resistance to 
 disease or injury should exposure occur.
13
  
 Secondary (2
0
) Prevention - aims to reduce the impact of a disease or injury that has 
 already occurred, by detecting and treating disease or injury as soon as possible, to 
 halt or  slow its progress.
13
  
 Tertiary (3
0
) Prevention - aims to soften the impact of an ongoing illness or injury 
 that has lasting effects, by helping people manage long-term, often complex health 
 problems and injuries (e.g. chronic diseases, permanent impairments).
13
 
 
CONSORT (Consolidated Standards of Reporting Trials) provide guidance to facilitate 
clarity, completeness, and transparency of reporting of all randomised controlled trials. 
Explicit descriptions, not ambiguity or omission, best serve the interests of all readers, and 
model the development of guidelines for reporting systematic reviews and meta-analyses of 
studies evaluating interventions, the explicit goal being, to improve reporting.
14
 
 
Systematic Review attempts to identify, evaluate and summarize all available evidence 
addressing a specific research question(s), with key characteristics including: clearly stated 
set of objectives with pre-defined eligibility criteria for studies; an explicit, reproducible 
methodology to minimize bias, thus providing more reliable findings; a systematic search that 
attempts to identify all studies meeting eligibility criteria; an assessment of risk of bias of the 
included studies; and a transparent, systematic presentation and synthesis of the 
characteristics and findings of the included studies, according to pre-specified protocol.
15
 
 
Meta-Analysis is the use of statistical methods to summarize the results of independent 
studies; many systematic reviews contain meta-analyses. By combining information from all 
relevant studies (two or more primary studies that addressed the same hypothesis in the same 
way) from a review whose methods were valid and reliable (reproducible), meta-analyses can 
provide more precise estimates of the effects of health care interventions than those derived 
from the individual studies included within a review. Meta-analyses also facilitate 
investigations of the consistency of evidence across studies, and the exploration of 
differences across studies.
15
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1. Introduction  
 Delivery of healthcare services in a world with limited resources and increasing 
pressure to create evidence-based quality patient outcomes
16
 may require interprofessional 
teams. Interprofessional teams (IPTs) are defined by Virani as various healthcare disciplines 
working together toward common goals to meet the needs of a patient population.
17
 One 
strategy to improve the efficiency and effectiveness of IPTs is to employ the services of an 
advanced practice Nurse Practitioner (NP). In Canada, NPs are defined as “registered nurses 
with additional educational preparation and experience who possess and demonstrate the 
competencies to autonomously diagnose, order and interpret diagnostic tests, prescribe 
pharmaceuticals and perform specific procedures within their legislated scope of practice.”2 
The demand for NPs in Canada continues to grow due to increasing recognition of their roles 
as clinical experts, leaders and change agents for improving access to high-quality, cost-
effective and sustainable healthcare.
18 
1.1 Statement of Problem 
 The body of research on the NP role has grown dramatically over past years.   
As a result, independent studies examining the effect of NPs are widely available but an 
aggregate analysis of these healthcare providers had never been performed.  The systematic 
assessment of quality, consistency, effectiveness, and scope of this review allows for a 
comprehensive understanding of the current state of knowledge (including information gaps) 
about NPs with respect to healthcare delivery.     
1.2 Purpose of Study 
 The purpose of the study was to systematically describe the literature pertaining to the 
nature and impact of nurse practitioner interventions in healthcare settings. The specific 
objectives of the study included 1) describing the types of activities that NPs have performed 
in randomised trials; 2) describing the types of endpoints evaluated; and 3) describing the 
impact of NPs on all quantitative patient outcomes, conducting a meta-analysis to measure 
the impact of NPs on patient outcomes from homogeneous studies where possible. 
1.3 Significance 
 NPs in Canada are frequently being incorporated into IPTs to improve the quality and 
efficiency of healthcare delivery, especially in complex systems.
19
 In order to invest in NPs 
most effectively, a clear understanding of their roles and impact on patient outcomes is 
needed, especially with respect to IPTs, recognized as potentially, the most cost-effective 
model of quality care delivery.
20 
 2 
 
2. Literature Review 
2.1 History of the Nurse Practitioner Role 
 In Canada, NPs are defined as “registered nurses with additional educational 
preparation and experience who possess and demonstrate the competencies to autonomously 
diagnose, order, and interpret diagnostic tests, prescribe pharmaceuticals and perform specific 
procedures within their legislated scope of practice.”2 NPs were introduced in remote regions 
and southern urban settings throughout Canada in an attempt to alleviate the shortage of 
family physicians in the early 1970s.
21
 By the late 1970s, it was suggested that NPs in Canada 
could help achieve the essence of primary health care according to its  five principles of 
accessibility, public participation, health promotion, appropriate technology, and intersectoral 
cooperation.
4,22
 However, for various reasons including a lack of NP role legislation, by the 
mid-1980s, NPs “disappeared in all but remote areas and a few sites in southern Canada.”23 
Ten years later, provincial and federal governments called for major primary health care 
reform, and so the role of the NP was again considered a viable strategy to deliver health care 
services.
23 
A $25 million Nursing Research Fund was created by Health Canada
24
 which 
supported several projects around the NP role including a landmark report in 2010 by 
DiCenso and Bryant-Lukosius on advanced practice nursing entitled “Clinical Nurse 
Specialists and Nurse Practitioners in Canada: A Decision Support Synthesis.”18 However, 
despite the increased research activities devoted to the NP’s role in Canadian health care 
settings, an aggregate evaluation of their activities and /or impact on patient care had never 
been undertaken. 
 DiCenso & Bryant-Lukosius made 11 recommendations for the following 
professional groups: the Nursing Community and its Partners, Senior Decision Makers in 
Policy and Practice, Educators, and Researchers, in order to guide positive change in both 
nursing role development and implementation.
25
 However, despite the very comprehensive 
approach taken to the creation of this report, these 11 recommendations were based on 
summaries of various types of evidence ranging from randomised controlled trials (RCTs) to 
focus groups and interviews,
18
 along with theoretical benefits of the NP role. Notably, a 
systematic review was not undertaken.  
2.2 Role of the Nurse Practitioner  
 The NP role was developed to ensure timely access to high-quality, cost-effective care   
for positive patient outcomes.
5
 At present, potential advantages of the NP role include 
increased access to care in primary healthcare services, especially for vulnerable groups, such 
as those in rural remote regions or Aboriginal people. As well, NPs may facilitate 
 3 
 
improvements in chronic disease management, nursing home care, emergency department 
wait times, or in special populations such as neonatology, cardiology, neurosurgery, or 
intensive care.
26
 It has also been suggested that the incorporation of NPs can result in lower 
health care costs.
27
 However, it is not currently clear whether the potential to reduce health 
care costs is associated with NP roles specifically or with nursing interventions in general.
28
 
Although many individual studies of NP interventions can be identified, the nature and 
consistency of the evidence examining exclusively NP interventions has never systematically 
been summarized.   
2.3 NP Implementation: Role Substitution or Interprofessional Teams 
 Over the years, NPs have assumed various health care functions depending on the 
setting and the needs of the community.  Originally, NPs were primarily involved in role 
substitution activities to allow alternative health care services to be provided when physician 
shortages were being experienced.
29
Although role substitution has its informal origins in 
outpost nursing of the 1890s, in areas such as the Northwest Territories, Labrador and 
Newfoundland,
21
 its formal origins in Canada occurred in the early 1970s. Parameters of the 
formal NP role were initially based on the educational program developed in1971 by the 
Faculty of Medicine and the School of Nursing at McMaster University, supported by the 
Ontario Ministry of Health
30
 in response to physician shortages in southern urban Ontario.
5
 
The joint statement issued in 1973 by the Canadian Medical Association and the Canadian 
Nursing Association, further outlined these parameters.
5
 Research on the NP role originally 
focussed on role substitution (RS), whereby NPs act as a replacement for the physician and 
are delegated the responsibilities of diagnosing, prescribing, and overseeing patient care. 
More recently, studies have focused on the benefits of adding NPs to interprofessional teams. 
For the purpose of this systematic review, an interprofessional team (IPT) is defined as the 
presence of at least one other health care provider working with the NP to deliver patient 
care, with an IPT study mutually exclusive to a RS study. As discussed above, team-based 
health care is considered a possible strategy to improve both efficiency and quality of health 
care in Canada.
17,19 
However, the most beneficial activities undertaken by NPs in the context 
of IPTs are not known.  
 2.3.1 NPs in Role Substitution. 
 Several studies suggest that appropriately trained nurses can produce high quality care 
and patient outcomes equivalent to primary care doctors. Laurant and colleagues performed a 
systematic review of role substitution studies (RCTs; controlled before and after; and 
interrupted time series) with various nursing professionals (NPs, Clinical Nurse Specialists, 
 4 
 
or other practice nurses) working as an intervention-substitute for usual care provided by a 
primary care physician (could include GPs, family doctors, pediatricians, general internists or 
geriatricians). This systematic review found nurses tended to provide more health advice and 
achieve higher levels of patient satisfaction compared to doctors.
28
 Another systematic review 
was published on the impact of nurses in only primary / community care, in this case, via RS 
and IPT, but NP studies were excluded.
31
 Horrocks and colleagues conducted a systematic 
review specifically regarding NPs as a first point of contact in primary care via RS, and 
concluded that increased availability of NPs would likely lead to high quality care with high 
levels of patient satisfaction.
32 
Specifically within the acute environment, another systematic 
review evaluated the use of NPs in RS or IPTs, to reduce overcrowding in both urban and 
rural emergency departments, suggesting that NPs may represent a viable, effective patient-
management option.
33
 Clearly, systematic reviews have been performed on NP-related 
research but none have been performed to provide an aggregate analysis of the NP role 
exclusively in and of itself, in both upstream primary care / community environments as well 
as in downstream outpatient / inpatient hospital environments.  
 2.3.2 NPs in Interprofessional Teams. 
 Several studies suggest NPs can facilitate important benefits to patient outcomes 
when participating in interprofessional teams (IPTs). Integration of NPs and pharmacists into 
a primary care network for the provision of chronic disease management services resulted in 
improved quality of care indicators.
34
 However, the extent to which these findings translated 
into improved patient outcomes was not examined. Significant improvements in patient 
outcomes and patient satisfaction were demonstrated through a NP-physician team approach 
to chronic disease management in a teaching hospital at modest incremental costs.
35 
However, in a large academic medical centre, Ettner and colleagues found that inpatient care 
using NPs in multidisciplinary teams was associated with cost savings compared to usual 
care. In this study, patients’ perceptions of care and quality of life were at least as good in the 
intervention as in the standard care group along with comparable patient health outcomes in 
both groups.
36
 
  Current knowledge about the benefits of NPs in health care settings is largely based 
on theoretical applications of the NP scope of practice along with various studies that 
examine diverse roles, settings, and endpoints. While it is possible that there are quite 
substantial benefits to be gained through use of NPs, the impact and roles of these health care 
practitioners have not been examined exclusively. A systematic review was undertaken to 
describe the current state of evidence and also to identify areas where evidence is lacking. 
 5 
 
Establishing a clear and comprehensive understanding of the current state of knowledge 
about NPs with respect to healthcare delivery through the conduct of this systematic review 
will enable a more meaningful investment in their services, particularly for the potential 
enhancement of IPTs. 
2.4 Purpose, Research Questions, and Hypotheses  
 The purpose of the study was to systematically describe the literature pertaining to the 
nature and impact of nurse practitioner interventions in health care settings. The specific 
research questions included:  
1) What types of intervention activities have been performed by NPs in randomised 
trials? 
2) What types of endpoint-outcomes have been quantitatively measured in randomised 
trials examining the impact of NPs? 
3) What is the impact of the NP on patient outcomes in each of four practice 
environments: primary health care, long term care, outpatient care / specialized 
referral care, and emergency department / acute inpatient hospital care? 
 Patient outcome data associated with NP practice in and of itself, in all four practice 
environments had not been known in the context of a systematic review. Research question 
three addressed this unknown with its directional hypothesis of beneficial NP impact on 
patient outcomes in each of the four different practice environments examined in this review. 
Each practice environment represented the “common ground” / constant variable for potential 
sets of calculations comparing the effect of the NP intervention to standard practice without 
NP intervention. Patient outcome data derived from RS or IPT studies are both outcome data 
from implementation of the same NP role defined by the CNA, measuring the effect of the 
NP according to the logic of random assignment, attributing differences between treatment 
and control groups to the effect of the intervention.
37  
 
Two hypotheses were developed prior to undertaking this systematic review.  First, it 
was expected that studies examining NPs in the context of role substitution (RS) would not 
find significant differences in patient outcomes compared to an active control.  In these 
studies, control patients are typically managed by licenced health care providers such as 
physicians and specialists who likely provide a high level of care at baseline. In contrast, a 
second hypothesis was developed for studies examining the benefits of NP interventions in 
the context of interprofessional teams (IPTs). NPs providing care in this context were 
expected to demonstrate significant improvements in patient outcomes compared to usual 
care.  Accordingly, determination of a combined effect from pooling RS and IPT studies was 
 6 
 
not expected to be undertaken due to the predicted differences in impact compared to control 
/ usual standard care. Further, it should be noted that the research methodology (i.e. the 
systematic review process) employed for this thesis may not allow formal hypothesis testing 
to be carried out due to the expected variability between available studies in terms of 
intervention activities and endpoint measures.  However, these hypotheses reflect the 
researcher’s expectations based on theoretical roles and the background literature review.       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 7 
 
3. Method 
3.1 Inclusion Criteria  
 A comprehensive literature search was undertaken to identify randomised trials 
evaluating the impact of NP interventions delivering care through role substitution (RS) or 
through collaboration on interprofessional teams (IPTs). Trials were included if they met the 
following inclusion criteria: 
 Randomised trial with randomisation at either the 1) individual level or 2) cluster 
level, only if there are multiple clusters ( > or = 15 clusters / group) in both 
intervention and control groups. 
 NP intervention implemented via either mode of role substitution (RS) or 
interprofessional team (IPT). All types of NPs were eligible, including PHCNP 
(Primary Health Care NP), ACNP (Acute Care NP), NNP (Neonatal NP), ARNP 
(Advanced Registered NP) etc. Context of program studies were included if the NP 
was the “+1” member of the intervention IPT, compared to an otherwise identical 
control IPT, or if the program was delivered exclusively by the NP(s).  
 Intervention must be delivered in one of the following settings: primary health care, 
long term care, outpatient care (not admitted overnight to hospital) / specialized 
referral care, emergency department / acute inpatient hospital care.  
 Risk of bias must be classified as low based on an assessment tool suggested by the 
Cochrane Collaboration
15
 and adapted by Donald and colleagues.
38
 
 Endpoint must be quantitatively measured within the following categories:  
 Death 
 Hospitalization (myocardial infarction / stroke / life-threatening event) 
 Treatment of a Chronic Disease (surrogate markers of disease may include 
physiologic markers e.g. blood glucose in diabetes; symptom severity e.g. 
post-operative symptoms in cardiac surgery outpatients; functional status e.g. 
peak flow in asthma patients; behaviour / lifestyle change e.g. diet in obese 
patients) 
 Drug Utilization (i.e. adherence or ‘appropriate prescribing’) 
 Resource Utilization (consultations, tests / investigations, referrals)  
 Cost 
 Quality of Life and / or Patient Satisfaction 
 Other 
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 Published in peer reviewed literature or grey literature, defined as reports produced by 
all levels of government, academics, business and industry in print and electronic 
formats but not controlled by commercial publishers.
15
  
 Publication date of the study in the year 2000 or later.  
 Study published in English. 
Exclusion Criteria 
Studies were excluded if they did not specify “nurse practitioner” as the sole nursing 
intervention. Examples of types of non-NP nursing professionals included: 
 clinical nurse specialists     
 community health nurses  
 public health nurses  
3.2 Literature Search Strategies  
Grey literature was searched using (alphabetically): The Agency for Healthcare 
Research and Quality (AHRQ), The Canadian Electronic Library, The Canadian Nurses’ 
Association, The Centre for Reviews and Dissemination, Center Watch, ClinicalTrials.gov,  
Grey Literature Report, Healthcare Standards Directory Online, the International Clinical 
Trials Registry Platform (ICTRP), The National Institute for Health and Care Excellence 
(NICE), The Ontario Health Technology Advisory Committee (OHTAC), Open Grey, 
ProQuest’s Dissertations and Theses Databases, The Saskatchewan Registered Nurses’ 
Association, and Turning Research into Practice (TRIP Database). Reference lists of relevant 
articles have been hand searched by the review author for potentially eligible studies. 
 The search strategy specific to Ovid MEDLINE (1973-April 2015) is outlined in 
Appendix F. The MEDLINE search strategy is a draft and was developed beginning with 
Ovid’s Expert Search for randomized controlled trials (#1 - #23 from the search string in the 
appendix). Ovid MEDLINE identified 1,028,182 RCTs from 1973 – Present. This expert 
search feature is more effective than simply selecting the “randomized controlled trial” filter 
because it includes related studies and terms such as single blind methods, double blind 
methods, random allocations, etc. The draft strategy continues by broadly singling out nurse 
practitioners (NPs). The “Nurse Practitioner” Medical Subject Heading is restricted to records 
which list this term as a major topic of the research article. However, a wide range of 
keywords and synonyms accompany the subject heading. These include records which 
include “nurse practitioner” in the title of a record as well as records which contain the term 
at least twice in an abstract. A comprehensive list of search terms is available upon request. 
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 On finalization, the search strategy from MEDLINE was translated, and used to 
search the Cumulative Index of Nursing and Allied Health Literature (CINAHL), PubMed, 
and EMBASE. Search terms included nurse practitioners, interdisciplinary patient care teams, 
interprofessional relations, nurse’s role etc. Databases such as The Cochrane Central Register 
of Controlled Trials and Web of Science’s Citation Index were also searched. However, these 
databases did not require search translations due to their varying interfaces and limited 
content compared to MEDLINE. The number of retrieved references were recorded and 
search strings for each database were saved. Searches can be re-run at any time. This data 
was managed in EndNote and included the amount of results from each database as well as 
the total amount of articles from each database (without duplicates). The publication date 
limit used in these searches was 1973 - present. Reference lists of relevant articles were hand 
searched by the review author for additional potentially eligible studies. Authors of relevant 
studies were contacted when necessary to clarify reported published information.  
3.3 Review Process   
 The initial list of studies identified from the electronic search described above was de-
duplicated prior to review.  Next, two reviewers independently assessed the electronic 
citations (+ abstracts if applicable) using the relevance tool presented in Appendix A. 
Potentially relevant articles from the citation review underwent a full article review including 
a ‘risk of bias’ assessment. Agreement between assessors was measured by the kappa 
statistic.
15
 Discrepancies between the two independent reviewers were resolved by a third 
person (D. Blackburn). 
 3.3.1 Validity Tool and Risk of Bias. 
 Risk of bias was assessed for all articles identified for the full-text review. Assessors 
used a tool adapted from the Cochrane collaboration
15
 and from Donald and colleagues
38
 
[Appendix B]. The tool was designed to assess risk of bias across the domains of selection, 
detection, attrition, reporting, and all other concerns for bias not addressed in the previous 
domains. A judgement was assigned as either Yes (a low risk of bias), No (a high risk of 
bias), or Unclear (insufficient detail) by answering pre-specified questions. Overall, risk of 
bias was assigned to each study as follows: low risk of bias (“at risk” or “No” judgment in 0-
1 category), moderate risk of bias (“at risk” or “No” judgment in 2-3 categories), high risk of 
bias (“at risk” or “No” judgment in 4-6 categories). The original Cochrane tool was modified 
following the justification of Donald and colleagues for the approach to NP interventions.
38
 
Specifically, the question about “blinding” was omitted from the tool because this convention 
is often impractical for NP intervention studies. Also, if outcomes had > 20 % missing data, 
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the study was judged to be at high risk of bias for “incomplete outcome data.” After the 
validity assessment was completed by two independent reviewers, discrepancies were 
resolved by consensus, and any unresolved issues were resolved by a third person (D. 
Blackburn).  
  3.3.2 Data Extraction and Synthesis.  
 Studies that met all inclusion criteria underwent data extraction by LT using a 
standardized form developed and piloted for this specific study [Appendix C] prior to 
approval of protocol. Data extraction was cross-checked by NL prior to data synthesis.  
Objective 1: to describe the types of activities that NPs have performed in randomised trials 
 All intervention activities undertaken by NPs in each study were described 
qualitatively within predefined categories derived primarily from the definition of the NP:
2
 a) 
diagnosis b) prescribing pharmaceuticals, c) clinical procedures, and d) strategies for 
behaviour change / education. The additional category of e) care coordination was created by 
the review authors to categorize activities not accommodated by the original four categories. 
Diagnosis was defined as the identification of a disease or condition by a scientific evaluation 
of physical signs, symptoms, history, lab test results and procedures,
3
 based on direct patient 
assessment, not withholding “diagnoses about higher levels of wellness.”9  In this review, 
diagnostic activities were divided into three sub-categories: open, limited, and diagnosis of 
disease status, with no evidence found of NPs diagnosing higher levels of wellness.  
 
Open diagnoses were assigned if the NP diagnostic activities were unrestricted, and 
often involved ‘ordering and interpreting diagnostic tests’ (X-ray, organ function tests, blood 
tests, cultures etc.) and referring patients for specialty care. Limited diagnoses detected 
specific types of conditions, diseases, or risk factors for disease based on inclusion criteria, 
clinical protocols or clinical algorithms. Finally, ‘diagnoses of disease status’ were assigned 
when the NP intervention focused on patient populations who had previously been diagnosed 
with a specific disease. These diagnoses were thus restricted to the risk stratification of 
specific conditions, often guided by protocols or algorithms for the purposes of optimizing 
ongoing disease management or supporting patients’ self-care. 
 Prescribing pharmaceuticals was defined as writing an order for a drug or treatment.
3
 
This activity was also sub-categorized by reviewers as open or limited.  Open prescribing was 
assigned if the NP was responsible for all aspects of medication therapy.  Limited prescribing 
often followed a protocol, restricted by condition or medication type.  The domain ‘clinical 
procedures’ included administration of intra-muscular / intra-articular medications, 
application of stitches / dressings to wounds, thoracentesis or chest tube placement for pleural 
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effusion in cardiac surgery patients, or other clinical activities requiring direct manipulation 
of the patient (clean or sterile).   
 Education was defined as intellectual, moral and social instruction, giving information 
on a particular subject to improve knowledge.
11 
 Educational activities were classified 
separately from ‘strategies for behaviour change’, where NPs undertook an interactive 
process such as motivational interviewing, to increase patients’ awareness of ‘readiness to 
change,’ for potential achievement of specific attainable goals related to a healthier lifestyle.  
In order to classify an activity as ‘strategies for behaviour change’, it had to be based on a 
psychological or cognitive model and delivered by NPs who received training in specific 
techniques.
12
 Both activities of education and ‘strategies for behavior change’ could occur 
within a single study and ranged from providing a patient with written educational material, 
to face-to-face goal-setting for behaviour change based on psychosocial theory (e.g. 
motivational interviewing). Improved knowledge and behaviour change toward healthier 
lifestyles, in turn, support preventive healthcare that hinders the occurrence of an illness or 
decreases the incidence of a disease.
3
 Three levels of prevention include: primary (aims to 
prevent disease or injury before it ever occurs) , secondary (aims to reduce the impact of a 
disease or injury that has already occurred, by detecting and treating disease or injury as soon 
as possible, to halt or slow its progress), and tertiary prevention (aims to soften the impact of 
an ongoing illness or injury that has lasting effects).
13
 The final category of NP activity was 
termed ‘care coordination.’ Care coordination activities could not be classified within the 
traditional categories of diagnosis, prescribing, clinical procedures, or education / strategies 
for behaviour change.  These interventions were typically delivered from a remote site via 
telephone or email and often required NPs to refer patients to appropriate services based on a 
limited assessment.  
 NP intervention activities were further organized by practice environment: primary 
health care, long term care, outpatient / specialized referral care, and emergency department / 
inpatient acute care; and by mode of NP implementation (RS or IPT), with an assessment 
made of the consistency of activities according to both setting and mode. Specifically, 
activities were grouped into the most common to least commonly undertaken in randomised 
trials. Ultimately, information on the types of activities undertaken in randomised trials was 
organized, synthesized and summarized in a clear and comprehensive fashion. 
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Objective 2: to describe the types of endpoints evaluated in RCTs examining the impact of 
NPs 
 The overall goal for objective two was to comprehensively describe the types of 
endpoints examined in NP intervention studies. All eight categories of quantitative endpoints 
in the review’s inclusion criteria were broadly categorized into five categories for clarity of 
reporting: 1) clinical outcomes: death, hospitalization for life-threatening event; 2) surrogate 
measures of disease including: a) physiologic markers: e.g. blood glucose for diabetes status; 
b) i) symptom severity: e.g. post-operative symptoms related to cardiac surgery;  ii) 
functional status: e.g. peak flow in asthma patients; and iii) behaviour / lifestyle change: e.g. 
diet and physical activity in obese patients; as well as c) drug utilization: e.g. medication 
compliance to lipid-lowering drugs in coronary heart disease patients; 3) resource utilization / 
cost; 4) overall quality of life / patient satisfaction; and 5) ‘other.’ Types of endpoints 
measured were reported with consideration of practice environment (i.e. primary health care, 
long term care, etc.) and mode of NP implementation (RS or IPT). The validity of each type 
of endpoint assessment was also examined and described. Overall, objective two resulted in a 
comprehensive description of the types of endpoints evaluated in NP intervention trials 
within each practice environment and each mode of NP implementation, with the quality / 
rigor of endpoint measurement also identified and described [Appendix I].  
Objective 3: to describe the impact of NPs on all quantitative patient outcomes from 
randomised trials, conducting a meta-analysis to measure the impact of NPs on patient 
outcomes from homogeneous studies where possible  
 The impact of NP interventions on patient outcomes was descriptively reported for all 
studies. Although the ‘ideal’ goal of this research was to quantify the impact of NPs on 
patient outcomes, it was recognized that calculation of both summary effects and / or 
variance may not be possible if available trials do not assess these outcomes, or if existing 
articles are of poor quality. With careful attention paid to the similarity of outcomes, disease 
states, study duration and practice settings of all studies comprising this review, one pair of 
homogeneous studies contained quantitative data that was able to be pooled and meta-
analyzed using Comprehensive Meta-Analysis.
39
  
  Amendments to the protocol were anticipated since the completion of a systematic 
review is an iterative process. The PRISMA (Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses; Appendix D) Statement acknowledges this iterative aspect of 
reviewing as necessary and appropriate within its guidelines for reporting systematic 
reviews.
40
 The Preferred Reporting Items for Systematic Review and Meta-Analysis 
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Protocols (PRISMA-P; Appendix E) Statement, recently published in early 2015, provides a 
17-item checklist to “facilitate the preparation and reporting of a robust protocol for the 
systematic review,” further emphasizing the importance of transparency in the conduct and 
reporting of a systematic review.
14,41 
Prior to screening for eligibility, the study protocol was 
registered on PROSPERO, an international prospective register of systematic reviews, 
publicly accessible with a Centre for Reviews and Dissemination (CRD) Number of 
42015023509.
42 
According to the PRISMA guidelines, modifications to the original protocol 
have been noted on PROSPERO.
43
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4.0 Results 
4.1 Literature Search  
 A comprehensive literature search was performed using Ovid MEDLINE (1973-April, 
2015). The search strategy from MEDLINE [Appendix F] was translated and used to search 
The Cumulative Index of Nursing and Allied Health Literature (CINAHL), PubMed, and 
EMBASE. The Cochrane Central Register of Controlled Trials and Web of Science’s 
Citation Index were also searched; however, these databases did not require search 
translations due to their varying interfaces and limited content compared to MEDLINE. 
Searches were performed in April 2015 and were re-run for the first time in July 2015. 
Database searches identified 2142 citations: 274 citations from MEDLINE, 85 from 
CINAHL, 799 from PubMed, 394 from EMBASE, 462 from Web of Science, & 128 from 
Cochrane Central Register of Controlled Trials [Figure 1]. Forty additional citations were 
identified through searches in 15 different grey literature sites as well as one additional 
citation from hand searching relevant articles’ reference lists. 
4.2 Title and Abstract Review 
 In total, 2,183 citations were identified. Our team (LT, NL, and DB) agreed to limit 
articles to publication year 2000 instead of the original publication year of 1973, to ensure 
studies reflected contemporary health care and the current status of the NP role itself. 
Additional amendments prior to screening were to include 1) cluster randomised trials with   
> 15 clusters in each of the intervention and control groups, and 2) program studies, referring 
to RCTs that tested intervention programs either delivered by the NP(s) or a team of health 
professionals that may include a NP. Amendments to the original protocol were updated on 
PROSPERO.
42
 
 Following de-duplication, a total of 1,188 citations and abstracts were screened for 
relevance. Screening of citations and abstracts by two independent reviewers (LT and NL) 
according to Relevance Tool [Appendix A] resulted in an exclusion of 1,122 citations. Forty-
nine articles were identified that did not clearly specify the type of APN (advanced practice 
nurse) credential of the nurse delivering the intervention (NP versus Clinical Nurse 
Specialist, or CNS). To seek clarification that the intervention be none other than a NP 
intervention, study authors of ambiguous APN articles were emailed. Five study authors 
replied with a “Yes” response to clarify that the APN intervention was delivered by a NP or 
NPs. Six authors replied to clarify that the APN intervention in nine different articles was 
delivered by a combination of APNs, such as NPs and clinical nurse specialists (CNSs). Four 
authors clarified that the intervention was delivered by only CNSs or “appropriately trained” 
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practice nurses. Remaining responses involved either a “bounce back” email that was 
apparently unreceived, a “No” response from the study author, or an absence of response.  
Database updates performed by the team’s librarian (MH) in July 2015 resulted in 59 
citations, all of which were redundant with the original set of search results except for one, 
which was an ambiguous APN article. The study author of this ambiguous APN article was 
emailed for clarification, but no response was received in return.  
4.3 Full Text Review 
 A total of 55 RCTs underwent full text review using the Validity Tool [Appendix B]. 
Twenty-nine trials were assessed as high quality / low risk of bias [Appendix G; Figure 1], 22 
were assessed as moderate quality (moderate risk of bias), and four were assessed as low 
quality (high risk of bias) studies [Appendix H; Figure 1]. A study with low risk of bias (zero 
‘at risk’ or ‘no’ judgments) and two ‘unclear’ judgements was included in the review, with 
the arbitration acknowledging that a genuine unknown may not be penalized, in the context 
of otherwise sufficient information regarding trial conduct.
15
 One of the originally included 
RCTs was recognized to contain a deficiency in criteria for inclusion, in terms of its lack of 
multiple clusters in each of the intervention and control groups. Upon agreement with the 
second independent reviewer (NL), this RCT was ultimately excluded from the review, 
resulting in a total of 39 articles (29 different RCTs) that underwent analysis of results 
[Appendix G; Figure 1]. Discrepancies between the two reviewers were resolved in all cases 
except for two studies assessed by a third reviewer (DB), resulting in their exclusion. Cohen’s 
kappa for agreement between the two independent reviewers (LT and NL) was 0.78, 
reflecting excellent agreement. 
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   Figure 1 PRISMA flow diagram  
      
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2142 records identified through 
electronic database search 
 
CINAHL (n=85), Cochrane Central 
Register of Controlled Trials (n=128), 
EMBASE (n=394), MEDLINE (n=274), 
PubMed (n=799), Web of Science (n=462) 
41 records identified through grey 
literature & hand search 
The Agency for Healthcare Research and Quality 
(AHRQ), The Canadian Electronic Library, Canadian 
Nurses’ Association, The Centre for Reviews and 
Dissemination, Center Watch, ClinicalTrials.gov, Grey 
Literature Report,  Healthcare Standards Directory 
Online, International Clinical Trials Registry Platform 
(ICTRP), The National Institute for Health and Care 
Excellence (NICE), The Ontario Health Technology 
Advisory Committee (OHTAC), Open Grey, 
ProQuest’s Dissertations and Theses Databases, The 
Saskatchewan Registered Nurses’ Association, and 
Turning Research into Practice (TRIP Database)   
Hand Search: Appendix C of DiCenso et al.’s Clinical 
Nurse Specialists and Nurse Practitioners in Canada: 
A Decision Support Synthesis (2010) 
1188 records identified after duplicates removed 
1188 citations screened for relevance  
1,122 citations 
excluded  
Did not meet inclusion / 
exclusion criteria of 
Relevance Tool for title / 
abstract review 
 
55 full text RCTs assessed for eligibility  
11 associated post hoc studies  
4 low quality and 
22 moderate 
quality RCTs 
excluded 
(1 associated post hoc) 
Did not meet inclusion 
/exclusion criteria 
using Risk of Bias Tool 
39 articles (29 high quality RCTs)  
included in the systematic review 
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4.4 Studies Meeting Inclusion Criteria  
 The 29 RCTs meeting all inclusion criteria originated from different countries in 
North America, Europe, Africa, and Asia [Figure 2]. All five trials from the Netherlands were 
published by unique authors / independent research groups.  
 
Figure 2 Country of origin for 29 high quality RCTs examining NP interventions 
 
 The majority of NP interventions addressed patients with chronic disease including: 
cardiovascular disease,
44-48
 respiratory disease,
8,49,50
 types one
7
 and two
6,51
 diabetes mellitus, 
cancer,
52,53
 post-stroke depression,
54
 rheumatoid arthritis,
55
 and obesity
56
 [Figure 3]. Obesity 
was recently classified by the Canadian Medical Association as a chronic disease,
57,58 
a 
disease that significantly and directly links with many other chronic diseases.
56
 Five trials 
were targeted to patients with specific conditions that are not, or may not be chronic / 
permanent: atopic dermatitis,
59
 urinary incontinence,
60
 menopause in breast cancer 
survivors,
61
 and patients with minor injuries presenting to emergency department.
62,63
 Two 
trials evaluated NP interventions for older adults post-hospitalization,
64,65
 and several trials 
assessed the effect of NPs providing health care to patients in primary health care (PHC) 
settings: PHC clinics,
66,67
 clinics within low socioeconomic populations,
8,68
 patients’ 
homes,
60,69
 and college classrooms, where the study intervention aimed to improve 
knowledge of sexually transmitted infections (STIs) among female college students.
70
 Only 
one trial tested an intervention in the acute inpatient environment, with NPs providing care to 
internal medicine patients
71
 [Figure 3]. 
 
13 
6 
5 
2 
2 
1 
United States 13
United Kingdom 6
Netherlands 5
Canada 2
South Africa 2
South Korea 1
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Figure 3 Health challenges studied in 29 RCTS 
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High 
Quality 
RCTs 
2000-
2014 
 
 
 
 
 
 Trials that evaluated the effect of primary prevention interventions (preventing 
disease / injury before it ever occurs)
13
 were found in two of the 29 (7%) studies.
69,70
 Ten of 
the 29 trials (34%) tested a secondary prevention intervention (targeting disease / injury as 
soon as possible to halt or slow its progress).
13
 The remainder of trials (17/29; 59%) 
measured patient outcomes that evaluated the effect of tertiary prevention interventions
13
 
(managing long-term, often complex health problems and injuries such as chronic diseases, 
permanent impairments) 
6-8,44-51,53-55,66,68,71
 [Figure 4]. Eight trials were based in primary 
health care settings 
8,56,60,66-70
 and eighteen were set in outpatient / specialized referral 
clinics;
6,7,44-55,59,61,64,65
 only three 
62,63,71
 were set in acute care hospitals, with none set 
exclusively in long term care.  
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Figure 4 NP interventions in 29 studies stratified by three levels of prevention*  
 
* Primary (1
0
)  - prevention of disease/injury before it occurs e.g. immunization, education on health/safety 
3,13
  
* Secondary (2
0
)  - early diagnosis, rapid initiation of treatment to halt or slow progress of disease/injury 
3,13
 
* Tertiary (3
0
) - ongoing management of long-term, complex disease(s) / permanent injury e.g. rehabilitation for        
maximal  recovery from permanent effects of cardiovascular events / permanent injury 
3,13
  
 
Figure 5 NP interventions in 29 studies stratified by three levels of prevention*and four 
settings 
 
* Primary (10) - prevention of disease/injury before it occurs e.g. immunization, education on health/safety 3,13  
* Secondary (2
0
)  - early diagnosis, rapid initiation of treatment to halt or slow progress of disease/injury 
3,13
 
* Tertiary (3
0
) - ongoing management of long-term, complex disease(s) / permanent injury e.g. rehabilitation for 
maximal recovery from permanent effects of cardiovascular events / permanent injury 
3,13  
2 RCTs 
(7%) 
10 RCTs 
(34%) 17 RCTs 
(59%) 
Primary Secondary Tertiary
2 
0 0 0 
3 
0 
5 
2 
3 
0 
13 
1 Primary  Prevention
Secondary Prevention
Tertiary Prevention
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4.5 Objective 1. NP Intervention Activities Performed in RCTs 
Overview:  
 The majority of RCTs in this review focused on the benefits of adding NPs to 
interprofessional teams (IPTs). Twenty out of 29 RCTs (69%) were classified as IPT  
trials.
6-8,44-48,50,51,53,54,60,61,64-66,68,70
 The remaining nine RCTs were clearly designed to compare 
the effectiveness of an intervention delivered by a NP to another practitioner (i.e. role 
substitution).
49,55,56,59,62,63,67,69,71
  Both role substitution (RS) and interprofessional team (IPT) 
trials were generally evenly spread across the timespan of this review. There are four RS 
trials published prior to 2009,
49,55,62,71
 
 
two published in 2009,
56,67
 and three published after 
2009.
59,63,69
 Ten IPT trials were published prior to 2009 
61,44,66,45,46,8,60,47,64,70
 three were 
published in 2009;
6,7,54
 and seven were published after 2009. 
51,,65,48,53,50,68
 In RS trials, NP 
interventions were compared to standard care delivered by hospital-based professionals: 
extended scope physiotherapists, emergency room doctors, and medical house-staff; 
62,63,71
 
general practice physicians (GPs);
56,67
 and various specialists including  rheumatology clinic 
physicians,
55
 a respirologist,
49
 a dermatologist,
72
and pediatricians.
69
 Interestingly, all nine RS 
trials were evenly distributed across practice settings: three RS trials each in primary health 
care,
56,67,69
 outpatient / specialized referral clinics,
49,55,59
 and acute care
62,63,71
 [Figure 6].  
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Figure 6 NP interventions in 29 studies stratified by mode of implementation* and setting 
 
*Role Substitution (RS) - the NP acts as a replacement for another health care provider, and is delegated the 
responsibilities of diagnosing, prescribing, and overseeing patient care; relates to the origin of the NP role in 
Canada in 1973 to create alternative health care services where / when physician shortages were being 
experienced
5
 
*Interprofessional Team (IPT) - the NP practices with at least one other health care provider to deliver 
patient/client care; IPT Study - mutually exclusive to a role substitution study 
  
 IPT trials were conducted in only primary health care 
8,60,66,68,70
 or outpatient / 
specialized referral clinics.
6,7,44-48,50-54,61,64,65
 IPT interventions involved teamwork with 
professionals including: GPs and cardiac surgeons;
46,48
 cardiologists;
44
 general internists and 
cardiologists;
45
 treating vascular specialists (vascular surgeon or neurologist);
47
 
pulmonologists;
50
 other NPs;
8
 pain clinic physician and other nursing specialists;
53
 a Diabetes 
Care Center team for types one and two diabetes patients (physicians, NPs, on-site 
pharmacists, nurse educators, nutritionists, and mental health professionals);
6,7
 a Diabetes 
Improvement Team for type two diabetes patients (physician, NP, registered dietician, and a 
diabetes nurse);
51
 study psychiatrist;
54
 psychiatric NP;
52
 family and staff in various older 
adult facilities: primary physicians and hip surgeons;
64
 medical and community services from 
the Health Maintenance Organization;
65
 study physicians;
61
 study conductors (educators);
70
 
continence NPs and continence advisory services (primary and hospital-based care);
60
 and 
NPs trained in motivational interviewing for addiction, supported by community resources.
68
 
One RCT utilized the same single NP for delivery of care to both the intervention and control 
groups.
66
 None of the RCTs tested their hypotheses exclusively within a long term care 
setting. 
3 
0 
3 3 
5 
0 
15 
0 
0
2
4
6
8
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 4.5.1 Five Domains of NP Intervention Activities 
 Activities delivered by NPs in each intervention were categorized into five domains: 
‘diagnosis,’ ‘prescribing pharmaceuticals,’ ‘clinical procedures,’ ‘strategies for behaviour 
change / education’ and ‘care coordination.’ All five domains of activity were observed in 
one outpatient intervention delivered to cardiac surgery patients post-discharge.
48
 Conversely, 
only one domain of activity was observed in two primary health care interventions: an 
educational lecture delivered to college students,
70
 and a session of motivational interviewing 
provided to low socioeconomic patients at high risk for alcohol / drug use, to facilitate 
strategies for behaviour change.
68
 All three acute care trials
62,63,71
 contained all domains of 
intervention activity except for the off-site activity of care coordination [Figure 7]. Various 
combinations of domains were noted in the remaining 23 interventions. Activities most 
commonly performed by NP interventions were in the domain of ‘education,’ observed in all 
29 RCTs. Strategies for behaviour change (which always included an educational component) 
were found in 13 RCTs. Diagnostic activities were performed in 27 RCTs, ‘prescribing’ in 20 
RCTs, ‘care coordination’ in 11 RCTs, and ‘clinical procedures’ in five RCTs [Table 1]. 
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Figure 7 Domains of activity in 29 NP interventions within different health care settings 
 
* Randomised Controlled Trials (RCTs)     
 
 4.5.2 NP Interventions in Three Health Care Settings   
 As expected, the type of care delivered by NP interventions varied across settings. NP 
interventions in primary health care contrasted with those in acute emergency department / 
inpatient hospital settings, where the urgent immediacy of care in the latter setting was 
essentially opposite to that noted in primary healthcare.  Although this observation is inherent 
to the settings themselves and not unique to NP interventions, what is notable in this review 
is the fact that all NP interventions performed in the outpatient / specialized referral setting 
were related to risk management of either chronic disease or older adults post-discharge to 
hospitalization, with the exception of two studies focussed on pediatric eczema
59
 and abruptly 
recurred menopause in breast cancer survivors
61
 [Table 1]. 
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Table 1 Type of care delivered by NP interventions in 29 RCTs according to domains, 
settings and study populations (disease state / wellness
9
) 
 Primary Health Care,
3
 
including First-Contact Care
4
 
Clinic/Private Home/Classroom 
Health Care  
Outpatient / Specialized 
Referral Care
3
 
Risk Management 
Emergency 
Department / Acute 
Inpatient Care
3
 
Urgent Health Care 
5 Domains  Coronary artery bypass graft 
surgery (Sawatsky
48
 IPT^^:  
D,P,CP,E,CC) 3
0
 
 
4 Domains Obesity (ter Bogt
56
 RS^: 
D,P,SBC,CC) 2
0 
 
Coronary heart disease (Allen
44
     
IPT^^: D,P,SBC,CC) 3
0
 
 
Type 2 diabetes (Ralston
6
      
IPT^^: D,P,SBC,CC) 3
0  
(Huizinga
51
IPT^^: 
D,P,SBC,CC) 3
0
 
Abdominal cancer (McCorkle
52
 
IPT^^: D,P,SBC,CC) 2
0
 
Advanced cancer (Kim
53
 IPT^^: 
D,P,SBC,CC) 3
0
 
Rheumatoid arthritis (Hill
55
 
RS^: D,P,CP,SBC) 3
0 
Older adults discharged from 
hospital (Enguidanos
65
 IPT^^:  
D,P,E,CC) 2
0
 
Minor injury 
Emergency 
Department (Cooper
62
 
RS^: D,P,CP,E) 2
0
 
 
 
Soft tissue injury 
Emergency 
Department 
(McClellan
63
 RS^:  
D,P,CP,E) 2
0
 
 
 
Internal medicine 
inpatients (Pioro
71
 
RS^: D,P,CP,E) 3
0
 
3 Domains 
 
 Maternal  /   infant health  
(Hannan
69
 RS^: D,E,CC) 1
0 
 
‘Common complaints’ (Dierick-
van Daele
67
 RS^: D,P,E) 2
0 
 
Respiratory disease 
(Fairall
8
IPT^^:  D,P,SBC) 3
0
 
 
Chronic musculoskeletal pain 
(Jones
66
 IPT^^: D,P,E) 3
0
 
 
Incontinence  
(Williams
60
IPT^^: D,P,E ) 2
0
 
Chronic heart failure (Ansari
45
 
IPT^^:  D,P,E) 3
0
 
Cardiovascular surgery 
(Tranmer
46
 IPT^^: D,E,CC) 3
0
 
COPD
+ 
(Berkhof
50
IPT^^:  
D,P,E) 3
0
 
Acute asthma  
(Nathan
49
 RS^: D,P,E) 3
0 
Hip fracture surgery 
(Krichbaum
64
 IPT^^:  
D,P,SBC) 2
0
 
Type 1 diabetes (McCarrier
7
 
IPT^^: D,E,CC) 3
0 
Atopic dermatitis (Schuttelaar
59
 
RS^: D,P,SBC) 2
0
 
Abruptly recurred menopause in 
breast cancer survivors (Ganz
61
 
IPT^^: D,P,SBC) 2
0  
 
2 Domains  
 
Cardiovascular disease  
(Goessens
47
 IPT^^: D,E) 3
0
 
Post-stroke depression 
(Mitchell
54
 IPT^^: D,SBC) 3
0 
 
1 Domains College education on sexually 
transmitted infection (Johnson-
Mallard
70
 IPT^^: E) 1
0
 
Addictions counselling 
(Mertens
68
 IPT^^: SBC) 3
0 
  
1
0
 Primary - prevention of disease/injury before it occurs e.g. immunization, education on health/safety 
3,13
  
2
0
 Secondary  - early diagnosis, rapid initiation of treatment to halt or slow progress of disease/injury 
3,13
 
3
0
 Tertiary - ongoing management of long-term, complex disease(s)/permanent injury
3,13  
^Role Substitution (RS) ^^Interprofessional Team (IPT)  
Domains: Diagnosis (D), Prescribing (P), Clinical Procedures (CP), Strategies for Behaviour Change (SBC), 
Education (E), Care Coordination (CC) 
+
Chronic Obstructive Pulmonary Disease (COPD)  
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 4.5.3 Diagnosis    
 The vast majority of RCTs (27/29; 93%) involved some type of diagnostic activity 
within their intervention, including all of the role substitution (RS) trials (n = 9) and 90% 
(18/20) of the interprofessional team (IPT) trials. The most common diagnostic activities 
identified, related to diagnosis of disease status (i.e. ongoing assessment), observed in 59% 
(17/29) RCTs.
6,7,44-47,49-51,53-56,59,61,66,69
 In approximately one third of the trials, (9/29 or 31%), 
the NP performed a limited diagnosis 
8,48,52,60,62-65,67
 while open diagnosis was observed in 
only one trial.
71
  
 The only intervention involving open diagnoses was based in a hospital setting where   
NPs were compared to medical house-staff in an internal medicine ward of a teaching 
hospital.
71
 The NPs (2.5 full-time equivalent NPs) appeared to lead the clinical care of all 
patients in a specific ‘NP ward,’ with a medical director present at daily rounds and available 
for consultation. Patients in the ‘house-staff ward’ were managed by residents and interns that 
rotated every month, and were supervised by an attending doctor. In both the NP and house-
staff wards, “ultimate responsibility for patient care rested with patients’ attending doctors.” 
However, NPs made clinical decisions with respect to patient management that previously 
had been performed by hospital physicians only. Thus, the intervention required NPs to 
independently diagnose and treat all patients assigned to their respective hospital ward.
71
    
 Interventions involving “limited diagnoses” were observed in nine RCTs. Although 
NP interventions focused on different types of patients across these studies, the nature of 
diagnostic activities were very similar in most cases, whether an IPT
8,48,52,60,64,65
 or RS study 
design was used.
62,63,67
 In general, patients presenting with certain conditions / symptoms 
were referred to NPs for ongoing management, including diagnoses of associated conditions. 
For example, in the RS study by Dierick-van Daele and colleagues, NPs were responsible for 
patients presenting with complaints common to a primary healthcare clinic, and performed 
relevant diagnoses pertaining to the initial complaint.
67
 The specified set of common 
complaints compiled for this study included “respiratory and throat problems, ear and nose 
problems, musculoskeletal problems and injuries, skin injuries, urinary problems, 
gynaecological problems and geriatric problems.”67 In two other RS studies, emergency 
department patients with minor injuries that fell within the studies’ protocols were assessed 
by NPs for specific diagnoses and subsequent management of the presenting problem.
62,63
  
 This approach to utilizing NPs for limited diagnostic activities was also applied within 
an IPT design to populations of low-income patients with respiratory illness,
8
 to women with 
complications following abdominal surgery for suspected ovarian cancer,
52
 and to outpatients 
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following coronary artery bypass graft (CABG) surgery.
48
 For example, NPs assessed 
patients presenting with ‘cough or difficult breathing’ and subsequently diagnosed patients 
within a limited set of diseases: tuberculosis (TB), upper and lower tract respiratory 
infections, asthma, chronic obstructive pulmonary disease (COPD), and TB / HIV co-
infection.
8
 For women with suspected ovarian cancer, the NP monitored for post-surgical 
thromboembolism, infections and chemotherapy induced side- effects, with additional 
support available from a psychiatric NP team member who assessed women in significant 
emotional distress.
52
  Post-discharge care of coronary artery bypass graft (CABG) surgery 
patients was provided by NPs who performed follow-up needs assessments by telephone, 
with additional care provided at an outpatient clinic if deemed necessary.
48
 Specific 
diagnostic algorithms were not used in this process; rather individualized assessments by the 
NP determined the course of management required. Complex issues such as heart failure, 
wound infections, and pleural effusions were seen at the NP follow-up clinic and required 
longer NP follow-up care.
48
  
Two IPT NP interventions focused on follow-up of older adults being discharged 
from hospital.
64,65
 In the first RCT, the NP assessed medical needs of patients without 
existing support, using a checklist of “transition intervention activities,” including 
psychosocial assessments.
65
  The second RCT tested the effect of a mobile service model, to 
guide the NP in facilitating improved overall health, function, and return-home outcomes in 
older adults following hip fracture surgery.
64
 Patients were followed by the NP for 
assessments of physical and psychosocial needs related to recovery from hip fracture surgery. 
This mobile service allowed the gerontologic NP to liaise between the patient, family and 
other health care providers.
64
 Another mobile service was observed in an IPT trial that tested 
the impact of primary health care provided by continence NPs to patients in their own homes, 
with NPs diagnosing urinary tract infections or candida.
60
 Of the nine RCT interventions 
employing limited diagnoses, the parameters of these activities were notably similar in both 
IPT and RS designs, by nature of the limited framework within which diagnosis took place. 
 The most common type of diagnostic activity identified in this systematic review was 
diagnosis of disease status, accounting for 63% of all NP interventions containing a 
diagnostic activity (17/27).
44-47,49,55,56,61,66,69, 6,7,50,51,53,54,59
  Of these, the majority of 
interventions focused on the management of chronic diseases such as medication titration in 
patients with diabetes mellitus,
6,7,51
 management of hypercholesterolemia in coronary heart 
disease,
44
 use of beta-blocker medication in chronic heart failure,
45
 and management of 
chronic pain in patients with advanced cancer.
53
 Other chronic diseases managed by NPs 
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included chronic obstructive pulmonary disease (COPD),
50
 rheumatoid arthritis,
55
 asthma,
49
 
and obesity.
56
 An example of NPs performing ‘diagnosis of disease status’ in the context of 
chronic disease management is found in the IPT trial by Goessens and colleagues.
47
 NPs 
tracked status of cardiovascular risk factors such as blood pressure and cholesterol in 
outpatients with various vascular diseases and directed management based on these ongoing 
assessments.
47
 In a RS trial by Nathan and colleagues, NPs followed-up with patients recently 
discharged from the hospital to monitor status of acute asthma exacerbations, peak flow 
measurements and other asthma symptoms, titrating medications (inhaled / oral 
corticosteroids) and readmitting acute asthma patients to hospital as required.
49
  Diagnosis of 
disease status was observed in another outpatient trial that focused on pediatric patients with 
mild, moderate and severe atopic dermatitis (eczema). The NP performed an exam of the skin 
and diagnosed particular allergies related to food, inhalants, or serum-specific 
immunoglobulin E allergens.
59
  
 4.5.4 Prescribing Pharmaceuticals 
 Prescribing pharmaceuticals, or ‘writing orders for drugs or treatments,3 occurred in 
20/29 (69%) of the RCTs. Open prescribing occurred in only one trial, the same trial that 
involved open diagnosis, where the NP managed all patients in an internal medicine ward of a 
teaching hospital.
71
 Changes in the availability of medical residents in 1989 led this hospital 
to create a ward staffed by NPs, at which time the NP role expanded from care of patients 
with chronic well-circumscribed illnesses (e.g. patients requiring prolonged courses of 
intravenous antibiotics) to care of general medical patients with acute medical conditions.
71
   
 Nineteen trials included limited prescribing as part of the NP intervention. Limited 
prescribing varied across a wide spectrum of discretion, including prescribing for multiple 
conditions /  risk factors,
8,48,52,56,60,62,63,67
 prescribing for a single condition/risk factor,
6,44,45,49-
51,53,55,59,61,66
 and prescribing within one particular drug class (non-steroidal anti-inflammatory 
drugs or NSAIDs).
66
  In some RCTs, investigators indicated that the scope of prescribing 
activities might have been greater if not for restrictive legislation in Europe
47,67
 and the U.S.
64
 
The majority of limited prescribing activities occurred in the context of tertiary prevention / 
chronic disease management (11/19 RCTs or 58%),
6,8,44,45,48-51,53,55,66
 with the remainder of 
prescribing activity occurring in secondary prevention RCTs.
52,56,59-63,67
 For example, NPs 
were responsible for titration of lipid-lowering medications in coronary heart disease 
patients,
44
 beta-blockers in patients with chronic heart failure,
45
 anti-hyperglycemic 
medications in patients with type two diabetes mellitus,
6,51
 and respiratory medications for 
patients with acute asthma.
49
 In terms of secondary prevention, dermatologic therapies were 
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prescribed by NPs for children with atopic dermatitis (eczema),
59
 as were medications / 
supplies for patients with incontinence.
60
  In a trial originating from a women’s health clinic 
for breast cancer survivors, NP prescribing was limited to the occurrence of distressing 
menopausal symptoms on discontinuation of estrogen replacement therapy.
61
 The most 
limited prescribing intervention was observed in a trial by Jones and colleagues, where the 
NP was solely focused on the reduction or discontinuation of over-the-counter non-steroidal 
anti-inflammatory drug (NSAID) use in patients with non-malignant, non-inflammatory 
musculoskeletal pain, particularly in the elderly with osteoarthritis.
66
 
 However, other interventions involved limited prescribing in a less restricted setting.  
For example, in the cluster RCT by Fairall and colleagues,
8
 the NP managed patients with a 
variety of respiratory conditions such as asthma, chronic obstructive pulmonary disease 
(COPD), tuberculosis (TB), lower / upper respiratory tract infections, and TB-HIV co-
infection. These NPs were granted authority to prescribe inhaled corticosteroids for asthma, 
short course oral corticosteroids for exacerbations of obstructive lung disease, and 
cotrimoxazole prophylaxis for symptomatic HIV infection.
8
  Prescribing of pain medication 
was performed in two trials involving cancer patients,
52,53
and in one trial of coronary artery 
bypass graft (CABG) outpatients, for whom alternate analgesics were prescribed as 
necessary.
48
 Self-adjustment of pain medication was taught to patients with advanced cancer, 
with an appropriate dosage recommended by a NP to each patient according to an algorithm 
for pain control.
53
 Collaborative prescribing plans were developed by NPs managing patients 
on their return home following abdominal surgery that may have entailed oophorectomy / 
hysterectomy. A psychiatric NP developed a collaborative prescribing plan with an oncology 
NP who monitored post-operative stabilization of patients and monitored chemotherapy side-
effects.
52
 
Limited prescribing was also performed in RCTs targeting patients with acute 
conditions. For example, NPs in emergency room settings managed patients with a variety of 
minor injuries.
62,63
 Although specific prescribing activities were not described in one of these 
two study methods, it was assumed limited prescribing occurred since the NP intervention 
was compared to emergency department doctors through a RS design.
62
  In the other RCT 
evaluating NPs in an emergency room setting, limited NP prescribing was clearly evident, 
and compared to that of extended scope physiotherapists and emergency room doctors, with 
NPs prescribing to 23.2% of their patients, ESPs to 3.6% of their patients, and doctors to 
42.2% of their patients.
63
 Finally, NPs performed medication reviews in two trials of older 
adult patients discharged from overnight stays in hospital.
65,64
 Medication assessment was 
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performed by the NP for the purposes of medication reconciliation, where any discrepancy in 
medication regimens between admission and discharge of care facilities was identified and 
resolved, discontinuing and writing new prescriptions when necessary.
73
 
 4.5.5 Clinical Procedures   
  Of the 29 RCTs identified in this review, five (17%) included clinical procedures as 
part of the intervention.
48,55,62,63,71
 Three of these interventions were situated in a hospital 
setting
62,63,71
 where NPs performed procedures on patients presenting to emergency 
departments 
62,63
 or to patients receiving care in an internal medicine ward.
71
 In each of these 
three trials, the actual clinical procedures were not explicitly described in the study methods. 
However, the reviewers assumed clinical procedures were performed based on the nature of 
the intervention described.  For example, in two of these trials, NPs provided care to patients 
presenting with minor injuries in the emergency department.
62,63
 NPs were responsible for the 
diagnosis and treatment of minor injuries such as sprains, burns, contusions, fractures, and 
minor head injuries. Thus, the performance of clinical procedures such as wound dressings, 
closed reduction of fractured bone, and application of splints and stitches were highly 
probable given the nature of the NP’s role in these studies.62,63 Similarly, in a study by Pioro 
and colleagues, NPs were responsible for the care of all patients admitted to an internal 
medicine ward with issues related to gastrointestinal, pulmonary, infectious, metabolic, 
neurological, cardiovascular and “other” conditions including substance abuse.71 Again, 
clinical procedures were not explicitly documented. However, the reviewers assumed these 
activities were performed by the NP given the broad scope of this intervention.
71
 
 The final two interventions involved clinical procedures in outpatient settings, 
examining the effectiveness of NP-led care for rheumatoid arthritis patients,
55
 and the 
effectiveness of NP follow-up care for newly discharged coronary artery bypass graft 
(CABG) patients.
48
  In the former trial, NPs were responsible for virtually all aspects of 
patient care in an outpatient setting (i.e. assessment, disease management, recommendations 
to rheumatologists / GPs regarding therapy, referrals, and counseling), including the 
administration of intra-articular or intra-muscular steroids when clinically indicated.
55
 In the 
latter trial, approximately 25% of the intervention group participants were seen in a NP 
follow-up clinic for complex cardiac surgery-related issues, such as heart failure, wound 
infections, and pleural effusions, potentially requiring thoracentesis for drainage and / or 
chest tube placement for continuous drainage.
48
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 4.5.6 Strategies for Behaviour Change / Education  
 All of the NP interventions identified in this review included some type of educational 
or behaviour change activity. Strategies for behaviour change always included an educational 
component and were part of the NP intervention in 13/29 (45%) original RCTs.
6,8,44,51-
56,59,61,64,68
 A good example of a behaviour change intervention was observed in the study by 
Mertens and colleagues.
68
 Primary care NPs were given a three-day training session in Brief 
Motivational Interviewing, based on Rollnick’s Health Behavior Change: A Guide for 
Practitioners.
74
 To maintain fidelity to the Brief Motivational Interviewing model, NP 
training was followed by regular supervision meetings (weekly for six weeks and monthly 
thereafter), during which time NPs listened to recordings of their interventions with their 
trainer. This trial tested the effectiveness of a brief motivational interviewing intervention 
(average duration 10 minutes) on reduction of high-risk alcohol and drug use in young adult 
primary care patients from a low-income population and country.
68
 Other RCTs described 
behaviour change interventions ranging from specific lifestyle modifications 
6,8,44,51,56
 to 
management of fatigue,
55
 pain,
53
 menopausal symptoms in breast cancer survivors,
61
  post-
stroke depression,
54
 coping with childhood illness
59
 and post-operative recovery
52,64
  
[Table 2].   
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Table 2 Behaviour change strategies conducted by NP interventions in 13 RCTs 
Lifestyle modifications 
Allen
44 
NP case management by ‘tailored lifestyle &  medication intervention + enhanced usual care,’ with counseling for lifestyle 
modifications in diet, physical activity, & smoking cessation; 1 year intervention post-discharge, in  outpatients who received 
coronary artery bypass grafting (CABG) surgery or percutaneous coronary intervention  
 
Sol
75
 (post hoc to Goessens
47
) 
‘NP at risk factor management clinic  + usual care’ for cardiovascular disease outpatients; 12 month intervention where patients’ 
motivation for achieving behavioural change was assessed; goals were set toward behavioural change in context of self-efficacy 
promotion 
 
Fairall
8 
‘Practical Approach to Lung Health in South Africa (PALSA) Intervention,’ an educational outreach program implemented by NPs 
including counseling for smoking cessation,  for patients with cough or difficult breathing on presentation / within last six months; 3 
month study period at 20 primary health care clinics  
 
Ralston
6 
‘NP coordination of Web-based care + usual care,’ for reduction of blood glucose in Type 2 Diabetes Mellitus patients, with 
counseling  to guide health behaviour change according to Wagner’s Chronic Care Model; 12 month intervention  
 
ter Bogt
56
 
Low-intensity (to prevent additional weight gain) lifestyle counseling by NPs: 4 individual visits and 1 feedback session by 
telephone over 1 year patients with BMI 25- 40, and either hypertension, dyslipidemia or both 
 
Huizinga
51 
‘Usual care + NP phone contact (quarterly and monthly)’ over 2 years for prevention of glycemic relapse (defined as an increase in 
HbA1c of > or = to 1% over baseline) in Type 2 Diabetes Mellitus patients. Intervention included identification of problems arising 
in self-care behaviours, anticipatory planning  and motivational interviewing for achievement of  mutually established goals 
 
Psychosocial Management of Pain and Fatigue 
Kim
53 
‘Usual care + daily phone monitoring (tele-monitoring)’ by NP for advanced cancer outpatients diagnosed with stage IV  solid 
tumor, moderate level of cancer-related pain (Visual Analog Scale score ≥4 out of 10 over last 24 h), and life expectancy >1 month; 
psychosocial pain management intervention for 1 week 
 
Hill
55 
‘Rheumatology NP (RNP) care’ including psychosocial management of fatigue in rheumatology outpatients; study period 12 months 
 
Psychosocial Management of Abruptly Recurred Symptoms 
Ganz
61
 
‘Comprehensive menopausal assessment’ targeting highly symptomatic women with the goal of reducing symptoms & improving 
quality of life, through education, counseling (including behavioral interventions, psychosocial support), & focused ‘non- estrogen 
replacement therapy’ interventions; delivered by NP to breast cancer survivors for 4 months  
 
Reduction in High-Risk Addiction Behaviour 
Mertens
68 
‘Single session of Brief Motivational Interviewing (average session 10 minutes) delivered by NP + referral list of support resources,’ 
in patients 18–24 years screened for high-risk alcohol and / or drug use; study period 3 months 
Post-Stroke Depression 
Mitchell
54
 
‘Brief psycho-social/behavioural intervention (9 in-person sessions with NP over 8 weeks) + usual care,’ alongside antidepressant 
medication in outpatients within 4 months of an ischemic stroke; 8 week intervention within a 24 month study period 
 
Coaching Support for Parents of Children with Eczema 
 Schuttelaar
59
 
NP-led care in  outpatients < 16 years, referred by  GPs or pediatricians with a diagnosis of eczema; 1 year study with intervention 
including application of social cognitive theory (Bandura)  that identifies factors influencing  self-management: self-efficacy, 
behavioural capability (knowledge and skills) & outcome expectations. The NP intervention reinforced belief in the parents’ own 
abilities with regards to controlling their child’s eczema, by teaching and counselling parents 
 
Post-Operative Counseling Support 
Krichbaum
64
 
‘Usual care + post-acute care coordination’ by gerontologic NP for hip fracture surgery outpatients; 6 month  intervention, including 
counseling older adult clients in a 12 month study period 
 
McCorkle
52 
18 contacts by an oncology NP during the first 6 months after hospital discharge, to assist surgical outpatients with suspected 
primary diagnosis of ovarian cancer in developing & maintaining self-management skills of physical & psychosocial health, through 
counseling  of patient and family caregiver; supplemented by  psychiatric NP consults if warranted; 6 month study duration 
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Figure 8 Frequency of strategies for behaviour change in NP interventions from 13 RCTs 
 
 A multifaceted intervention involving educational and lifestyle / behaviour change 
activities was observed in a web-based intervention for patients with type two diabetes.
6
 The 
NP facilitated behaviour change, providing strategies according to Wagner’s Chronic Care 
Model,
76
 comprised of four essential health system elements for high-quality chronic disease 
care: self-management, decision support, delivery system design, and clinical information 
systems. Following an initial one-hour consultation consisting of problem identification, goal 
setting, and skill development, ongoing patient education occurred through an interactive 
web-based tool focused on nutrition, medications, and exercise. Patients electronically 
submitted blood glucose readings and communicated regularly with the NP through secure e-
mail.
6
 
 Traditional educational activities alone, without a behaviour change component, were 
provided by the NP in 16/29 (55%) RCTs,
7,45-50,60,62,63,65-67,69-71
 either: over the phone,
46,48,65,69
 
face-to-face (i.e. in a hospital,
62,63,71
 an office,
45,47,49,50,66,67
 classroom,
70
 or the patient’s 
home
60,65,66
), or via written material (leaflets 
45,60,66,69,70
 or an electronic platform 
6,7
). 
Education was delivered to individuals, families
69
 or groups.
70
 In one trial, education served 
as the sole activity of the NP intervention. In this case, the NP intervention was an 
educational lecture about sexually transmitted infections (STIs) to a group of female college 
students of child-bearing age, to potentially reduce knowledge gaps related to STI morbidity 
associated with reproductive health: chronic pelvic pain, pelvic inflammatory disease, 
infertility, ectopic pregnancy, compromised birth outcomes, and cervical cancer.
70
 A trial 
Lifestyle Diet, Physical Activity
Smoking Cessation
 Addiction Reduction
Depression Post-Stroke
Pain Management
Fatigue Management
Menopause Counseling
Parental Coaching
Post-Operative  Counseling
0 1 2 3 4 5
Number RCTs  
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testing an intervention on maternal / infant health in mothers and infants with good health at 
baseline, involved NPs phoning post-partum mothers on six occasions to provide education 
and screen for health concerns.
69
   
In most RCTs, NP education was one component of a multifaceted intervention.  
Trials varied with respect to the amount of detail provided about educational activities; 
however, patient knowledge, attitudes, and / or beliefs were clearly prioritized in virtually all 
trials. For example, in a RCT evaluating specialized outpatient services for older adults, 
education was provided to reinforce discharge teaching (self-management of target symptoms 
and side-effects).
65
 Less detail was provided in the emergency department trials, although 
teaching on discharge was assumed to have taken place as an essential standard of care.
62,63
  
More detail is found in an intervention focusing on patients with incontinence problems, 
where NP’s provided education on non-pharmacologic management including healthy eating 
/ fluid intake, bladder training, and pelvic floor awareness in addition to physical 
examinations, diagnostic assessment, and prescribing.
60
 Education activities within 
multifaceted interventions often included teaching self-management skills.                               
 Self-management teaching was most commonly observed in interventions for chronic 
disease management.
7,46,47,49,50,66
 For example, patients were engaged in creating plans of 
self-care to manage chronic musculoskeletal pain,
66
 to self-monitor and respond to symptoms 
of chronic obstructive pulmonary disease,
50
  and to alter lifestyle for management of 
cardiovascular risk factors
47
 as well as type one diabetes mellitus.
7
 Similar to the web-based 
study of type two diabetes patients, education from an NP was delivered to patients with type 
one diabetes via a web-based platform that included a daily “diabetes diary,” an “action 
planner”, and a portal providing patients with an array of diabetes related information, for 
ongoing updates to their learning and self-management.
7
 Whether primary,
70
 secondary,
60,65
 
or tertiary prevention,
7,46,47,49,50,66
 self-management teaching was most prevalent in NP 
interventions that facilitated patients’ long term management of tertiary level, irreversible 
chronic disease.  
 4.5.7 Care Coordination 
 Care coordination involved activities that could not be completely classified within 
the traditional categories of diagnosis, prescribing, clinical procedures, or strategies for 
behaviour change / education. As already noted in the previous four domains, the 11 
interventions classified in this domain
6,7,44,46,48,51-53,56,65,69
 do include varying degrees of 
activity in the traditional categories, but in many cases, these were largely achieved offsite, 
and lacked in-person contact between NPs and patients. Care coordination activities were 
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delivered from a remote site via telephone or email and often, required NPs to refer patients 
to appropriate services based on a limited assessment. NPs coordinated with patients via the 
phone in nine RCTs.
44,46,48,51-53,56,65,69
 In four of these nine trials, NPs implemented their 
intervention completely via phone.
46,51,53,69
 Two trials implemented their NP intervention 
primarily via email.
6,7
 
 An example of a care coordination activity completed exclusively via phone was 
conducted in a population of outpatients recently discharged after cardiac surgery.
46
 NP 
phone sessions provided ongoing information and assessment, assisted with self-management 
of common symptoms, and facilitated referrals to appropriate health care resources for 
resolution of some of the presenting problems.
46
 Patient care algorithms related to chest pain, 
gastrointestinal disturbances, infection, leg swelling, shortness of breath, and sleep pattern 
disturbances were developed and approved by an interdisciplinary joint practice committee, 
and were used as guidelines for the provision of care.
46
 Similarly, a NP intervention for 
postpartum mothers and newborns was delivered completely by telephone.  NPs collected 
information and referred patients as appropriate to their primary care physician or even 911 
emergency services based on the verbal interview.
69
 For patients with type two diabetes 
mellitus, NPs implemented their intervention completely via phone, although intervention 
protocols and guidelines occasionally entailed coordinating with the study dietician.
51
 In a 
study of advanced cancer patients, following an in-person 30 minute standardized education 
session in a pain clinic, pain management for these patients was subsequently coordinated 
exclusively by the NP via phone.
53
  
 Care coordination of patients discharged after a coronary artery bypass graft (CABG) 
surgery, entailed initial screening by the NP via telephone, who then directed patients to 
either follow-up with their primary care provider, the cardiac surgeon, the emergency 
department; or to receive further monitoring by the NP, which was provided by a subsequent 
telephone call or an in-person appointment at the NP follow-up clinic.
48
  A combination of 
phone, home visits, and clinic appointments was also utilized for a NP intervention delivered 
in the post-operative period to women with suspected ovarian cancer.
52
 Phone contact was an 
adjunct to in-person care in a study that measured the effectiveness of NP care in 
hyperlipidemia management for coronary heart disease patients. The phone activity allowed 
the NP to coordinate with the patient for the purposes of adjusting appropriate lipid-lowering 
medications on the basis of the results of follow-up blood tests, and for reinforcement of 
lifestyle counseling.
44
 Most of the interventions employing care-coordination activities were 
focused on assisting patients in developing and maintaining self-management skills, to 
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facilitate patients’ active participation in treatment decisions, and to monitor and manage 
patients’ physical and psychological health.52,65    
 Email was used as the primary mode of communication for two NP interventions 
focusing on patients with diabetes mellitus.
7,6
 In both RCTs, an initial in-person, one-hour 
consultation conducted by the NP was followed by subsequent implementation of web-based 
modules designed to improve diabetes self-care. The NP provided feedback in both studies to 
patients’ uploaded information (both patient and provider were able to view the trended 
displays of blood glucose readings, and data entries for medication, nutrition, and exercise) 
and to patients’ correspondence via email.6,7  Information on the types of NP intervention 
activities undertaken in randomised trials, from the most to least commonly undertaken, was 
organized by practice setting and mode of NP implementation, with an assessment of the 
consistency of activities according to both setting and mode [Table 3].  
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Table 3 Distribution of NP intervention activities by setting and mode 
 
NP 
Intervention 
Activities 
Diagnosis 
 
Prescribing 
 
 
Clinical 
Procedures 
Education / Strategies 
for Behaviour Change 
Care 
Coordina- 
tion 
TOTAL 29 
RCTs*  
27 RCTs* 20 RCTs* 5 RCTs* Education   
Only / 
 
 
16 RCTs* 
 
Behavior 
Change 
Strategies, 
including 
education  
13 RCTs* 
 
11 RCTs* 
PHC** 
8 RCTs* 
75% 
6/8 RCTs 
63% 
5/8 RCTs 
0% 
0/8 RCTs 
62.5% 
 
5/8 RCTs 
37.5% 
 
3/8 RCTs 
25% 
2/8 RCTs 
LONG TERM 
CARE 
 
0 RCTs* 
0% 
 
0/0 RCTs 
0% 
 
0/0 RCTs 
0% 
 
0/0 RCTs 
0% 
 
0/0 RCTs 
0% 
 
0/0 RCTs 
OUTPATIENT/ 
Specialized 
Referral 
18 RCTs* 
 
100% 
18/18 
RCTs 
67% 
12/18 RCTs 
11% 
2/18 RCTs 
44% 
8/18 RCTs 
56% 
10/18 
RCTs 
50% 
9/18 RCTs 
ACUTE 
INPATIENT 
3 RCTs* 
100% 
3/3 RCTs 
100% 
3/3 RCTs 
100% 
3/3 RCTs 
100% 
3/3 RCTs 
0% 
0/3 RCTs 
0% 
0/3 RCTs 
NP 
Intervention 
Activities 
Diagnosis 
 
Prescribing 
 
 
 
Clinical 
Procedures 
 
Education / Strategies 
for Behaviour Change 
Care 
Coordina- 
tion 
RS^ Mode 
9 RCTs* 
9/9: 3 
Acute, 3 
Outpatient,  
3 PHC** 
8/9: 3 Acute, 3 
Outpatient, 2 
PHC** 
4/9: 3 Acute, 1 
Outpatient  
6/9: 3 
Acute, 1 
Outpatient, 
2 PHC** 
3/9: 2 
Outpatient, 
1 PHC** 
2/9: 2 
PHC** 
IPT^^ Mode 
20 RCTs* 
18/20: 15 
Outpatient, 
3 PHC** 
 
12/20: 9 
Outpatient,  
3 PHC** 
1/20: 1 
Outpatient 
10/20: 7 
Outpatient, 
3 PHC** 
10/20: 8 
Outpatient, 
2 PHC** 
9/20: 9 
Outpatient 
  * Randomised Controlled Trials (RCTs)   ** Primary Health Care (PHC)  
  ^Role Substitution (RS)   ^^Interprofessional Team (IPT) 
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4.6 Objectives 2 and 3. Quantitative Endpoints and Impact on Patient Outcomes 
Overview: 
 The impact of 29 NP interventions was assessed through various study endpoints 
relating to a) clinical outcomes (life-threatening events and death); b) surrogate measures of 
disease (physiologic markers, ‘symptom severity, functional status, behaviour / lifestyle 
change,’ and drug utilization); c) resource utilization / cost; d) overall quality of life / patient 
satisfaction; and e) ‘other.’ The three most common types of endpoints were: surrogate 
measures of disease (24/29 trials; 83%); global quality of life / patient satisfaction (15/29 
trials; 52%); and resource utilization / cost (14/29 trials; 48%).  
 Patient outcomes were analysed to determine the impact of NP interventions in 29 
RCTs. Almost half of the RCTs (13/29; 45%) described their calculation of the minimum 
sample size required to ensure a sufficiently high likelihood of yielding statistically 
significant results;
37
 the remaining 16/29 (55%) of the trials did not calculate minimum 
sample sizes, although 5/29 (17%) of these trials were identified as exploratory pilot 
studies.
7,45,50,64,65
 Nevertheless, the value of statistical significance, reflecting ‘technically 
successful research’ that reasonably concludes results are due to the intervention, does not 
void meaningful test results that are not statistically significant (uncertain relationship 
between the independent variable of the intervention and the dependent variable of the 
result), yet may be clinically significant, with results derived from sound scientific study 
designs.
77
 Among the 29 RCTs included in this review, statistically significant differences 
between NP interventions versus control were observed in a) 16 RCTs relating to surrogate 
measures of disease;
6,8,44,45,47,50,52-56,60,61,63,66,68
 b) 10 RCTs measuring resource utilization / 
cost;
27,49,50,62,65-67,69,78,79
 c) one RCT measuring global / overall quality of life;
52
 d) seven  
RCTs measuring patient satisfaction;
46,48,55,59,60,62,67
 and e) four RCTs measuring “other” 
outcomes
7,62,69,70
 [Table 4]. 
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Table 4 Statistically significant NP impact on patient endpoint-outcomes 
Physiologic 
Marker Outcomes 
 
CVD * 
^^Allen 44 
Blood Lipids 
 
^^ Goessens 47 
CVD Risk Factors 
Respiratory 
Disease 
^^ Fairall 8 
Tuberculosis Detection 
(sputum microscopy/ 
culture) 
Type Two Diabetes 
Mellitus 
^^ Ralston 6 
Glycated  
Hemoglobin 
Obesity  
^ ter Bogt  
Risk Factors 
Associated with 
Obesity: systolic 
blood pressure,56  
fasting glucose80 
i. Symptom 
Severity 
 
 ii. Functional 
Status 
 
iii. Behaviour / 
Lifestyle Change 
Outcomes 
 
CVD * 
^^ Allen 44 
iii. Diet and 
Exercise 
 
 
Respiratory 
Disease 
^^ Berkhof 50 
ii. Health Status of 
Chronic Obstructive 
Pulmonary Disease 
Suspected Ovarian 
Cancer  
^^ McCorkle 52 
i. Cancer-Specific QOL  
Advanced Cancer 
^^ Kim 53 
i. Pain Ratings and 
Cancer-specific QOL 
Incontinence 
^^ Williams 60 
^^ Williams, post 
hoc 81 
i. Symptom Severity 
/  Cure  
Obesity  
 
^ ter Bogt 56 
i. Body Weight 
Loss and Waist 
Circumference 
 
^ ter Bogt82  
iii. Physical 
Activity  
Rheumatoid 
Arthritis 
^ Hill 55 
i. Fatigue  
Breast Cancer 
Survivors  
^^ Ganz 61 
i. Menopause Symptoms 
ii. Sexual Functioning 
Addiction 
^^ Mertens 68 
iii. Alcohol and  
Drug Use 
Ischemic Stroke  
^^ Mitchell 54 
i. Post-stroke 
Depression 
 
Drug Utilization 
Outcomes 
 
Respiratory 
Disease 
^^  Fairall 8 
Inhaled 
Corticosteroids 
Emergency 
Department 
^ McClellan 63 
Medication 
Administration  
CVD 
^^ Ansari 45 
Target Use of Beta-
Blocker Medication 
Self-Reported  
Drug Utilization  
^^ Jones 66 
Self-reported 
NSAID Reduction 
Acute  
Resource 
Utilization / Cost  
Outcomes 
Emergency 
Department 
^ Cooper 62  
Patient Wait Time 
   
Outpatient 
Resource 
Utilization / Cost  
Outcomes 
Respiratory 
Disease 
^ Nathan 49 
Clinic Attendance 
^^ Berkhof 50 
PHC** and 
Outpatient Clinic 
Visits 
Suspected Ovarian 
Cancer  
 
^^ McCorkle, post hoc 79 
Primary Health Care 
Visits  
Older Adults Post 
Hospital Discharge 
 
^^ Enguidanos 65 
Physician Office 
Visits 
Pediatric Eczema 
^ Schuttelaar,post 
hoc78 
Annual Family 
Costs per Patient 
(including Societal 
Costs) 
Primary Health 
Care Resource 
Utilization / Cost  
Outcomes 
 
Common 
Complaints 
^ Dierick-van Daele 
Consult Time and 
Return Visits67 
Direct Costs per 
Consult / Study 
Clinics27 
Non-Malignant, Non-
Inflammatory 
Musculoskeletal Pain 
 
^^ Jones 66   
NSAID Costs    
Post-Partum 
Mother / Infant  
 
^ Hannan 69 
Total Healthcare 
Charges  
 
Global Quality of 
Life 
Outcomes 
 
Suspected Ovarian 
Cancer  
^^ McCorkle52  
SF-12 physical and 
mental components 
   
Patient 
Satisfaction 
Outcomes 
Minor Injury 
  
^ Cooper 62  
  
Post-Operative to 
Cardiovascular 
Surgery   
^^ Tranmer 46  
 
^^ Sawatsky 48 
Rheumatoid 
Arthritis  
^ Hill 55 
 
Pediatric Eczema  
^ Schuttlelaar 59 
 
PHC  ‘Common 
Complaints’ 
^ Dierick-van 
Daele 67 
 
Incontinence 
^^ Williams 60 
Other  
Outcomes 
Minor Injury 
^ Cooper 62  
Quality of Clinical 
Documentation 
Type One Diabetes 
Mellitus 
^^ McCarrier 7 
Self-Efficacy 
Post-Partum 
Mother / Infant  
^ Hannan 69 
Perceived Maternal 
Health / Stress 
College Women 
^^ Johnson-
Mallard 70 STI 
Knowledge and 
Perceived Risk  
* Cardiovascular Disease (CVD)      ** Primary Health Care (PHC)         ^Role Substitution (RS)           ^^Interprofessional Team (IPT) 
  
3
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Table 5 Abridged: Results of NP Interventions on primary* patient outcomes, or on the ‘first outcome reported’ in trials without endpoints pre-
specified as primary or secondary (**see Appendix J for complete reporting of patient outcomes in each of 29 RCTs; section 4.6 resumes on 
page 62) 
 
Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Pioro
71
 2001 
 
 
U.S. 
Acute Care 
Inpatient  
 
 
 
Internal 
medicine 
wards at a 
single center 
teaching 
hospital, 
Cleveland, 
Ohio, 
affiliated with 
Case Western 
Reserve 
University 
 
 
3
0 
Tertiary 
Prevention
13
 
RS^ 
 
Admission  
to 6 weeks 
post-
discharge; 
1.5 years 
study 
duration 
 
381 patients, 
18–69 years, 
gastro- 
intestinal, 
pulmonary, 
infectious, 
metabolic/ 
substance 
abuse, 
neurological, 
cardio- 
vascular and 
“other” 
acute 
illnesses 
Intervention = 
NP-based care   
(n=193) 
 
 
Control = 
House-staff care   
 
(n=188) 
 
Diagnosis 
 
Prescribing 
 
Clinical 
Procedures 
 
Education 
 
1) *Adverse  
Events 
 
2) *Resource & 
Cost 
 
Feb. 17, 2017 
$1.00 U.S =  
$1.31 Canadian 
$0.76 U.S. = 
$1.00 Canadian 
 
3) **Functional 
Status 
 
4) **Global 
Quality of   Life     
1)  *Overall Adverse Events (transfers to ICUs, hospital-acquired complications,   
and in-hospital mortality) 
NP  7.5%   House-staff  11.8%  
Difference  - 4.3% (95% CI -10.2, 1.6) 
p > 0.10 
 
2) *Resource & Cost 
a. Mean length of hospital stay  
NP 5.0 days   House-staff  5.3 days   
Difference -0.3 (95% CI -1.2, 0.6 days)  
p > 0.10 
 
b. Mean number of consultations to other services (e.g. respiratory therapy) 
NP 1.4  House-staff 1.4  Difference -0.0 (95% CI -0.2, 0.3) 
p > 0.10 
 
c. Mean total hospital charges, costs (U.S.$)  
NP $8854   House-staff  $9426  
Difference -$572 (95% CI -$2704, $1560)   
p > 0.10 
 
d. Mean total ancillary charges, costs (U.S.$)  
NP  $4960   House-staff  $5358  
Difference -$399 (95% CI -$1820, $1023)  
p > 0.10 
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Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Allen
44
 2002 
U.S. 
Outpatient / 
Specialized 
Referral  
 
Outpatient 
clinic of Johns 
Hopkins 
Hospital, 
Baltimore, 
Maryland  
 
3
0 
Tertiary 
Prevention
13
 
 
Post hoc 
analysis: 
Paez
83
 (2006) 
Cost-
effectiveness  
Appendix I-6 
 
IPT ^  ^
 
Intervention 
for one year 
post-
discharge 
 
 
 
 
228 
coronary 
heart disease 
outpatients 
who 
received 
coronary 
artery 
bypass 
grafting or 
percutaneous 
coronary 
intervention 
Intervention = 
NP case 
management + 
Enhanced Usual 
Care (EUC)  
  
(n = 115) 
 
 
Control =  
Enhanced Usual 
Care (EUC) 
from primary  
providers &/or 
cardiologists  
 
(n =113)  
 
Diagnosis    
 
Prescribing 
 
Strategies for 
Behaviour 
Change  
 
Care 
coordination 
1) 1) *Lipid Goals: 
 
Total cholesterol  
 
Low density 
lipoprotein 
cholesterol  
(LDL-C, “bad” 
cholesterol)  
 
Triglyceride 
levels 
 
High density 
lipoprotein 
cholesterol  
(HDL-C, “good” 
cholesterol) 
2) **Drug 
Compliance  
3) **Diet and 
Exercise 
1) *Mean (SD) Lipid Levels at 1 year  
a. Total Cholesterol  
NP 4.1mmol/L (0.7)  EUC 4.6mmol/L (0.6) 
Difference = 0.5 mmol/L    p < 0.0001 
 
b. Low-density lipoprotein cholesterol (LDL-C) 
NP 2.2mmol/L (0.57)  EUC 2.67mmol/L (0.57) 
Difference = 0.47 mmol/L   p < 0.0001 
 
c. Triglycerides  
NP 3.57 mmol/L (1.53)  EUC  4.25 mmol/L (1.79) 
Difference = 0.68 mmol/L   p = 0.002 
 
d. High-density lipoprotein cholesterol (HDL-C) increased modestly in both 
groups 
 
e. Achieved LDL-C treatment goal < 2.59 mmol/L 
NP 65%   EUC 35% 
Difference = 30%  p =0.0001 
 
     Hypercholesterolemia  defined as LDL-C level  > 2.59 mmol/L  or  
     total cholesterol level > 5.18 mmol/L         
 4
1
 
 
Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Jones 2002
66
 
England 
 
Primary 
Health Care  
 
 
Patients were 
examined at 
their general 
practice or 
their homes, 
Nottingham-
shire  
 
 
 
 
 
 
 
3
0 
Tertiary 
Prevention
13
 
 
IPT^^  
 
6 months   
 
 
222 patients, 
from 5 
general 
practices, 
 > or = to 18 
years; 
NSAID 
prescriptions 
for > or = to 
6 weeks of 
previous 
year 
‘Active 
Intervention’ = 
NP assessment, 
patient-tailored 
educational 
package, with 
request to 
withdraw 
NSAIDS and 
use alternative 
therapy  +  
Usual GP Care  
(n =110) 
 
‘Control 
Intervention’ =  
NP assessment 
& basic NSAID 
education  + 
Usual GP Care 
(n=112) 
Diagnosis 
Prescribing 
Education 
 
 
 
 
 
Feb.17, 2017 
£ 1.00 Great 
Britain  = 
$1.62 
Canadian 
£ 0.62 Great 
Britain =  
$1.00 
Canadian 
1) *Self-reported 
reduction in oral 
NSAID dose at 
six months  
 
 
2) **Changes in 
total prescription 
data 
 
 
3) **NSAID 
costs; health 
service costs 
  
 
4) **Global QOL 
 
1) *Self-reported reduction in oral NSAID dose by 50% or less, at 6 months  
 
Active NP Intervention 38 % (42/110) patients 
Control 13% (14/112) patients  
Difference = 25% 
p < 0.0001 
 
 
 
  
Ansari
45
 2003 
U.S. 
 
Pilot RCT  
 
 
IPT ^^ 
 
Median 
follow-up 
period = 12 
months 
 
169 CHF 
Notification 
Intervention  
Internists 10 
Cardiologists 2 
NPs 3 
(n = 64 patients) 
   
 
Diagnosis 
Prescribing 
Education 
1) *Target beta 
blocker use in 
chronic heart 
failure patients 
  
 
1) *Beta Blocker Use 
 
a. Patients initiated or up-titrated on beta-blockers 
 
Notification group 16% (10/64)  
NP facilitator 67% (36/54)  
Control group 27% (14/51) 
 p < 0.001 
 4
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Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Outpatient / 
Specialized 
Referral  
 
 
Single 
academic 
medical 
centre, 
San Francisco, 
California 
 
3
0 
Tertiary 
Prevention
13
 
outpatients 
randomized 
into three 
groups; 
providers 
were also 
individually 
randomized 
into three 
groups, to 
decrease the 
likelihood of 
contaminatio
n between 
patients and 
providers 
 
NP Facilitator 
Intervention  
Internists 19 
Cardiologists 3 
NPs 3 
(n = 54 patients) 
 
 
 
Control   
Internists 16 
Cardiologists 4 
NPs 4 
(n = 51 patients) 
 
2) **Emergency 
Room visits / 
Hospitalizations 
 
 
3) **Mortality 
b. Percent patients to target guideline dose  
 
Notification group 2% (1/64)  
NP facilitator 43% (23/54)  
Control group 10% (5/51) 
p < 0.001 
 
 
c. Mean length of time from initiation to target dose (months)  
 
Notification 9.3 
NP facilitator 5.9 
Control 8.5 
p < 0.001 
 
 
Hill
55
 2003 
England 
Outpatient / 
Specialized 
Referral  
 
Traditional 
rheumatology 
outpatient 
clinic 
managed by 
Junior 
RS ^ 
Six clinic 
visits within 
12 months 
study period 
 
80 
rheumatoid 
arthritis 
(RA)  
outpatients, 
18 years or 
Intervention = 
Rheumatology 
NP (RNP) care 
 
(n =39)  
 
 
 
 
 
 
Control = Junior 
Hospital Doctor 
(JHD) care 
 
( n= 41) 
Diagnosis 
Prescribing 
Clinical 
Procedures 
 
Strategies for 
Behaviour 
Change 
1) *Disease 
Activity Score at 
24 and 48 weeks  
 
2) **Plasma 
Viscosity 
  
3) **Pain 
physical function  
psychological 
status   
 
4) **Changes to 
medications  
 
 1) *Disease Activity Score (DAS28)  
 
Week 24  
NP 35/39,  JHD 34/41 
 
Patients Scores Unchanged: NP 19  JHD 25 
Patients Scores Worsened: NP 6    JHD 5  
Patients Scores Improved: NP 10   JHD 4  
 
no p-value reported 
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Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Hospital 
Doctors 
(JHDs) within 
a teaching 
hospital 
affiliated with 
the University 
of Leeds  
 
3
0 
Tertiary 
Prevention
13
 
older, to 
rheumatolog
y clinic on at 
least three 
previous 
occasions  
5) **Lab tests, 
investigations, 
referrals 
 
 
 
6) **Patient 
Satisfaction  
 
 
 
7) **Knowledge 
Week 48  
NP 36/39,  JHD 35/41 
 
Patients Scores Unchanged: NP 19   JHD 22  
Patients Scores Worsened: NP 6   JHD 7  
Patients Scores Improved: NP 11  JHD 6  
 
no p-value reported 
 
Tranmer
46
 
2004 
Canada  
 
Outpatient / 
Specialized 
Referral  
Patients 
recruited from 
teaching 
hospital 
affiliated with 
Queen’s 
University, 
Kingston, 
Ontario  
3
0 
Tertiary 
Prevention
13
 
 
IPT ^^ 
 
Five week 
intervention 
  
 
200 cardiac 
surgery 
outpatients, 
discharged 
from first 
cardiac 
surgery with 
no stay at 
Intensive 
Care Unit 
Intervention = 
Usual Care + 
NP initiated 
phone contacts 
(n= 102) 
 
 
 
Control = Usual 
Care (UC) 
education 
booklet, home-
care follow-up 
as necessary, 
and NP contact  
information 
(n= 98) 
Diagnosis  
 
Education  
 
Care 
Coordination 
1) *Global 
Quality of Life  
 
 
2) **Post-
operative 
symptom distress  
 
3) **Healthcare 
Utilization 
 
 
4) **Patient 
satisfaction  
1) *Mean (SD) Global Quality of Life at 5  weeks post-discharge, SF-36 
 NP 92/102    UC 92/98 
 
Physical scale  
NP  36.3 (6.4)   UC 36.2 (7.5) 
Difference 0.04 (95% CI –1.99 to 2.08) 
p = 0.97  
 
 
Mental scale 
NP  50.4 (11.5)   UC  51.7 (11.9)  
Difference –1.25 (95% CI –4.54 to 2.04) 
p = 0.45 
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Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Fairall
8
 2005 
South Africa 
Primary 
Health Care 
 
 
40 primary 
health care 
clinics in the  
Free State  
staffed by 
NPs; 
pragmatic 
cluster RCT 
with primary 
health care 
clinic the unit 
of random 
allocation  
 
 
 
 
 
3
0 
Tertiary 
Prevention
13
 
IPT ^^ 
 
Three month 
study period  
 
1,999 
patients with 
cough or 
difficult 
breathing on 
presentation  
or within 
past 6 
months 
  
Intervention =, 
an educational 
outreach 
program 
(expanded 
prescribing 
provisions with 
locally tailored 
guidelines) 
implemented by 
NPs 
 
20 clinics; 
1000/1999 
patients  
 
 
Control = Usual 
Care, no 
educational 
outreach  
 
20 clinics; 
999/1999 
patients 
 
Diagnosis 
Prescribing  
Strategies for 
Behaviour 
Change 
1) *Case 
detection of 
tuberculosis by 
sputum 
microscopy or 
culture for 
tuberculosis  
 
2) *Prescriptions 
for inhaled 
corticosteroids to 
treat asthma; 
antibiotic 
prescriptions for 
upper and lower 
respiratory tract 
infections  
3) **Number of 
HIV patients 
receiving 
prescriptions for 
cotrimoxazole 
prophylaxis  
 
1) *Case detection of tuberculosis (TB) at 3 months 
 
Outreach Intervention 6.4% (57/892)  Control 3.8% (34/890) 
OR = 1.72 (95% CI  1.04-2.85) 
p = 0.04 
ICC = 0.007 
2) *Prescriptions at 3 months 
 
a. Inhaled corticosteroids for asthma 
 
Outreach Intervention 13.7% (137/1000)  Control 7.7% (77/999) 
OR = 1.90 (95% CI  1.14 to 3.18) 
p = 0.006 
ICC = 0.019  
 
 
b. Antibiotics for upper and lower respiratory tract infections  
 
Outreach Intervention 39.7% (397/1000 ) vs Control 39.4% (394/999 ) 
OR = 1.01 (95% CI  0.74 to 1.38) 
p = 0.95 
ICC = 0.042 
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Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Goessens
47
 
2006 
Netherlands 
Outpatient / 
Specialized 
Referral  
 
 
Risk-factor 
management 
clinic in the 
University 
Medical 
Center, 
Utrecht 
 
 
 
3
0 
Tertiary 
Prevention
13
 
 
 
Post hoc 
analysis  
Sol
75
 (2008)  
Self-efficacy  
Appendix I-10 
 
IPT ^^ 
 
One year 
intervention  
  
 
236 
cardiovascul
ar disease 
(CVD) 
patients with 
two or more 
modifiable 
risk factors:  
 
smoking, 
hypertension
dyslipidemia 
diabetes, 
obesity, 
hyperhomoc
ysteinemia 
 
 Intervention = 
NP at risk factor 
management 
clinic  + Usual 
Care   
 
(n=119) 
 
 
Control = Usual 
Care (UC) by 
GP and treating 
vascular 
specialist  
 
(n=117)  
 
 
CVDs included: 
Peripheral 
arterial disease, 
Abdominal 
aortic aneurysm, 
Cerebrovascular 
disease, 
Coronary heart 
disease 
Diagnosis 
Education 
 
 
 
 
 
 
At the time of 
the trial, an 
NP in the 
Netherlands 
was not 
formally 
allowed to 
prescribe; 
instead, a 
study 
physician 
prescribed or 
changed 
medication 
for patients in 
the trial 
1) *Treatment 
goals: lipid, blood 
pressure, BMI 
(body mass 
index), blood 
glucose, 
homocysteine and 
smoking 
 
 
2) **Self-reported 
drug utilization 
 
 
 
 
3) **Overall 
quality of life  
1)*Percentage of  patients who achieved treatment goals at mean follow-up of 14 
months  (range 10-22) 
 
a. Low-density lipoprotein (LDL) cholesterol treatment goal  < or equal to 
3.1 mmol/L 
NP 88 
UC 67 
OR = 3.5 (95% CI 1.5–8.6) 
 
b. Total cholesterol (mmol/L) treatment goal < 5.0 mmol/L 
NP 79 
UC 61 
OR = 3.3 (95% CI 1.5–7.3)  
 
c. Systolic blood pressure (mm Hg) treatment goal < 140 mmHg 
NP 63 
UC 37 
OR = 2.7 (95% CI 1.3–5.4) 
 
d. Body mass index (kg/m2) treatment goal < 25 kg/m2  
NP 38    
UC 24  
OR = 4.0 (95% CI 1.2–13.1) 
 
e. Differences non-significant:  Diastolic BP, HDL-C, Triglycerides, Fasting 
Blood Glucose, Homocysteine, Waist Circumference, Smoking  
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Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Nathan
49
 
2006 England 
 
Outpatient / 
Specialized 
Referral  
 
West Suffolk 
hospital 
outpatient 
clinic  
 
3
0 
Tertiary 
Prevention
13
 
RS ^ 
 
6 month 
study  
 
154 
outpatients > 
16 years 
recently 
discharged 
from 
hospital 
related to  
acute asthma 
 
Intervention = 
NP care  
 
(n= 78) 
 
 
Control = 
Respirologist 
care  
 
(n=76) 
Diagnosis 
Prescribing 
Education 
1)* Number of 
acute asthma 
exacerbations 
within 6 months 
of  hospital 
discharge 
 
2) **Peak flow 
 
3) **Disease-
specific QOL 
 
4) **Resource 
utilization 
1) *Number acute asthma exacerbations at 6 months 
  
NP 98/174 exacerbations 
Respirologist 76/174 exacerbations 
 
Difference 22 exacerbations 
 
p = 0.368  
McCarrier
7
 
2009 U.S.  
 
Pilot RCT  
 
Outpatient / 
Specialized 
Referral  
Diabetes Care 
Center, 
University of 
Washington 
Seattle, 
Washington  
 
3
0 
Tertiary 
Prevention
13
 
IPT ^^ 
 
 
One year 
intervention  
 
 
 
78 Type I 
Diabetes 
outpatients, 
21 - 49 years 
at least one 
A1c test  > 
or = to 7% in 
prior year  
Intervention = 
NP coordination 
of Web-based 
care + usual 
care  
(n =42)   
 
 
 
Control = Usual 
Care (UC) from 
multidisciplinar
y practice team 
at Diabetes Care 
Center    
(n = 36) 
Diagnosis 
Education 
Care 
Coordination 
1) *Difference in 
mean Hemoglobin 
A1c from baseline 
to 12-month 
follow-up  
2) **Diabetes-
specific self-
efficacy 
1) *Mean (SD) change hemoglobin A1c values at 1 year 
 
 
NP - 0.37 (1.3) 
UC: + 0.11 (1.4) 
Absolute difference = 0.48 (95% CI -1.2 2 to 0.27)  
 
p = 0.160 
 
 
 
 4
7
 
 
Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Mitchell
54
 
2009 U.S. 
 
Outpatient / 
Specialized 
Referral  
 
 
 
Outpatient 
clinic, 
including 
rehabilitation 
facilities, 
University of 
Washington 
Seattle, 
Washington  
 
 
 
 
 
3
0 
Tertiary 
Prevention
13
 
IPT ^^ 
 
 
8 week 
intervention 
within 24 
months 
  
101 patients 
within 4 
months of an 
ischemic 
stroke and 
diagnosis of 
clinical 
depression; 
follow-up 
contact 
included 
patients’ 
private 
homes  
 
Intervention =  
Psychosocial 
intervention  
(9 NP sessions) 
+ Usual Care, 
including 
antidepressants   
 
(n=48) 
 
 
 
Control = Usual 
stroke provider 
care (UC), 
including 
antidepressants  
 
(n=53)  
Diagnosis  
 
Strategies for 
Behaviour 
Change 
1) *Post-stroke 
depressive 
symptomology 
(reduction in 
depressive 
symptoms) 
 
2) **Limitations 
in ability 
(physical 
function), 
participation and 
overall stroke 
impact 
1) *Mean change (SD) Hamilton Rating Scale for Depression (HRSD), 12 months  
    
NP  - 9.2 (5.7) 44/48 patients 
UC - 6.2 (6.4) 48/53 patients 
    
Difference -2.9 (CI -5.4 to -0.4)    
 
p=0.023 
 
 Remission (defined as HRSD < or = 9) at 9weeks 
NP 47% (45/48)    UC 19% (53/53) 
Difference 28 % OR = 4.8 (CI 1.8 to 12.9) p = 0.001 
 Remission at 21weeks 
NP 46% (46/48)     UC 22% (50/53) 
Difference 24% OR=3.4 (CI 1.3 to 8.7) p = 0.008 
 Remission at 12 months 
NP 48% (44/48)     UC 27% (48/53) 
Difference21%  OR=2.7 (CI 1.1 to 6.6) p = 0.031 
 Remission at 24 months  
NP 65% (44/48)     UC 46% (48/53) 
              Difference 19% OR =2.3 (CI 0.8  to 6.7) p = 0.130 
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Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Ralston
6
 
2009 U.S. 
 
Outpatient / 
Specialized 
Referral 
University of 
Washington  
Internal 
Medicine 
Clinic 
  
 
3
0 
Tertiary 
Prevention
13
 
 
IPT ^^ 
 
12 months 
 
 
 
83 Type II 
Diabetes 
outpatients, 
18-75 years, 
glycosylated 
hemoglobin  
> or = to 7% 
at least 2 
clinic visits 
in prior year 
 
Intervention = 
NP coordination 
of Web-based 
care  +   
Usual Care  
 
(n=42) 
 
 
Control = Usual  
Care (UC) from 
an internal 
medicine 
physician   
 
(n=41) 
Diagnosis 
Prescribing 
Strategies for 
Behaviour 
Change 
Care 
Coordination 
1) *Absolute 
change in 
glycated 
hemoglobin at 12 
months 
2) **Blood 
pressure, total 
plasma 
cholesterol  
3) **Healthcare 
utilization 
1) *Absolute change in glycated hemoglobin at 12 months 
 
      Target for glycated hemoglobin is < 7% A1c, 
      equivalent to blood glucose concentration  <  than 8.6 mmol/L  
 
 
      NP 33% at target 
 
      UC 11% at target 
 
      Difference 22% 
  
      p = 0.03 
 
Huizinga
51
 
2010 U.S. 
 
Outpatient / 
Specialized 
Referral  
Outpatient 
clinic of Johns 
Hopkins 
Hospital, 
Baltimore, 
Maryland  
 
3
0 
Tertiary 
Prevention
13
 
IPT ^  ^
 
 
Two year 
study 
165 Type II 
Diabetes 
outpatients, 
18-75 years, 
with recent    
glycemic 
control  
2 Intervention 
Groups ‘Usual 
Care + NP 
phone contact’ 
 
1) Quarterly 
contact, every 3 
months (n =55) 
2) Monthly 
contact (n =55)  
 
Control = Usual 
Care in Diabetes 
Improvement 
Program (n= 55)  
Diagnosis 
 
Prescribing 
 
Strategies for 
Behaviour 
Change  
 
Care 
Coordination 
1)*Glycemic 
relapse 
1)*Glycemic  relapse, defined as an increase in HbA1c of  > or = to 1% over      
      baseline, at 2 years 
 
 Quarterly contact 21% (10/48) patients relapsed  
 
 Monthly contact 29% (15/52) patients relapsed 
 
 Usual care  25% (12/48) patients relapsed  
 
               p = 0.83  
 
Prevalence of relapse did not differ between groups over follow-up time, nor did 
the cumulative incidence of relapse differ between treatment groups (p = 0.72) 
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Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Kim
53
 2013 
South Korea 
Outpatient / 
Specialized 
Referral  
 
Pain Clinic of 
the Yonsei 
University 
Health 
System, Seoul  
 
3
0 
Tertiary 
Prevention
13
 
IPT ^^ 
1 week 
intervention  
 
108 
advanced 
cancer 
outpatients, 
20 - 80 years 
moderate 
level of 
cancer-
related pain 
Intervention = 
Usual Care + 
daily phone 
monitoring 
(tele-
monitoring)  
by NP (n = 54) 
 
Control = Usual 
Care (UC) with 
standardized 
pain education 
by NP (n = 54) 
Diagnosis 
 
Prescribing 
 
Strategies for 
Behaviour 
Change  
 
Care 
Coordination 
1) *Reduction in  
average pain 
levels  
 
2) **Performance 
status / functional 
impairment; 
anxiety/ 
depression, 
distress  
3) **Cancer 
specific 
symptoms  
(EORTC  
QLQ-C30) 
 
1)*Reduction in average pain ratings on Brief Pain Inventory in Intervention group         
compared to control, at 1 week 
 
      (0 = no pain; > or = to 4 = average pain; 10 = ‘pain as bad  as you can imagine’)  
 
 
Number patients experiencing average pain intensity at 1 week 
 
NP  19% (10/54)    
UC  35% (19/54) 
 
Difference 16% 
 
p = 0.02 
 
Sawatsky
48
 
2013 Canada 
Outpatient / 
Specialized 
Referral  
St. Boniface  
Hospital, 
University of 
Manitoba, 
Winnipeg, 
Manitoba 
3
0 
Tertiary 
Prevention
13
 
IPT ^  ^
 
Six week 
intervention 
 
204 cardiac 
surgery 
outpatients 
following 
first time 
coronary 
artery 
bypass graft  
Intervention =  
Usual Care + 
NP phone 
contact  (n= 97)  
Control = Usual 
Care (UC) 
primary care 
appointment  
within 1 week, 
visit to  cardiac 
surgeon for all 
patients at 6 
weeks (n=107)  
All 5 domains: 
  
Diagnosis 
 
Prescribing 
 
Clinical 
Procedures  
 
Education 
 
Care 
Coordination 
1) *Global quality 
of life 
2) **Symptoms in 
cardiac surgery 
recovery 
3) **Health 
resource use 
4) **Patient 
satisfaction 
1)* Mean (SD) Global Quality of Life at 2 and  6 weeks post-discharge, SF-36  
Physical component  
2 weeks NP 19.0 (3.4)  UC 18.0 (3.4) 
p = 0.04 
6 weeks  NP 22.2 (4.2)  UC 22.0 (4.0) 
p = 0.69 
 
Mental component  
2 weeks NP 21.5 (2.1)  UC 21.5 (2.3) 
p = 0.87 
6 weeks NP 21.3 (2.3)  UC 21.1 (2.3) 
p = 0.67 
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Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Berkhof
50
  
2014 
Netherlands 
 
 
 
Pilot RCT 
 
 
 
 
 
 
Outpatient / 
Specialized 
Referral 
Large teaching 
hospital in 
Zwolle, 
Netherlands 
 
 
 
 
3
0 
Tertiary 
Prevention
13
 
 
IPT ^^ 
2 year study 
  
100 COPD 
(Chronic 
Obstructive 
Pulmonary 
Disease) 
outpatients 
 > or = to 40 
years, COPD 
GOLD 
(Global 
initiative for 
staging Obst
ructive Lung 
Disease: 1 = 
mild; 4 = 
very severe), 
stage 
 > or = to 2, 
smoking 
history > 10 
pack-years 
Intervention = 
patient-initiated 
visits with 
pulmonary NP 
upon increase of 
symptoms. NP 
followed an ‘on-
demand 
protocol’ with   
consult to 
pulmonologist 
for urgent 
problems  
 
(n =49)  
 
Control = Usual 
Care (UC) via 
outpatient visits 
initiated by 
pulmonologist, 
to either the 
pulmonologist 
or to the  
pulmonary NP 
 
(n=51)   
Diagnosis 
Prescribing 
Education 
 
 
 
 
 
Feb. 17, 2017 
€1.00 Euro = 
$1.53 
Canadian  
€0.72 Euro = 
$1.00 
Canadian 
1) *Mean change 
in Clinical COPD 
Questionnaire 
(CCQ)   
 
2) **Time to first 
exacerbation 
COPD  
 
3) **Visits to 
general practice 
physicians, 
pulmonologists, 
and pulmonary 
NPs  
 
4) **Total 
treatment costs  
 
5) **Disease-
specific quality of 
life (St. George’s 
Respiratory 
Questionnaire, 
SGRQ) 
 
6) **Global  
quality of life 
1) *Mean (SE) change COPD status at 2 years 
 
Lower score on Clinical COPD Questionnaire (CCQ) = less deterioration / 
better health status 
 
Minimal clinically important difference (MCID) of CCQ total score is 0.4 
 
 
 
Symptom domain of the CCQ 
 
NP  0.14 (+ or - 0.14)  in 40/49 patients 
UC  0.58 (+ or - 0.16)  in 29/51 patients 
 
Difference = - 0.44 (+ or -  0.21)  95% CI -0.87 to -0.023 
p = 0.04 
 
Absolute difference between groups of 0.44 met the MCID for a clinically 
relevant effect 
 
 
 
 
 5
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Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Mertens
68
 
2014 
South Africa 
 
Primary 
Health Care 
Large public 
sector primary 
healthcare 
clinic in Delft, 
near Cape 
Town 
 
3
0 
Tertiary 
Prevention
13
 
IPT ^  ^
 
Three month 
study period 
 
403 patients 
18–24 years 
of  low 
socio- 
economic 
status,  
screened for 
high-risk 
alcohol and / 
or drug use 
Intervention = 
session of Brief 
Motivational 
Interviewing 
(average session 
10 minutes) by 
NP + referral 
list of resources 
(n=206)   
 
Control = 
minimally 
enhanced usual 
care with 
referral list of 
resources 
(n=197) 
 
Strategies for 
Behaviour 
Change 
1)*Rates of at-
risk alcohol use 
and drug use at 
three month 
follow-up 
 
1) *Mean percent  reduction in ASSIST scores at 3 months  
(Alcohol, Smoking and Substance Involvement Screening Test)  
 
 Alcohol  
NP  38.3 % 
Control 20.9%     p = 0.0293 
 
 Cannabis  
NP 28.3% 
Control 9.8%       p = 0.1119 
 
 Methamphetamine 
              NP 57.2% 
              Control 76.9%      p = 0.2264 
 
 
 
Ganz
61
 2000 
U.S. 
Outpatient / 
Specialized 
Referral  
Jonsson 
Comprehensiv
e Cancer 
Center,  
University of 
California,  
IPT ^^ 
Intervention 
period of 4 
months 
76 surviving 
breast cancer 
patients with 
abruptly 
recurred 
menopausal 
Intervention = 
comprehensive 
menopausal 
assessment  
(CMA)  
delivered by NP    
 
( n=37) 
 
Control = Usual 
Care (UC) + 1 
contact from 
Diagnosis 
Prescribing  
Strategies for 
Behaviour 
Change 
1) *Composite 
menopausal 
symptom scale  
 
2) **Vitality, 
from Medical 
Outcomes Study 
Short Form 36 
(SF-36)  
1)   *Menopause  symptom-scale score, mean change (reduction) from 
baseline to 4 months   
 
NP 0.61 (95% CI 0.40–0.82) 33/37 patients 
UC 0.19 (95% CI −0.06 to 0.44) 39/39 patients  
 
 p = 0.0004 
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Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Los Angeles, 
California 
 
 
2
0 
Secondary 
Prevention
13
 
symptoms, 
due to 
discontinued 
estrogen 
replacement 
therapy 
related to 
breast cancer   
research 
assistant at 2 
months, asking 
of therapies for 
symptom 
management  
 
( n= 39) 
 
 
3) **Cancer 
Rehabilitation 
Evaluation 
System (CARES) 
Sexual 
Functioning Scale 
Cooper
62
 
2002 
Scotland 
Acute Care 
Emergency 
Department 
 
A single 
Accident and 
Emergency 
Department 
of Glasgow 
Royal 
Infirmary, 
Glasgow  
 
2
0 
Secondary 
Prevention
13 
RS ^ 
2 month 
study 
duration 
204 patients 
over 16 
years, with 
minor injury 
that fell 
within the 
emergency 
NP (ENP) 
protocol 
Intervention = 
ENP care  
(n = 102) 
Control = 
Senior House 
Officer (SHO) 
care (n = 102) 
 
Diagnosis 
 
Prescribing 
 
Clinical 
Procedures 
 
Education 
 
1) Resource 
Utilization: 
consult time and 
referral to follow-
up clinics  
2) Unplanned 
Follow-up 
3) Missed Injuries  
4) Patient 
Satisfaction 
5) Quality of  
Clinical 
Documentation 
6) Recovery at  
one month  
Endpoints not pre-specified as primary / secondary 
 
1
st
 Outcome Reported 
 
1)  Resource Utilization  
 
a.  a.   Patient’s average wait time: ENP 48.6 minutes  SHO 70.1 minutes 
b.  95% CI  11.2–31.8 minutes, p < 0.001 
 
b. Total consult time (including treatment time): ENP 30.0 minutes  SHO 24.9  
minutes  95% CI  -1.3 to 11.5 minutes, p < 0.115 
 
c. Seeking  advice from senior medical staff [when X-ray interpretation for which 
ENPs were required to consult was excluded; SHOs were not required to 
consult X-ray interpretation]  ENP 20.9%   SHO 11.5%, p < 0.21  
 
d. Numbers of X-rays requested  ENP 56.6%  SHO 47.5%, p =  0.2 
 
e. Referral to follow-up clinics ENP 33.3 %   SHO 27.5%, p = 0.358 
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Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Williams 
60
  
2005 
England 
 
 
 
Primary 
Health Care 
Patients’ 
homes in 
Leicestershire 
Rutland 
 
 
 
 
2
0 
Secondary 
Prevention
13
 
 
Post hoc 
analysis 
Williams
81
  
(2011) 
Long term 
follow-up  
Appendices I-
3, I-7 
IPT ^^ 
Six month 
intervention  
 
 
3746 
patients aged 
40 years and 
over living 
in private 
households; 
incontinence 
several times 
per month or 
more to  
several times 
a year; 
reported 
impact of 
symptoms 
on quality of 
life 
Intervention = 
continence 
service provided 
by NPs  
(n = 2958) 
Control = usual 
primary care, 
GP and 
continence 
advisory 
services (n=788) 
 
 
4:1 ratio was 
deemed 
necessary to 
ensure sufficient 
intervention 
data for 
evaluation of 
detrusor over-
activity and 
urodynamic 
stress 
incontinence 
 
 
Diagnosis 
Prescribing 
Education 
 
 
Feb.17, 2017 
£ 1.00 Great 
Britain  = 
$1.62 
Canadian 
£ 0.62 Great 
Britain =  
$1.00 
Canadian 
1) *Improvement 
in one or more 
symptoms of 
which cure (no 
symptoms) is a 
subset  
 
 
2) **Number of  
symptoms 
alleviated  
 
 
3) **Resources: 
healthcare 
professional 
contacts, 
investigations; 
cost-effectiveness  
 
 
4) **Patient 
satisfaction and 
patient perception 
of problem 
1) *Improvement in 1 or more symptoms 
 incontinence, urgency, frequency, nocturia 
 
a. 3 months       
NP 60%  (1417/ 2378 responders)  
Control 48% (281/584 responders) 
Difference 12% (95% CI 7 to 16%) 
p < 0.001 
 
b. 6 months  
NP 62% (1369/2201 responders) 
Control 52% (277/536 responders) 
Difference 10% (95% CI 6 to 15%) 
p < 0.001 
 
Cure = 0 symptoms 
a. 3 months 
NP 25%, 591/2378  
Control 15%, 88/584   
Difference 10% (95% CI 6 to 13%) 
 p < 0.001 
 
b. 6 months 
NP 28%, 624/ 2201 
Control 19%, 104/536 
Difference 9% (95% CI 5 to 13%) 
p < 0.001 
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Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Krichbaum
64
 
2007  
U.S  
 
 
Pilot RCT  
 
 
Outpatient /  
Specialized 
Referral  
 
Follow-up at 
subacute, long 
term care, 
rehabilitation 
facilities, and 
private homes  
 
 
2
0
 Secondary  
Prevention
13
 
 
 
IPT ^^  
 
 
 
 
Six month 
intervention 
in 12 month 
study  
 
 
33 hip 
fracture 
surgery 
outpatients  
> or = 65 
years, 
recruited 
from two 
hospitals in 
St. Paul, 
Minnesota  
  
Intervention = 
usual care + 
post-acute care 
coordination by 
mobile 
gerontologic NP  
(n=17)  
 
Control = usual 
care by hospital 
and individual 
surgeon’s 
protocols (n=16)  
Diagnosis,  
 
 
Prescribing 
(medication 
reconciliation)  
 
 
Strategies for 
Behaviour 
Change  
1) Self-rated 
health  
 
 
2) Level of 
geriatric 
depression  
 
 
3) Activities of 
daily living 
(ADLs) and 
instrumental 
activities of daily 
living (IADLs)  
Endpoints not pre-specified as primary / secondary 
 
 
1st Outcome Reported  
 
1) Self-rated health (Global Health (GH) self-ratings - higher scores better)  
 
Mean (SD) symptoms at 12 months  
 
NP 4.1 (0.95)  
Control 4.0 (0.71)  
 
Difference non-significant  
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Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Dierick-van 
Daele
67
 2009 
Netherlands 
 
Primary 
Health Care 
 
Trial 
affiliation  
University of 
Maastricht; 
Foundation for 
Development 
of Quality  
Care in 
General 
Practice, 
Eindhoven  
 
2
0 
Secondary 
Prevention
13
 
 
Post hoc 
analysis 
Dierick-van 
Daele
27
 
Economic 
evaluation  
Appendix I-7 
 
RS ^ 
 
Two week 
intervention 
in six month 
study  
 
 
1,591 from 
15 general 
practices, 
patients 16 
years and 
older, with 
respiratory/ 
throat, 
ear/nose 
musculoskel
etal/skin 
injuries, 
urinary/ 
gynaecologi
cal / geriatric 
problems 
Intervention = 
patient care 
from newly 
graduated NP 
(Master Degree 
of Advanced 
Nursing 
Practice), 
experience 
ranging from  
1 to 5 years;  
12 NPs  
 
(n = 817) 
 
 
 
Control = 
patient care 
from GP with an 
average of 16 
years’ 
experience;  
50 GPs  
 
(n = 684) 
 
Diagnosis 
Prescribing  
 
Education 
1) Duration of 
consultation  
 
2) Medical 
resource use 
 
3) Number of 
prescriptions 
given 
 
 
4) Patient 
satisfaction and 
patient 
perceptions of 
quality of care 
Endpoints not pre-specified as primary / secondary 
 
1
st
 Outcome Reported  
 
1) Duration of consultation (minutes), mean (SD) 
 
NP 12.22 (5.7 minutes) 
GP 9.20 (4.8 minutes) 
 
p < 0.001 
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Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
McCorkle
52
  
2009 U.S. 
 
Outpatient / 
Specialized 
Referral 
 
Patient contact 
made at 
private homes 
or by phone, 
northeast 
Connecticut  
 
Trial approved 
by Yale 
University, 
New Haven, 
Connecticut  
 
2
0 
Secondary 
Prevention
13
 
classification 
with regards to 
suspected  (not 
definitive) 
ovarian 
cancer, the 
study’s target 
disease 
 
IPT ^^ 
 
 
Six month 
study  
 
 
 
149 post-
surgical 
outpatients 
21 years or 
older, with 
suspected 
primary 
diagnosis of 
ovarian 
cancer after 
abdominal 
surgery, 
prognosis of 
at least 6 
months, with 
order to 
initiate 
chemo-
therapy   
 
 
Intervention  = 
18 contacts by 
an oncology NP, 
supported by 
psychiatric NP 
(PSYNP) 
consults (32/74 
intervention 
patients)  when 
warranted for 
high emotional 
distress = 
Distress 
Thermometer  > 
or = to 4 
(n=74)  
Attention 
Control = nine 
contacts by 
research 
assistant, 
supported by 
medical social 
worker (no data 
for patient 
contact with 
social worker) 
(n = 75) 
Diagnosis 
Prescribing 
  
Strategies for 
Behaviour 
Change 
 
Care 
Coordination 
 
 
*Quality of Life 
(QOL) 
1. Cancer specific 
 
a) Center for 
Epidemiological 
Studies -
Depression  
(CES-D) 
b) Ambiguity 
subscale of the 
Mishel 
‘Uncertainty in 
Illness’ Scale 
(MUIS)  
c) Symptom 
Distress Scale 
(SDS)  
2. Overall / 
Global QOL 
a) SF-12 physical 
component  
b) SF-12 mental 
component  
*QOL was measured at baseline (24–48 hours after surgery), 1, 3, and 6 months 
post-surgery 
 
3 types of mixed effect regression models estimated the ‘rates of change’ (effect 
estimates) in different QOL measures over time: 
 
(1) Oncology NP intervention without PSYNP (Appendix J)  
(2) Oncology NP intervention with PSYNP 
 Rate of reduction in MUIS score & Rate of improvement in the SF-12 
score was significantly greater for intervention vs control: 
Uncertainty of Illness (MUIS)  
effect estimate = - 0.03917 ± se 0.00915,  p < 0.0001  
SF-12 mental component 
effect estimate = 0.02300 ± se 0.00748,  p = 0.0023  
 
 Rate of change in CES-D scores was significantly greater for control vs 
intervention  
CES-Depression (CES-D) 
effect estimate = 0.03594 ± se 0.01213,  p = 0.0033  
 Poor model fit - no effect estimate data for SDS or SF-12 physical  
Symptom Distress Scale (SDS) 
SF-12 physical component 
(3) PSYNP separate from Oncology NP  (Appendix J) 
 
 
Post hoc analysis:   McCorkle
79
 (2011) Healthcare utilization Appendix I-6 
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Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
ter Bogt
56
 
2009 
Netherlands 
 
Primary 
Health Care 
 
11 general 
practices (1-7 
GPs and 1-3 
NPs per 
location),  
Groningen, 
northern 
Netherlands 
 
 
2
0 
Secondary 
Prevention
13
 
although now 
considered a 
chronic 
disease, 
obesity is 
reversible, 
thus secondary 
prevention 
RS ^ 
One year 
study 
 
457 patients 
with BMI 25 
– 40 kg/m2 
and either 
hypertension 
dyslipidemia 
or both 
 
 
Obese: BMI 
> or = to 30 
kg/m
2 
 
Overweight: 
BMI < 
30kg/m
2 
 
 
 
Intervention = 
low-intensity 
(for prevention 
of additional 
weight gain) 
lifestyle 
counseling by 
NPs  
 
(n =225)  
 
 
 
 
 
Control = usual 
primary health 
care from GPs  
(n = 232)  
 
 
Diagnosis 
Prescribing 
  
Strategies for 
Behaviour 
Change 
 
 
Care 
Coordination 
 
 
 
 
1) *Changes in 
body weight 
after one year 
of intervention 
 
2) **Waist 
circumference  
 
3) **Blood 
pressure, total 
cholesterol, and 
fasting glucose 
one year after 
intervention 
 
1) *Percentage change in body weight at 1 year 
 
   NP -1.9% (95% CI -2.5, -1.2) 200/225 patients 
         UC -0.9% (95% CI -1.5, -0.2)  214/232 patients 
         Difference 1.0% 
 
p < 0.05 
 
 
Weight losers (successful) and stabilizers (percentage of subjects who gained 
less than 1% body weight by end of study) at 1 year 
 
Women 
NP 72.8% (75/103) patients  
UC 64.0% (73/114) patients  
Difference 8.8% non-significant 
 
Men 
NP 80.6% (79/98) patients  
UC 65.3% (66/101) patients  
 
Difference 15.3%  p < 0.05  
 
 
 
Post hoc analysis ter Bogt
82
 (2011) One-Year Follow-up Appendix I-3 
Post hoc analysis ter Bogt
80
 (2011) Three-Year Follow-up Appendices I-2, I-3 
Post hoc analysis Driehuis
84
 (2012) Three-Year Follow-up Appendix I-3 
 
 
 5
8
 
 
Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Schuttelaar
59
 
2010 
Netherlands 
Outpatient / 
Specialized 
Referral  
Dermatology 
outpatient 
clinic at the 
University 
Medical 
Center, 
Groningen 
 
2
0 
Secondary 
Prevention
13
 
 
Post hoc 
analysis: 
Schuttelaar
78
 
Costs and 
cost-
effectiveness 
analysis 
Appendix I-6 
 
RS ^ 
 
1 year study 
 
160 patients 
< 16 years: 
80 patients 
aged < or = 
to 4 years & 
80 patients 
aged 4–16 
years, all 
new referrals 
from GPs or 
pediatricians 
with a 
diagnosis of 
eczema  
 
 
 
Intervention = 
NP-led care  
(n = 81): 
 
Age < or = to 4 
years (n = 40) 
Age 4-16 years 
(n = 41) 
 
 
Control = 
conventional 
care by 
dermatologist  
(n = 79) 
  
Age < or = to 4 
years (n = 40) 
 
Age 4-16 years 
(n = 39) 
Diagnosis 
Prescribing 
  
Strategies for 
Behaviour 
Change 
 
 
1) *Change in 
quality of life of 
the child  at 12 
months 
 
2) **Eczema 
severity 
 
3) **Family 
impact of 
childhood eczema 
 
4) **Patient 
satisfaction at 4, 
8, and 12 months 
1) *Eczema-specific Quality of Life (higher scores representing a poor quality of 
life) at 12 months 
 
 Infants’ Dermatitis Quality of Life Index, mean (SD) 
NP 5.7 (5.4)   Dermatologist 5.6 (3.9) 
p = 0.26 
 
 Children’s Dermatology Life Quality Index, mean (SD)  
NP 4.9 (3.5)   Dermatologist 5.6 (4.2) 
p = 0.55 
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Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Enguidanos
65
  
2012 U.S 
Pilot RCT 
Outpatient / 
Specialized 
Referral  
 
Health 
Maintenance 
Organization 
(HMO), Los 
Angeles 
County, 
California  
 
2
0 
Secondary 
Prevention
13
 
IPT ^^ 
6 months 
199 at-risk 
hospitalized 
older adults 
discharged 
home 
without in-
home care 
(e.g., home 
health/ 
hospice) or 
caregivers 
Intervention = 
Brief NP 
Transition: up to 
3 home visits, 2 
phone calls 
within 72 hours 
of discharge 
(n = 100) 
 
 
Control = usual  
care, case 
management 
services (wait 
time 2-14 days) 
(n =99) 
Diagnosis 
Prescribing 
(medication 
reconciliation) 
  
Education 
Care 
Coordination 
1) Efficacy in 
Self-Care 
2) Home Care 
Patient 
Satisfaction  
3) Emergency 
room visits, 
hospital re-
admission, days 
re-hospitalized, 
physician office 
visits, and home 
health care days 
 
Endpoints not pre-specified as primary / secondary 
 
1
st
 Outcome Reported  
 
    1) Efficacy in Self-Care at 6 months 
 
     No significant differences between groups  
 
 
McClellan
63
 
2012  
England 
Acute Care 
Emergency 
Department 
 
A single, inner 
city, adult ED  
of University 
Hospitals  
Bristol  
RS ^ 
    
Eight week 
study period 
372 patients 
with 
peripheral 
soft tissue 
injury,  older 
than 16 
years  
Intervention = 
patient 
management  
arrival to 
discharge by 
Emergency NP 
or Extended 
Scope Physio-
therapist (ESP) 
 
ENP (n = 123)  
ESP  (n = 126) 
 
Diagnosis  
 
Prescribing  
 
Clinical 
Procedures  
 
Education 
 
1) *Functional 
recovery to upper 
/ lower extremity  
2) **Preference-
based health 
utility scores  
 
3) **Medication 
administration  
 
4) **Global 
quality of life  
1) *Functional recovery to upper / lower extremity  at 8 weeks  
 
Percentage return to normal function, MCID of 9 
               95% Confidence Intervals 
 
Dr 45 to 80 (63.3%) (68/123)  
ESP 52.5 to 65.0 (59.2%) (72/126)  
               ENP 55.0 to 66.3 (60.0%) (73/123)  
 
Equivalence Trial - designed to show that two interventions do not differ by more 
than a pre-specified unimportant  margin;
85
 equivalence margin was set at five 
(calculated using the smallest minimal clinically important difference (MCID) from 
all outcome  measures) 
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Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
 
 
2
0 
Secondary 
Prevention
13
 
Control = 
routine doctor 
care from arrival 
to discharge 
( n =123) 
 
5) **Number of 
days unable to 
work 
 
 
 
 
Post hoc analysis McClellan
86
 (2013)  A randomised trial comparing the cost 
effectiveness of different emergency department healthcare professionals 
in soft tissue injury management Appendix I-5 
 
Johnson-
Mallard
70
  
2007 U.S. 
 
Primary 
Health Care 
 
Set at two 
different 
universities; 
study authors 
affiliated with 
the University 
of South 
Florida, 
Tampa, 
Florida  
 
  
1
0 
Primary 
Prevention
13
 
IPT ^^ 
 
2 week study 
 
 
104 female 
college 
students, 18-
48 years, in 
presumably 
good health, 
not exposed 
to lectures 
on sexually 
transmitted 
infections  
 
 
Intervention = a 
brief, 30 minute 
educational / 
behavioral 
intervention 
delivered  
by an NP  
at one week 
 
(n =51) 
 
 
 
Control = no 
educational / 
behavioral 
intervention 
 
(n = 53) 
Education 1) 1) Knowledge of 
sexually 
transmitted 
infections (STIs) 
including 
knowledge of pre 
and post-natal 
morbidity / 
mortality 
 
 
2) 2) Perceived risk 
of sexually 
transmitted 
infection 
 
Endpoints not pre-specified as primary / secondary 
 
1
st
 Outcome Reported  
 
    1) STI knowledge survey two weeks following the initial pre-test (higher scores 
indicate greater knowledge of  STIs), one week post intervention, mean (SD) 
 
NP Education  26.1 (2.6) 
Control  21.0 (2.3) 
p < 0.0001 
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Author, Year 
Country 
 
Setting  
 
Level of     
Prevention 
 
Design, 
Duration, 
Study 
Population 
(disease 
state / health 
condition / 
wellness
9
) 
               
 Patients (N)                   NP
Intervention 
Domains 
(Objective 1) 
 
Endpoints 
(Objective 2) 
  
Primary* Patient Outcomes / ‘First Outcome Reported’ in Studies without 
pre-specified Primary versus Secondary Endpoints (abridged Objective 3) 
Hannan
69
  
2012 U.S.  
Primary 
Health Care 
Study patients 
were recruited 
prior to 
discharge 
from Jackson 
Memorial 
Hospital, in 
the inner city 
of Miami, 
South Florida  
 
1
0 
Primary 
Prevention
13
  
RS ^ 
 
 
 
1st 2 months 
post-birth 
 
 
 
139  healthy 
first-time 
mothers,  
18 years or 
older, each 
of whom 
delivered a 
healthy,  
full-term 
single infant; 
 low-income 
family  
Intervention = 
follow-up 
phone-calls  by 
pediatric NP 
with ‘back-up’ 
pediatric 
physician 
available for 
consultation    
(n =70) 
 
Control = 
routine  
pediatrician 
appointment in 
2 months 
 
(n =69) 
Diagnosis 
 
Education 
 
Care 
Coordination 
 
 
 
 
 
 
 
Feb. 17, 2017 
$1.00 U.S =  
$1.31 
Canadian 
$0.76 U.S. = 
$1.00 
Canadian 
1) Maternal health 
 
2) Infant health  
 
 
 
3) Infant 
morbidity: urgent 
care visits, 
Emergency Room 
(ER) visits, 
hospitalizations  
 
 
 
4) Health care 
charges: urgent 
care visits, 
Emergency Room 
(ER) visits, and 
re-hospitalizations 
 
 
Endpoints not pre-specified as primary / secondary 
 
1
st
 Outcome Reported  
 
1) Maternal Health Outcomes at 2 months Post Birth  
 
 Mean (SD) Perceived Maternal Health  
NP 18.61 (1.74)   Control 17.2 (2.69) 
p < 0.0004   
 
 Mean (SD) Perceived Stress  
NP 14.71(3.95)    Control 24.64(4.61) 
p < 0.0001 
 
 Perception of Social Support 
Differences non-significant 
*Primary Endpoint   **Secondary Endpoint    ^Role Substitution (RS)   ^^Interprofessional Team (IPT)  
17   Tertiary (3
0
) Prevention
13
 RCTs Pioro (2001),
71
 Allen (2002),
44
 Jones (2002),
66
 Ansari (2003),
45
 Hill (2003),
55
 Tranmer (2004),
46
 Fairall (2005),
8
 Goessens (2006), 
47
 
Nathan (2006),
49
 McCarrier (2009),
7
 Mitchell (2009),
54
 Ralston (2009),
6
 Huizinga (2010),
51
 Kim (2013),
53
 Sawatsky (2013),
48
 Berkhoff (2014),
50
 Mertens (2014)
68
 
10   Secondary (2
0
)
 
Prevention
13
 RCTs Ganz (2000),
61
 Cooper (2002),
62
 Williams (2005),
60
 Krichbaum (2007),
64
 Dierick-van Daele (2009),
67
 ter Bogt (2009),
56
 
Schuttelaar (2010),
59
 McCorkle (2009),
52
 Enguidanos (2012),
65
 McClellan (2012)
63
 
2 Primary (1
0
)
 
Prevention
13
 RCTs  Johnson-Mallard (2007),
70
 Hannan (2012)
69
 
 
**see Appendix J for complete reporting of patient outcomes in each of 29 trials
  
62 
 
  4.6.1 Clinical Endpoint-Outcomes (life threatening events or death)    
  Only three trials out of the 29 RCTs identified in this review measured clinical 
outcomes,
45,49,71
 with no statistically significant differences detected
87,88
 [Appendix I-1]. 
However, two of these interventions were tested in a RS design where the NP was compared 
to another practitioner.
49,71
 The third trial was a pilot IPT study that was significantly 
underpowered for comparison between three groups, with clinical endpoints measured as 
secondary endpoints (the primary endpoint was drug utilization).
45
 Further, pilot studies are 
usually underpowered as they are  not formally powered to assess effect;
89
 their main focus is 
one of feasibility rather than statistical significance,
90
 with recommendations to not provide 
formal significance levels for pilot studies.
89
  
 The RS trial that evaluated care provided by NPs and usual house staff to hospitalized 
patients in internal medicine wards, detected no statistically significant differences in clinical 
outcomes.
88
 The percentage of patients experiencing a composite outcome of transfers to 
intensive care units (ICUs), hospital acquired complications, and in-hospital mortality was 
7.5% among NP treated patients compared to 11.8% in the house staff group  
(p > 0.1).
71
 However, a serious breach following the randomization process may have 
resulted in a NP intervention group with less severe disease than controls. Crossover of 
89/193 (46%) patients to the house-staff ward occurred after  randomization for the following 
reasons: 1) unavailability of beds on the NP ward, accounting for approximately a third of the 
crossovers; 2) request of attending doctors wanting the flexibility to pre-empt randomization 
according to patient health status, accounting for approximately 20% of the crossovers; and 
3) NPs’ concerns that staffing was inadequate to accept new admissions, particularly for 
patients requiring frequent ‘off-hours’ monitoring, with NPs only scheduled to be at the 
hospital between 0730-2000 hours on weekdays, and for morning rounds on weekends
71
 
[Table 5, Appendices G and I-1]. 
 The second RS trial measured the clinical endpoint ‘number of acute exacerbations at 
six months’ as its primary endpoint, and detected no statistically significant differences 
between asthma patients receiving care from a NP versus a respirologist.
49
 A total of 174 
acute exacerbations were recorded over the six-month study period, with 98/174 (56%) 
occurring in the NP group and 76/174 (44%) occurring the respirologist group, p = 0.368. 
Four types of acute exacerbations were further analysed according to: 1) hospital 
readmission; 2) emergency nebulization; 3) number of exacerbations requiring any 
emergency treatment; and 4) the number of exacerbations requiring an additional intervention 
of intravenous or oral steroids during exacerbation. However, differences between groups in 
 63 
 
all four types of acute exacerbations were also not statistically significant
49
 [Table 5 and 
Appendix I-1]. 
 Only one IPT trial that was a pilot study, evaluated the impact of a NP intervention on 
clinical outcomes.
45
 Clinical endpoints of emergency room (ER) visits, hospitalizations and 
mortality were secondary measures [Appendix J], with data collected as an indicator of safety 
(to confirm no increase in adverse events), not efficacy (reduction in adverse events).
45
 
Seventy four providers were randomized into three groups, with each group comprised of 
internists, cardiologists, and NPs. One group provided usual care, another provided care 
enhanced with notifications for drug treatment, and the third group utilized NPs to facilitate 
the initiation, titration and stabilization of patients on beta blocker medication. At 12 month 
follow-up, no statistically significant differences were observed in the percentage of patients 
requiring ER care or hospitalization: usual care group 49% (25/51), notification group 45% 
(29/64), and NP facilitator group 43% (23/54), p = 0.81.  Although all-cause mortality was 
measured, the results could not be interpreted due to a lack of power (i.e. only one death was 
recorded in the notification group) 
45
 [Appendices I-1 and J]. Measurements of 
hospitalization in all other studies of this review focussed on all-cause hospitalizations in the 
context of health care utilization, and thus were reported under the category of  ‘resource 
utilization / cost.’  
 4.6.2 Surrogate Measures of Disease Endpoint-Outcomes (physiologic markers, 
 ‘symptom severity, functional status, behaviour / lifestyle change,’ and drug 
 utilization) 
 Surrogate measures of disease control were assessed in the majority of this review’s 
trials (24/29; 83%).  Among these, ‘symptom severity, functional status, behaviour / lifestyle 
change’ endpoints were the most commonly evaluated, in 18/29 trials [Appendix I-3]. Drug 
utilization endpoints were measured in eight of this review’s 29 trials [Appendix I-4], while 
physiologic markers were measured in eight of the trials measuring chronic disease 
[Appendix I-2].  
Physiologic Surrogate Markers  
 In the eight RCTs containing physiologic surrogate markers as endpoints, 
cardiovascular risk factors (e.g. blood pressure, blood lipids including cholesterol) and blood 
glucose indices were the most common markers tested. However, other markers such as lung 
sputum tests for tuberculosis, and plasma viscosity related to inflammation in rheumatoid 
arthritis, were also observed in this review.  Five study interventions were associated with 
statistically significant improvements; four used an IPT design and one used a RS design. 
 64 
 
The largest impact on physiologic markers was observed in a study where NPs diagnosed 
status of hypercholesterolemia in post-operative coronary heart disease (CHD) patients.
44
 
Activities of the NP intervention in this study included medication adjustment according to a 
study algorithm, and lifestyle counselling for behaviour change strategies with follow-up 
phone contact. Sixty-five percent of patients in the NP group compared to 35% of patients in 
the usual care group  achieved the American National goal for low density lipoprotein 
cholesterol in CHD patients (p = 0.0001) 
44
 [Table 5; Appendix I-2]. A similar study of 
vascular disease patients reported statistically significant improvements in achievement of 
treatment goals related to multiple types of physiologic markers: systolic blood pressure  
(OR = 2.7; 95% CI 1.3–5.4), total cholesterol (OR = 3.3; 95% CI 1.5–7.3), low density 
lipoprotein (LDL) cholesterol (OR = 3.5; 95% CI 1.5–8.6), and body mass index (OR = 4.0; 
95% CI 1.2–13.1).47 However, between-group differences for diastolic blood pressure, high 
density lipoprotein (HDL) cholesterol, triglycerides, fasting blood glucose, homocysteine 
levels, waist circumference, and smoking were not statistically significant
47
 [Table 5; 
Appendix I-2]. 
 Virtually the same set of cardiovascular risk factors were measured in a study 
examining the effect of a behaviour change intervention delivered by NPs to obese patients,
56
 
with secondary endpoints [Appendix J] including total cholesterol and components of 
metabolic syndrome: a combination of at least three risk factors (including high fasting blood 
glucose, high blood pressure, low level of high-density lipoprotein cholesterol, high level of 
triglycerides, and abdominal obesity) being associated with an increased risk for development 
of diabetes and cardiovascular disease.
3
 While no significant differences were observed with 
respect to total cholesterol or fasting glucose concentrations between groups, analysis of 
groups stratified by gender revealed a greater reduction in systolic blood pressure of 14 
mmHg for obese men in the NP group compared to a reduction of 5 mmHg in obese men 
from the usual care group (p < 0.05)
56
 [Appendices I-2 and J]. In one of three post-hoc 
analyses, physiologic markers of blood pressure, fasting glucose, and blood lipids were again 
measured after three years, where a statistically significant improvement in fasting blood 
glucose was reported, with a reduction in the NP group of  - 0.02 mmol/L versus an increase 
in the GP group of 0.10 mmol/L (p = 0.02).  Between-group differences in patient outcomes 
of total cholesterol and systolic blood pressure were non-significant
80
 [Appendix I-2]. Blood 
glucose was also favourably impacted by a NP intervention targeting patients with type two 
diabetes, using a web-based platform. Target levels of glycosylated hemoglobin (A1c < 7%) 
 65 
 
were achieved in 33%  of participants in the NP group compared to 11%  in usual care after 
12 months (p =0.03)
6
 [Table 5; Appendix I-2]. 
 No significant differences were detected in two RCTs measuring endpoints of 
glycemic control, related to both type one
7
 and type two
51
 diabetes. A web-based NP 
intervention for patients with type one diabetes and moderate-to-poor glycemic control at 
baseline, did not find statistically significant reductions in hemoglobin A1c values, despite 
non-significant improvements at each time point examined.
7
 A trial testing a NP phone 
intervention for patients who had recently achieved glycemic control in their type two 
diabetes, found no statistically significant differences between groups in the outcome of 
reduced glycemic relapse
51
[Table 5; Appendix I-2]. 
 Physiologic markers were also used to evaluate NP interventions among patients with 
other medical conditions.  Educational outreach and NP management of respiratory diseases 
in patients from 20 primary care clinics located within an impoverished area of South Africa, 
was associated with improved detection of tuberculosis (OR 1.72, 95% CI 1.04 to 2.85,  
p = 0.04, ICC = 0.007) 
8
 [Table 5; Appendix I-2]. At an outpatient specialist clinic for 
rheumatoid arthritis, physiologic measures of disease activity related to plasma viscosity 
(secondary endpoint) were not significantly different in patients receiving care from a 
rheumatology NP, compared to patients receiving care from junior hospital physicians
55
 
[Appendices I-2 and J]. Distinctions between NP interventions associated with statistically 
significant differences in physiologic marker endpoints, and those associated with non-
statistically significant differences, point to these studies using different NP interventions on 
different study populations, with different control groups for different study durations. 
However, when results are not “statistically significant” it cannot be assumed that there was 
no impact.
88
 
Symptom Severity, Functional Status, Behaviour / Lifestyle Change  
  More than half of this review’s RCTs (18/29; 62%), including 4/10 post hoc analyses 
[Appendix I-3] measured ‘symptom severity, functional status, or behaviour / lifestyle 
change.’ While most of these studies focused on patients with chronic diseases, ‘symptom 
severity, functional status, and behaviour / lifestyle change’ were also assessed for NP 
interventions based in acute care, an NP intervention for breast cancer survivors, and for 
patients receiving an NP intervention post hip-fracture surgery. Ten out of 18 NP 
interventions were associated with at least one statistically significant difference in a 
‘symptom severity, functional status, and behaviour / lifestyle change’ endpoint [Table 4], 
 66 
 
and consisted of various combinations of NP activity domains: diagnosis, prescribing, clinical 
procedures, strategies for behaviour change / education, and care coordination [Table1].  
 Symptom severity was assessed in 15 RCTs.  Most of these trials examined outpatient 
NP interventions where symptom severity was usually combined with functional status 
assessments. For example, in an IPT pilot trial that tested the benefits of an accessible 
pulmonary NP for outpatients with chronic obstructive pulmonary disease (COPD), symptom 
severity was measured according to the mean change in the Clinical COPD Questionnaire 
(CCQ) scores, alongside a functional status endpoint of time to first exacerbation.
50
 Patients 
randomized to the NP intervention experienced slower deterioration over 24 months 
compared to usual care in the symptom domain of the CCQ (0.14, +/- 0.14 in the NP group 
versus 0.58, +/- 0.16 in usual care, p = 0.04), with the difference of 0.44 meeting the minimal 
clinically important difference (MCID) for the CCQ total score of 0.4 [Table 5]. However, no 
significant statistical impact was found in secondary endpoints of median time to first 
exacerbation (p = 0.40) or in the symptom domain of the St. George’s Respiratory 
Questionnaire (SGRQ, p = 0.10), although the difference of 7.7 between groups on the 
symptom domain of the SGRQ did meet the MCID of 4 for the SGRQ total score
50
 
[Appendices I-3 and J]. Symptomology and functional status were assessed in outpatients 
with rheumatoid arthritis who were managed by a NP compared to a physician. Greater 
numbers of intervention than control patients showed improvement in the study’s primary 
endpoint, the Disease Activity Score 28 (DAS 28, comprised of four measures: erythrocyte 
sedimentation rate related to inflammation, the patient’s global assessment of disease, the number 
of tender joints, and the number of swollen joints using the 28-joint count), although no p-values 
were reported [Table 5].  Differences in the secondary endpoint of physical function, 
measured by the Arthritis Impact Measurement Scale (AIMS) were non-significant, yet a 
67% improvement in the length of fatigue was found in intervention patients compared to 
control patients at 48 weeks study completion, with median values (range) of 60 minutes  
(0 - 600 minutes) in the NP group versus 270 minutes (0 - 600 minutes) in the control group, 
p = 0.02.  However, measures of fatigue were based on self-reported data in the absence of a 
formal measurement tool, and data regarding the number of patients per group for 
comparison of the fatigue outcome were incomplete
55
 [Appendices I-3 and J]. 
 Three RCTs focused on the care of cancer outpatients. Two of these trials measured 
both symptomology and functional status,
53,61
 while one trial measured symptomology 
alone.
52
 A trial of daily telemonitoring by NPs to advanced cancer patients was associated 
with a 16% reduction in its primary endpoint of ‘average pain ratings’ on the Brief Pain 
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Inventory (BPI).  Only nineteen percent of intervention patients, compared to 35% of control 
patients experienced average pain intensity (scored as > or = to 4 on the BPI) at 1 week, p = 
0.02
53
[Table 5]. A significant difference (p = 0.03) was also found in the ‘physical function’ 
component of the EORTC QLQC-30 tool (European Organization for Research and 
Treatment of Cancer Quality of Life Questionnaire). All other secondary outcomes were non-
significant, with functional impairment measured using the Karnofsky performance score, the 
Hospital Anxiety Depression Scale (HADS) and the Distress Thermometer
53
 [Appendices I-3 
and J]. Breast cancer survivors experiencing menopausal symptoms due to estrogen therapy 
discontinuation, were randomized to usual care or a NP intervention consisting of counselling 
and recommendation of non-estrogen therapies. Patients in the NP group experienced reduced 
symptoms of menopause, measured using a composite symptom scale (p = 0.0004) [Table 5], 
and improvements in the secondary endpoint of sexual functioning, measured using the 
Cancer Rehabilitation Evaluation System (CARES) Sexual Functioning Scale (p = 0.04)
61
 
[Appendices I-3 and J]. Finally, women who had undergone surgery for suspected ovarian 
cancer received regular NP supportive care in follow-up, including a psychiatric NP for 
patients in high emotional distress.  Intervention effects on cancer-specific quality of life 
were measured at baseline (24 – 48 hours after surgery), one, three and six months post- 
surgery, using three different self-report questionnaires: the Center for Epidemiological 
Studies–Depression Scale (CES-D), the ambiguity subscale of the Mishel Uncertainty in 
Illness Scale (MUIS), and the Symptom Distress Scale (SDS).
52
 In all three tools, reduced 
scores indicate reduced symptom severity. The effect of various combinations of oncology 
NP and psychiatric NP care on the rate of improvement in quality of life was examined using 
three types of mixed effect regression models: 1.(oncology NP intervention without 
psychiatric NP) oncology NP; 2.(oncology NP with psychiatric NP) oncology NP + psychiatric NP; and 
3.(psychiatric NP separate from oncology NP) psychiatric NP. All three models found that rates of 
improvement in ‘uncertainty in illness’ outcomes on the MUIS (reduced scores) were 
significantly greater for intervention patients than for control: effect estimate oncology NP  = - 
0.04847 ± se 0.01394 , p = 0.0006; effect estimate oncology NP + psychiatric NP  =   - 0.03917, ± se 
0.00915, p < 0.0001; and effect estimate psychiatric NP  = - 0.04978 ± se 0.02094, p = 0.0181.
52
 
Intervention patients’ rate of reduction in symptom distress (SDS) was significantly greater 
than control when the psychiatric NP was analysed as a separate factor: effect estimate 
psychiatric NP = - 0.1164 ± se 0.01284, p < 0.0001. However, according to the CES-D tool, no 
significant rates of reduction in depressive symptoms were found for intervention patients in 
any of the three models [Table 5; Appendices I-3 and J]. Study authors suggested that anxiety 
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may be more reflective of existential concerns over time than depressive symptoms in women 
recovering from cancer surgery and undergoing chemotherapy.
52
 
 Depressive symptoms were measured in stroke survivors after psychosocial-
behavioral sessions delivered by a NP.
54
 Symptom severity was measured by the Hamilton 
Rating Scale for Depression (HRSD), alongside secondary measures of physical function, 
participation, and overall stroke impact, using the Barthel Index of Activities of Daily Living 
and the Stroke Impact Scale. While results for secondary measures were non-significant, 
depression levels were favourably impacted by nine psychosocial-behavioral sessions 
delivered by a NP over eight weeks, with mean HRSD scores (reduced scores better) of - 9.2 
± 5.7 intervention versus - 6.2 ± 6.4 control (p = 0.023) at 12 months. Throughout the trial, 
the percentage of patients in remission (i.e. HRSD < or = to 9) was greater for intervention 
patients than control patients. Differences were statistically significant at 9 weeks (OR = 4.8, 
CI 1.8 - 12.9, p = 0.001), 21 weeks (OR = 3.4, CI 1.3 - 8.7, p = 0.008) and 12 months (OR = 
2.7, CI 1.1 - 6.6, p = 0.031); however, after 24 months of follow-up, the difference in 
remission rates was no longer statistically significant (NP 65% patients in remission vs usual 
care 46% patients in remission, p = 0.13). Patient contact in this trial was made either at 
patients’ private homes or outpatient clinics, including rehabilitation facilities54 [Table 5]. In 
contrast, the NP intervention for primary health care patients with incontinence occurred 
primarily within patients’ homes. Statistically significant reductions were found in symptoms 
using a validated symptom severity questionnaire, and at three months, the percentage of 
patients reporting no symptoms or ‘cured’ was 25% in the intervention group and 15% in the 
standard care group (95% CI = 6 to 13, p < 0.001)
60
 [Table 5]. Significant differences in 
‘improvement in one or more symptoms’ were maintained in a long term follow-up study 
conducted six years later (p = 0.02)
81
 [Appendix I-3]. 
 Behaviour / lifestyle change relating to physical activity and diet were found in 
patients that received individualized NP management following coronary artery bypass 
surgery. Favourable effects were demonstrated at one year study completion for secondary 
endpoints of diet: total fat (p = 0.009), saturated fat (p = 0.004), cholesterol (p = 0.006); and 
physical activity (14% increase in metabolic equivalent (MET) hours per week compared to 
usual care, p = 0.02)
44
 [Appendices I-3 and J]. Behaviour / lifestyle change was also assessed 
in obese patients.  The lifestyle counselling intervention delivered by NPs led to significant 
weight loss among obese (BMI > or = to 30 kg/m
2
) and moderately overweight (BMI 25 - 30 
kg/m
2
) patients, with percentage weight loss after one year significantly improved for 
intervention patients (mean change NP -1.9% (SD 4.9) versus GP -0.9% (SD 5.0), p < 0.05)
56
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[Table 5]. However, data stratified for obese and moderately overweight patients did not 
show statistically significant differences between groups. Nonetheless, significant reductions 
were found in waist circumference, with a reduction of 2.8 cm for men in the NP group 
compared to 0.9 cm in usual care, p < 0.05 
56
 [Appendices I-3 and J]. Behaviour / lifestyle 
change was further assessed in two post hoc analyses of the lifestyle counselling intervention 
for obese patients, measuring one and three year effects respectively. At one year follow-up, 
an increase in walking of 33 minutes per week in the NP group compared to a decrease in 
walking of 5 minutes per week in the usual care group was observed (p < 0.05).
82
 However, 
by three year follow-up, significant differences in percentage weight loss, waist 
circumference,
80
 and physical activity
84
 were not maintained. No significant differences were 
found in diet at both one and three year follow-up 
82,84
 [Appendix I-3]. Finally, behaviour / 
lifestyle change relating to rates of alcohol and drug use in low-income, young adult primary 
care patients was evaluated using the ASSIST (Alcohol, Smoking & Substance Involvement 
Screening Test) tool. Developed by the World Health Organization, this tool assessed the 
effectiveness of a brief motivational interviewing intervention conducted by NPs. Significant 
reductions in alcohol ASSIST scores were observed in the intervention group compared to 
usual care (p = 0.0293), while differences between groups for cannabis (p = 0.1119), and 
methamphetamines (p= 0.2264) were non-significant [Table 5].
68
 
 Symptom severity, functional status, and behaviour / lifestyle change endpoints were 
not consistently improved by NP interventions, with some interventions positively impacting 
certain endpoints but not others. For example, in the intervention targeting cardiac surgery 
outpatients, no significant differences were observed in the mean number of total symptoms 
between the intervention and control groups, measured by the validated Memorial Symptom 
Assessment Scale.
46
 However, in another intervention targeting coronary artery bypass graft 
(CAGB) surgery outpatients, the overall mean scores measured by the validated ‘Symptom 
Inventory,’ showed a significant difference at two weeks (NP 45.2 (SD 10.2) versus usual 
care 50.4 (SD 12.6), p = 0.002), but by trial completion at six weeks, the significant 
difference did not persist ( p = 0.23)
48
 [Appendices I-3 and J]. In other cases, no significant 
differences were detected on these outcomes overall. A six-month intervention by a geriatric 
NP for post-surgical hip fracture outpatients resulted in no statistically significant differences 
between groups for self-rated health, level of depression, activities of daily living (ADLs), or 
instrumental ADLs (IADL), using the Global Health self-ratings, Geriatric Depression Scale 
and Functional Status Index  respectively. However, this pilot trial’s sample size was only 33 
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patients, with 10 patients lost to follow-up: four patients withdrew (three control and one 
treatment) and six died (three from each group) [Table 5; Appendices I-3 and J].
64
 
 Symptom severity and functional status were also measured in several RCTs using RS 
designs.  In these studies, non-significant differences may be considered a positive result 
considering the comparator groups were typically managed by established providers. For 
example, measures of eczema severity (secondary endpoint, Appendices I-3 and J) in children 
using SCORAD (SCORing Atopic Dermatitis); and disease-specific quality of life (primary 
endpoint, Table 5) for children aged < or = to 4 years according to the Infants’ Dermatitis 
Quality of Life Index (IDQOL), and for children aged 4 -16 years according to the Children’s 
Dermatology of Life Quality Index (CDLQI), were not significantly different for patients 
receiving care from a NP or a dermatologist.
59
 A NP intervention on an internal medicine 
hospital ward detected no statistically significant differences in measures of functional status, 
activities of daily living, symptom severity, and patient assessments of care, compared to 
regular house staff care. However, this trial’s post-randomization breach resulted in crossover 
of 89 NP patients to the house-staff ward, with only 104 patients admitted to the NP ward 
after randomization of 193 patients to the NP ward, suggesting possible selection bias
71
 
[Appendices G, I-3 and J]. 
 Another acute care RS trial compared care delivered by an emergency department NP 
for patients with soft tissue injuries to care provided by extended scope physiotherapists 
(ESPs) and doctors. Non-significant differences were detected in primary measures of 
functional recovery outcomes, using the “Disability of the Arm, Shoulder and Hand” score 
for upper-extremity injuries, and the “Lower Extremity Functional” score for lower-extremity 
injuries
63
[Table 5]. Symptoms of swelling and stiffness in minor injury patients treated either 
by a NP or a senior house officer in an emergency department, were measured in a one month 
follow-up questionnaire, alongside functional status in terms of time to recovery, level of 
activity, sleep patterns, and productivity (time off work). Again, differences in symptoms and 
functional status between minor injury patients in intervention and control groups were all 
non-significant.
62
 Finally, differences in secondary measures of peak flow were not 
significantly different between acute asthma outpatients managed by NPs or respirologists
49
 
[Appendices I-3 and J]. 
Drug Utilization  
 The impact of NP interventions on drug utilization was measured in 8/29 studies 
(28%) [Appendix I- 4]. Statistically significant differences were associated with four 
interventions, in terms of 1) appropriate prescribing of inhaled corticosteroids for asthma,
8
 2) 
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reduced chronic oral non-steroidal anti-inflammatory drug (NSAID) use for chronic 
musculoskeletal pain,
66
 3) administration of medications for treatment of soft tissue injury in 
an emergency department,
63
 and 4) target use of beta-blocker medication for chronic heart 
failure patients.
45
 
 A NP intervention comprised of expanded prescribing provisions within an 
educational outreach program, sought to improve the case management of respiratory disease 
patients in primary health care clinics in South Africa. However, the intervention’s impact on 
anti-infective / anti-inflammatory drug utilization for tuberculosis, tuberculosis / HIV co-
infection, upper / lower respiratory tract infection, asthma, and chronic obstructive pulmonary 
disease was inconsistent. For example, NP care increased the use of inhaled corticosteroids 
(outreach 13.7% (137/1000) versus control 7.7% (77/999), OR 1.90, 95% CI 1.14 to 3.18,  
p = 0.006, ICC = 0.019), while no statistically significant differences were observed for co-
trimoxazole use in patients with HIV, or in antibiotic prescribing overall.
8
 Results for 
utilization of antibiotics were similar between groups, with 39.7% (397/1000) of outreach 
patients versus 39.4% (394/999) control patients receiving prescriptions (OR 1.01, 95% CI 
0.74 to 1.38, p = 0.95, ICC = 0.042). However, the lack of change in antibiotic prescribing 
may well be appropriate for the severe case mix comprising the study population. Within the 
subset of ‘patients with predefined markers of severe diseases,’ more referrals to physicians 
occurred at intervention clinics
8
 [Table 5]. 
 An intervention delivered by a single NP to five different primary health care clinics 
targeted patients with non-malignant, non-inflammatory musculoskeletal pain who regularly 
used non-steroidal anti-inflammatory drugs (NSAIDs). The six month NP intervention 
consisted of individualized strategies to reduce NSAID use (e.g. strategies on weight 
reduction, exercise, relaxation, etc.). Reduced NSAID use was this study’s primary endpoint,  
measured with a self-administered questionnaire that was validated with computerized 
prescription records.
66
 In the intervention group, 38% (42/110) had either discontinued or 
reduced their NSAID dose by ≥ 50% compared to 12.5% (14/112 patients) of the control 
group (p < 0.0001).
66
  However, this self-reported endpoint was inevitably influenced by the 
element of ‘social desirability,’ where the active intervention provided advice for reduction of 
NSAID use
66
 [Table 5].  
 Drug utilization in treatment of soft tissue injury was examined as a secondary 
endpoint in a RS trial based in an emergency department, where medication use between 
three groups of professionals (NPs, extended scope physiotherapists, and doctors) was 
reported as administered to 23.5% of all participants, although no raw data is shown.
63
 The 
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extended scope physiotherapist (ESP) group administered medication to 3.6% of patients, 
compared to 23.2% for NPs and 42.2% for doctors (p < 0.001). Interpretation of this 
difference is complicated by the lack of information underlying this result. While actual 
numbers of treatments appeared to differ significantly (data not shown), practitioners were 
reported to be clinically equivalent
63
 [Appendices I- 4 and J]. 
 Adjustment of medication was measured in three IPT interventions targeting 
outpatients with cardiovascular disease (CVD).
44,45,47
 Utilization of beta-blocker medications 
was significantly improved by a NP intervention in chronic heart failure outpatients receiving 
either usual care, electronic prescriber notifications, or NP facilitation, with the proportion of 
outpatients reaching target doses of beta-blocker medication measured as a primary 
endpoint.
45
 In the NP facilitator group, 67% (36/54) of patients were either initiated or up-
titrated on beta-blockers, compared to 16% of the notification group (10/64) and 27% of the 
usual care group (14/51), p < 0.001.
45
 Also, more subjects in the NP facilitator group reached 
target doses compared to control and notification groups: 43%; 23/54 versus 10%; 5/51 and 
2%; 1/64 respectively, p < 0.001.
45
 Further, among patients who reached target doses of beta-
blockers, the mean length of time from initiation to target dose was also lowest in the NP 
facilitator arm (5.9 months), compared to the control group (8.5 months) and the notification 
group (9.3 months), p < 0.001
45
  [Table 5]. 
 A RCT of patients with four types of established cardiovascular disease (CVD): 
peripheral arterial disease, abdominal aortic aneurysm, cerebrovascular disease, and coronary 
heart disease, compared usual care to ‘NP management of risk factors in addition to usual 
care.’47 Self-reported use of medications after one year (antiplatelet agents, blood pressure-
lowering agents, lipid-lowering agents, glucose-lowering agents, ACE-inhibitors / 
angiotensin II antagonists, and folic acid)  was measured as a secondary endpoint, while the 
primary endpoint was the achievement of treatment goals in physiologic CVD risk factors.
47
 
A NP helped patients develop action plans that included aspects of lifestyle and medication, 
following a protocol for each risk factor. At one-year follow-up, medication use increased in 
both groups, but more so in the intervention group for five out of six types of medication. 
However, the study physician was required to prescribe or change medication during the trial, 
since a NP was not formally allowed to prescribe in the Netherlands. While study authors did 
not report p-values for these self-reported measures, the largest differences were noted in the 
utilization of lipid lowering drugs, ACE-inhibitors / angiotensin II antagonists, and folic acid. 
Lipid lowering drugs were used by 89% (80/90) NP patients versus 73% (55/75) usual care 
patients; ACE-inhibitors / angiotensin II receptor antagonists, by 76% (57/90) NP patients 
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versus 53% (40/75) usual care patients; and folic acid was used by 61% (55/90) NP patients 
versus 28% (21/75) usual care patients. Glucose-lowering agents were used by 19% (17/90) 
NP patients versus 16% (12/75) usual care patients,  blood pressure lowering agents by 77% 
(69/90) NP patients versus 69% (52/75) usual care patients, with virtually identical use of 
antiplatelet agents by 90% (81/90) NP patients versus 91% (68/75) usual care patients
47
 
[Appendices I-4 and J]. 
 Non-significant differences in drug utilization were detected in a study of patients 
who had received coronary revascularization surgery, followed by a NP intervention 
comprised of ‘individualized case management of cardiovascular risk factors in addition to 
usual care.’44 Four to six weeks following cardiac surgery, the need for / adequacy of drug 
therapy was evaluated by the NP according to lipid management algorithms. Medication was 
initiated or adjusted at a serum concentration of low-density lipoprotein cholesterol (LDL-C) 
> 2.20 mmol/L, with patient progress periodically assessed through plasma lipid and liver 
function tests. When the response to drug therapy was adequate, the patient was retested 
every three months, or more frequently for drug combinations requiring closer follow-up. 
Part of the NP intervention also included lifestyle modifications, including nutritional 
counseling and exercise plans, which were emphasized as an integral part of lipid 
management in conjunction with pharmacotherapy. At one year, eighty-seven percent 
(100/115) of patients in the NP group and 79% (89/113) of patients in the usual care group 
were on lipid-lowering drugs, p = 0.1.
44
 Among patients on pharmacotherapy, 97% in both 
groups were taking a single statin agent (HMG coenzyme A reductase inhibitor)
44
 
[Appendices I-4 and J]. As discussed previously, non-significant differences in RS studies 
can be interpreted differently than those for IPT studies. For example, a RS study compared 
care provided by a single NP with over 20 years of rheumatology experience to traditional 
care provided by Junior Hospital Doctors (JHDs) two years into their rheumatology training 
rotation. No significant differences were observed in the use of intra-muscular steroids at 48 
weeks: NP 15% (36/234) versus JHD 13% (29/226). Medication changes on consult with the 
study rheumatologist were also similar between both practitioners: NP 24% (56/234) versus 
JHD 22% (50/226) 
55
 [Appendices I-4 and J]. 
 Using a similar RS design, patients in primary health care clinics were randomized to 
newly graduated NPs or GPs with an average of about 16 years’ experience. The numbers of 
prescriptions given for respiratory / throat infections, ear infections, and urinary tract 
infections at primary health care clinics were not significantly different for endpoints of one 
prescription given (NP 55.0% (411/747) versus GP 54.2% (352/650), p = 0.75), two 
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prescriptions given (NP 16.9% (126/747) versus GP 19.5 % (127/650), p = 0.20), or three or 
more prescriptions given (NP 8.8% (66/747) versus GP 7.8% (51/650), p = 0.51). However, 
set in the Netherlands in the year 2009, NPs in this RCT had no full authority to prescribe 
medications, such that GPs validated the NPs’ prescriptions. As a result, substantial 
confounding by the physician’s role cannot be ruled out67 [Appendices I-4 and J]. 
 4.6.3 Resource Utilization / Cost Endpoint-Outcomes  
 Fourteen RCTs contained at least one measurement of resource utilization or 
cost.
6,46,48-50,55,60,62,63,65-67,69,71
  Resource utilization / cost was evaluated in separate post hoc 
publications for six interventions
27,78,79,81,83,86
 [Appendices I-5 – I-7]. Endpoints under this 
category primarily focused on hospital care (emergency department visits, inpatient 
admissions, length of stay, readmission to hospital, hospital lab tests), but also included 
outpatient visits (visits to outpatient clinics, specialist consultations), family practice visits in 
the primary health care setting, and various associated costs. Whether set in primary health 
care, outpatient settings, or acute care, trials measuring resource utilization / cost virtually all 
evaluated acute care resources (12/14 RCTs).
6,46,48-50,55,60,62,63,65,69,71
 However, only 3/29 
(10%) of this review’s RCTs were actually set in acute care,62,63,71 with all three acute care 
RCTs designed as RS trials, to compare the effectiveness of two or more different types of 
health care providers. 
 Controversy accompanied appropriate approaches taken to cost analyses of 
equivalence trials, designed to show that two interventions do not differ in either direction 
(‘zone of indifference’ regarding superiority / inferiority) by more than a pre-specified 
insignificant amount (i.e., a two-sided test).
85
 Two RS trials of this review used cost 
minimization analysis,
27,86
 a method considered rarely appropriate for evaluation of cost for 
health effects.
91
 The premise for this method is that the intervention and control treatments 
are equally effective yet few interventions are actually equally effective. Evidence must 
support the claim that outcomes are the same enabling an analysis of costs only, with the least 
costly alternative considered the most efficient.
91
 In terms of categorization of costs for 
analysis, the Panel on Cost-Effectiveness (CE) in Health and Medicine further asserts it is 
uncontroversial for cost-effectiveness analyses (CEAs) informing societal resource allocation 
to include societal costs. Health intervention studies informing societal resource allocation 
are to include resource costs from a long-term, societal perspective, where the numerator of a 
CE ratio captures changes in resource use associated with an intervention while the 
denominator captures changes in health associated with an intervention. The societal 
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perspective dictates that all impacts on human health and resources must be included in either 
the numerator or denominator of a CE ratio to avoid incomplete analyses.
92
 
Acute Inpatient Care  
 All three RCTs set in acute care were RS trials that measured resource utilization, but 
only one statistically significant between-groups difference was found, in wait times for 
minor injury patients treated by NPs and senior house officers.
62
 The average wait for each 
practitioner at this study’s emergency department (ED) was 70.1 minutes for the senior house 
officer (n=102) compared to 48.6 minutes for the NP (n=102), (95% CI 11.2–31.8 min, p < 
0.001)
62
 [Table 5]. Although cost was not measured, cost implications include costs of 
professional service time and costs of the patient’s time spent waiting, in terms of 
productivity loss and personal payment for health care. Differences between groups in 
resource outcomes of total consult time, seeking advice, X-ray requests, referral to follow-up 
clinics, unplanned follow-up, and missed injuries, were not statistically significant
62
 
[Appendices I-5 and J]. A trial set in an inner city emergency department (ED), measured 
functional recovery to the injured extremity as its primary endpoint, to evaluate clinical 
effectiveness of three ED professionals: NP, ESP (extended scope physiotherapist) and 
doctor. Number of days off work was reported as a secondary outcome in this trial, with care 
provided by NPs and ESPs reported to be equivalent to routine care provided by doctors.
63
 In 
the post hoc economic evaluation that employed the method of cost minimization analysis on 
the premise that the three groups of ED professionals were clinically equivalent,
63
 the cost of 
NP care was found equivalent to routine care, while ESPs were either equivalent or cheaper. 
Both ESPs and NPs were found to incur greater indirect costs associated with follow-up 
appointments. However, limitations to endpoint assessment included no verification of self-
reported time spent with patients by each professional group, time upon which calculations 
were based, resulting in estimates that may not be robust
86
 [Appendices I-5 and J]. NP care 
for general medical inpatients was assessed for length of hospital stay, number of 
consultations to other services, hospital charges, and overall costs, compared to traditional 
house staff. Only non-significant differences were detected, with NPs incurring higher 
pharmacy and lab costs, shorter length of hospital stay, smaller total and ancillary hospital 
charges, lower costs in radiology and respiratory therapy, less transfers to intensive care units 
and less hospital acquired complications (p > 0.1)
71
 [Table 5]. 
Specialized Outpatient Care 
 Ten NP interventions from the outpatient setting were evaluated for their impact on 
resource / cost endpoint-outcomes, seven within the original trial,
6,46,48-50,55,65
 and three 
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resource / cost evaluations occurring post hoc to the original trial.
78,79,83
 Statistically 
significant differences were detected in five interventions, two of which were reported in post 
hoc analyses.
78,79
 However, eight out of 10 outpatient studies used endpoint assessment tools 
of limited quality, based on estimations of health care utilization according to patient self-
report in the absence of a tool formally tested for reliability / validity [Appendix I-6]. Two 
RCTs of respiratory disease measured outpatient resource use, one a RS trial evaluating care 
provision for acute asthma patients,
49
 and the other an IPT trial testing a patient-initiated 
strategy for care of chronic obstructive pulmonary disease (COPD) patients.
50
 In the RCT of 
acute asthma patients, resource measurements included hospital clinic attendance; visits to 
general practice offices, emergency departments, or ambulance paramedics for exacerbations; 
and hospital readmissions.
49
 The mean number of follow-up clinic appointments attended was 
1.97 in the NP group (130 clinics /66 patients) versus 2.23 in the doctor group (147 clinics 
/66 pts), with a statistically significant relative risk of 0.88 (95% CI 0.70 to 1.12), p = 0.011. 
Differences in resource use for exacerbations were non-significant, e.g. relative risk of 
hospital readmission = 0.40 (95% CI 0.14 – 1.12, p = 0.09)49 [Appendices I-6 and J].  
 An on-demand strategy of outpatient-scheduling for COPD patients was tested in an 
IPT trial where patients were instructed to call the pulmonary NP on an increase of 
symptoms. Subsequent costs were calculated in relation to the number of visits to GPs, 
pulmonologists, pulmonary NPs, and hospitals. GPs and pharmacists were contacted to 
collect healthcare resource use in primary care while the hospital’s computer system was 
used to identify visits to pulmonologists, pulmonary NPs and emergency rooms. Costs were 
then evaluated from two perspectives: healthcare provider (GP, pulmonologist, and 
pulmonary NP as outpatient providers; emergency department and pulmonary ward as 
inpatient providers), and healthcare insurance costs for all aforementioned providers.
50
 In 
primary care, reductions in GP visits for COPD were found to be statistically significant in 
the on-demand versus control group: median score with range NP 4 (0-32) versus GP 5 (0-
20), p = 0.01. The number of visits to the pulmonary NP increased significantly in the on-
demand versus control group: median score with range NP 1 (0-14) versus Doctor 0 (0-4),  
p = 0.003, while no statistically significant differences were detected between groups for 
exacerbations, visits to the pulmonologist, and hospitalizations.
50
 Total costs were lower in 
the intervention group, owing in part to the slower COPD deterioration in the NP group, 
reflected in the statistically significant differences in the symptom domain of the Clinical 
COPD Questionnaire (section 4.6.2). Although total costs were lower for the on-demand 
group from both perspectives: 1) healthcare provider (mean savings of € 518 per intervention 
 77 
 
patient) and 2) healthcare insurance / reimbursement (mean savings of € 458 per intervention 
patient), these lower costs were not statistically significant
50
 [Appendices I-6 and J]. NP 
support to outpatients following surgery for suspected ovarian cancer did not result in 
significant differences in the number of self-reported hospitalizations, emergency room or 
oncology outpatient visits. However, based on regression modelling, primary health care 
visits were estimated to be lower in the NP group, with statistically significant differences in 
estimated effect sizes: NP 1.58 (n = 59) versus control 2.45 (n = 62), p = 0.0003
79
  [Appendix 
I-6]. 
 Another RCT examining resource use of patients immediately following their hospital 
discharge, tested the effect of a ‘brief NP intervention’ on older adults transitioning home, in 
terms of ED visits, hospital admissions, days hospitalized, and number of physician office 
visits.
65
 Patients randomized to the NP intervention group had significantly fewer physician 
office visits throughout the six month study duration: NP (n=100) mean 9.94 (SD 8.5) versus 
usual care (n=99) mean 11.72 (SD 7.7), p = 0.036. However, no significant differences were 
observed for ED visits (NP mean 0.50 (SD 1.2) versus usual care mean 0.99 (SD 2.5), p = 
0.096), days spent in the hospital, home health care days of service, or hospital re-admissions 
65
 [Appendices I-6 and J]. The only other statistically significant difference found in resource 
/ cost endpoints of outpatient studies, compared care provided by NPs and dermatologists to 
children with eczema and their families.
59
 This trial’s post hoc cost-effectiveness analysis 
(CEA) included costs measured from a societal perspective as well as a current report on 
international costs of eczema in children, for accurate comparison with costs in the present 
study.
78
 The mean annual family costs / patient were significantly higher at €608 in the 
dermatologist group compared to €302 in NP group (mean difference - €306, 95% CI - €475 
to - €16), with treatment of mild, moderate and severe levels of eczema, incurring higher 
mean annual healthcare costs in the dermatologist group than in the NP group, by €427,  
€314, and €315 per child respectively. Lower costs in the intervention group were largely due 
to the lower salary of the NP combined with a lower number of outpatient visits in children 
aged < 4 years in the NP group.  Also, patients randomized to NP care had fewer GP visits in 
the follow-up period compared to those managed by a dermatologist
78
 [Appendix I-6]. 
 In five outpatient RCTs, no significant differences were detected / reported in 
resource utilization / cost endpoints. Three of these interventions consisted of risk factor 
management in post-surgical cardiovascular disease (CVD) patients, one consisted of web-
based blood glucose management in type two diabetes patients, and the other consisted of an 
intervention designed to test substitution of a rheumatology NP for junior house doctors 
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(JHDs) in outpatient care of rheumatoid arthritis patients. Two RCTs of post-cardiac surgery 
outpatients evaluated the effect of NP support in addition to usual care, on emergency 
department visits and hospital admissions, tracked through patient self-report.
46,48
 Non-
significant differences in healthcare resource use were found by outpatients who underwent 
coronary artery bypass grafting, with the control group self-reporting higher totals of 7 more 
emergency department (ED) visits and 4 more hospitalizations by six week study completion 
than the intervention group. Study authors noted potential clinical significance, based on less 
physician visits, ED visits, and hospital readmissions overall for intervention patients than for 
control patients.
48
 The other RCT of cardiac surgery outpatients tracked patient flow  for five 
weeks following hospital discharge and found non-significant differences in the other 
direction, with ED visits self-reported for 23% (21/92) intervention patients versus 16% 
(15/92) control patients (p = 0.36), and hospital readmissions self-reported for 9.8% (9/92) 
intervention patients versus 8.7% (8/92) control patients, p = 0.85 
46
 [Appendices I-6 and J]. 
 A short term economic evaluation was undertaken to determine if a NP intervention 
focused on cholesterol management in high risk coronary heart disease patients,
44
 justified 
the additional costs associated with the expanded service provision.
83
 This was not a 
comprehensive cost-effectiveness analysis (CEA) that considered savings associated with the 
prevention of cardiovascular events by assuming the societal perspective, but a CEA that only 
provided a basic understanding of the cost-effectiveness of NP case management for 
reduction in low-density lipoprotein cholesterol (LDL-C) levels.
44
 The annual incremental 
cost of NP case management of hypercholesterolemia was $26.03 per mg/dL and $39.05 per 
percentage reduction in LDL-C.
83
 Despite less NP time required for patient management over 
time, these time-savings were offset by more expensive, escalating drug treatment in most 
patients.  As a result, the significant reduction in LDL-C among intervention patients, was not 
attained within the range of cost-effectiveness anticipated when compared to control
83
 
[Appendix I-6]. Delivering an NP intervention through a web-based platform may generally 
be expected to reduce costs of patient management. However, the NP intervention designed 
to manage patients’ type two diabetes was associated with non-significant differences in 
measures of resource utilization, including visits to primary care clinics, outpatient clinics, 
specialty physician offices, and inpatient days during a two year period. Yet this IPT web-
based RCT for type two diabetes patients was only powered to test its hypothesis on the 
physiologic marker of glycated hemoglobin.
6
 Finally, a RS intervention for rheumatoid 
arthritis outpatients found lower numbers of lab tests, X-rays, and GP visits in the NP group 
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compared to control, although 20% more referrals to other health professionals were made in 
the NP group (no p values reported)
55
 [Appendices I-6 and J]. 
Primary Health Care  
 Resource utilization / cost endpoints were assessed for four NP interventions 
delivered from primary care settings,
60,66,67,69
 including two post hoc analyses
27,81
 
[Appendix I-7]. Cost assessments specifically, included a cost minimisation evaluation of NP 
substitution for GPs,
27
 as well as two cost-effectiveness analyses (CEAs): one of a continence 
service (home care)
60
 and another of its long term follow-up study.
81
 Although three 
interventions were associated with statistically significant results, all endpoint assessments 
were of limited to low quality. In a RCT comparing NPs to GPs in primary health care 
clinics, resources were evaluated according to duration of consultations, patient outcomes 
(return visits; productivity losses), and medical resource consumption (diagnostic 
procedures), with no report of acute care utilization in this trial.
67
 The number of 
prescriptions issued were tracked as a measure of medical resource consumption rather than 
drug utilization per se [Appendix I-4]. Statistically significant between-group differences 
included longer face-to-face consults with patients, with NPs at 12.22 minutes (SD = 5.7) 
versus GPs at 9.20 minutes (SD = 4.8), p < 0.001, and more frequent re-attendance of NP 
patients than GP patients, with a difference of 5.2% (p = 0.04). Patients’ productivity losses 
were reported to be identical at a mean value of 1.11 days. No statistically significant 
differences between groups were found in the percentage of prescriptions given, whether one 
(p = 0.75), two (p = 0.20), or three or more (p = 0.51) prescriptions were given; nor in the 
investigations (p = 0.55) or referrals (p = 0.24) carried out. However, neither was there any 
conclusive properties-information reported for the study questionnaires that provided data for 
group comparisons, but only a justification of validity according to the study authors’ 
assurance on discussion with two GPs with research experience
67
 [Appendix I-7]. In the post 
hoc economic evaluation of this trial, costs of GP versus NP consultations were estimated 
from practice and societal perspectives.
27
 Direct costs were significantly lower for 
consultations by NPs versus GPs, with a mean difference of €8.21 per consultation  
(p = 0.001).
27
 Overall direct costs (resource use, length of consultations, costs of follow-up 
consultations, and salary costs) were also significantly lower in study clinics that integrated 
NPs, compared to control clinics that did not integrate NPs, with a mean difference in direct 
costs of €3.45 per consultation in favour of study clinics (NP or GP consultations), p = 0.04.27 
Cost differences were mainly caused by the difference in salary between NPs at €41,160.00 
per year and GPs at €94, 475.92 per year (p.e30) 27 [Appendix I-7]. 
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 The only other RCT in this review that measured resource / cost endpoints that were 
not based in acute care, involved an NP intervention providing advice for reduction of non-
steroidal anti-inflammatory drug (NSAID) use in patients with chronic musculoskeletal 
pain.
66
 Resource utilization was measured in terms of i) costs of the NP-based educational 
service, including clinic / home visits; and ii) patient costs, including travel and time for 
appointments with the NP, excluding costs incurred by patients resulting from the advice 
given (e.g. additional purchases of drugs and equipment such as hot and cold packs / wraps, 
posture support braces, specialized footwear etc.). However, outcome assessment for both 
groups was based on treatment by the same single NP, with changes in health service use, 
drug and patient costs all self-reported, and not inclusive of all (societal) costs.
66
 The NSAID 
study is the only study in this review that focused on the discontinuation of medications. 
Chronic NSAID users’ prescription costs were significantly lowered in the intervention group 
compared to control. Forty-two (38%) intervention patients either stopped taking oral 
NSAIDs altogether or reduced their dose by 50% or more, compared to 14 (13%) control 
group patients (p < 0.0001) [Appendix I-4]. Although this trial found a significant reduction 
of 2.61 British pounds in median NSAID costs for intervention patients over six months  
(p = 0.008), a non-significant increase in total prescription costs occurred in both groups, to a 
larger degree in the intervention group. The overall mean cost of the NP intervention was 
calculated to be £40.70 per patient, with no known comparator value provided for standard 
GP service. Mean patient travel costs were reported as £0.83 per patient, with no comparative 
control cost provided 
66
 [Appendices I-7 and J].  
 Resource utilization and cost endpoints were evaluated in a RS trial of low-income 
mothers and infants during the first two months post-partum. A NP intervention comprised of 
six follow-up phone calls on post-hospital discharge days 3, 7, 14, 21, and months 1 and 2, 
screened for concerns and offset challenges such as language barriers and sparse social 
support that could impede health care access. Usual care was comprised of information taken 
home on hospital discharge, and a pediatrician appointment at two months.
69
 Investigators 
quantified the costs for infants’ emergency department visits, urgent-care-centre visits, or re-
hospitalisations, at two months post-hospital discharge. Intervention costs included 
estimations of NP services based on the time required for phoning patients, charting / filing, 
consulting with physicians, as well as administration time.
69
 Where the intent of this RCT 
was to provide a comparison of health care charges between groups, distinctions were thus 
noted by the study authors in terms of health care charges being inequivalent to 
comprehensive costs that include societal costs. Health care charges associated with the 
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intervention infants’ emergency room visits, urgent-care-centre visits, or re-hospitalisations, 
as well as charges associated with the intervention service at two months post-discharge, 
resulted in total intervention group charges of $14,333, compared to $70,834 for the control 
group, a difference of $56,501, p < 0.05. In addition to the study authors’ acknowledgement 
that this RCT does not provide a formal cost comparison inclusive of societal costs, further 
perspective is noted in the small sample size of this trial, resulting in a cost differential that 
was largely comprised of the difference in hospitalizations (one hospitalization in the 
intervention group vs three hospitalizations in the control group)
69
 [Appendices I-7 and J].  
 Finally, resource / cost evaluation of a NP-led continence service was made based on 
patient interviews regarding contacts with National Health Service providers for urinary 
symptoms and use of consumables (incontinence supplies and prescription medicines), at six 
months
60
 [Appendix J] and at six-year follow-up
81
 [Appendix I-7]. However, while costs of 
usual care services were taken from published national cost data, costs of the intervention 
service were only estimated based on a ‘home care’ service model, with in-home interviews 
conducted at baseline, three, and six months. Intervention patients that received the NP-led 
service reported higher cost and lower cost-effectiveness at six months for symptom 
reduction.
60
 Patients were included in the cost-effectiveness analysis (CEA) only if full costs 
and number of symptoms alleviated could be calculated at both the three and six-month home 
interview, resulting in only 905/3746 or 24% of the total group of study patients completing 
resource data for the CEA: 734 patients from the intervention arm and 171 from the standard 
care arm (individual randomization occurred at a ratio of 4:1 for NP patients: usual care 
patients, in order to ensure sufficient numbers of intervention patients for evaluation of 
symptoms).
60
  Not accounting for 76% of the total participants, 81% (734/905) of the patients 
that provided  data for the CEA were intervention patients while 19% (171/905) of the 
patients that provided data for the CEA were standard care patients.
60
 While the quality and 
validity of a CEA depend crucially on the quality of the underlying data that describe the 
effectiveness of interventions and the course of illness without intervention,
92
 neither the 
original incontinence trial
60
 nor the long-term follow-up
81
 tabled any stratification of cost 
(only the distinction between National Health Service costs and individual costs, with 
reference to an online Supplementary Table 4 that is no longer available). In the long term 
follow-up study, costs in the NP arm were again reported higher than those in the standard 
care arm, although these differences in cost were not statistically significant
81
 [Appendix I-7]. 
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 4.6.4 Global Quality of Life / Patient Satisfaction Endpoint-Outcomes 
Global Quality of Life 
 Quality of life endpoints were measured in 9/29 (31%) trials [Appendix I-8]. All 
quality of life measurements were made by the reliable and valid SF-36 tool (or the shorter 12 
and 8 item versions), providing information regarding non-specific, overall functional health 
and well-being from the patient's point of view.
93
 Overall / global quality of life (versus 
disease-specific quality of life, noted in ‘symptom severity’ of section 4.6.2) was measured 
for several different types of NP interventions targeting patients with chronic disease, 
remitted breast cancer, chronic musculoskeletal pain, as well as hospitalized patients. 
 Only one RCT detected statistically significant intervention effects on global quality 
of life outcomes, in women recovering from surgery for suspected ovarian cancer. 
Significant results were revealed in regression modelling, used to evaluate the effect of 
various combinations of oncology NP and psychiatric NP (PSYNP) care on patients’ rate of 
change in global quality of life (QOL) over time, compared to control.
52
 This trial used the 
SF-12 tool to measure global QOL (higher scores indicate better health) alongside measures 
of cancer-specific QOL, reported earlier in section 4.6.2.  The rate of improvement over time 
in both physical and mental components of the SF-12 were reported as ‘estimated effect’ 
values derived from the model, with each of three models built to reflect the variable 
assignment of the PSYNP for women in the intervention group in high emotional distress:  
1) the PSYNP component significantly increased the rate of improvement over time in both 
physical and mental components of the SF-12: a) physical effect estimate  = 0.1948 ± se 
0.03877, p < 0.0001  and b) mental effect estimate = 0.06558 ± se 0.01676, p = 0.0001;  
2) the oncology NP without the PSYNP resulted in less favorable significant differences in 
the physical SF-12 score: effect estimate = - 0.07599 ± se 0.02425, p = 0.0019, with  non-
significant differences in the mental SF-12 score: effect estimate = 0.01776 ± se 0.01138,  
p = 0.1195; and 3) the oncology NP and PSYNP components analysed together found a 
significant difference in mental SF-12 scores: effect estimate = 0.02300 ± se 0.00748,  
 p = 0.0023, while study authors reported a poor model fit related to the physical 
component of the SF-12
52
 [Table 5, Appendices I-8 and J]. 
 The remaining eight RCTs did not detect significant differences in global QOL. Two 
of these trials employed a RS design: one compared care delivered by NPs, extended scope 
physiotherapists and physicians for emergency department patients with soft tissue injuries,
63
 
and the other compared care delivered by NPs to that provided by regular house-staff for 
acute internal medicine patients;
71
 in both cases, no significant differences in global QOL 
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were detected. In addition, the six IPT trials that did not detect statistically significant 
differences in global quality of life outcomes included three outpatient interventions that 
focused on patients with cardiovascular disease,
46-48
  a NP intervention providing on-demand 
care for COPD patients,
50
 NPs providing symptom management to breast cancer survivors,
61
 
and the intervention for reduction of chronic oral non-steroidal anti-inflammatory drug 
(NSAID) use in patients with chronic musculoskeletal pain
66
 [Appendix I-8]. 
Patient Satisfaction  
 Patient satisfaction endpoints were measured in 8/29 (28%) trials and one post hoc 
analysis, with statistically significant improvements observed in seven out of eight trials 
[Appendix I-9]. However, none of these studies measured patient satisfaction as a primary 
endpoint [Appendix J]. A RS trial that compared care of minor injury patients by NPs or 
senior house officers (SHOs) at an emergency department, found significant differences in 
four out of eight measures of patient satisfaction.
62
 Each patient was asked to complete the 
satisfaction questionnaire immediately after their treatment and prior to leaving the 
emergency department. Although there was no combined summary score, the eighth question 
asked of overall patient satisfaction. Significant differences were found in the following 
questions: NPs were easy to talk to (NP 97.6 (n=85) versus SHO 84.0 (n=81), p = 0.009), 
patients were given information on accident and illness prevention (NP 75.3 (n=81) versus 
SHO 45.2 (n= 73), p = 0.001),  patients were given enough information on their injury (NP 
95.2 (n=83) versus SHO 82.5 (n=80), p = 0.007), and overall, patients were more satisfied 
with treatment provided by NPs than by SHOs (NP 98.8 (n=85) versus SHO 87.7 (n=81), p < 
0.001). Differences between groups regarding the patient feeling able to ask questions, 
understanding advice received, feeling that the providers listened and gave enough time, were 
all non-signficant
62
 [Appendices I-9 and J]. 
 In the outpatient setting, coronary artery bypass graft (CABG) patients were found to 
be more satisfied with NP follow-up than usual care at two and six week time points, 
according to two questions from the Client Satisfaction Questionnaire (CSQ-8, a four point 
Likert-scale questionnaire; higher scores represent higher levels of satisfaction): 1) ‘quality of 
service’ received at two weeks, p = 0.003, and at six weeks, p = 0.005; and 2) the ‘amount of 
help’ received, at two weeks, p = 0.001, and at six weeks, p = 0.002 (individual data not 
shown).
48
 The other RCT of cardiac surgery outpatients treated by a NP phone intervention, 
used a questionnaire developed by Shortell et al. (2000) consisting of 24 closed-ended 
questions regarding patients’ perceptions of their hospital care, returning home issues, and 
related heart patients’ needs. Out of seven patient satisfaction measures within the five-week 
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post-discharge intervention, one statistically significant outcome and one borderline 
significant outcome were observed respectively: higher satisfaction in ‘achieving best 
recovery possible’ (NP 71.3% (n=102) versus usual care 63.5% (n=98), p = 0.03) and higher 
satisfaction with ‘side effect information’ (NP 61.5% (n = 102) versus usual care 54.0% 
(n=98), p = 0.05). While five out of seven measures of post-discharge patient satisfaction 
yielded non-significant results, all differences were in the direction of the intervention. 
However, the pooled score of mean percentages for patient satisfaction with recovery at the 
end of five weeks post-hospitalization was non-significant with NP 60.5% (20.4) versus usual 
care 55.7% (20.8), p = 0.08
46
 [Appendices I-9 and J]. 
 Two additional outpatient RCTs, both RS, found statistically significant differences in 
patient satisfaction outcomes. Parents ranked patient satisfaction with care provided by a NP 
and dermatologist for infants and children with eczema, using the Client Satisfaction 
Questionnaire-8 (CSQ-8, higher scores represent higher levels of satisfaction). Parents of 
infants and children with eczema who received treatment from a NP, were significantly more 
satisfied than those receiving usual dermatologist care, at all time points: 4 months (NP 27.1 
(3.9) versus usual care 24.4 (3.4), p < 0.001); 8 months (NP 27.3 (4.0) versus usual care 24.3 
(3.3), p < 0.001); and 12 months, (NP 26.9 (4.9) versus usual care 24.8 (4.3), p < 0.023).
59
 
For rheumatoid arthritis patients, overall patient satisfaction increased significantly for NP 
patients while remaining relatively stable in patients cared for by Junior House Doctors 
(JHDs). Median values with range for overall patient satisfaction were: NP baseline 3.57 (2.3 
- 4.9)  to 48 weeks 4.1 (2.4 - 4.9),  difference of = 0.53, versus JHD baseline 3.60 (2.1 - 4.8) 
to  48 weeks 3.56 (2.4 - 4.7), difference of = - 0.04, between groups p < 0.001.
55
 A pilot trial 
that was designed to assess its ‘Brief Nurse Practitioner Transition’ (BNPT) intervention for 
older adult outpatients transitioning home from hospital, found no significant differences 
compared to usual care provided by the Health Maintenance Organization (HMO). This 
trial’s ‘Home Care Satisfaction Measure’ evaluated older adults’ level of involvement in 
health care decision making, information / education received, emotional support, 
coordination / continuity of care, problem solving, and overall quality of care
65
 [Appendices 
I-9 and J]. 
 Interventions from two RCTs set in primary health care, one RS and one IPT, were 
both associated with statistically significant differences in patient satisfaction, although in 
both cases, tools used for endpoint assessment were of limited quality. The RS trial that 
compared care provided by NPs and GPs for patients with common complaints, measured 
patient satisfaction using a tool comprised of 12 items, partly derived from a validated 
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instrument (Wensing et al. 1997) as well as a questionnaire developed for patients seeking 
‘same day’ consultations (Kinnersley et al. 2000). However, the content validity of this 
questionnaire was assessed by two GPs with research experience, with no reference made to 
psychometric standards (instrument construction and measurement procedures) necessary for 
group comparisons. Test-retest information regarding the reliability of the individual 
questionnaires was also not provided.
93
 Patient satisfaction related to communication, 
attitude, provision of information and overall satisfaction, was scored on a Likert-scale 0–10, 
but showed no statistically significant differences in any component measure, with overall 
satisfaction of the NP group (n=683) mean 8.19 (1.18) versus GP group (n=609) 8.20 (1.26), 
p = 0.83. Only in a sub-group of patients who reported at least one chronic disease (n = 583), 
were statistically significant differences found between groups: NP mean 8.35 (SD 1.07) 
versus GP mean 8.11 (SD 1.32), p = 0.02.
67
 Although this significant difference is relatively 
small, such that it may not be meaningful in practical terms, in the context of chronic disease, 
it is also possible that this small difference may actually contain clinical significance, in 
terms of the importance in everyday life over the long term, for chronic disease clients / 
others with whom these clients interact.
94
 Finally, patients with incontinence evaluated 
patient satisfaction with services using a questionnaire that asked a single open-ended, 
exploratory question, with no indication of reliability / validity properties related to the 
conversion of patients’ descriptive answers into quantitative results compared between 
groups. Differences in patient satisfaction outcomes for patients with incontinence were: at 
three months, NP  52% (1294/2498)  versus usual care 45% (276/618), 7% difference (95% 
CI 3-12%), p = 0.001; and at six months NP 64% (1428/2236)  versus usual care 53% 
(289/546), 11% difference (95% CI 6-16%), p < 0.001.
60
 At the long term six year follow up, 
there were no significant differences between-groups in patient satisfaction: NP 55% 
(1152/2109) versus usual care 52% (306/591), 3% difference (95% CI -2-7%), p = 0.2
81
  
[Appendices I-9 and J]. 
 4.6.5 ‘Other’ Endpoint-Outcomes 
 Significant improvements were found in four out of seven trials and one post hoc 
analysis that measured “other” outcomes not classified by previous categories: maternal / 
infant health,
69
 knowledge,
70
 quality of clinical documentation,
62
 and psychosocial self-
efficacy
7
 (patient’s belief system / confidence to carry out the behaviour necessary to reach a 
desired goal) [Appendix I-10]. A wellness-based trial (inclusion criteria of good health at 
baseline), measured endpoints of maternal / infant health: perceived maternal health, 
perceived maternal stress, social support, and infant health.
69
 Seventy out of 139 newly 
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discharged, first time low-income mothers in good health postpartum with healthy full-term 
infants, received intervention that resulted in significantly lower perceived maternal stress 
(total perceived stress scale scores range 0 - 40 with higher scores indicating higher perceived 
stress; scores between 14-26 indicate moderate stress): NP mean 14.71 (SD 3.95) versus 
usual care mean 24.64 (SD 4.61), p < 0.0001.
69
  Greater perceived maternal health was also 
significantly improved for intervention participants: NP mean 18.61(SD 1.74) versus usual 
care mean 17.20 (SD 2.69), p < 0.0004, although with scores ranging from 10 (average 
health) – 20 (perfect health), the difference of 1.41 in mean scores within this range may not 
be clinically significant. Intervention mothers’ perceptions of increased social support, and 
intervention infants’ healthier weight gain with fewer emergency room visits, were non-
significant
69
 [Table 5; Appendix I-10].    
 The only other wellness-based trial of this review included women aged 18 to 48 of 
child-bearing age, with NP (n =51) and usual care (n = 53) groups in presumably good health 
at baseline, and not yet exposed to any formal nursing class lectures about sexually 
transmitted infections. Knowledge and perceived risk of sexually transmitted infection in 
female college students were measured following an educational NP intervention.
70
 
Significant differences were found in both endpoints of ‘knowledge’ (p < 0.0001) and 
perceived risk of sexually transmitted infection (p < 0.0001)
70
 [Table 5].  Disease-specific 
knowledge was measured in rheumatoid arthritis outpatients following NP and Junior 
Hospital Doctor care, but only non-significant differences were detected in this endpoint on 
study completion at 48 weeks.
55
 Additional “other” endpoints  included ‘quality of clinical 
documentation,’ measured in a RS trial of minor injury emergency department (ED) patients, 
where the aim of the trial was to test methods and tools that could easily be used to evaluate 
the quality of emergency NP-led care in different EDs.
62
 Using a ‘Documentation Audit 
Tool’ developed for this study (double blind peer-reviewed), NPs were reported to have 
written notes of higher quality (94/186 notes) than senior house officers (92/186 notes for 
SHOs). Scored out of 30 points, comparisons of documentation quality were ENP 28.0/30 
versus SHO 26.6/30, p < 0.001
62
 [Appendices I-10 and J]. 
 Self-efficacy (patients’ belief system for effecting change) was measured in a web-
based pilot trial of type one diabetes patients,
7
 in a pilot trial of older adults transitioning 
home from hospital,
65
 and in a post hoc analysis of cardiovascular disease (CVD) patients 
attending a risk factor management clinic.
75
 A significant difference was found between type 
one diabetes patients receiving usual care and patients receiving intervention, in terms of self-
efficacy with blood glucose management, measured by the Diabetes Empowerment Scale 
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(NP mean + 0.14 (SD 0.62) versus usual care mean - 0.16 (SD 0.62), effect size of 0.30 (95% 
CI 0.01 to 0.59), p = 0.044).
7
 In contrast, no significant differences in self-efficacy were 
observed in the pilot trial that evaluated older adult outpatients transitioning home from 
hospital, following its intervention of up to three home visits and two telephone calls from an 
NP;
65
 nor in the post hoc analysis of an NP intervention providing risk factor management  
for CVD outpatients.
75
 Finally, a RS trial comparing pediatric care provided by a NP to that 
provided by a dermatologist, detected no significant between-groups differences in ‘family 
impact’ related to childhood eczema at baseline, 4, 8, or 12 months. However, given the 
nature of a RS design, these non-significant differences actually represent positive results 
between care provided by a NP and care provided by a specialist physician
59
 [Appendices  
I-10 and J].    
 4.6.6 Meta-Analysis     
 Reporting of all quantitative patient outcome data from this systematic review’s 
results includes a meta-analysis of NP impact on patient outcomes from homogenous RCTs. 
Although no combinations of similar study populations, disease states, outcomes, study 
durations and settings were found among RS trials, similarity of outcomes in similar 
populations, disease states, study durations and practice settings, were found in two 
combinations of two IPT trials: a set of two cardiac surgery outpatient RCTs of five to six 
weeks duration, measuring symptom severity, resource utilization, quality of life and patient 
satisfaction;
46,48
 and a set of two one-year RCTs of cardiovascular disease (CVD) outpatients,  
measuring blood lipid levels according to treatment goals, and drug utilization.
44,47
 However, 
the latter set of RCTs evaluating blood lipids contained some heterogeneity in their study 
populations: where one trial was comprised exclusively of coronary heart disease patients,
44
 
the other trial was comprised of patients with one (or more) of four different CVDs: 
peripheral arterial disease, abdominal aortic aneurysm, cerebrovascular disease, and coronary 
heart disease.
47
 The former set of cardiac surgery outpatient RCTs was clearly homogenous 
for further analysis of pooled quantitative data. Non-significant results for all endpoints 
indicated statistical uncertainty in intervention effect, but not an absence of effect.
37,87
  
 Of the four sets of similar outcomes for cardiac surgery outpatients, resource 
utilization data regarding hospital readmission comprised count data most clearly matched 
(i.e. in terms of emergency room (ER) visits, one study measured ‘at least 1 visit to the ER’46 
while the other study simply measured ‘total ER visits’).48 Remaining endpoint-outcomes in 
this pair of studies contained differences including different measurement tools (e.g. different 
symptom severity instruments), different reporting of data (e.g. no individual data shown for 
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statistically significant patient satisfaction outcomes in the study by Sawatsky and 
colleagues
48
), or in the case of global / overall quality of life outcomes, results were of a 
generic nature that authors of the SF-36 instrument explain are not designed or intended to 
serve as substitutes for traditional measures of clinical endpoints. Rather, generic measures 
reflect the combined effects of primary and comorbid conditions while disease-specific 
measures reflect mainly the primary disease; as such, generic and disease-specific outcomes 
are best reported in conjunction with each other.
93
 As a result, meta-analysis on the practical 
outcome of unexpected hospital readmission follows, to provide meta-data as required in the 
transparent reporting of a systematic review, and in particular, according to the protocol of 
this systematic review.   
 Equipoise is demonstrated by transparently reporting pooled data from trials found to 
be homogenous, versus incompletely reporting data to a partial degree, without computation 
of summary effect in trials found to be homogenous. Particularly in a review designed to 
capture all quantitative patient outcome data from all settings, transparency is upheld by 
providing quantitative analysis that is complete. Given the purpose of this systematic review, 
to “systematically describe the literature pertaining to the nature and impact of NP 
interventions in health care settings” (section 1.2), obligation rests on provision of data 
analysis in full. The statement of problem for this thesis (section 1.1) articulates that 
“independent studies examining the effect of NPs are widely available but an aggregate 
analysis of these health care providers had never been performed. The systematic assessment 
of quality, consistency, effectiveness, and scope of this review allows for a comprehensive 
understanding of the current state of knowledge (including information gaps) about NPs with 
respect to health care delivery.” Indeed, among many reasons noted by Borenstein, Hedges, 
Higgins and Rothstein for conducting meta-analysis, one reason rests in the logic of trying to 
understand an entire body of evidence through meaningful synthesis of results that have been 
gathered systematically, as opposed to understanding studies individually in isolation,
37
 
without consideration paid to the body of evidence as a whole. Reasons for conducting meta-
analyses thus lie beyond the simple reporting of summary effect data, and also include the 
insight gained by the analysis in terms of designing future research. Certainly this meta-
analysis clearly identifies areas where evidence is lacking. That is, the limitations of this 
systematic review’s small-scale meta-analysis, clearly indicate that a greater number of RCTs 
with larger sample sizes, testing similar interventions in similar circumstances, are necessary 
to allow for more useful meta-analyses in the future. The level of analysis that this meta-
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analysis provides, brings a new perspective for future designs of prospective randomized 
research testing the effect of the NP.   
 The larger understanding of this review’s entire body of evidence that is gained by the 
dimension of meta-analysis, also includes understanding the limitations of the technique of 
meta-analysis itself. Limitations of meta-analysis are similar to those inherent to a systematic 
review and include: 1) publication bias, referring to the publication or non-publication of 
research findings depending on the nature and direction of the results;
15
 2) limited availability 
of methodologically rigorous, high quality (low risk of bias) studies; and 3) non-biased 
reporting and analysis of all data. However, analysis of funnel plot asymmetry to test for 
publication bias is not relevant to this meta-analysis of only two studies, since a minimum of 
10 studies are required for sufficient capacity to detect bias.
15,39
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Table 6 Similar parameters of resource utilization by cardiac surgery outpatients 
Author, 
Year 
 
RCT 
Design  
(RS ^ or 
IPT ^^) 
 
 
 
Study 
Population 
(Similar 
Disease State) 
Study 
Duration 
Control 
 
Intervention  Outcome Comment  
Tranmer 
2004 
46
 
 
IPT ^^ 
 
200 
postoperative 
cardiac 
surgery 
outpatients 
discharged 
from first 
cardiac 
surgery  
 
Five week 
study 
intervention 
delivered 
offsite via 
telephone; 
study 
patients 
recruited 
from 
hospital 
prior to 
discharge 
 
Control = 
Usual Care 
(UC) 
including  
education 
booklet, 
home-care 
follow-up as 
necessary, 
and NP 
contact 
information, 
with 
instruction 
to call with 
questions or 
concerns 
(n= 98) 
 
Intervention = 
Usual Care (UC) 
+ NP initiated 
phone contacts 
for patients in 1
st
 
5 weeks 
following 
hospital 
discharge 
 
(n= 102) 
 
Total 
hospital 
readmission
s at 5 weeks 
post-
discharge 
NP + UC  9 
UC   8 
p = 0.85 
Resource 
use was 
tracked 
through 
patient 
self-report 
Sawatsky 
2013 
48
 
 
IPT ^^ 
 
204 
postoperative 
cardiac 
surgery 
outpatients 
following first 
time coronary 
artery bypass 
graft (CABG) 
surgery 
 
Six week 
study 
intervention 
delivered 
offsite via 
telephone; 
study 
patients 
recruited 
from 
hospital 
prior to 
discharge. 
Patients with 
significant 
issues/conce
rns were 
seen at an 
NP Follow-
up (NPFU) 
Clinic 
Control = 
Usual Care 
(UC) 
including 
advice to 
make 
primary 
care 
provider 
appointment  
within 1 
week; return 
visit to  
cardiac 
surgeon was 
scheduled 
for all 
patients at 6 
weeks 
(n=107)  
  
Intervention = 
Usual Care (UC) 
+ NP phone 
contact at 2-3 
days post-
discharge for 6 
weeks, with  
recommendations 
to follow-up with 
primary care 
provider, cardiac 
surgeon, receive 
additional phone 
contact from NP, 
go to NPFU 
clinic, or to local 
ED 
(n= 97)  
Total 
hospital 
readmission
s at 6 weeks 
post-
discharge 
NP + UC 15 
UC  19 
No p values 
reported 
Resource 
use self-
reported, 
at the 2 
and 6-
week post-
discharge 
interviews 
 
     ^ Role Substitution (RS)    ^^ Interprofessional Team (IPT) 
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 The proportion of hospital readmissions was compared between the intervention and 
control groups of two homogenous IPT trials.
46,48
 Intervention effect data for both trials of 
cardiac surgery outpatients, as well as the pooled summary effect is displayed below.  
 
 
 
Study name Statistics for each study Risk ratio and 95% CI
Risk Lower Upper 
ratio limit limit p-Value
Tranmer, 2004 1.081 0.435 2.688 0.867
Sawatsky, 2013 0.871 0.469 1.617 0.661
0.932 0.559 1.555 0.788
0.01 0.1 1 10 100
NP + Usual Care Usual Care
NP + UC vs UC on Hospitalization of Post-Surgical CV Outpatients
Meta Analysis
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 The intervention effect on hospitalization in the Tranmer trial is a risk ratio is 1.081, 
and in the Sawatsky trial, the intervention effect is a risk ratio is 0.871. Below the null value 
of 1.000 (no difference between groups), the risk ratio of 0.871 means that the risk of 
becoming hospitalized in Sawatsky’s intervention group is approximately 12.9% lower than 
the risk of becoming hospitalized in Sawatsky’s usual care group (12.9% less than a risk ratio 
of 1.0). Above the null value of 1.000, the risk ratio of 1.081 means that the risk of becoming 
hospitalized in Tranmer’s intervention group is approximately 8.1% higher than the risk of 
becoming hospitalized in Tranmer’s usual care group. The greater degree of sampling error in 
the Tranmer trial is shown by the wider confidence interval; the true intervention effect could 
be a risk ratio anywhere within the range defined by the confidence interval’s lower limit of 
0.435 and upper limit of 2.688. Since this interval includes the null value of 1.000, the effect 
is statistically non-significant, with a p-value of 0.867. In the Sawatsky trial, the confidence 
interval, although more narrow, providing a more precise estimate (less sampling error), also 
crosses the null value of 1, with a lower limit of 0.469 and an upper limit of 1.617. Again, 
since this range includes 1.000, the intervention effect is statistically non-significant, with a 
p-value of 0.661. However, the superior precision of Sawatsky’s effect estimation shown by 
Sawatsky’s more narrow confidence interval, is reflected in the larger solid square displayed 
in the forest plot, indicating a greater weight assigned to this more precise RCT, using the 
random effects model.
37
 
 Although there is no statistical certainty upon which to draw conclusions (all effect 
sizes are non-significant), this uncertainty in intervention effect on the patient outcome of 
hospital readmission does not equate to an absence of effect.
87,88
  Given that the contribution 
made to the totality of evidence in a systematic review by studies with statistically non-
significant results is as important as the  contribution made by studies with statistically 
significant results, this lack of statistical certainty does not provide basis for exclusion of the 
effect data from the review’s body of evidence.15 Rather, the opposite is the case. To maintain 
the scientific integrity of the systematic nature of this review (no reporting bias), the mean 
summary effect was computed. Using the random effects model, which gives random effects 
weights to both RCTs for computation, synthesis of the mean summary effect of the two 
RCTs resulted in a summary risk ratio of 0.932, with a confidence interval of 0.559 to 1.555, 
and a non-significant p-value of 0.788. This result indicates a 7% lower risk of hospitalization 
for patients in the intervention group compared to control, although this lower risk is 
statistically non-significant since the 95% confidence interval contains the null value of 
1.000. With reasonable certainty, a 95% level of confidence, the mean summary risk ratio for 
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this sample of two studies falls somewhere in the range of 0.559 to 1.555, and is statistically 
non-significant with a p-value of 0.788. The null hypothesis therefore cannot be rejected 
since the true risk ratio for this sample of two RCTs may be 1.000 (within the range of 0.559 
to 1.555). As a result, statistical uncertainty remains regarding the effect of the NP 
intervention on hospitalization in these two trials, in terms of the NP intervention effect being 
more or less effective than control in preventing hospitalization. 
 A small amount of dispersion in the observed effect size is displayed in the forest plot, 
with risk ratios equalling 0.871 and 1.081. Some of the observed dispersion may be due to 
differences in the true effects, and some of the dispersion may be due to random sampling 
error. The Q value (sensitive to the ratio of the observed variation to random sampling 
error),
37
 of 0.148 is less than the degrees of freedom (an approximation of sample sizes; a 
different value for different statistical tests),
77
 which means that the amount of dispersion 
seen in the observed effects displayed in the forest plot, is less than we would expect based 
purely on the random sampling error, providing no evidence that the true effects actually do 
vary. Thus, there is no evidence of heterogeneity, accompanied by a non-significant p-value 
of 0.701. It follows then that I
2
, the proportion of dispersion that is probably due to true 
effects rather than random sampling error
37
 is 0.000%, and the estimate of the variance in the 
true effect sizes between studies, represented by the population value Tau
2
 statistic (used to 
assign weights under the random effects model),
37
 is 0.000%. 
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5.0 Discussion 
 A systematic review was performed to identify randomised controlled trials (RCTs) 
testing the effectiveness of NP interventions on quantitative patient outcomes, in order to 
systematically describe the current state of evidence (nature and impact) in all health care 
settings, and also to identify areas where evidence is lacking. Of the 29 RCTs identified, the 
majority focused on NP interventions targeting patients with chronic diseases. These 
interventions were typically examined on ambulatory patients using an interprofessional 
(IPT) trial design. The contexts in which the NP role was implemented in these 29 studies 
were vastly different, across all settings and all levels of prevention.  Consequently, the 
nature of this systematic review’s results lend themselves more toward a formative 
evaluation, providing potential guidance toward health services improvements, than a 
summative evaluation, although neither of these formal processes were within the realms of 
this systematic review’s protocol.95 However, the current body of high quality (low risk of 
bias) studies with the highest internal validity (RCTs) offers a platform of evidence that has 
been organized, synthesized and summarized in a clear and comprehensive fashion within the 
rigorous methodology of a systematic review.   
Main Findings and Limitations   
 Out of 89 classes of endpoint-outcomes listed in 10 tables [Appendix I], results for 43 
patient outcome classes (43/89; 48%) were statistically significant [Table 4], associated with 
26/29 (90%) different RCT interventions. This is a conservative measure of the total number 
of significant outcomes in this review, meaning that the proportion of total classes [Appendix 
I] to classes with significant outcomes [Table 4] reflects outcome classes as opposed to 
individual patient outcomes themselves. For example, ‘cardiovascular risk factors’ noted as 
one class in Table 4, and listed as a statistically significant class in Appendix I-2, contains 
four significant differences in patient LDL-cholesterol, total cholesterol, systolic blood 
pressure, and body mass index.
47
 Statistically significant effect sizes ranged from between-
groups differences of 40% (p < 0.001) in chronic heart failure outpatients that were initiated 
or up-titrated on beta-blocker medication, with 33% (p < 0.001) more chronic heart failure 
patients from the NP intervention group reaching target guideline doses of beta-blockers;
45
 to  
a mean change in the Diabetes Empowerment Scale score of 0.30 (95% CI 0.01 to 0.59, p = 
0.044) in the evaluation of type one diabetes patients’ self-efficacy.7 Three RCTs did not 
detect any statistically significant differences between groups in patient outcomes: 1) a RS 
trial measuring the effect of NP care on outcomes for internal medicine patients, compared to 
usual care by house-staff,
71
 2) an IPT trial measuring the effect of a mobile NP service on 
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recovery of 33 hip fracture surgery patients post-hospital discharge (10 patients lost to 
follow-up),
64
 and 3) an IPT trial measuring the effect of a NP phone intervention on 
preventing glycemic relapse in type two diabetes patients who had recently achieved 
glycemic control.
51
 Interventions associated with statistically significant outcomes were often 
associated with clinical significance for the patient, in terms of the minimal clinically 
important difference (MCID, the smallest change in a patient outcome that a patient would 
identify as important for potential change in patient management
15
) but not consistently. For 
example the exploratory pilot trial that tested a patient-initiated system of scheduling 
treatment for symptoms of chronic obstructive pulmonary disease (COPD), found statistically 
and clinically significant differences in the symptom domain of the ‘Clinical COPD 
Questionnaire’ (CCQ, specific to COPD); borderline significant differences in the symptom 
domain of St. George’s Respiratory Questionnaire (SGRQ is less specific to COPD than the 
CCQ; the SGRQ is designed to measure impact on overall health and perceived well-being in 
patients with respiratory diseases in general), reaching the MCID for the SGRQ; and 
differences in certain SF-36 domains (non-disease-specific / global quality of life measure) 
that reached the MCID, yet were too variable overall to be considered significant (bodily 
pain, role emotional, and mental health).
50
 Further, it was not uncommon that a study 
contained statistically significant patient outcomes in certain endpoint categories but not in 
others, resulting in an overall sense of clinical significance to the study itself. For example, 
the study intervention of Web-based NP case management for Type 1 Diabetes patients did 
not have a statistically significant impact on physiologic markers [Appendix I-2], but was 
associated with a beneficial, statistically significant effect on self-efficacy (‘other’ outcome), 
related to the patient’s self-management of their chronic illness [Appendix I-10].7 
  Specific domains of activity indicated that diagnostically, NPs were rarely used to full 
scope, with open diagnosis occurring only in 1/29 RCTs, limited diagnosis in 9/29 RCTs, and 
diagnosis of disease status in 17/29 RCTs. It followed that open prescribing occurred in only 
one out of 20 RCTs, with prescribing activity in the remaining 19 RCTs of a limited nature. 
Clinical procedures were the least commonly performed activity although this was not 
surprising given that only three out of 29 RCTs were set in acute care. ‘Strategies for 
behaviour change’ relative to education activity were found prevalent in the outpatient 
environment at 56% of all activity in this domain, addressing the higher proportion of chronic 
disease for outpatients [upper segment Table 3]. Conversely, the activity of education which 
is classic prevention, was predominantly found in the primary health care environment 
further upstream at 62.5% of all activity in this domain, in the management of a higher 
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proportion of primary and secondary prevention trials with less chronic disease [upper 
segment Table 3]. In the most urgent environment of acute care, no evidence of ‘strategies for 
behaviour change’ was found, although education was always inferred in the intervention 
(instructions during hospital stay / discharge teaching). Care coordination, an offsite activity, 
naturally did not occur in the acute care environment, and was found in 50% of all outpatient 
trials and 25% of all primary health care trials [upper segment Table 3]. 
  In terms of the mode of NP implementation, naturally, care coordination occurred 
more-so in IPT trials (9/20; 45%) relative to RS trials (2/9; 22%) [lower segment Table 3]. 
Further, IPT trials contained the higher proportion of non-acute trials set in less urgent 
environments than RS trials, with likely, more availability of time in which to exercise 
strategies for behaviour change. Strategies ranged from practitioner-to-patient in RS trials,
56
 
to team-to-family in IPT trials where the patient included family.
64
 In contrast, the traditional 
activities of diagnosis, prescribing and clinical procedures were performed less often in the 
IPT mode than in the RS mode, while strategies for behaviour change and care coordination 
may be considered to be more proactive activities employed by collaborative team modes of 
care [lower segment Table 3].  
 The most critical life-threatening endpoint-outcomes were categorized first, notably 
the smallest category of endpoint-outcomes. This review found the largest category of 
endpoints to be ‘surrogate measures of disease’ indicating an emphasis in NP intervention 
research less directly on the immediate life-threatening issues of individual patients, and 
more-so on the ‘systems-threatening issues’ of long term tertiary prevention manifest in the 
permanent aspects of chronic disease. Resource utilization / cost endpoints were measured in 
all settings and found results ranging from significant reductions in healthcare charges for 
low-income maternal / infant patients
69
 [Table 4; Appendix I-7] to non-significant reductions 
in hospital / ancillary costs for internal medicine patients
71
 [Appendix I-5]. However, the 
quality of these estimates was often limited related to the component of self-reported data 
(e.g. cost diaries) that was not able to be consistently cross-checked with formal medical 
records. One RCT reported higher utilization of emergency care for intervention patients 
post-operative to suspected ovarian cancer, with control patients visiting primary care 
significantly more frequently
79
 [Table 4; Appendix I-6]. Additional significant results were 
found in endpoints of patient satisfaction, reported in seven out of eight RCTs [Table 4; 
Appendix I-9] and in “other” endpoints, reported in four out of eight RCTs [Table 4; 
Appendix I-10], from all settings in both cases. Only one RCT found statistically significant 
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improvement in overall / global quality of life, for women discharged home post-operative to 
suspected ovarian cancer
52
 [Table 4; Appendix I-8]. 
 Twenty-six RCTs found a total of 43 classes of statistically significant endpoint-
outcomes [Table 4]. Where nine out of these 26 RCTs found statistically significant results in 
resource / cost outcomes, five of these trials were RS and four were IPT trials. Significant 
resource / cost outcomes were thus, relatively evenly distributed between the RS and IPT 
design. However, on consideration of all statistically significant endpoint-outcomes, 17/43 
(40%) classes of statistically significant results were derived from 8/9 (89%) of the RS trials, 
that overall, comprise only 31% (9/29) of the review’s RCTs.  Almost half of the review’s 
statistically significant outcome classes were derived from the less prevalent RS mode of 
implementation [Table 4]. This is surprising in light of our hypotheses that anticipated the 
opposite. It was anticipated that IPT studies would have produced the highest number of 
statistically significant differences based on the IPT design of the “+1” team member, and 
that RS results would generally be at best, equivalent between intervention and control 
groups.  
 Based on these findings, it appears that the greatest clarity in learning of differences 
that distinguish the NP role from that of other health care providers (within specific contexts), 
may be derived from RCTs of the RS design. This is not to say that focus of potential future 
change initiatives in practice, be based primarily / necessarily on direct translation of actual 
RS study designs, but rather that the most informative research may focus on RS designs, to 
inform practice that inevitably necessitates IPT frameworks. Interestingly, in both cases of 
RS / IPT trials, a common approach found in study design was with regards to ‘utilization of 
the NP role within a team framework.’ In other words, study authors would commonly 
explore the question "how can the NP be utilized in a way that maximizes or "potentiates" the 
productivity and expertise of the complementary provider(s)?” This question was explored 
regardless of whether the trial was RS or IPT. For example, strategic use of the NP was 
discussed by Dierick van Daele following the economic evaluation of their RS trial on 
common complaints in primary health care.
27
Authors maintained that when common 
conditions are extracted from the repertoire of GP consultations, the GP role may then be 
allowed to expand, to focus on patients with more complex diagnoses or multi-morbidity, and 
to coordinate with other professionals, reflecting teamwork strategies on the part of GPs, 
teamwork strategies that stem from the discussion of a RS trial. While healthcare system 
redesign requires the system to take a long-term perspective, and may be difficult to achieve 
in practice, mutual goals more easily and appropriately become the focus for change when 
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goals are set within the framework of IPT that includes the patient at the center of both the 
team and the larger frame.  
 An example of an IPT trial that explored the question "how can the NP be utilized in a 
way that maximizes or "potentiates" the productivity and expertise of the complementary 
provider(s)?” was found in a pilot RCT of chronic heart failure (CHF) patients’ adherence to 
beta-blocker medication.
45
 The NP facilitator intervention was designed to maximize specific 
aspects of the NP role, with study authors stating "We used a NP in our study because 
physical examinations play an important role in patient selection and monitoring during beta-
blocker initiation” (p. 2803).45 The NP was supervised by two cardiologists until the CHF 
patient reached the target or maximum tolerated beta-blocker dose, at which time, the patient 
was returned to their primary care provider for all additional care. This exploratory pilot RCT 
contains the review’s largest effect, a 33% difference between the NP facilitator intervention 
and the control group in the number of CHF patients on target doses of beta-blockers at study 
end (median follow-up, 12 months, p < 0.001).
45
 However, past ensuring that application of 
the NP role maximally aligns within the context and goal of the patients’ needs, the NP role, 
as with any other advanced healthcare professional is complex, so that it may be counter-
productive to speculate on a single dimension of the NP role’s “dose” affecting positive 
impact in a clear way, without oversimplifying the role itself, and the patients’ needs in 
context.  
 Limitations of the body of evidence in this review include an absence of power 
analysis to determine appropriate sample size in the majority of RCTs (16/29; 55%), limiting 
the rigor within which most patient outcomes were assessed. A limitation of this review’s 
results framework includes the potential overlap between quality of life endpoint categories, 
with disease-specific quality of life endpoints classified within the category of ‘surrogate 
measures of disease,’ and ‘non-disease-specific, global quality of life’ endpoints classified 
within the category of ‘quality of life / patient satisfaction.’ As the authors of the SF-36 tool 
explain, global / generic quality of life measures are universally valued in health status 
assessment, but are not age, disease, condition, or treatment specific. As such, they are not 
designed or intended to serve as substitutes for traditional clinical endpoints measures.
93
 
Where ideally, the impact of disease on health status is evaluated using both generic and 
disease-specific measurement tools in parallel, then accordingly, ideally, these two types of 
quality of life measures would have also been reported in parallel in this review. Analysis of 
patient-satisfaction outcomes involved little common ground for between-study comparisons, 
based on the fact that different tools were used in each study that measured patient 
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satisfaction.  Unique to the category of ‘other’ endpoint-outcomes were both sets of wellness-
based outcomes,
69,70
 and all measures of self-efficacy.
7,65,75
 
 Limitations of this review overall, include 1) the limited number of homogenous 
RCTs that could be appropriately combined for analysis of quantitative data, and 2) the 
temporal bias of the literature, including RCTs published only since the year 2000, with the 
intention of maintaining relevance to present healthcare system dynamics and to the present 
nature of the NP role itself, according to the rationale that both the healthcare system and the 
NP role itself, have changed significantly since 1973. Further, categorization of NP practice 
into domains for the purpose of objective one, facilitated reporting of the research on 
exclusively the NP role in randomised trials, but does not exemplify the complete nature of 
the NP role in practice. Results of the present systematic review and meta-analysis provide 
insight into the nature and impact of NP interventions tested in RCTs, through various 
combinations of domain activity.  Execution of a single domain of education / strategies for 
behaviour change activity, in the absence of any other activity in two RCTs’ tests of NP 
effectiveness,
68,70
 constitute limitations in the aggregate body of RCT data, given the multi-
faceted nature of the NP role. 
Context of Other Evidence  
 There are no previous systematic reviews of randomised controlled trials testing the 
effectiveness of NP interventions in all settings. However, two landmark RCTs
29,96
 that were 
designed upon the formation of an educational program for NPs, jointly sponsored by the 
School of Nursing and the Faculty of Medicine at McMaster University in 1971, provide 
contrasting perspective to the eight primary health care RCTs of this review [Appendix K]. 
Designed at a time of patient saturation in family practice clinics (no new patients accepted) 
and nurse surplus in Ontario, Canada, these two RCTs evaluated the NP role at the time of its 
formal inception into the healthcare system in 1973.
5
 Findings of this review indicate that 
randomised trial research on the NP role has since expanded from the original primary health 
care setting into the outpatient and acute care settings, six times more so in the outpatient 
than the acute care setting (18 outpatient RCTs: 3 acute care RCTs), with no randomised NP 
research to date set exclusively in long term care. The only two RCTs designed to test 
interventions in older adult populations were pilot trials.
64,65
 
 The original non-inferiority trial that ran from July 01, 1971 to July 01, 1972 was 
designed by Dr. W. Spitzer, a Canadian physician with background in primary care practice 
and epidemiology.
29
 This RCT tested the effects of the newly defined NP role compared to 
GPs, on patient health status in primary care, with the family as the unit of random allocation 
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[Appendix K]. In this non-inferiority trial, the greatest degree of ‘worse functional outcomes’ 
tolerated from NP care before declared ‘inferior’ was set at ‘5% worse.’  Study results 
indicated that the probability of NP patients being ‘worse-off by 5% or more’ was 0.008, or a 
likelihood of one chance out of 125 chances.
97
 Results showed the NP to be clinically safe, 
effective and cost-effective from a societal perspective, based on patient outcomes and a 22% 
net increase in families accepted into primary care practice during the one year trial period. 
Families receiving primary health care continued to increase so that at one year follow-up, an 
additional increase of 19% plateaued at 41% more families (2256 families receiving care by 
June 30, 1973) compared to the baseline value of 1598 families receiving care on July 01, 
1971.
29
 However, this societal benefit was not realized economically by the physicians’ 
primary care practice, due to restricted reimbursement for NP services. At the time of the 
trial, Ontario regulations did not permit billing for unsupervised NP services previously 
provided by GPs, where GP services were reimbursed by government health insurance 
according to the Ontario medical association’s fee schedule.29 A second RCT accompanied 
the original non-inferiority trial, in order to test the effects of NPs upon the professionals 
themselves, in a team mode, with NPs functioning as co-practitioners alongside GPs in 
intervention practices, compared to usual care provided by GPs and RNs in control 
practices
96
 [Appendix K]. Despite positive results in the professional outcomes of job 
satisfaction, views of each other’s role, and impact on clinical activities, and despite positive 
financial results found in the economic evaluation of this same trial (net earnings of the 
experimental practices increased in three practices, remained unchanged in two, and 
decreased in one practice; compared to no change in four control practices, an increase in 
one, and a decrease in another control practice, even without reimbursement for unsupervised 
NP services),
98
 no regulatory changes were made to govern reimbursement of NP services at 
that time. As noted in 1973, whether or not patients and practitioners were both positively 
affected by the integration of NP services, replication of new modes of care would not be of 
benefit to the public without regulatory change that is viable to all professionals according to 
the primary  interests of the public their professional services are intended to serve.
98
  
 Almost 50 years ago, during the time of family practice saturation in southern 
Ontario, the element in question was how to meet the demand for health services in primary 
care. By now, the element in question relates instead to the health system in its entirety, in 
terms of health services delivery to the public in all settings, not only in primary care, but 
with NP services as one component, currently found heavily imbalanced downstream 
according to the results of this systematic review. In fact, the proportion of 9/12 RCTs (75%) 
 101 
 
that were not set in acute care but nonetheless, reported acute care utilization, suggests a 
significant reliance on acute care services by patients from the outpatient and primary health 
care settings. Utilization of NP services predominantly downstream in the outpatient (18 
RCTs) and acute care (3 RCTs) settings relative to primary health care (8 RCTs), compound 
financial challenges to the system in these downstream settings that are also generally, more 
expensive. In contrast, wellness-based outcomes such as the maternal / infant health 
69
 and 
knowledge,
70
 have the potential to compound economically in the other direction, through 
practical benefits inherent to primary prevention. Negotiation of cost components associated 
with new models of care, recognized by the original landmark trials as the fulcrum point for 
further replication of NP integration or not,
98
 was evaluated approximately midway between 
1973 to present, in the 1996 Recommendations of the Panel on Cost-Effectiveness in Health 
and Medicine.
92
  
 The Panel on Cost-Effectiveness in Health and Medicine examined costs associated 
with health interventions, and recognized the societal perspective that encompasses 
prevention initiatives upstream, in addition to the more commonly considered downstream 
costs. Major categories of resource / costs identified by the Panel include costs of health care 
services; costs of patient time expended for the intervention; costs associated with caregiving 
(paid or unpaid); other costs associated with illness such as childcare and travel expense; 
economic costs borne by employers, other employees, and the rest of society, including 
‘friction costs’ associated with absenteeism and employee turnover; and costs associated with 
non-health impacts of the intervention, for example, on the educational system, the criminal 
justice system, or the environment.
92
 In terms of this review, while RCTs commonly provide 
individual patient data for cost-effectiveness analyses, a single RCT is unable to compare all 
available options, provide evidence on all relevant interventions, or be conducted over a long 
enough time to capture differences in economic outcomes (or even measure those outcomes), 
thus necessitating decision analytical modelling, that compares the expected costs and 
consequences of decision options by synthesizing information from multiple sources.
99
 
However, in this systematic review, related to the careful attention paid to similarity of 
studies for meta-analysis, correspondingly, it was verified that no combinations of economic 
evaluations were eligible for comparability of treatment patterns across jurisdictions.
100
  
 Yet statistically significant resource / cost outcomes were found in nine out of 14 
RCTs that measured these endpoints, in all settings [Table 4]. Cost endpoints in particular, 
were measured again, in only nine
27,50,60,66,69,71,78,83,86
 of the 14 studies measuring resource / 
cost endpoints. Four of the nine studies measuring cost, found statistically significant 
 102 
 
reductions for 1) outpatient care of pediatric eczema patients and their families,
78
 2) primary 
health care in patients with ‘common complaints,’27 3) NSAID  costs in patients with chronic 
musculoskeletal pain,
66
 and 4) costs for postpartum care of maternal / infant patients.
69
 
Societal costs were acknowledged in three of these four trials,
27,66,78
 although two of these 
cost analyses were conducted post hoc to the original trial.
27,78
 Methods of cost analysis used 
in this review included cost minimization evaluation in two RS studies,
27,86
 and cost-
effectiveness analyses (CEAs) in four studies (one RS study
78
 and three IPT studies
60,66,83
), 
with three RCTs not referring to a formal method of cost analysis: an IPT pilot trial reported 
“total costs of healthcare resource use per COPD outpatient;”50 a RS trial acknowledged its 
intention was not to conduct a comprehensive cost analysis but rather, to only report a 
comparison between groups on “total healthcare charges;”69 and lastly, a RS trial of internal 
medicine inpatients assessed costs of care to principally reflect the use of discretionary 
hospital resources (e.g. bed days, diagnostic tests), for between-group comparison, without 
any analysis of the salary differential between NP and house-staff , nor the costs of the 
medical director, or of providing off-hours coverage by residents.
71
 Three studies found that 
statistically significantly reduced cost was largely due to the salary differential of 
professionals within the trial: NPs and GPs in primary health care;
27
 NPs and dermatologists 
in outpatient care;
78
 and NPs and pediatricians in primary health care.
69
   
 Interestingly, where acute care utilization was the most prevalent type of resource 
utilization reported in this review, measured in 12 out of 14 RCTs that measured resource / 
cost endpoints, only one acute care RCT found a significant result in its endpoint of wait 
times for emergency department patients, without any associated cost evaluation.
62
  The most 
commonly found significant differences in resource utilization were reductions in primary 
health care (PHC) visits, measured in four outpatient studies regarding: older adults 
transitioning home post-hospital discharge,
65
 women discharged home post-operative to 
suspected ovarian cancer,
79
  pediatric patients with eczema and their families,
78
 and COPD 
patients that utilized an on-demand, patient-initiated system of outpatient scheduling.
50
 This 
latter ‘on-demand’ intervention of patient-initiated scheduling, tested in a pilot trial of COPD 
outpatients, represents a novel pro-active approach to health care that was also observed in 
the pro-active phone intervention for low-income postpartum mothers and infants.
69
 Both 
RCTs increased access to the NP, with interventions resulting in clinically and statistically 
significant improvements at lower total costs in both cases. Low-income postpartum families 
with mothers and infants in good health at baseline, experienced statistically significantly 
improved maternal health outcomes [Appendix I-10], and statistically significantly reduced 
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healthcare charges for their infants [Appendix I-7].
69
 COPD outpatients were more in control 
of their symptoms, experiencing significantly less deterioration in their COPD symptoms 
(Clinical COPD Questionnaire (CCQ) symptom scores reached the minimal clinically 
important difference, or MCID), while experiencing cost-savings from both the healthcare 
provider and the healthcare insurance perspective. However, compared to the control group 
of COPD patients, reductions in total costs for intervention outpatients from both the provider 
and insurance perspectives, were not statistically significant, although this RCT was a pilot 
trial not designed for cost analysis.
50
 
 Indeed, Bauer, an internationally recognized medical economist with 17 years’ 
experience as professor of statistics and research at two medical schools, recognized the 
necessity of “allowing patients to receive all the clinical and economic benefits of direct 
access to NPs, where Americans are paying an unnecessarily high price for a system that 
denies direct access to the cost-effective provider of many basic health services.”20 Novel 
proactive, collaborative approaches seen in this review through the patient-initiated system of 
outpatient scheduling
50
 as well as in the primary prevention intervention for low-income 
postpartum families, delivered offsite via phone,
69
 provide examples of patient-focussed 
approaches to proactive healthcare at reduced cost.  The primary prevention RCT is also an 
example of a RS trial whose research evidence ultimately informs practice that utilizes a team 
framework. That is, evidence from the RS trial (that compared offsite NP care to routine 
pediatrician care), may inform future practice of collaboration between the NP and the 
postpartum mother. Bauer also recognized that NPs are leaders in providing home care and 
care at worksites, two locations where demand is growing faster than the health system’s 
capability to meet challenges.
20
 NP interventions contained the component of home care 
services in six (6/29; 21%) of this review’s RCTs: a trial of a newly designed incontinence 
service delivered by NPs,
60
 a trial of a NP-delivered educational package for NSAID 
reduction in patients with chronic musculoskeletal pain,
66
 a trial of psychosocial sessions 
delivered by a NP for depression in ischemic stroke outpatients,
54
 as well as three RCTs that 
followed patients discharged home from hospital: women with suspected ovarian cancer,
52
 
hip fracture surgery patients,
64
 and older adults discharged home from hospital stays.
65
  
Implications for Future Research 
 New perspectives for future design of prospective randomised research testing the 
effectiveness of the NP role were noted within the limitations of this review’s meta-analysis: 
a greater number of RCTs with larger sample sizes, testing similar NP interventions in similar 
circumstances, are necessary to allow for more useful meta-analyses in the future. In terms of 
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specific RCT design, based on the proportion of significant findings derived from the RS 
trials of this review, with note taken of the non-inferiority design of the landmark RS trial of 
1974 (comparing NP care to GP care with the family as the unit of random allocation), future 
RCTs may consider application of the non-inferiority RS design. Traditionally, significance 
testing in randomised between-group studies, has examined the superiority of an 
experimental treatment to a comparator group. However, research questions that seek to 
determine whether two treatments are neither clinically nor statistically different, have 
become increasingly important in light of prevailing system constraints. For example, if a 
novel intervention claims to be safe, high quality, and potentially less expensive / more 
accessible, then the research goal may be to show that its effectiveness is not much less if at 
all, than that of standard treatment in a particular context. Tests of whether novel 
interventions are at least as effective as established interventions with proven effectiveness, 
provide answers that traditional superiority designs cannot completely address.
85
 
 Furthermore, despite common interchange in terminology, non-inferiority trials differ 
from equivalence trials. Where non-inferiority trials determine whether an intervention is “no 
worse” than standard treatment, using a one-sided statistical test (non-inferiority margin), 
equivalence trials determine whether an intervention is either “no better or no worse” than 
standard treatment, using a two-sided statistical test (equivalence margin). Equivalency 
designs are less commonly used in therapeutic trials evaluating effectiveness, since the study 
objective in a therapeutic trial is to show that a new treatment is not inferior to a standard 
(non-inferiority design), versus showing that the new treatment is neither inferior nor superior 
to the standard (equivalency design). However, methodological challenges inherent to the 
design of a non-inferiority trial are considerable since a poor trial design can erroneously 
suggest a similarity. Challenges include: the choices of an active control treatment (this 
design cannot be used without a well-established standard treatment), a non-inferiority 
margin, sample size and statistical analysis.
85
 Two trials
27,86
 from this review performed cost 
minimization evaluations (on the knowledge or assumption that competing interventions had 
the same health effects, comparison was made on cost alone; controversial method, since two 
interventions are rarely equally effective
91
)  post hoc to their RS trials, deemed equivalence 
trials.
63,67
However, only one of these two trials actually designated a margin of equivalence,
63
 
within which the intervention may be shown to be neither inferior nor superior to the standard 
treatment.
85
  
 Overall, the twenty-nine RCTs (year 2000 – present) of this systematic review 
provide evidence that may inform utilization of NP services to the extent of its findings, 
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according to the summary of quantitative data that it provides from all settings studied (no 
studies were set in long term care). Given the deliberately broad scope of the systematic 
review’s design, NP intervention impact was not expected to be determined in terms of a 
definitively clear and exact numeric value, but rather NP impact was expected to be largely 
described as thoroughly as the protocol outlined would be done, with quantitative meta-
analysis conducted where possible. Transparent analysis of NP effect  included primarily 
descriptive report of various endpoints unable to be pooled, as well as results from one pair of 
homogenous IPT trials pooled for quantitative meta-analysis.
37
 Results suggest that NP 
interventions, whether tested in RS or IPT designs, may be effective in primary health care, 
outpatient care and acute care settings on aspects of virtually all endpoint categories [Table 
4], with the exception of clinical outcomes. No statistically significant differences were found 
in the clinical outcomes of this review, although of the three RCTs that measured clinical 
endpoints, two were RS trials comparing practitioners in specific contexts,
49,71
 and the third 
was an IPT pilot trial designed less for hypothesis testing than for learning of research 
feasibility
45
 [Appendix I-1]. Only one study out of nine that measured global quality of life 
detected significant results, derived from mixed effects regression models.
52
 However, all 
nine trials that measured global, overall quality of life, used the medically-oriented SF-36 
tool (or smaller derivations) to measure patient outcomes resulting from nursing interventions 
[Appendix I-8]. 
 The context of all settings in this review, and the evaluation of all quantitative patient 
outcomes of NP interventions tested in RCTs, may together, provide insight into the design, 
function, and limitations of the health system as a larger whole. That is, results of this review 
presented within its system context of all settings, may provide insight into the design and 
functional challenges of adequate health service provision overall, within a systems-level-
context of limitations. For example, while service challenges in primary health care were 
initially addressed in part by the formal inception of NPs in the early 1970’s, present day 
challenges continue to utilize the capacity of the versatile NP role in addressing still similar 
challenges, now amplified across the entire system in all settings, limiting the system by this 
very amplification. Despite the burden healthcare carries in terms of chronic disease 
management (tertiary prevention), reflected in 17 out of 29 (59%) RCTs of this review, only 
41% of the review’s RCTs focused on either primary prevention, aiming to prevent disease or 
injury before it ever occurs;
13
 or secondary prevention, aiming to reduce the impact of a 
disease or injury that has already occurred, to halt or slow its progress.
13
 Furthermore, of the 
10 RCTs categorized as secondary prevention trials, only one trial focussed its intervention 
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on obese / overweight patients with the explicit goal of disease prevention.
56
 Two out of 29 
RCTs (7%) from this review were designed in the context of primary prevention, evaluating 
NP intervention effects upon the maintenance of good health
69,70
 [Table 5; Appendices I-7 
and I-10]. 
 Reinforcing this imbalance in the primary-to-secondary-to-tertiary prevention 
spectrum, is the fact that the single RCT that tested an intervention explicitly for prevention, 
was also the one and only RCT that focused on the issue of obesity,
56
 known to be very 
significantly and directly linked with many other chronic diseases.
56
 This scarcity of RCT 
evidence testing NP intervention effects on the highly-linked condition of obesity (now 
considered a chronic disease in itself),
57
 is an example of a very significant design challenge 
for future research. Similarly, despite the expanding demographics of aging populations, 
there was not one RCT found in this review set exclusively in long term care. The trial that 
evaluated older adults postoperative to hip fracture examined some of the patients in the long 
term care environment, but only as one of three non-acute settings in which follow-up took 
place.
64
 Recognition of large and very significant gaps such as these, between research 
conducted and challenges currently faced in healthcare, statistically and demographically, 
may serve as a starting point for collaborative solutions management across settings.   
Conclusion 
 Delivery of healthcare services in a world with limited resources and increasing 
pressure to create evidence-based quality patient outcomes,
16
 may require evidence-informed 
IPTs that most effectively utilize resources, resources that include patients themselves in an 
integral, central position within healthcare teams in all settings. The high quality (low risk of 
bias) research findings of this systematic review reveal substantial gaps between activities set 
in downstream environments relative to the upstream settings requiring development. These 
gaps point to the design of future research that may illuminate more clearly, necessary new 
directions in healthcare that are balanced between the up and the downstream, so that health 
services may be experienced by all members of the public, in all regions, remote and urban. 
Integration of innovative, pro-active patient-centered initiatives further upstream into the 
healthcare system may prevent the lifelong management of chronic health challenges that 
drain both the individual patient, and the system itself in the long term. Key elements of this 
system include the five principles of the 1984 Canada Health Act: universality, portability, 
public administration of funds, accessibility, and comprehensiveness. Evaluation of these 
principles in the face of many complex challenges requires expert opinion, recently supplied 
by the Honorable Dr. Kevin Lynch, Former Clerk of the Privy Council, in his statement: 
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“there is enormous scope for innovation consistent with the principles of the Canada Health 
Act” (December 04, 2015).101 Balancing complex healthcare demands through strategic and 
innovative application of ever evolving knowledge, together with patients as partners in their 
own healthcare management, restores the resourcefulness needed to meet complex, systemic 
challenges throughout all components of the healthcare continuum, both the up and the 
downstream, over the long term. 
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Appendix A Relevance Tool 
Study Citation (surname of first author, title, year first full report of study published, 
publisher, abstract / full article) 
Reviewer Initials: ____________ 
 
INCLUSION CRITERIA 
 Randomised trial.  Randomisation at both 1) individual level & 2) cluster level, 
only if there are multiple clusters (> 15 clusters / group) in both intervention 
and control groups. 
 NP Intervention implemented via either mode of role substitution (RS) or 
interprofessional team (IPT). All types of NPs will be eligible. Various titles 
include PHCNP (Primary Health Care NP), ACNP (Acute Care NP), NNP 
(Neonatal NP), ARNP (Advanced Registered NP), ANP (Advanced NP) etc. 
Context of program studies will be included if the NP is the “+1” member of 
the intervention IPT compared to an otherwise identical control IPT, or if the 
program is delivered exclusively by the NP(s). 
 Primary health care patients, long term care residents, outpatients (not admitted 
overnight to hospital) / specialized referrals, OR emergency department patients 
/ acute inpatients receive the intervention.   
 Quantitative endpoint must be from the following categories: 
 Death 
 Hospitalization (MI / stroke / life-threatening event) 
 Treatment of a Chronic Disease (surrogate markers of disease may 
include physiologic markers e.g. blood glucose in diabetes; symptom 
severity e.g. post-operative symptoms in cardiac surgery outpatients; 
functional status e.g. peak flow in asthma patients; behaviour/lifestyle 
change e.g. diet in obese patients) 
 Drug Utilization (i.e., adherence or ‘appropriate prescribing’)  
 Resource Utilization (consultations, tests / investigations, referrals) 
 Cost 
 Quality of Life and / or Patient Satisfaction 
 Other 
 Publication date of the study 2000 or later. 
 Study published in English.  
 
EXCLUSION CRITERIA 
Studies will be excluded if they do not specify “nurse practitioner” (with various 
descriptive wording noted above possibly preceding the title of NP) as the sole nursing 
intervention. Examples of other types of non-NP nursing professionals include: 
 Clinical Nurse Specialist  
 Community Health Nurse  
 Public Health Nurse  
Must satisfy all 6 inclusion criteria and 3 exclusion criteria 
 
INCLUDE?  YES      NO 
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Appendix B Validity Tool 
 Risk of Bias Assessment  
Domain Risk of bias Support for judgement from 
Criteria Table 8.5c (Higgins & 
Green, 2008, p. 198) according to 
modifications by Donald et al., 
2014, p. 3) 
Loca-
tion  
in text 
(page) 
Yes, 
Low 
risk 
No, 
High 
risk 
Unclear 
Random sequence 
generation likely 
to produce 
comparable 
groups 
(selection bias) 
   
 
 
 
 
 
Allocation 
concealment so 
that group 
allocation could 
not be foreseen in 
advance  
(selection bias) 
   
 
 
 
 
 
  
Appropriate 
method or source 
was used to collect 
objective outcome 
measures 
(detection bias) 
   
 
 
 
 
 
Outcome data 
complete for 
objective 
measures at > or = 
to 80% of sample 
& missing data 
imputed 
appropriately 
 (attrition bias) 
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Outcome reporting 
All outcomes 
described in the 
methods section 
were reported in 
results  
(reporting bias) 
   
 
 
 
 
 
 
Other biases 
detected in the 
study may, among 
others, include:  
Contamination 
Bias (e.g. the 
control group had 
exposure to the 
intervention) 
Measurement Bias 
(e.g. whether the 
study used a 
validated tool / 
procedure to 
objectively 
measure the 
outcome) 
   
 
 
 
 
 
 
 
 
 
 
 
 
Notes: 
 
 
 
 
Overall Risk of Bias = 
Low: 0-1 ‘at risk’ or ‘no’ judgements 
Moderate: 2-3 ‘at risk’ or ‘no’ judgements 
High: 4-6 ‘at risk’ or ‘no’ judgements 
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Appendix C Data Extraction Form 
 
1. General Information 
Citation 
Country and Year of Intervention 
Purpose 
 
 
Study Design 
 
 
Environment for Type of Care (Circle one)  Primary Health Care / Long Term 
Care / Outpatient (not admitted overnight to hospital) or Specialized Referral Care 
/ Emergency Dept. Care or Acute Inpatient Hospital Care 
Specific Description of Practice Environment 
 
Types of NPs 
 
Types of IPT members 
 
Patient population: Inclusion / exclusion criteria for study participation 
 
Baseline Characteristics / Description of final study sample (n) as stated in study 
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2. Intervention 
Mode of NP Implementation (circle one):     a) RS                                        b) IPT  
 
Types of NP intervention activities undertaken:                                            
DETAILS: 
 Diagnosis 
 
 Prescribing i) ordering medications in acute care  
    
 
                    ii) ordering medications in primary care, long term care or 
outpatient      
 
 
                         
                        including the ongoing medication management of chronic 
disease patients 
 
 
 Clinical Procedures 
 
 
 Education & ‘Strategies for Behaviour Change’ 
 
 
 
 Care Coordination 
 
 
Description of Control (or Standard Care) 
 
 
Comments:   
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3. Endpoints/ Results 
Endpoint #1 
 Death 
 Hospitalization (MI / 
stroke / life-
threatening event) 
 Treatment of a 
Chronic Disease 
(surrogate markers 
may include 
improvements in BP 
for hypertension, 
blood glucose for 
diabetes mellitus, 
etc.) 
 Resource Utilization 
(consultations, 
tests/investigations, 
referrals) 
 Drug Utilization (i.e., 
adherence or 
‘appropriate 
prescribing’)  
 Cost 
 Quality of Life &/or 
Patient Satisfaction 
 Other 
 Primary Endpoint 
 Secondary Endpoint 
 
Details as stated in study / 
Derivation: 
 
Validity of endpoint: 
 
Primary Endpoint 
 
Secondary Endpoint 
 
 
Follow-up complete? 
 
 
Results: 
   
 
Intervention: 
 
 
 
 
Control: 
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Endpoint #2 
 Death 
 Hospitalization (MI / 
stroke / life-
threatening event)  
 Treatment of a 
Chronic Disease 
(surrogate markers 
may include 
improvements in BP 
for hypertension, 
blood glucose for 
diabetes mellitus, 
etc.) 
 Resource Utilization 
(consultations, 
tests/investigations, 
referrals) 
 Drug Utilization (i.e., 
adherence or 
‘appropriate 
prescribing’)  
 Cost 
 Quality of Life &/or 
Patient Satisfaction 
 Other 
 Primary Endpoint 
 Secondary Endpoint 
 
Details as stated in study / 
Derivation 
 
 
Validity of endpoint: 
 
Primary Endpoint 
 
Secondary Endpoint 
 
 
Follow-up complete? 
 
Results: 
 
Intervention: 
 
 
 
Control: 
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Endpoint #3 
 Death 
 Hospitalization (MI / 
stroke / life-threatening 
event) 
 Treatment of a Chronic 
Disease (surrogate 
markers may include 
improvements in BP 
for hypertension, blood 
glucose for diabetes 
mellitus, etc.) 
 Resource Utilization 
(consultations, 
tests/investigations, 
referrals) 
 Drug Utilization (i.e., 
adherence or 
‘appropriate 
prescribing’)  
 Cost 
 Quality of Life &/or 
Patient Satisfaction 
 Other 
 Primary Endpoint 
 Secondary Endpoint 
 
Details as stated in study / 
Derivation: 
 
Validity of endpoint: 
 
 Primary Endpoint 
 
Secondary Endpoint 
 
Follow-up complete? 
Results: 
 
Intervention: 
 
 
 
Control: 
 
 
Statistical methods used & 
appropriateness  
 
 
 
4. Other 
Key conclusions of 
study authors as 
stated in study 
 
 
References to other 
relevant studies 
 
Correspondence 
required for further 
study information  
 
 
Notes 
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Appendix D PRISMA Statement 
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Appendix E PRISMA-P 2015 Checklist 
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Appendix F Draft Search Strategy in Ovid MEDLINE 
Ovid MEDLINE search strategy for the role and impact of Nurse Practitioners in Randomized 
Controlled Trials  
-------------------------------------------------------------------------------- 
1. Randomized controlled trials as Topic/ 
2. Randomized controlled trial/ 
3. Random allocation/ 
4. Double blind method/ 
5. Single blind method/ 
6. Clinical trial/ 
7. exp Clinical Trials as Topic/ 
8. or/1-7 
9. (clinic$ adj trial$1).tw. 
10. ((singl$ or doubl$ or treb$ or tripl$) adj (blind$3 or mask$3)).tw. 
11. Placebos/ 
12. Placebo$.tw. 
13. Randomly allocated.tw. 
14. (allocated adj2 random).tw. 
15. or/9-14 
16. 8 or 15 
17. Case report.tw. 
18. Letter/ 
19. Historical article/ 
20. Review of reported cases.pt. 
21. Review, multicase.pt. 
22. or/17-21 
23. 16 not 22 
24. nurse practitioner.mp. or *Nurse Practitioners/ 
25. family nurse practitioner.mp. or *Family Nurse Practitioners/ 
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26. pediatric nurse practitioner.mp. or *Pediatric Nurse Practitioners/ 
27. (nurse adj2 practitioner*).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier] 
28. nurse practitioner.ab. /freq=2 
29. advanced practice nursing.mp. or *Advanced Practice Nursing/ 
30. 24 or 25 or 26 or 27 or 28 or 29 
31. interprofessional relations.mp. or Interprofessional Relations/ 
32. Intervention Studies/ or intervention.mp. 
33. patient care team.mp. or *Patient Care Team/ 
34. Interdisciplinary Communication/ or interdisciplinary.mp. 
35. nurse role.mp. or Nurse's Role/ 
36. interprofessional team.mp. 
37. role substitution.mp.  
38. Nurse Practitioners/cl, og, sn, ut [Classification, Organization & Administration, Statistics 
& Numerical Data, Utilization] 
39. team function.mp. 
40. endpoint.mp. or Endpoint Determination/ 
41. 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 
42. 23 and 30 and 41 
43. limit 42 to (english language and yr="1973 -Current") 
 *************************** 
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Appendix G Risk of Bias of Included RCTs 
Overall 
Risk of 
Bias of 
Included 
Studies 
(n=29) 
Random 
sequence 
generatio
n: 
selection 
bias 
Allocation 
concealmen
t: selection 
bias 
Collectio
n of 
objective 
outcome 
measure: 
detection 
bias 
Outcom
e data at 
least > 
or = to 
80% of 
sample: 
attrition 
bias 
Outcomes 
completel
y 
reported  
in results:  
reporting 
bias 
Other: 
include
s any 
and all 
other 
biases 
found 
in RCT 
Low 
Risk 
of 
Bias 
/ 
High 
Qual
ity 
RCT 
Ganz, 
2000
61
  U* U* Y Y Y Y Low 
Pioro,  
2001
71
  Y Y** Y N Y Y Low 
Allen,  
2002
44
  Y Y Y N Y Y Low 
Cooper, 
2002
62
  Y Y Y Y Y Y Low 
Jones,  
2002
66
  
Y U Y Y Y Y Low 
Ansari,  
2003
45
  Y U Y Y Y Y Low 
Hill, 
2003
55
  Y U 
 
Y Y Y Y Low 
Tranmer, 
2004
46
  Y U Y Y Y Y Low 
Fairall,  
2005
8
  Y Y Y Y Y U Low 
Williams, 
2005
60
  Y Y Y Y Y Y Low 
Goessens, 
2006
47
  Y N (Zelen design)  Y Y Y U Low 
Nathan, 
2006
49
  Y U Y Y Y Y Low 
Johnson-
Mallard, 
2007
70
  Y U Y Y Y Y Low 
Krichbaum
, 2007
64
  Y Y Y N Y Y Low 
Dierick-
van Daele,  
2009
67
  
Y Y Y Y Y Y Low 
 122 
 
McCarrier, 
2009
7
  Y U Y Y Y Y Low 
McCorkle, 
2009
52
 Y Y Y Y Y U Low 
Mitchell, 
2009
54
  Y U Y Y Y Y Low 
Ralston, 
2009
6
  Y Y Y Y Y Y Low 
ter Bogt, 
2009 
56
 Y U Y Y Y N Low 
Huizinga, 
2010 
51
 Y Y Y Y Y Y Low 
Schuttelaar
, 2010 
59
 Y Y Y Y Y Y Low 
Enguidano
s, 2012 
65
 U Y Y Y Y N Low 
Hannan, 
2012 
69
 Y U Y Y Y Y Low 
McClellan, 
2012 
63
 U Y Y Y Y Y Low 
Kim, 2013 
53
 Y U Y Y Y Y Low 
Sawatsky, 
2013 
48
 Y U Y Y Y Y Low 
Berkhof, 
2014 
50
 Y U Y N Y Y Low 
Mertens,  
2014 
68
 U Y Y Y Y Y Low 
* Baseline measurements and randomization occurred at a subsequent in-person visit. Participants were 
stratified by age (< or = to 55 years versus >55 years) and tamoxifen use (currently used versus not used) as part 
of the randomization procedure; at baseline visit, patient obtained random assignment,  Table 1, Ganz (2000), p. 
1055.  
 Sequence Generation (selection bias): The simple statement that “patient obtained random assignment” 
is insufficient to be confident that the allocation sequence was genuinely randomized (unbiased). 
 Allocation Concealment (selection bias): Proper concealment of the allocation sequence is necessary to 
secure strict implementation of the allocation sequence without foreknowledge of intervention 
assignments. Allocation concealment refers to techniques used to implement the sequence shielding 
those who admit participants to a study from knowing the upcoming assignments.
15
 
 
** Post-randomization breach in patient assignment: crossover of 89 NP patients to house-staff ward; only 104 
patients were admitted to NP ward after randomization of 193 patients to NP ward. Reasons noted: 
1) unavailable beds on NP ward (almost 1/3 of cross-overs); 2) request of attending doctors (more than 1/5 of 
cross-overs) with flexibility to pre-empt randomization based on doctors’ concerns that certain patients that may 
be ‘too sick’ / require ‘off-hours’ monitoring, during which time NPs were unavailable; and 3) request of NPs, 
based on concerns for adequate staffing; the RCT utilized 2.5 full-time-equivalent NPs, on the unit from  
0730 - 2000 on weekdays and for morning rounds on weekends (Pioro, 2001, p. 29). 
 
However, it is unclear as to whether patient assignment post-randomization, truly represents selection bias, a 
systematic error that over or underestimates the intervention effect.
15
 An Unclear judgement may not be 
penalized with a No judgement. Further, colleagues Donald et al. (2014, Figure 2, p. 13) categorized this RCT to 
contain a low risk of selection bias in their systematic review on cost-effectiveness of NPs and CNSs.
38
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Appendix H Risk of Bias of Excluded RCTs 
Overall Risk of 
Bias of Excluded 
Studies (n=27) 
Random 
sequence 
generatio
n: 
selection 
bias 
Allocation 
concealmen
t: selection 
bias 
Collectio
n of 
objective 
outcome 
measure: 
detection 
bias 
Outcom
e data 
at least 
> or = 
to 80% 
of 
sample: 
attrition 
bias 
Outcome
s 
completel
y 
reported  
in results:  
reporting 
bias 
Other: 
include
s any 
and all 
other 
biases 
found 
in RCT 
Over- 
all 
Risk 
of 
Bias 
Porrett (2001) A 
prospective 
randomized trial 
of consultant-led 
injection 
sclerotherapy 
compared NP-led 
non-invasive 
interventions in 
the management 
of patients with 
haemorrhoids. 
Colorectal 
Disease U U N N N N 
High 
Risk 
Vernooij (2012) 
Internet based 
vascular risk 
factor 
management for 
patients with 
clinically 
manifest vascular 
disease: 
randomised 
controlled trial. 
BMJ U U N Y Y 
N, N, 
N 
High 
Risk 
 Hanrahan (2014) 
A pilot RCT: 
testing a 
transitional care 
model for acute 
psychiatric 
conditions. 
Journal of the 
American 
Psychiatric 
Nurses 
Association 
 
Y U N Y Y 
N, N, 
N 
High 
Risk 
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 Wheelock 
(2015) SIS.NET: 
a RCT evaluating 
a web-based 
system for 
symptom 
management 
after treatment of 
breast cancer. 
Cancer U U Y N N N, N,  
High 
Risk 
 Beckham (2007) 
Motivational 
interviewing with 
hazardous 
drinkers. Journal 
of American 
Academy Nurse 
Practitioners Y U N Y Y N 
Moder
ate  
 Dyar (2012) A 
NP directed 
intervention 
improves the 
quality of life of 
patients with 
metastatic 
cancer: results of 
a randomized 
pilot study, 
Journal of 
Palliative 
Medicine  U U Y N Y N 
Moder
ate  
Kinnersley 
(2007) 
Randomised 
controlled trial of 
nurse 
practitioner 
versus general 
practitioner care 
for patients 
requesting "same 
day" Y N Y N Y Y 
Moder
ate 
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consultations in 
primary care. 
BMJ 
Mundinger 
(2000) Primary 
care outcomes in 
patients treated 
by nurse 
practitioners or 
physicians: a 
randomized trial. 
JAMA U Y N N Y N 
Moder
ate  
Venning (2000) 
Randomised 
controlled trial 
comparing cost 
effectiveness 
of general 
practitioners and 
nurse 
practitioners in 
primary care. 
BMJ Y N N N Y Y 
Moder
ate  
Whitaker (2001) 
Botulinum toxin 
for people with 
dystonia treated 
by an outreach 
NP: a 
comparative 
study between a 
home and a clinic 
treatment 
service. Archives 
of Physical 
Medicine and 
Rehabilitation Y U N Y Y N 
Moder
ate  
Oslin (2002) 
Alcoholism 
treatment 
adherence: older 
age predicts 
better adherence 
and drinking 
outcomes. 
American Journal 
Geriatric 
Psychiatry U U U N N Y 
Moder
ate 
Heitkemper 
(2004) Self-
management for 
women with 
irritable bowel U N U U Y N 
Moder
ate 
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syndrome. 
Clinical 
Gastroenterology 
and Hepatology  
Krein (2004) 
Case 
management for 
patients with 
poorly controlled 
diabetes: a 
randomized trial. 
American Journal 
of Medicine Y N U Y Y N 
Moder
ate 
Limoges & 
Rickabaugh  
(2004) 
Evaluation of 
TENS during 
screening flexible 
sigmoidoscopy. 
Gastroenterology 
Nursing   U N N Y Y U 
Moder
ate 
Purath (2004) A 
brief intervention 
to increase 
physical activity 
in sedentary 
working women. 
Canadian Journal  
Nursing Research N N Y Y Y N 
Moder
ate 
Robbins (2006) 
Girls on the move 
program to 
increase physical 
activity 
participation. 
Nursing Research Y U N Y Y N 
Moder
ate 
Sledge (2006) A 
randomized trial 
of primary 
intensive care to 
reduce hospital 
admissions in 
patients with 
high utilization of 
inpatient 
services. Disease 
Management Y Y Y N Y N 
Moder
ate 
Smith (2006)  
Primary care 
clinicians treat 
patients with 
medically Y N Y Y U N 
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unexplained 
symptoms: a 
RCT. Journal  
General Internal  
Medicine 
 
 
Moder
ate 
Marion (2009) 
The well woman 
program: a 
community-based 
randomized trial 
to prevent STIs in 
low-income 
African American 
women. Research 
in Nursing & 
Health Y N Y N Y Y 
 
 
 
 
 
Moder
ate 
Whittemore 
(2009) 
Translating the 
diabetes 
prevention 
program to 
primary care: a 
pilot study. 
Nursing Research Y U N Y Y N 
Moder
ate 
Stone (2010)  
Active care 
management 
supported by 
home tele-
monitoring in 
veterans with 
type 2 diabetes: 
the Dia-Tel 
randomized 
controlled trial. 
Diabetes Care Y N Y Y Y N 
Moder
ate 
Limoges-
Gonzalez (2011)  
Comparisons of 
screening 
colonoscopy 
performed by a 
NP and 
gastroenterologis
ts. 
Gastroenterology 
Nursing N N U Y U U 
Moder
ate 
Beaver (2012) An 
exploratory RCT 
comparing 
telephone and Y U Y N Y N 
Moder
ate 
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hospital follow-
up after 
treatment for 
colorectal 
cancer. 
Colorectal 
Disease 
Bell et al. (2012) 
Mobile phone-
based video 
messages for 
diabetes self-care 
support. Journal 
of Diabetes 
Science and 
Technology N U Y Y Y N 
Moder
ate 
Goldie (2012) 
Nurse 
Practitioners in 
postoperative 
cardiac surgery: 
are they 
effective? 
Canadian Journal 
of Cardiovascular 
Nursing U U Y N Y N 
Moder
ate 
Konkle-Parker 
(2012) Pilot 
testing of an HIV 
medication 
adherence 
intervention in a 
public clinic in 
the Deep South. 
Journal of the 
American 
Academy of 
Nurse 
Practitioners U U Y N Y N 
Moder
ate 
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Appendix I: Endpoint Assessment per Endpoint Category and 10 Post Hoc Analyses  
Table I-1 Clinical Endpoint-Outcomes  
 
No statistically significant differences in 2 RS^ studies (positive results) 
Adverse Events in Internal Medicine Inpatients, Acute RS 
Total Number Acute Exacerbations in Asthma Patients, Outpatient RS 
No statistically significant differences in IPT^^ study 
Adverse Events in Chronic Heart Failure Patients, Outpatient IPT (pilot study) 
Author, Year 
RS^ / IPT^^ 
Setting  
Study 
Population 
Duration, Site 
Intervention 
 
Results 
 
(Outcome data 
analyzed by Intention 
to Treat, ITT, on the 
basis of all 
randomized patients, 
as randomized, 
unless otherwise 
noted) 
 
 
 
Quality of 
Endpoint 
Assessment / 
Comments 
 
Pioro, 2001 
71
 
 
RS ^ 
 
Acute Inpatient  
 
 
 
381 
heterogeneous 
internal medicine 
inpatients 
18–69 years, 
admitted for 
gastrointestinal, 
pulmonary, 
infectious, 
metabolic/ 
substance abuse, 
neurological, 
cardiovascular 
and “other” acute 
illnesses; study 
duration  from 
hospital 
admission to 6 
weeks post-
discharge at 
single center 
teaching hospital, 
U.S. 
Intervention = 
NP-based care  
(n=193) 
 
Control=House-
staff care  
 
(n=188) 
 
 
 
 
 
Post-
randomization 
breach in patient 
assignment for 
possible selection 
bias: crossover of 
89 NP patients to 
house-staff ward, 
with 104 patients 
admitted to NP 
ward after 
randomization of 
193 patients to 
NP ward. 
Reasons: 
unavailable beds 
on NP ward; 
house-staff & 
NPs’ requests 
(see Appendix G) 
*Adverse Events  
 
Transfers to ICUs,  
NP 3.6% 
House-staff 6.9% 
Difference -3.3% 
(95% CI -7.8, 1.2) 
p > 0.10 
 
In-hospital mortality  
NP 1.6%  
House-staff 1.1%  
Difference 0.5% 
(95% CI -1.8, 2.8) 
p > 0.10  
 
30-day post 
discharge mortality 
NP 3.6% 
House-staff  3.2% 
Difference 0.4 % 
(95% CI -3.2, 4.0) 
p > 0.10   
 
 
>1 Hospital acquired 
complication 
NP 5.3% 
House-staff 8.6% 
Difference -3.3% 
(95% CI -8.4, 1.8) 
p > 0.10 
 
Overall Adverse 
Events (including 
only transfers to 
ICUs, in-hospital 
mortality, and 
hospital-acquired 
complications) 
NP 7.5% 
House-staff 11.8% 
Difference - 4.3%  
(95% CI -10.2, 1.6) 
 p > 0.10 
Data obtained 
from medical 
records, hospital 
databases   
 
 
 
Incomplete 
reporting of raw 
data in Table 2: 
no fraction of 
patients 
comprising 
percentages was 
reported. 
 
 
 
 
It is unclear as to 
whether patient 
assignment post-
randomization, 
truly represents 
selection bias, a 
systematic error 
that over or 
underestimates 
the intervention 
effect. An Unclear 
judgement may 
not be penalized 
with a No 
judgement.
15
  
(see Appendix G) 
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Nathan, 2006 
49
 
RS ^ 
 
Outpatient / 
Specialized 
Referral 
 
154 outpatients  
> 16 years of age 
recently 
discharged from 
the hospital as a 
result of acute 
asthma; 6 months 
study duration 
post-discharge at 
hospital 
outpatient clinic, 
England 
 
 
Intervention = 
NP care  
 
(n= 78) 
 
 
Control = 
Respirologist 
care  
 
(n=76) 
 
 
 
 
 
*Number acute 
asthma exacerbations 
at 6 months 
 
NP 98/174 
exacerbations 
  
Respirologist 76/174 
exacerbations 
 
Difference 22 
exacerbations  
p = 0.368  
 
4 types exacerbations 
1) Mean number 
hospital readmissions 
per patient  
NP 0.07 
Respirologist 0.18  
Relative risk of 
readmission = 0.40 
(95% CI  0.14 to 
1.12) p = 0.09 
 
2) Emergency 
nebulization in 
accident & 
emergency 
departments, general 
practice, or by 
ambulance 
paramedics  
NP 35 times (17 
different patients) 
Respirologist 16 
times (10 different 
patients) 
 
No p-value reported 
 
3) Mean number of 
exacerbations 
per patient requiring 
any emergency 
treatment (hospital 
admission or 
emergency 
nebulization) 
 
NP  0.59  
Respirologist  0.43 
Relative risk = 1.37 
(95% CI 0.84 to 2.21)   
Non-significant 
difference  
(CI includes null 
value of 1) 
 
4) IV or oral steroids 
during exacerbation 
(excluding patients 
using increased 
inhaled 
corticosteroids)  
NP 51.9%  
(27/52patients)   
Respirologist  48.1%  
(25/52 patients) 
Difference 3.8% 
p=0.572  
 
Mean number  
exacerbations 
requiring IV/oral 
steroids per patient 
NP  1.18 
Respirologist 0.91  
Relative risk =1.30 
(95% CI 0.93 to 1.81) 
Non-significant 
No 
inconsistencies 
were found 
between data 
sources: patient 
diary card, 
emergency 
department 
attendance 
records, and 
general practice 
records  
  
 
Limited control 
for intervention 
effect, related to 
confounding 
factor of home 
nebulizers used 
by ‘a few 
patients’ to self-
administer 
bronchodilators  
(Nathan, 2006, p. 
53) 
 
 
 
Ansari, 2003 
45
  
 
Pilot RCT with 
2 levels of 
individual 
randomization  
 
IPT ^^ 
Outpatient / 
Specialized 
Referral 
 
 
169 Chronic 
Heart Failure 
(CHF) patients 
were individually 
randomized into 
Notification 
Intervention  
Beta-blocker 
advocacy 
 
Internists 10 
Cardiologists 2 
NPs 3 
(n = 64 patients) 
 
 
 
NP Facilitator 
Intervention 
Initiation, 
titration, and 
stabilization of 
CHF patients on 
Adverse Events 
1) Hospitalizations / 
Emergency Room 
visits 
Notification  
45% (29/64 patients)  
 
NP Facilitator 
43% (23/54 patients) 
  
Control 
49% (25/51 patients)  
 
p = 0.81 
 
 2) Mortality 
Notification  
2% (1/64 patients) 
 
Nurse Facilitator 
9% (5/54 patients) 
 
Control 
14% (7/51 patients) 
 
p = 0.05 
 
Only 1 outcome of 
death recorded in the 
notification group 
eliminates ability to 
statistically infer 
impact on mortality  
Data regarding 
hospitalizations, 
ER visits, and 
deaths obtained 
from medical 
records and 
patient contact at 
3-month intervals 
 
Information was 
collected on 
adverse events  as 
an indicator of 
safety not efficacy 
(e.g. to confirm 
no increase in 
adverse events, vs 
an efficacious 
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3 groups 
 
74 providers 
(internal 
medicine doctors, 
cardiologists and 
NPs) were also 
individually 
randomized into 
3 groups, to 
decrease the 
likelihood of 
contamination, 
i.e. patients 
receiving care 
from their regular 
providers 
 
Median follow-
up period = 12 
months, at an 
academic 
medical center,  
U.S. 
 
 
beta-blockers 
 
Internists 19 
Cardiologists 3 
NPs 3 
(n=54 patients) 
 
 
 
Control   
Provider 
education 
regarding beta 
blocker 
guidelines  
 
Internists 16 
Cardiologists 4 
NPs 4 
(n=51 patients) 
 
 
 
 reduction in 
adverse events) 
 
 
*Primary Endpoint     ^ Role Substitution (RS)     ^^ Interprofessional Team (IPT) 
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Table I-2 Physiologic Surrogate Marker Endpoint-Outcomes 
Statistically significant differences in 4 IPT^^ studies, 1 RS^ study  
 Blood Lipids in Coronary Heart Disease Patients, Outpatient IPT  
 CVD Risk Factors in Cardiovascular Disease Patients, Outpatient IPT 
 Glycated Hemoglobin in Type 2 Diabetes Patients, Outpatient IPT  
 Tuberculosis Detection (sputum microscopy / culture) in Respiratory Disease 
 Patients, Primary Health Care IPT    
    Risk Factors Associated with Obesity: Systolic Blood Pressure and Fasting Glucose, 
 in Obese / Moderately Overweight Patients, Primary Health Care RS  
 (original study and post hoc analysis) 
 
No statistically significant differences in 2 IPT^^ studies, 1 RS^ study   
 Glycated Hemoglobin in Type 1 Diabetes Patients, Outpatient IPT (pilot study) 
 Glycemic Relapse in Type 2 Diabetes Patients, Outpatient IPT  
 Plasma Viscosity in Rheumatoid Arthritis Patients, Outpatient RS 
 
Author, Year 
RS^ / IPT^^ 
Setting  
Study Population, 
Duration, Site 
Intervention 
 
Results 
 
(Outcome data 
analyzed by 
Intention to 
Treat, ITT, on the 
basis of all 
randomized 
patients, as 
randomized, 
unless otherwise 
noted) 
 
 
 
Quality of 
Endpoint 
Assessment / 
Comments 
 
Allen, 2002 
44
 
IPT ^^ 
Outpatient / Specialized 
Referral 
 
228 coronary heart 
disease (CHD) 
outpatients who received 
coronary artery bypass 
grafting (CABG) surgery 
or percutaneous coronary 
intervention 
(angioplasty) with  
hypercholesterolemia 
(low density lipoprotein 
cholesterol level > 2.59 
mmol/L  or total 
Intervention = 
NP case 
management 
(individualized 
lifestyle and 
pharmacologic 
intervention) + 
Enhanced Usual 
Care (EUC)  
 
 (n = 115) 
 
 
Control =  
Enhanced Usual 
Care (EUC) from 
primary  
providers &/or 
cardiologists 
including full 
lipid profiles at 4 
weeks, 6 and 12 
months after 
* Mean (SD) 
Lipid levels at 1 
year 
 
Total Cholesterol 
(TC) 
 
NP  
4.1mmol/L (0.7) 
EUC   
4.6mmol/L (0.6) 
Difference = 0.5 
mmol/L 
p < 0.0001 
 
*Low-density 
lipoprotein 
cholesterol 
(LDL-C, ‘bad’ 
cholesterol) 
 
NP 2.20 mmol/L 
(0.57) 
*Triglycerides 
(TG) 
 
NP 3.57 mmol/L 
(1.53) 
EUC  4.25 mmol/L 
(1.79) 
Difference = 0.68 
mmol/L 
p = 0.002 
 
* Achieved  
LDL-C treatment 
goal  < 2.59 mol/L 
 
NP 65%    
EUC 35% 
Difference 30% 
p = 0.0001 
 
* High-density 
lipoprotein 
High quality 
endpoint 
assessment 
from blood 
chemistry 
results of lab 
lipid profile 
reports 
 
Attrition: 31% 
  
69%; 158/228 
outpatients 
completed 12 
mo. follow-up 
(77% NP 
patients; 62% 
UC patients) 
 
Control of 
hypercholeste
rolemia in 
patients who 
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cholesterol level > 5.18 
mmol/L); intervention 
for one year post-
discharge, at outpatient 
clinic of large tertiary 
hospital, U.S. 
discharge, and  
goals for levels of 
lipoproteins, diet 
and physical 
activity  
 
(n =113)  
EUC 2.67mmol/L 
(0.57) 
Difference = 0.47 
mmol/L 
p < 0.0001 
cholesterol (HDL-
C, ‘good’ 
cholesterol) 
increased modestly 
in both groups 
have 
undergone 
coronary 
revascularizati
on can be 
improved by 
NP case 
management 
as per study 
 
Goessens, 2006 
47
 
IPT ^^ 
Outpatient / Specialized 
Referral 
 
Cardiovascular disease 
(CVD) 
Peripheral arterial 
disease 
Abdominal aortic 
aneurysm  
Cerebrovascular disease 
Coronary heart disease 
(CHD) 
 
236 CVD outpatients 
with two or more 
modifiable risk factors: 
smoking, hypertension, 
dyslipidemia, diabetes, 
obesity, 
hyperhomocysteinemia.  
 
 
Intervention for  one year 
after randomization at a 
risk-factor management 
clinic in the University 
Medical Center (UMC) 
Utrecht,  Netherlands 
 
 
Intervention  
= NP at risk 
factor 
management 
clinic  + usual 
care  
 
(n=119) 
 
Control = Usual 
Care (UC) by GP 
and treating 
vascular 
specialist 
 
(n=117)  
 
 
 
 
Percent patients 
who achieved 
treatment goals at 
mean follow-up 
of 14 months 
(range 10-22) 
 
1. LDL 
cholesterol 
treatment goal   
< or equal to 3.1 
mmol/L 
 
NP 88 
UC 67 
 
OR 3.5 
95% CI  1.5–8.6 
 
2. Total 
cholesterol 
treatment goal   
< 5.0 mmol/L 
 
NP 79 
UC 61 
 
OR 3.3 
95% CI  1.5–7.3 
 
 
3. Systolic Blood 
Pressure treatment 
goal  < 140 mmHg 
 
NP 63 
UC 37 
 
OR 2.7 
95% CI  1.3–5.4 
 
4. BMI  treatment 
goal < 25 kg/m
2
  
 
NP 38 
UC 24 
 
OR 4.0 
95% CI  1.2–13.1 
 
Differences non-
significant:  
Diastolic BP, 
HDL-C, 
Triglycerides, 
Fasting Blood 
Glucose, 
Homocysteine, 
Waist 
Circumference, 
Smoking 
 
Patients were 
randomized 
before 
informed 
consent was 
obtained, 
according to 
Zelen design, 
yet treatment 
consent is 
always sought 
before actual 
intervention, 
Torgerson & 
Roland (1998) 
 
Physical exam 
(by NP, GP or 
vascular 
specialist) for 
CV risk 
profile at 1 
year,  
measured in 
risk factor 
management 
clinic.  
Attrition 31% 
(71/236) 
patients: 
61 patients 
gave no 
informed 
consent post 
randomization
(24 patients 
randomized to 
intervention & 
37 to control); 
10 patients 
did not 
complete 
study: 4 
deaths / 
group, 1 
moved, & 
another 
developed co-
morbidity 
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Ralston, 2009 
6
 
 
IPT ^^ 
 
Outpatient / Specialized 
Referral 
 
83 Type II Diabetes 
Mellitus outpatients,  
18 - 75 years with 
glycosylated hemoglobin 
(GHb) in prior year   
> or = to 7%,  at least 2 
clinic visits in prior year 
 
 
12 month intervention 
period, at the University 
of Washington General 
Internal Medicine Clinic, 
a teaching clinic that 
provides care to 7, 707 
patients, staffed by 25 
faculty, 48 residents, and 
an NP, for case 
management of chronic 
disease patients, U.S.  
(Ralston, 2009,  p. 234) 
 
 
Intervention = NP 
coordination of 
Web-based care + 
usual care 
 
(n=42) 
 
 
 
Control = usual  
 care (UC)  from 
an internal 
medicine 
physician  
 
(n=41) 
 
 
 
All providers 
used the same 
Electronic 
Medical Record 
(EMR) 
 
  
 
*Physiologic 
markers at 12 
months 
 
Target: 
glycosylated 
hemoglobin < 7% 
 
 
Absolute change 
in glycosylated 
hemoglobin  
 
NP Web 
intervention 33% 
at target 
 
UC 11% at target 
 
Difference = 22% 
 
p =0.03 
 
At 12 months mean 
changes  in risk 
factors between 
groups were non-
significant (no 
individual data 
shown) 
 
 Systolic BP 
p = 0.84 
 
 Diastolic BP  
p = 0.96 
 
 Total 
cholesterol  
p = 0.38  
High quality 
endpoint 
assessment 
using GHb  
rapid 
immunoassay
s in Bayer Lab 
DCA-2000+ 
analyzer   
 
Incomplete 
reporting of 
raw data in 
Table 3: no 
fraction of 
patients 
comprising 
percentages 
was reported 
 
Patient / 
provider Web 
access to 
same 
Electronic 
Medical 
Record 
(EMR) can 
improve 
glycemic 
control in 
Type II 
Diabetes 
Mellitus 
outpatients, as 
per study  
ter Bogt, 2009 
56
 
American Journal of 
Preventive Medicine 
Groningen Overweight 
and Lifestyle (GOAL) 
study 
RS ^ 
 
Primary Health Care 
(PHC) 
 
457 PHC patients with 
BMI 25- 40, and either 
hypertension, 
dyslipidemia or both; one 
year study  period at 11 
Intervention = 
low-intensity (for 
prevention of 
additional weight 
gain) lifestyle 
counseling by 
NPs: 4 individual 
visits and 1 
feedback session 
by telephone over 
one year 
 
(n =225)  
 
 
Control = usual 
GP care  
(n = 232)  
 
 
Physical exam 
Physiologic 
markers at 1 year 
 
Blood pressure 
(BP)  
 
1) Reduction in 
SBP (mmHg) in 
obese men (BMI 
> or = 30 kg/m
2
) 
NP -14  
UC -5  
 
Difference =  9 
mmHg reduction 
in SBP 
 p < 0.05 
2) Mean 
reduction (SD) in 
SBP (mmHg)  in  
Blood lipids  
1) Mean change 
(SD) in total 
cholesterol 
(mmol/L) in 
women  
(BMI 25-40 kg/m
2
) 
NP + 0.02 (0.8) 
UC - 0.06 (0.8) 
 
Absolute 
difference = 0.08 
mmol/L  
non-significant  
 
2) Mean change 
(SD) in total 
cholesterol 
(mmol/L ) in men 
(BMI 25-40 kg/m
2
) 
 
Physical exam 
by a trained 
research team; 
blood samples 
were collected 
by the trained 
research team;  
samples were 
analyzed in a 
central lab 
using certified 
lab assays 
General linear 
model (GLM) 
showed that 
gender is an 
effect 
modifier; data 
thus reported 
separately for 
men & 
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general practice locations 
(1-7 GPs and 1-3 NPs 
per location), 
Netherlands  
 
 
 
Obesity  
BMI > or = to 30 kg/m
2
 
 
 
 
 
Moderately Overweight  
BMI 25 - 30 kg/m
2
 
 
 
done by a trained 
research team 
that measured  
body weight, 
length, waist 
circumference, 
and blood 
pressure 
 
men (BMI 25 -40 
kg/m
2
)  
NP -8.5 (16.8)  
UC -5.3 (12.7)  
Difference non-
significant  
 
3) Mean 
reduction (SD) in 
SBP (mmHg) 
women (BMI 25 
- 40 kg/m
2
)  
 
NP -5.3 (20.1)  
UC -2.2(16.5)  
 
Difference = 3.1 
mmHg   
non-significant  
 
NP - 0.18 (0.6) 
UC + 0.03 (0.7)  
Absolute 
difference = 0.21 
mmol/L 
non-significant  
 
Mean reduction 
(SD) Fasting 
Glucose (mmol/L) 
at 1year  
 
Women (BMI 25 -
40 kg/m
2
) 
NP - 0.08 (0.6) 
UC- 0.11 (0.5) 
 
Difference = 0.03 
mmol/L 
non-significant  
 
Men  
(BMI 25-40 kg/m
2
) 
NP -0.03 (0.6) 
UC -0.05 (0.8) 
Difference = 0.02 
mmol/L 
non-significant  
 
women 
 
Attrition 9% 
(41/457); 24 
intervention 
patients  + 17 
control 
patients = 41 
patients 
withdrew by 1 
year end of 
trial 
 
A low-
intensity 
lifestyle 
intervention 
can improve 
systolic blood 
pressure in 
obese men as 
per study  
 
#ter Bogt, 2011 
80
 
 
Post Hoc Analysis to ter 
Bogt (2009); Archives of 
Internal Medicine 
 
RS ^ 
 
Primary Health Care 
(PHC) 
 
3-year follow-up to the 
Groningen Overweight 
and Lifestyle (GOAL) 
study; following the 
initial one year study, 1 
individual visit and 2 
feedback sessions 
occurred over the next 2 
years, Netherlands 
 
 
Intervention = 
low-intensity (for 
prevention of 
additional weight 
gain) lifestyle 
counseling by 
NPs  
 
(n=171) patients  
 
 
 
Control = usual 
GP care  
(n=186) patients  
BP, blood lipid 
and fasting 
glucose levels 
after 3 years  
 
Mean change 
(SD) in fasting 
glucose (mmol/L) 
 
NP −0.02 (0.49) 
UC  0.10 (0.53) 
 
p = 0.02  
 
 
Mean change (SD) 
total cholesterol 
(mmol/L) 
 
NP 0.07 (0.92) 
UC −0.05 (0.93) 
 
p = 0.15 
 
Mean change (SD) 
Systolic BP  
(mm Hg) 
 
NP −5.9 (17.3) 
UC −3.8 (14.5) 
 
p = 0.38 
 
Data on 
secondary 
outcomes of 
physiologic 
markers at 3 
year follow-
up not 
stratified by 
gender while 
general linear 
model (GLM) 
from the 
original study 
showed that 
gender is an 
effect 
modifier. 
A low-
intensity 
lifestyle 
intervention 
may sustain 
improved 
fasting 
glucose levels 
for obese 
patients 3 
years after 
intervention. 
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Fairall, 2005 
8
 
 
Cluster  RCT, unit of 
random allocation =  
primary health care 
(PHC) clinic 
 
 
IPT ^^ 
 
 
Primary Health Care 
(PHC) 
 
 
Priority Respiratory 
Diseases: LRTI (lower  
respiratory tract 
infection), URTI (Upper 
RTI), asthma, 
tuberculosis (TB), HIV, 
and chronic obstructive 
pulmonary disease 
(COPD) 
 
 
 
40 primary health care 
(PHC) clinics staffed by 
NPs were randomized, 
including 1,999 patients 
with cough or difficult 
breathing on 
presentation, or within 
past 6 months; three 
month study period, 
South Africa 
Intervention = 
PALSA  
(Practical 
Approach to 
Lung Health in 
South Africa) 
Intervention, an 
educational 
outreach program 
of expanded 
prescribing 
provisions with 
locally tailored 
guidelines, 
implemented by 
NPs 
 
20 clinics 
randomized to 
outreach 
intervention, 
including 
1000/1999 
patients  
 
 
 
Control = Usual 
NP Care, with no 
new training in 
educational 
outreach program 
20 clinics 
randomized to 
usual care, 
including 
999/1999 patients 
*Case detection 
of tuberculosis 
(TB) at 3 months 
 
Educational 
Outreach 
Intervention  
6.4% (57/892) 
 
Control   
3.8% (34/890) 
 
Denominator 
limited to all 
patients who had 
not been 
diagnosed with 
tuberculosis (TB) 
before 
educational 
outreach started  
 
OR =1.72 (95% 
CI 1.04 to 2.85) 
p= 0.04 
ICC=0.007 
 
 
 
 
 
 
 
 Limited data 
collection 
related to 
patient self-
report for 
unknown 
quantity of 
data: results 
of sputum 
microscopy  
or culture 
documented 
on TB card, or 
by patient 
report 
 
Patients and 
fieldworkers 
were blind to 
the 
intervention 
status of each 
clinic 
Educational 
outreach with 
integrated 
case 
management 
can improve 
case detection 
of TB without 
extra staff, in 
resource poor 
setting as per 
study 
McCarrier, 2009 
7
 
IPT ^^ 
 
Outpatient / Specialized 
Referral 
 
Pilot RCT  
 
 
78 Type 1 diabetes 
mellitus outpatients 
randomized,  
21 -49 years with at least 
one A1C test > or = to 
Intervention = NP 
coordination of 
Web-based care + 
usual care 
 
(n =42)   
 
 
Control = usual 
care (UC) from 
team at Diabetes 
Care Center 
(DCC)  
(n = 36) 
*Mean (SD) 
change 
hemoglobin A1c 
values at 1 year 
 
NP - 0.37 (1.3) 
 
UC: + 0.11 (1.4) 
 
Absolute 
difference = 0.48 
(95% CI -1.22 to 
0.27) 
p= 0.160 
 
 High quality 
endpoint 
assessment 
based on rapid 
immunoassay 
tests, obtained 
from the 
electronic 
medical 
record, 
accessible to 
both patient / 
provider, for 
Web-based 
diabetes case 
management  
Small sample 
size with 
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7% in previous 12 
months; one year 
intervention period at the 
Diabetes Care Center 
(DCC):  
multidisciplinary practice 
team includes physicians, 
NPs, on-site pharmacists, 
nurse educators, 
nutritionists, and mental 
health professionals, 
affiliated with the main 
University of 
Washington Medical 
Center, U.S. 
 
 
attrition at 
17% (13/78), 
7 patients 
from UC 
group + 6 
patients from 
NP group, 
limited ability 
to detect 
statistically 
and clinically 
significant 
differences 
 
Huizinga, 2010 
51
 
IPT ^^ 
Outpatient / Specialized 
Referral 
 
 
165 Type 2 diabetes 
mellitus outpatients, 18-
75 years, initially 
referred to Diabetes 
Improvement Program 
(DIP) for  poor glycemic 
control (A1c > 8%) with 
subsequent successful   
improvement in 
glycemic control. DIP 
success defined as ≥ 1% 
decline in A1c during 
DIP. 
Two year study 
intervention delivered 
offsite via telephone; 
based at an academic 
medical centre, U.S. 
2 Intervention 
Groups Usual 
Care + NP phone 
contact over 2 
years:  
 
1) Quarterly 
contact (every 3 
months)  (n = 55) 
 
2) Monthly 
contact (n =55)  
 
 
 
Control = Usual 
care (UC) 
through routine 
follow-up in 
Diabetes 
Improvement 
Program 
(n = 55)  
*Glycemic  
relapse, defined 
as an increase in 
HbA1c of  > or = 
to 1% over 
baseline, at 2 
years 
 
Quarterly contact 
21% (10/48) 
patients relapsed  
 
 
Monthly contact 
29% (15/52) 
patients relapsed 
 
 
UC  25% (12/48) 
patients relapsed  
 
p=0.83  
 
Prevalence of 
relapse did not 
differ between 
groups over 
follow-up time, nor 
did the cumulative 
incidence 
of relapse differ 
between treatment 
groups (p = 0.72) 
Precision & 
accuracy of  
HbA1c 
measurement 
according to 
the DCCT 
(Diabetes 
Control & 
Complications 
Trial) method,  
National 
GlycoHb 
Standardizatio
n Program 
Test was 
performed in 
a study 
population 
already 
motivated 
with previous 
glycemic 
control.  
Study 
protocol did 
not contain 
care strategies 
for patients 
who relapsed, 
and was not 
powered for 
sub-group 
analysis 
between its 3 
groups 
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Hill, 2003 
55
 
RS ^ 
Outpatient / Specialized 
Referral  
 
80 Rheumatoid Arthritis 
(RA) outpatients, 18 
years or older, to 
rheumatology clinic on at 
least three previous 
occasions; study period 
of 12 months, at a 
traditional rheumatology 
outpatient clinic 
managed by junior 
hospital doctors (JHDs) 
within a large teaching 
hospital, England 
 
Intervention = 
rheumatology NP 
(RNP) care 
 
 
(n =39)  
 
 
 
 
 
Control = junior 
hospital doctor 
(JHD) care 
 
 
( n= 41)  
Plasma Viscosity 
at 48 weeks 
(Inflammation, 
accompanied by 
changes in 
plasma protein, 
can increase 
plasma viscosity) 
  
 
 
Median value 
mPa (range)  
 
RNP 1.62 mPa 
(1.49– 1.85)   
 
 JHD  1.63 mPa 
(1.50–1.97) 
 
Difference  
nonsignificant 
 
 
 
 
 
 
 
 
Plasma 
viscosity 
(cells / solid 
matter e.g. 
protein, 
suspended in 
plasma of 
blood) 
laboratory test  
has high 
sensitivity 
(little 
alteration may 
be 
pathologically 
important)  
but low 
specificity, 
Késmárky 
(2008) 
 
 
 
*Primary Endpoint     ^ Role Substitution (RS)     ^^ Interprofessional Team (IPT)    #Post Hoc Analysis 
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Table I-3 Symptom Severity, Functional Status, Behaviour/Lifestyle Change  
 
i. Symptom Severity (symptom - indication of disease or change in condition
3
) 
 
Statistically significant differences in 4 IPT^^ studies   
      Pain Ratings and Cancer-Specific QOL in Advanced Cancer Patients, Outpatient IPT 
Menopause Symptoms in Breast Cancer Survivors with abruptly recurred menopause, 
Outpatient IPT 
Cancer-Specific QOL in Post-operative Women with Suspected Ovarian Cancer, 
Outpatient IPT    
Body Weight Loss and Waist Circumference in Obese / Moderately Overweight Patients, 
Primary Health Care RS  
Symptom Severity / Cure in Patients with Incontinence, Primary Health Care IPT 
(original study and post hoc analysis)  
Fatigue in Rheumatoid Arthritis Patients, Outpatient RS 
Post-stroke Depression in Ischemic Stroke Patients, Outpatient IPT 
No statistically significant differences in 4 IPT^^ studies, 5 RS^ studies (positive results)    
Disease-specific Symptoms St. George Respiratory Questionnaire in COPD Patients, 
Outpatient IPT (pilot study) 
Post-operative Symptoms in Cardiac Surgery Patients, Outpatient IPT 
Post-operative Symptoms in CABG Patients, Outpatient IPT 
Post-operative Symptoms in Hip Fracture Surgery Patients, Outpatient IPT (pilot study) 
Disease-specific Symptoms St. George Respiratory Questionnaire in Acute Asthma 
Patients, Outpatient RS 
Symptoms Internal Medicine Inpatients six weeks post-discharge, Acute RS 
Symptom Severity in Minor Injury Emergency Department Patients, Acute RS 
Disease Activity, Psychological Status, Pain Rheumatoid Arthritis Patients, Outpatient 
RS 
Eczema-specific Quality of Life Infants / Children with Atopic Dermatitis, Outpatient RS 
 
ii. Functional Status  
 
Statistically significant differences in 3 IPT^^ studies and 1 RS^ study  
        Health Status COPD Patients, Outpatient IPT (pilot study) 
Sexual Functioning in Breast Cancer Survivors with abruptly recurred menopause, 
Outpatient IPT 
No statistically significant differences in 1 IPT^^ and 3 RS^ studies 
  Functional Impairment (chemotherapy) in Advanced Cancer Patients, Outpatient IPT 
ADL/IADLs in Internal Medicine Inpatients six weeks post-discharge, Acute RS 
Percentage Return to Normal Function Soft Tissue Injury Emergency Department 
Patients, Acute RS   
Peak Flow in Acute Asthma Patients, Outpatient RS 
 
iii. Behaviour / Lifestyle Change  
 
Statistically significant differences in 2 IPT^^ studies, 1 RS^ study 
Diet and Exercise in Coronary Heart Disease Patients, Outpatient IPT 
Alcohol and Drug Use in Low-Income Addictions Patients, Primary Health Care IPT 
      Physical Activity in Obese / Moderately Overweight Patients, Primary Health Care RS 
(post hoc analysis) 
No statistically significant differences in 1 IPT^^ study  
Distress; Hospital Anxiety Depression in Advanced Cancer Patients, Outpatient IPT 
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Symptom Severity, Functional Status, Behaviour/Lifestyle Change Endpoint-Outcomes 
Author, Year 
RS^ / IPT^^ 
Setting  
Study 
Population, 
Duration, Site 
Intervention 
 
Results 
 
(Outcome data analyzed 
by Intention to Treat, 
ITT, on the basis of all 
randomized patients, as 
randomized, unless 
otherwise noted) 
 
 
 
 
Quality of 
Endpoint 
Assessment / 
Comments 
 
Allen, 2002 
44
 
IPT ^^ 
Outpatient / 
Specialized 
Referral 
 
228 coronary 
heart disease 
(CHD) 
outpatients who 
received 
coronary artery 
bypass grafting 
(CABG) surgery 
or percutaneous 
coronary 
intervention 
(angioplasty), 
with  
hypercholesterol
emia (low 
density 
lipoprotein 
cholesterol level 
> 2.59 mmol/L  
or total 
cholesterol level 
> 5.18 mmol/L); 
intervention for 
one year post-
discharge, at 
outpatient clinic 
of large tertiary 
hospital, U.S. 
 
Intervention= 
NP case 
management 
(individualized 
lifestyle and 
pharmacologic 
intervention) + 
Enhanced Usual 
Care  
 (n = 115) 
Control =  
Enhanced Usual 
Care (EUC) from 
primary  
providers &/or 
cardiologists 
including full 
lipid profiles sent 
to patients and 
their physicians 
at 4 weeks, 6 and 
12 months after 
discharge, 
including  
goals for levels 
of lipoproteins, 
diet and physical 
activity 
 
(n =113)  
 
Diet and exercise at 1 
year 
 
Mean dietary intake (SD) 
in calories 
 
Total fat 
 
NP 33.2% (+ or - 6.7%) 
EUC 34.6%  
(+ or - 6.5%) 
Difference 1.4% 
p = 0.009  
 
 
Saturated Fat 
 
NP 10.1% (2.2%)  
EUC 11.0% (2.3%) 
Difference 1.1% 
 p = 0.004 
 
 
Dietary 
Cholesterol (mg) 
NP 254.2 (99.8) 
EUC 292.0 
(104.9) 
Difference 37.8  
p = 0.006 
 
 
Dietary fiber 
NP 22.2 (7.2) 
 EUC 21.3 (5.7) 
Difference 0.9  
p = 0.28 
 
Exercise at a 
level of 6 MET 
(metabolic 
equivalent) 
hours/week or 
more  
  
NP 40%   
(46/115)  
EUC 26% 
(29/113)  
Difference 14% 
p = 0.02 
 
Endpoint 
assessment based 
on the Block 
Health Habits 
and History 
questionnaire 
food frequency 
instrument, 
reviewed by 
study dietician; 
and the validated 
Physical Activity 
questionnaire that 
quantified weekly 
energy 
expenditure in 
metabolic 
equivalent (MET) 
hours 
Incomplete 
reporting of raw 
data in Table II: 
no fraction of 
patients 
comprising 
percentages of 
dietary intake 
was reported.  
Diet and exercise 
in CHD patients 
with 
hypercholesterole
mia can be 
improved by a 
NP case 
management 
program as per 
study 
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ter Bogt, 2009 
56
 
American 
Journal of 
Preventive 
Medicine; 
Groningen 
Overweight and 
Lifestyle 
(GOAL) study 
RS^ 
Primary Health 
Care (PHC) 
457 PHC 
patients with 
BMI 25- 40 
kg.m
2
, and either 
hypertension, 
dyslipidemia or 
both; one year 
study  period at 
11 general 
practice 
locations (1-7 
GPs and 1-3 NPs 
per location), 
Netherlands  
 
Obesity BMI > 
or = to 30 kg/m
2
)  
 
Moderately 
Overweight BMI 
25 - 30 kg/m
2
 
Intervention = 
low-intensity  
lifestyle 
counseling by 
NPs over one 
year: 4 
individual visits 
and 1 feedback 
session by 
telephone 
 
(n =225)  
 
 
The relatively 
low intensity of 
the lifestyle 
counseling 
strategy was only 
expected to 
prevent (further) 
weight gain or 
establish 
marginal weight 
loss 
 
 
Control = usual 
GP care  
 (n = 232)  
 
 
 
 
 
 
*Percentage change in 
body weight at 1 year  
 
NP -1.9% (95% CI -2.5, 
-1.2) 200/225 patients 
 
UC -0.9% (95% CI -1.5, 
-0.2) 214/232 patients 
Difference 1.0% 
p < 0.05 
 
 
 
*Weight losers 
(successful) and 
stabilizers (percentage of 
subjects who gained less 
than 1% body weight 
from baseline to 1 year) 
 
Women 
NP 72.8% (75/103) 
patients  
UC 64.0% (73/114) 
patients  
 
Difference 8.8% 
p < 0.05 
 
Men 
NP 80.6% (79/98) 
patients  
UC 65.3% (66/101) 
patients  
 
Difference 15.3% 
p < 0.05  
 
Mean (SD) Waist 
circumference 
(cm) at 1 year  
 
Women 
NP -2.0 (7.8) 
(103/225) 
patients 
UC -1.5 (6.8) 
(114/232) 
patients  
 
Difference 0.5  
Non-significant 
 
Men 
NP -2.8 cm (6.2) 
(98/225)  patients 
UC -0.9 cm (4.5) 
(101/232) 
patients   
 
Difference 1.9  
p < 0.05 
   
Endpoint 
assessment based 
on physical exam 
by  trained 
research team  
 
In non-medically 
indicated 
patients, the NP 
lifestyle 
counseling was 
explicitly aimed 
at weight 
stabilization, with 
the hypothesis of 
study being that 
an early focus on 
preventing 
(progression of) 
overweight and 
comorbidities 
through weight 
stabilization vs 
weight loss, may 
be more 
successful in the 
long term 
#ter Bogt, 2011 
80
 Archives of 
Internal  
Medicine  
 
Post Hoc 
Analysis to ter 
Bogt (2009) 
 
RS ^ 
Primary Health 
Care (PHC) 
3-year follow-up 
to the Groningen 
Overweight and 
Lifestyle 
(GOAL) study, 
Netherlands 
Intervention = 
low-intensity (for 
prevention of 
additional weight 
gain) lifestyle 
counseling  
 
1 individual visit 
and 2 feedback 
sessions occurred 
over 2 years 
following the 
original RCT 
 
(n=171)  
 
Control = usual 
GP care  
(n=186)   
Mean (SD) percentage 
change in body weight at 
3 years 
 
 
NP −1.2 (5.8) 
(171/171) patients   
 
UC −0.6 (5.6)  
(186/186) patients 
 
p = 0.37 
  
 
 
Mean (SD) 
change in waist 
circumference 
(cm) at 3 years  
 
NP −0.8 (7.1) 
(169/171) 
patients  
 
UC 0.4 (7.2) 
(182/186) 
patients 
 
p = 0.11 
Endpoint 
assessment based 
on physical exam 
by  trained 
research team  
 
Data at 3 year 
follow-up was 
not stratified by 
gender while the 
general linear 
model from the 
original study 
showed that 
gender is an 
effect modifier  
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#ter Bogt, 2011 
82
  Public Health 
Nutrition  
 
Post Hoc 
Analysis  to ter 
Bogt (2009) 
  
RS ^ 
Primary Health 
Care (PHC) 
1 year follow-up 
to the original 
Groningen 
Overweight and 
Lifestyle 
(GOAL) study; 
post hoc 
included 341 
GOAL patients 
who completed a 
Food Frequency 
and the Physical 
Activity 
Questionnaire, 
Netherlands  
Intervention =  
low-intensity 
lifestyle 
counseling from 
NPs 
 
( n=169)  
 
 
 
 
 
Control = usual 
GP care  
 (n=172)  
 
 
 
 
Physical activity at 1 
year 
 
Mean change in walking  
(minutes/week) from 
baseline to end of study 
at 1 year 
NP 33 min/week 
(95% CI 3, 63)  
UC -5 min/week 
(95% CI -28, 18) 
 
p = 0.05 
 
Diet at 1 year 
 
No significant 
differences in 
changes to 
nutrient intake 
between groups 
 
 
 
General linear 
model from 
original study 
showed that 
gender is an 
effect modifier; 
yet data at 1 year 
follow-up was 
not stratified by 
gender  
Endpoint 
assessment based 
on validated 
questionnaires: 
SQUASH (Short 
Questionnaire to 
Assess Health-
Enhancing 
Physical 
Activity) and 
FFQ (food 
frequency 
questionnaire) at 
baseline and after 
1 year 
A lifestyle 
intervention can 
improve obese  
patients’ physical 
activity (walking, 
minutes/week), 
as per study, 
although data is 
limited by self-
report 
 
 
#Driehuis, 2012 
84
  Patient 
Education and 
Counseling 
 
Post Hoc 
Analysis to ter 
Bogt (2009) 
 
RS ^ 
Primary Health 
Care (PHC) 
Three-year 
follow-up on  
338 GOAL 
patients who 
completed the 
Food Frequency 
Questionnaire 
and/or the ‘Short 
Questionnaire to 
Assess Health-
enhancing 
physical activity’ 
at 3 years, 
Netherlands 
Intervention =  
low-intensity 
lifestyle 
counseling from 
NPs for three 
years. In the 2 
years after the 1 
year GOAL 
study, patients 
had one meeting 
with the NP and 
received two 
feedback phone 
calls each year 
 
(n=162) 
 
 
 
Control = usual 
GP care  
 (n=176) 
Physical Activity at 3 
years  
  
Mean change (SD) in 
total physical activity 
(minutes/week) between 
baseline and 3 years 
 
 
NP -167 (1321)  
111/ 162 patients  
 
UC -92 (1218) 137/176  
patients 
 
p = 0.387 
 
  
 
 
Diet at 3 years 
 
Mean change 
(SD) in total 
daily energy 
intake (kJ/day) 
between baseline 
and 3 years 
 
NP -587 (2059) 
158/162 patients 
 
UC -523 (2114) 
172/176 patients 
 
p = 0.737 
 
Endpoint 
assessment based 
on validated 
questionnaires: 
SQUASH (Short 
Questionnaire to 
Assess Health-
Enhancing 
Physical 
Activity) and 
FFQ (food 
frequency 
questionnaire) at 
baseline and after 
3 years 
Reduction of  
intervention  
intensity to one 
meeting and two 
feedback phone 
calls per year, 
likely contributed 
to relapse of total 
physical activity  
in both groups 
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Berkhof, 2014 
50
  
IPT ^^ 
 
Outpatient / 
Specialized 
Referral 
 
Pilot study  
 
 
 
100 chronic 
obstructive 
pulmonary 
disease (COPD) 
outpatients > or 
= to 40 years, 
COPD GOLD 
stage > or = to 2 
(Global initiative 
for staging 
Obstructive 
Lung Disease: 1 
= mild; 4 = very 
severe),  
smoking history 
>10 pack-years 
 
 
 
2 year study at a 
large teaching 
hospital, 
Netherlands 
 
Intervention = 
patient-initiated 
outpatient  visits 
with pulmonary 
NP upon 
increase of 
symptoms 
(dyspnea, cough, 
sputum, 
hemoptysis, or 
thoracic pain); 
NP followed an 
‘on-demand 
protocol’ that 
included  consult 
with 
pulmonologist 
for urgent 
problems 
 (n =49)  
 
 
Control= usual 
care (UC) of 
traditional 
outpatient visits 
initiated by 
pulmonologist, 
to the 
pulmonologist or 
the pulmonary 
NP 
(n=51)   
 
*Mean (SE) deterioration 
in COPD status at 2 
years  
Clinical COPD 
Questionnaire (CCQ) 
scores range from 0 to 6; 
lower score signifying 
better health status; 
minimal clinically 
important difference 
(MCID) of CCQ total 
score is 0.4 
 
NP 0.14 (+ or - 0.14) 
40/49 patients 
UC 0.58 (+ or - 0.16) 
29/51 patients 
 
Difference = - 0.44 (+ or 
-  0.21) 
95% CI -0.87 to -0.023  
p = 0.04 
meeting the MCID for a 
clinically relevant effect 
 
 
Median time to 1st 
exacerbation COPD (in 
1
0
 & 2
0
 care) at 2 years  
 
NP 307 days  + or - 61.6 
days  
(95% CI 186.3 to 427.7) 
UC 335 days + or - 60.2 
days  
(95% CI 217.0 to 453.0) 
 
Difference 28 days 
p = 0.40 
Mean (SE) St. 
George’s 
Respiratory 
Questionnaire 
(SGRQ), 
symptom domain 
at 2 years (higher 
score on SGRQ 
= worse health 
status; minimal 
clinically 
important 
difference 
(MCID) of 
SGRQ total score 
is 4) 
 
NP 2.6 (3.0), on 
38/49 patients 
 
UC 10.3 (3.4) 
30/51patients 
 
Difference of 
7.7 (4.6) 
95% CI  -16.8 to 
1.4 
p = 0.10 
meeting MCID 
for a clinically 
relevant effect 
 
Endpoint 
assessment for 
disease-specific 
quality of life 
based on reliable 
and valid tools:  
1) Clinical COPD 
Questionnaire 
(CCQ)  
2) St. George 
Respiratory 
Questionnaire 
(SGRQ) 
Results are 
exploratory: the 
on-demand 
system had not 
been investigated 
before in COPD 
patients 
 
Less deterioration 
in disease-
specific health 
status can occur 
in a patient -
initiated system 
of on-demand NP 
care as per study, 
although 
endpoint 
assessment of 
time to 
exacerbation was 
based on self-
reported data 
 
Hill, 2003 
55
 
RS^  
Outpatient / 
Specialized 
Referral 
80 Rheumatoid 
Arthritis (RA) 
outpatients, 18 
years or older, to 
rheumatology 
clinic on at least 
three previous 
occasions; study 
period of 12 
Intervention = 
rheumatology 
NP (RNP) care 
 
(n =39)  
 
 
 
Control = junior 
hospital doctor 
(JHD) care 
 
( n= 41)  
*Disease Activity Score 
(DAS28) 
 
Week 24 
NP 35/39 patients 
JHD 34/41patients 
 
Scores Unchanged 
NP 19 patients 
JHD 25 patients 
 
Scores Worsened  
NP 6 patients 
JHD 5 patients 
 
Scores Improved  
NP 10 patients  
Week 48 
Physical function 
Median (range)  
NP 3.0  
(0.8 – 8.2) 
JHD 3.8 
(0.4 – 7.6) 
Difference 
nonsignificant 
 
Week 48 
Psychological 
status Median 
(range)  
NP 2.7  
(0.7 – 7.5) 
JHD 2.5 
Endpoint 
assessment based 
on the DAWN 
Visual DAS28 
calculator, and 
the Arthritis 
Impact 
Measurement 
Scales (AIMS) 
validated by 
Meenan et al. 
(1980) modified 
for British use 
(Hill et al., 1990) 
 
Patient 
assessments were 
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months, at a 
traditional  
rheumatology 
outpatient clinic 
managed by 
junior hospital 
doctors (JHDs) 
within a large 
teaching 
hospital, 
England 
JHD 4 patients, 
 
no p-value reported 
 
 
Week 48 
NP 36/39 patients 
JHD 35/41patients 
 
Scores Unchanged 
NP 19 patients 
JHD 22 patients 
 
Scores Worsened  
NP 6 patients 
JHD 7 patients 
 
Scores Improved  
NP 11 patients 
JHD 6 patients 
 
no p-value reported 
 
 
 
 
(0.2 – 6.7) 
Difference 
nonsignificant  
 
Week 48 Pain, 
Median (range)  
NP 5.7 (2.0 - 9.0)  
JHD 6.0 (1.5-9.5) 
Difference non-
significant 
 
Week 48 Length 
of morning 
stiffness 
(minutes), 
Median (range) 
NP 60 (0–600) 
JHD 37.5 (0-270) 
Difference 22.5 
nonsignificant 
 
Week 48 Fatigue 
(minutes) 
Median value 
(range)  
NP 60 (0–600) 
JHD 270 (0-600) 
p=0.02 
 
undertaken  by an 
independent 
research 
assistant, blind to 
group allocation 
 
Incomplete data 
regarding number 
of patients per 
group for 
comparison of 
measure fatigue,   
based on self-
reported data in 
absence of formal 
measurement tool 
 
Multiple JHDs 
were involved in 
the study versus 
only one RNP  
resulting in bias 
associated with 
the NP (with 1 
NP, cannot 
calculate 
variability 
through SD, for 
integration into 
effect estimate 
calculations)  
 
Kim, 2013 
53
 
 
IPT ^^ 
 
Outpatient / 
Specialized 
Referral 
 
108 advanced 
cancer 
outpatients,  
20 - 80 years 
diagnosed with  
stage IV 
advanced solid 
tumor, moderate 
level of cancer-
related pain 
(Visual Analog 
Scale score ≥4 
out of 10 over 
Intervention = 
usual care + 
daily phone 
monitoring (tele-
monitoring) by 
NP  
(n = 54) 
 
 
 
 
 
 
Control = usual 
care (UC) of 
standardized pain 
education by NP 
in both study 
arms at first visit  
 
(n = 54)  
*Reduction in average 
pain ratings at 1 week, 
Brief Pain Inventory  
(0 = no pain; > or = to 4= 
average pain; 10 = ‘pain 
as bad  as you can 
imagine’)  
 
Number patients 
experiencing average 
pain intensity at 1 week 
 
NP  19% (10/54)    
UC  35% (19/54) 
Difference 16% 
 
p = 0.02 
 
 
1 week Functional 
impairment, mean (SD) 
(Karnofsky performance 
score, 100 is "perfect" 
health and 0 is death) 
NP 66 (8.0) 
UC 65 (9.2)  
1 week % 
patients ≥ score 
of 4 on Distress 
Thermometer  
(0 = not 
distressed, to  
10 = extremely 
distressed) 
NP 83% (45/54)  
UC 91 % (49/54) 
Difference 8 % 
p = 0.09  
 
European 
Organisation for 
Research and 
Treatment of 
Cancer Quality 
of Life 
Questionnaire 
(EORTC QLQ-
C30) 
Physical 
function, mean 
(SD) at 1 week 
(higher scores 
Endpoint 
assessment based 
on the Wisconsin 
Brief Pain 
Inventory (BPI) , 
Hospital Anxiety 
Depression Scale, 
Distress 
Thermometer and 
the Karnofsky 
performance 
score, all 
standardized & 
well-validated 
 
All calculations 
were reported to 
have used actual 
per protocol data, 
with report of no 
adjustments made 
for missing data  
 
 145 
 
last 24 h), and 
life expectancy 
>1 month; 
intervention 
period of 1 week 
at an outpatient 
pain clinic, 
South Korea 
 
 
Difference 3  
p = 0.68 
 
 
1 week % patients with 
score≥ 11, Hospital 
Anxiety Depression 
Scale (0 – 7 = normal, 
8 – 10  = borderline 
abnormal, 
11 – 21 = abnormal) 
NP 57% (31/54 ) 
UC 54% (29/54)  
Difference 3% 
p = 0.34 
 
represent higher 
levels of 
functioning) 
 
NP 56 (23)  
UC 55 (21)  
p = 0.03 
 
Differences in all 
other component 
scores of the 
EORTC QLQ-
C30 were non-
significant  
 
 
Ganz, 2000 
61
 
IPT ^^ 
 
Outpatient / 
Specialized 
Referral 
  
76 breast cancer 
survivors with 
abruptly recurred 
menopause 
symptoms due to 
discontinued 
estrogen 
replacement 
therapy (ERT) 
related to breast 
cancer; 
intervention 
period of 4 
months at an 
outpatient clinic, 
U.S. 
Intervention = 
comprehensive 
menopausal 
assessment or 
CMA: targets 
highly 
symptomatic 
women with the 
goal of reducing 
symptoms & 
improving 
quality of life, 
through 
education, 
counseling, 
& focus on  
non-ERT 
interventions; 
delivered by NP  
   
( n=37) 
 
 
 
Control = usual 
care (UC) +1 
contact from 
research assistant 
at 2 months 
asking of 
therapies used 
for symptom 
management 
 
 
( n= 39) 
*Mean change 
(reduction) from baseline 
to 4 months in 
menopause  symptom-
scale score  
 
NP 0.61  
(95% CI 0.40–0.82) 
33/37 patients 
 
UC 0.19  
(95% CI −0.06 to 0.44) 
39/39 patients 
 
p = 0.0004 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mean change 
from baseline to 
4 months sexual 
functioning scale 
(Cancer 
Rehabilitation 
Evaluation 
System, CARES) 
 
NP 0.38  
(95% CI 0.05–
0.71) 
33/37 patients 
 
UC 0.015  
(95% CI −0.37 to 
0.40) 
39/39 patients 
 
p = 0.04 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Endpoint 
assessment based 
on the 
Menopausal 
Symptom Scale 
Score for seven 
symptoms,  
adapted for this 
study from the 
Breast Cancer 
Prevention Trial 
Symptom 
Checklist 
 
 
 
 
Instead of using 
intention to treat 
analysis, 
estimation of 
intervention 
efficacy was 
made according 
to methods 
described by 
Angrist JD, 
Imbens GW, 
Rubin DB. 
Identification of 
causal effects 
using 
instrumental 
variables. J Am 
Stat Assoc 1996 
(Ganz, 2000, p. 
1056)  
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IPT ^^  
 
Outpatient / 
Specialized 
Referral  
 
149 post-surgical 
outpatients 21 
years or older, 
suspected 
primary 
diagnosis of 
ovarian cancer 
after abdominal 
surgery, 
prognosis of at 
least 6 months, 
with an order to 
initiate 
chemotherapy 
 
 
 
 
Contact with 
study patients 
made at private 
homes or by 
telephone, U.S. 
 
Intervention  = 
18 contacts by an 
oncology NP, 
supported by 
psychiatric NP 
(PSYNP) 
consults (32/74 
intervention 
patients)  when 
warranted for 
high emotional 
distress = 
Distress 
Thermometer  > 
or = to 4 (n=74)  
 
Attention Control 
= 9 contacts by 
research 
assistant, 
supported by 
medical social 
worker (no data 
for patient 
contact with 
social worker) 
(n = 75) 
 
Cancer-specific 
quality of life 
(QOL) tools: 
 
a) Center for 
Epidemiological 
Studies-
Depression Scale 
(CES-D) (total 
score range 0 to 
60; score > or = 
to16 indicates 
impairment)  
 
b) Ambiguity 
subscale of the 
Mishel 
‘Uncertainty in 
Illness’ Scale 
(MUIS)  
(scores range 13 
to 65; higher 
scores, more 
uncertainty) 
 
c) Symptom 
Distress Scale 
(SDS) (rated 
from 1–5; “1” 
indicates 
absence/low 
symptoms; “5” 
=  high symptom 
severity) 
Cancer-specific QOL 
measured at baseline 
(24– 48 hours after 
surgery) 1, 3, and 6 
months post-surgery 
 
Adjusted QOL baseline 
scores were included as 
covariates in 3 types of 
mixed effect regression 
models, built to estimate 
‘rates of change’  in 
different QOL measures 
over time: 
 
(1) Oncology NP 
without PSYNP  
Effect Estimate (EE) 
      
 Uncertainty of Illness 
(MUIS)  
EE  = - 0.04847 
± se 0.01394, p = 0.0006   
Rate of reduction in 
MUIS score was 
significantly greater for 
intervention vs control  
 
CES-Depression  
(CES-D) 
EE = 0.06566 
 ± se 0.02190, p = 0.0030  
 
Symptom Distress Scale 
(SDS) 
EE  = 0.05092 
± se 0.01638, p = 0.0021   
 
Rate of change in  
CES-D, and SDS was 
significantly greater for 
control vs intervention 
  
 
 
(2) Oncology NP with 
PSYNP  
Effect Estimate (EE) 
 
 
Uncertainty of Illness 
(MUIS)  
EE  = - 0.03917 
± se 0.00915, p < 0.0001   
 
Rate of reduction in 
MUIS score was 
significantly greater for 
intervention vs control  
(2) Oncology NP 
with PSYNP  
continued 
 
CES-Depression 
(CES-D)  
EE  = 0.03594  
± se 0.01213, p = 
0.0033  
 
Rate of change in 
CES-D score was 
significantly 
greater for 
control vs 
intervention  
 
Symptom 
Distress Scale 
(SDS) 
Poor model fit – 
no EE data 
 
3) PSYNP 
without 
Oncology NP 
Effect Estimate 
(EE) 
 
The PSYNP 
component 
significantly 
increased the rate 
of improvement 
over time in all 
QOL measures 
except for the 
CES-D  
 
Uncertainty of 
Illness (MUIS)  
EE = - 0.04978  
± se 0.02094, 
p = 0.0181  
 
Symptom 
Distress Scale 
(SDS) 
EE = - 0.1164 
± se 0.01284, 
p < 0.0001  
 
CES-Depression 
(CES-D) 
 
EE = 0.01662 
± se 0.03549, 
p = 0.6400   
non-significant 
rate of change 
Standardized 
tools reliable and 
valid: Center for 
Epidemiological 
Studies-
Depression Scale 
(CES-D); Mishel 
‘Uncertainty in 
Illness’ Scale 
(MUIS); and  
Symptom 
Distress Scale 
(SDS) 
 
Baseline 
measures were 
obtained prior to 
randomization, 
with significant 
differences found 
in the CES-D and 
MUIS baseline 
scores; lower 
baseline QOL 
overall in the NP 
intervention 
group 
 
Baseline QOL 
scores were 
adjusted for 
model testing, 
with final 
covariates 
including age, 
marital status, 
number of 
comorbidities, 
disease status 
(recurrence or 
not), and 
education level 
 
 
 
Cancer care that 
addresses both 
physical and 
emotional QOL 
in synchrony, 
may contribute to 
enhanced rate of 
improvement in 
QOL as per study  
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IPT ^^ 
 
Primary Health 
Care (PHC) 
 
3746 PHC 
patients aged 40 
years and over 
living in private 
households, with 
incontinence 
several times per 
month or more, 
or several times 
a year, and 
reported impact 
of symptoms on 
quality of life. 
 
 
Six month 
intervention 
period, at 
patients’ homes 
in Leicestershire 
and Rutland, 
England 
 
 
Intervention = 
continence 
service provided 
by NPs 
(n = 2958) 
Control = 
existing usual 
primary care 
including GP and 
continence 
advisory services  
 
(n =788) 
 
 
4:1 ratio was  
deemed 
necessary to 
ensure sufficient 
intervention data 
for evaluation of 
detrusor muscle 
(wall of bladder)   
over-activity and 
urodynamic 
stress 
incontinence 
(involuntary 
leakage of urine 
with increased 
intra-abdominal 
pressure in the 
absence of 
detrusor 
contraction) 
*Improvement in one or 
more symptoms , cure 
(no symptoms)  
at 3 months  
 
 
NP 60%  
(1417/ 2378 responders)  
 
Control 48%  
(281/584 responders) 
 
12% difference  
(95% CI 7 to 16) 
 p < 0.001 
 
6 months  
NP 62% 
(1369/2201 responders) 
 
Control 52%  
(277/536 responders) 
 
10% difference  
(95% CI 6 to 15)  
p < 0.001 
 
 
Cure  = 0 
symptoms 
 
3 months 
NP 25% 
(591/2378) 
Control 15% 
(88/584)  
 
10% difference 
(95% CI 6 to 13)  
p < 0.001 
 
 
6 months 
NP 28% 
(624/ 2201) 
 
Control 19% 
(104/536) 
 
9% difference 
(95% CI, 5 to 13) 
p < 0.001 
 
 
 
Number of  
symptoms 
alleviated  
 At 3 and 6 
month time 
points, the 
percentage of 
responders 
reporting each of 
all four 
symptoms 
/events were 
statistically 
significantly less 
in the 
intervention 
group than 
control, with the 
exception of one 
borderline result 
at p = 0.066.  
Differences 
between groups 
ranged from 
11%, p <0.001 to 
4%, p = 0.066 
Endpoint 
assessment based 
on the Leicester 
Urinary 
Symptom  
Questionnaire 
(developed for 
this study. Shaw 
(2004) reported 
high internal 
consistency, with 
measures of 
construct validity 
as hypothesised, 
and test-retest / 
inter-rater 
reliability 
moderate to 
excellent 
 
 
 
 
 
Significant 
improvements in 
the ‘number of 
symptoms 
improved,’ 
including ‘cure’ 
(no symptoms), 
were found for  
patients using the 
NP service, as 
per study 
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Post Hoc 
Analysis 
 
Six year follow-
up to Williams 
(2005) 
 
 
IPT ^^ 
Primary Health 
Care (PHC) 
 
November 2016 
£ 1.00 Great 
Britain  = $1.67 
Canadian 
£ 0.60 Great 
Britain =  $1.00 
Canadian 
Intervention = 
continence 
service provided 
by NPs 
(n = 2958) 
 
Control = 
existing usual 
primary care 
including GP and 
continence 
advisory services  
(n =788) 
 
The NP 
continence 
service was 
designed for the 
trial, and funded 
only for the 
trial’s duration, 
not for the 
interim period of 
6 years (expiry 
date unknown) 
 
Long term improvement 
in one or more symptoms 
at 6 years 
 
NP 72%, 1530/ 2045 
Control 67%, 380/567 
 
Difference 5% 
(95% CI  0.6 to 9) 
 
p = 0.02 
 
 
 
 
 
 
Cure (no 
symptoms) at 6 
years  
 
NP 31%, 
643/2069 
 
Control 27%, 
156/571   
 
Difference 4% 
(95% CI -0.4 to 
8) 
 
p = 0.08 
 
   
Service was 
specifically 
designed for 
study purposes 
 
 
Funding of the 
continence 
service was not 
possible 
following 
completion of  
the research 
program, post 
original trial 
 
 
Mitchell, 2009 
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IPT ^^ 
Outpatient / 
Specialized 
Referral 
101 patients 
within 4 months 
of an ischemic 
stroke, verified 
by computerized 
tomography 
(CT) scan or 
magnetic 
resonance 
imaging (MRI) 
and diagnosis of 
clinical 
depression;  
eight week 
intervention 
within a 24 
month study 
period, at 
outpatient 
clinics, including 
rehabilitation 
facilities, or 
private homes, 
U.S. 
Intervention =  
Brief psycho-
social/behaviour
al intervention:  
nine in-person 
sessions with NP 
over 8 weeks + 
usual care, 
including 
antidepressant 
medication  
(n=48) 
 
 
Control = usual 
care (UC) by 
stroke care 
provider 
including 
antidepressant 
medication 
(n=53)  
 
*Mean change Hamilton 
Rating Scale for 
Depression (HRSD) at 
12 months 
NP  -9.2 (5.7) 
44/48 patients 
UC: -6.2 (6.4) 
48/53 patients 
Difference of -2.9  
(CI -5.4 to -0.4), 
p = 0.023 
 
Percent of patients in 
remission (HRSD < or = 
to 9) at 9 weeks  
 
NP 47%   
45/48 patients 
UC 19%  
53/53 patients 
Difference 28 % 
OR = 4.8  
(CI 1.8 to 12.9) 
p = 0.001 
 
Remission at 21weeks 
NP 46% (46/48 patients) 
UC 22% (50/53 patients) 
Difference 24% 
OR = 3.4 (CI 1.3 to 8.7) 
p = 0.008 
Remission at 12 
months 
NP 48% (44/48 
patients) 
UC 27% (48/53 
patients) 
Difference 21% 
 OR = 2.7 
(CI 1.1 to 6.6)  
p = 0.031 
 
Remission at 24 
months  
NP 65% (44/48 
patients) 
UC 46% (48/53 
patients) 
Difference 19% 
OR = 2.3  
(CI 0.8  to 6.7) 
p = 0.130 
 
Measures of 
overall stroke 
impact, 
limitations in 
physical 
function, social  
participation at 
12 months, were 
non-significant 
Endpoint 
assessment based 
on the reliable 
and valid HRSD 
(Hamilton Rating 
Scale for 
Depression), the 
Barthel Index for 
measuring 
physical activity, 
and the Stroke 
Impact Scale  
 
 
Analysis per 
protocol, with 9% 
(9/101) of 
patients lost to 1 
year follow-up 
 
 
Family 
participation  / 
patient support 
was not a 
consistent factor 
between groups  
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IPT ^^ 
 
Primary Health 
Care (PHC) 
 
 
 
 
403 PHC clinic 
patients  
18–24 years, 
screened for 
high-risk alcohol 
and / or drug 
use; study period 
three months at a 
large PHC clinic, 
South Africa 
Intervention = 
Single session of 
Brief 
Motivational 
Interviewing 
(average session 
10 minutes) 
delivered by NP 
+ referral list of 
resources  
(n=206)   
 
Control = 
minimally 
enhanced usual 
care including 
referral list of 
resources  
(n=197)  
 
*Mean percent  
reduction in ASSIST 
scores  for alcohol use  
at 3 months  
ASSIST = Alcohol, 
Smoking and Substance 
Involvement Screening 
Test 
 
NP  38.3 % 
Control 20.9%  
 
p = 0.0293 
 
 
Mean percent 
reduction in 
ASSIST scores 
for cannabis use 
at 3 months 
 
NP 28.3% 
Control 9.8% 
p = 0.1119 
 
 
Mean percent 
reduction in 
ASSIST scores 
for 
methamphetamin
e use at use  
at 3 months 
 
NP 57.2% 
Control 76.9%   
p = 0.2264 
 
Endpoint 
assessment used 
the ASSIST tool: 
Six questions / 
each substance 
reported, scored 
for low risk use 
or medium/ high 
risk use. The 
World Health 
Organization 
developed and 
validated this tool 
in PHC clinics in 
high, middle-and 
low-income 
countries 
including South 
Africa 
Raw data in 
Table 2 
incomplete: no 
fraction of 
patients 
comprising 
percentages was 
reported. 
Attrition 40/403 
or 10% 
Tranmer, 2004 
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IPT ^^ 
 
 
Outpatient / 
Specialized 
Referral 
 
200 cardiac 
surgery 
outpatients 
discharged from 
first cardiac 
surgery with no 
stay at Intensive 
Care Unit (ICU). 
Five week study 
intervention 
delivered offsite 
via telephone; 
study patients 
recruited from 
hospital prior to 
discharge, 
eastern Canada 
Intervention = 
Usual Care + NP 
initiated phone 
contacts for 
patients in 1
st
 5 
weeks following 
hospital 
discharge 
 
(n= 102) 
 
 
Control = Usual 
Care (UC) 
including 
education 
booklet, home-
care follow-up as 
necessary, and 
NP contact 
information, with 
instruction to call 
with questions or 
concerns 
 
(n= 98)  
Mean number (SD) post-
operative symptoms  
at week 5 
 
 
Physical symptoms 
 
NP 3.5 (2.6) 
UC 3.8 (2.9)  
p = 0.39 
 
 
Psychological symptoms 
 
NP 2.4 (2.1) 
UC 2.3 (2.2)  
p = 0.64 
 
Cardiac 
symptoms 
 
NP 1.5 (1.1) 
UC 1.7 (1.1)  
p = 0.29 
 
 
 
 
 
 
Total symptoms 
 
NP 8.1 (5.0) 
UC 8.5 (5.5)  
p = 0.74 
The  Memorial 
Symptom 
Assessment 
Scale’s (MSAS) 
reliability and 
validity was 
established in 
cancer patients, 
not cardiac 
patients, although 
cardiac 
symptoms were 
added to this 
study’s 
measurement  
scale, including: 
palpitations, 
shortness of 
breath, and leg 
swelling  
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Outpatient / 
Specialized 
Referral  
 
204 
postoperative 
cardiac surgery 
outpatients 
following first 
time coronary 
artery bypass 
graft (CABG) 
surgery. Six 
week study 
intervention 
delivered offsite 
via telephone; 
study patients 
recruited from 
hospital prior to 
discharge. 
Patients with 
significant 
issues/concerns 
were seen at an 
NP Follow-up 
(NPFU) Clinic, 
western Canada 
 
Intervention = = 
Usual Care + NP 
phone contact at 
2-3 days post 
discharge for 
needs 
assessment, with 
recommendation
s to follow-up 
with primary 
care provider, 
cardiac surgeon, 
receive 
additional phone 
contact from NP, 
go to NPFU 
clinic, or to local 
ED   
 
(n= 97)  
 
 
Control = Usual 
Care (UC), 
including advice 
to make primary 
care provider 
appointment  
within 1 week; 
return visit to  
cardiac surgeon 
was scheduled 
for all patients at 
6 weeks 
 
(n=107)   
 
Mean (SD) summary 
symptom-score  
(number and frequency 
of symptoms) 
 
2 weeks 
 
NP 45.2 (10.2) 
UC 50.4 (12.6)  
 
Difference 5.2 
 
p = 0.002    
 
 
 
 
6 weeks  
 
NP 41.2 (11.1) 
UC 43.2 (11.1) 
Difference 2.0 
 
 
p = 0.23 
 
 
Palpitations and 
leg pain were  
reported with 
less frequency in 
NP group versus 
UC at 6 weeks 
post-discharge  
p < 0.05  
 
no individual 
data shown 
 
Endpoint 
assessment based 
on the ‘Symptom 
Inventory,’ a 20-
item 
questionnaire 
developed to 
measure 
specific 
symptoms related 
to cardiac surgery 
recovery 
   
Chronbach’s 
alpha  = 0.80 
(Artinian & 
Duggan 1993) 
 
 
 
 
 
 
Disruption of 
randomized 
sample: once 
intervention was 
established, 
several control 
patients were 
pulled from trial, 
deemed too ill for 
the study 
(Sawatsky, 2013, 
p. 2085) 
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IPT ^^ 
Outpatient / 
Specialized 
Referral 
Pilot study  
 
33 hip fracture 
surgery 
outpatients at 
least 65 years 
 
Six  month  
intervention in a 
12 month study 
period; mobile 
NP followed the 
patient to all 
discharge 
locations, 
including 
subacute care 
facilities, long 
term care 
facilities, 
rehabilitation 
agencies, and 
private homes, 
U.S.  
 
Intervention = 
usual care + 
post-acute care 
coordination by 
gerontologic NP 
 
(n=17) 
 
 
 
 
Control = usual 
care according to 
hospital and 
individual 
surgeon’s 
protocols for the 
post-acute care 
period 
 
(n=16) 
 
Mean (SD) symptoms at 
12 months all non-
significant  
 
 
Self-rated health  
(Global Health self-
ratings - higher scores 
better) 
 
NP 4.1 (0.95) 
Control 4.0 (0.71) 
 
 
 
 
 
Depression 
(Geriatric Depression 
Scale - higher scores 
worse)  
 
NP 2.2 (2.4) 
Control 1.7 (1.7) 
 
Activities of 
daily living 
(ADLs: higher 
scores worse) 
 
1. Mobility 
NP 1.42 (0.48) 
Control 1.24 
(0.34)  
 
2. Personal care 
NP 1.22 (0.32) 
Control 1.41 
(0.53)  
 
 
Instrumental 
ADLs (IADLs: 
(higher scores 
worse) 
 
1. Home chores 
NP 1.44 (0.19) 
Control 1.48 
(0.51)  
 
2. Social 
NP1.54 (0.61) 
Control 1.39 
(0.49)  
Endpoint 
assessment based 
on Global Health 
self-ratings, the 
Geriatric 
Depression Scale, 
and the 
Functional Status 
Index  
 
High attrition 
(30%; 10/33) 
Four patients 
withdrew: 3 
control and 1 
intervention 
Six patients died, 
three from each 
group:  
3 to cancer, 1 
from myocardial 
infarction, 1 from 
stroke, and 1 
from post-
operative  
complications 
 
Schuttelaar, 
2010     
 
RS ^ 
 
Outpatient / 
Specialized 
Referral 
 
160 patients  
< 16 years: 80 
patients aged < 
or = to 4 years 
and 80 patients 
aged 4–16 years, 
all new referrals 
from GPs or 
pediatricians 
with a diagnosis 
of atopic 
dermatitis 
(eczema); 1 year 
study at an 
outpatient clinic, 
Netherlands 
Intervention = 
NP-led care 
(n = 81) 
Age < or = to 4 
years (n = 40) 
 
Age 4-16 years 
(n = 41) 
 
Control = 
conventional 
care by 
dermatologist  
(n = 79) 
 
Age < or = to 4 
years (n = 40) 
 
Age 4-16 years 
(n = 39) 
*Eczema-specific 
Quality of Life  
(higher scores poorer  
quality of life)  
 
 
Mean (SD) Infants’ 
Dermatitis Quality of 
Life Index at 12 months 
 
NP 5.7 (5.4) 
Dermatologist 5.6 (3.9) 
p= 0.26 
 
 
Mean (SD) Children’s 
Dermatology Life 
Quality Index at 12 
months 
 
NP 4.9 (3.5) 
Dermatologist 5.6 (4.2) 
p= 0.55 
Mean (SD) in 
eczema severity 
at 12 months  
 
NP 13.2 (16.6) 
(73/81) 
 
Dermatologist  
13.1 (17.1) 
(70/79) 
 
 
Between-groups 
difference  
reported as 0.2  
 
(95% CI 5.4 to 
5.7),  p = 0.9  
 
 
 
 
Endpoint 
assessment used 
the ‘SCORing 
Atopic 
Dermatitis’ 
(SCORAD) index 
 
 
 
Intervention 
treatment  
primarily carried 
out by one NP in 
single 
dermatology 
outpatient clinic  
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RS ^ 
 
Acute Inpatient  
 
381 
heterogeneous 
internal medicine 
inpatients 
18–69 years, 
admitted for 
gastrointestinal, 
pulmonary, 
infectious, 
metabolic/ 
substance abuse, 
neurological, 
cardiovascular 
and “other” 
acute illnesses; 
study duration  
from hospital 
admission to 6 
weeks post-
discharge at 
single center 
teaching 
hospital, U.S. 
 
 
Intervention = 
NP-based care  
(n=193) 
 
Control=House-
staff care  
 
(n=188) 
 
Functional Status at 6 
weeks following 
discharge  
(no standard deviations 
accompanied report of 
mean values) 
 
Mean change in 
activities of daily living 
 
NP 0.1 (76/193) 
House-staff 0.2 (86/188)  
 
Difference - 0.1  
(95% CI -0.5, 0.3) 
 
p < 0.10 
 
 
Mean change in 
independent activities of 
daily living  
 
NP 1.4 (76/193) 
House-staff 2.1 (86/188)  
 
Difference - 0.7  
(95% CI -1.4, 0.1) 
 
0.05 < p < 0.10 
 
 
Mean Decrease 
in Symptom 
Severity 
at 6 weeks 
following 
discharge 
 
 
NP 4.0 (76/193) 
House-staff 4.7 
(86/188)  
 
Difference  -0.7 
(95% CI -2.6, 
1.2) 
p > 0.1 
 
Patient 
Assessment of 
Care at 6 weeks 
following 
discharge 
(mean overall 
rating:0–100)  
 
NP 84.7 (76/193) 
House-staff 80.7 
(86/188)  
 
Difference 4.0 
(95% CI -3.0, 
11.0)  
p > 0.1 
 
 
Outdated 
references 
regarding tools 
used for 
functional status 
data, collected 
via patient 
interview: Katz et 
al. 1963; Lawton 
& Brody 1969; 
higher scores 
worse 
 
 
 
Although 
interviews were 
carried out by a 
trained research 
assistant, attrition 
by 6 weeks was 
57%, with only 
43% of patients 
completing 
interview data at 
6 weeks.  
Reasons included 
failure to obtain 
patient consent, 
patient too ill, 
patient unable to 
speak English, 
failure to 
complete the 
mental status 
screen, and 
‘other.’ 
 
 153 
 
McClellan, 2012 
63
 
RS ^ 
 
Acute 
Emergency 
Department  
Equivalence 
Trial - designed 
to show that two 
interventions do 
not differ in 
either direction 
(‘zone of 
indifference’ 
regarding 
inferiority or 
superiority / 
‘equivalence 
margin’) by 
more than a pre-
specified 
unimportant or 
insignificant 
amount (i.e., a 
two-sided test)
85
 
 
372 patients with 
peripheral soft 
tissue injury, 
older than 16 
years, eligible 
for management 
by any of 3 
professionals: 
Emergency NP 
(ENP), Extended 
Scope 
Physiotherapist 
(ESP), 
Emergency 
Department (ED) 
Doctor.  
Eight week study 
period at a single 
inner city ED, 
England  
Intervention = 
patient 
management  
from arrival to 
discharge by 
ENP or ESP 
ENP (n = 123)  
ESP (n = 126) 
 
 
 
 
Control = routine 
ED doctor care 
from doctors of 
all grades  
 
( n =123)  
 
*Percentage return to 
normal function at 8 
weeks 
 
MCID (minimal 
clinically important 
difference) of 9 
 
 
95% CIs  
 
Dr 45 to 80 (63.3%) 
(68/123) 
 
ESP 52.5 to 65.0 
(59.2%) (72/126) 
 
ENP 55.0 to 66.3 
(60.0%) (73/123)  
 
 
 
Preference-based 
health utility 
scores at 8 weeks 
for percentage 
recovery to 
preinjury levels 
 
MCID of 5 using 
the Short Form-
6D (SF-6D) 
 
95% CIs  
Dr 86.2-105.8 
(92.2%) (68/123)  
 
ESP 93.2-100 
(94.3%) (72/126)  
 
ENP 87.8 to 99.5 
(92.2%) (73/123) 
 
 
 
 
 
All 3 groups 
were reported 
clinically 
equivalent 
 
Equivalence 
margin of five 
was calculated 
using the smallest 
MCID from all  
outcome  
measures 
 
High reliability & 
validity to the 
‘Disability of the 
Arm, Shoulder 
and Hand’ 
(DASH) score 
and the ‘Lower 
Extremity 
Functional Score’ 
(LEFS) for 
calculation of the 
percentage return 
to normal 
function; the  
MCIDs for these 
outcomes 
facilitated 
assessment of  
equivalence  
 
 
Main analysis 
was by intention-
to-treat; a per-
protocol (PP) 
analysis was also 
undertaken 
(McClellan, 
2012, p.3) 
although no PP 
data is shown 
 
Cooper, 2002 
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RS ^ 
 
Acute 
Emergency 
Department  
Intervention = 
ENP-led care 
(n = 102) 
 
Control = Senior 
House Officer 
Follow-up on recovery at 
one-month  
 
ENP n = 63 patients 
SHO n = 65 patients 
 
Non-significant 
differences between 
groups included: 
 
Questionnaire 
yielded a 64% 
response rate, 
following postal 
reminder  
 
Limitations 
inherent to all 
self-completion 
questionnaires: 
 
1) refusal to 
complete/return 
the questionnaire; 
bias if non-
responders  
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204 patients over 
16 years, with 
minor injury that 
fell within the 
ENP (emergency 
NP) protocol, at 
a single Accident 
and Emergency 
(A & E) 
Department 
 
 
2 month study 
duration, 
Scotland 
(SHO)-led care 
(n = 102) 
 
Level of symptoms 
Swelling  p = 0.92 
Stiffness  p = 0.80 
 Time to fully recover  
p = 0.96  
 
 
Level of activity 
Looking after 
themselves  p = 0.58 
Ability to go to work / 
school   p = 0.40 
Sleep pattern   p = 0.87 
Productivity / time off 
work  p = 0.14 
 
 No individual data  
 shown 
   
differ from 
responders 
 
2) Patients may 
also ask other 
people to assist in 
completing the 
questionnaire, or 
even complete it 
on their behalf, 
prejudicing the 
sample 
 
3)Lack of ability 
to read (low 
literacy levels / 
illiteracy in 
patients) may 
contribute to 
nonresponse 
Nathan, 2006 
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RS ^ 
 
Outpatient / 
Specialized 
Referral 
 
154 outpatients  
> 16 years of age 
recently 
discharged from 
hospital related 
to acute asthma 
 
Six month study 
duration post-
discharge, from  
hospital 
outpatient clinic, 
England 
 
 
 
Intervention = 
NP care  
 
(n= 78) 
 
 
Control = 
Respirologist 
care  
 
(n=76) 
 
 
 
 
Mean (SD) percentage 
drop in peak flow at 6 
months 
 
NP 3.92% (12.4) 
Control 2.53% (11.5) 
 
Difference  1.39%  
(95% CI  – 3.84 to 6.63) 
p = 0.122 
 
 
 
St. George’s Respiratory  
Questionnaire (SGRQ) 
higher score indicates 
greater limitations 
 
Mean (SD) percentage 
reduction in SGRQ score 
at 6 months  
NP 3.94% (14.34) 
(49/78)  
Control 5.02% (16.43)  
(52/76)  
 
Difference = 1.08% 
(95% CI  – 5.0 to 7.2) 
p = 0.727 
 
 
 
Airways 
Questionnaire 20 
(AQ20) high 
score indicates 
poor quality of 
life 
 
 
Mean (SD) 
change in AQ20 
score at 6 months  
 
NP 0.47 (3.73) 
reduction   
(49/70) 
 
Control 0.31 
(3.53)  increase  
(52/66) 
 
Between-groups 
difference of 
0.78  
(95% CI  – 0.64 
to 2.19) 
p = 0.285 
Data collected by 
an independent 
research assistant 
who was unaware 
of the group to 
which the patient 
was allocated  
 
Endpoint 
assessment of 
peak flow based 
on clinic 
measures at 2 
weeks and  6 
months 
 
SGRQ and  
AQ20 both 
reliable and valid  
 
*Primary Endpoint      ^ Role Substitution (RS)     ^^ Interprofessional Team (IPT)     #Post Hoc Analysis 
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Table I-4 Drug Utilization Endpoint-Outcomes 
Statistically significant differences in 3 IPT^^ studies, 1 RS^ study 
Inhaled Corticosteroids in Respiratory Disease Patients, Primary Health Care IPT 
Self-reported NSAID Reduction in Patients with Chronic Non-malignant, Non-
inflammatory Musculoskeletal Pain, Primary Health Care IPT 
Target Use of Beta-Blocker Medication in Chronic Heart Failure Patients, Outpatient 
IPT (pilot study) 
Medication Administration for Soft Tissue Injury Emergency Department Patients, Acute 
RS 
 
No statistically significant differences in 2 IPT^^ studies, 2 RS^ studies (positive results)    
Compliance to Lipid-Lowering Medication in Coronary Heart Disease Patients, 
Outpatient IPT  
Self-Reported Drug Utilization in Cardiovascular Disease Patients, Outpatient IPT 
Medication Adjustment for Improved Symptom Control in Rheumatoid Arthritis Patients, 
Outpatient RS  
Numbers of Prescriptions to Patients with ‘Common Complaints’ Primary Health Care 
RS  
 
Author, Year 
RS^ / IPT^^ 
Setting  
Study Population, 
Duration, Site 
Intervention 
 
Results 
 
(Outcome data 
analyzed by 
Intention to 
Treat, ITT, on 
the basis of all 
randomized 
patients, as 
randomized, 
unless otherwise 
noted) 
 
 
 
Quality of 
Endpoint 
Assessment / 
Comments 
 
Fairall, 2005 
8
 
 
Cluster  RCT 
 
unit of random allocation 
= clinic 
 
IPT ^^ 
 
Primary Health Care 
(PHC) 
 
 
Priority Respiratory 
Diseases: LRTI (Lower  
Respiratory Tract 
Infection), URTI (Upper  
Respiratory Tract 
Infection), asthma, 
tuberculosis (TB), HIV, 
and Chronic Obstructive 
Pulmonary Disease 
(COPD) 
Intervention = 
PALSA  
(Practical 
Approach to Lung 
Health in South 
Africa) an 
educational 
outreach program 
of  expanded 
prescribing 
provisions with 
locally tailored 
guidelines, 
implemented by 
NPs 
 
20 clinics 
randomized to 
outreach 
intervention 
(1000/1999 
*Prescriptions at 
3 months 
 
Inhaled 
Corticosteroids 
for asthma 
 
Outreach 13.7% 
(137/1000) 
Control 7.7% 
(77/999) 
OR = 1.90 
(95% CI = 1.14 
to 3.18) 
p = 0.006 
ICC = 0.019  
Antibiotics for 
URTI & LRTI  
Outreach 39.7% 
(397/1000 ) 
Prophylactic 
cotrimoxazole 
prescriptions for 
HIV patients 
with a diagnosis of 
tuberculosis  
 
Outreach 7.8%, 
(13/167)   
 
Control 
7.5% (11/147)  
Difference= 0.3% 
Non-significant 
 
 
Smoking cessation    
 
Outreach 12.2%, 
(20/164)  
Endpoint 
assessment by 
fieldworkers 
blinded to the 
intervention, was  
based on data 
collection from 
patient-held 
records, together 
with records of 
dispensed drugs  
Patients and 
fieldworkers were 
blind to the 
intervention status 
of each clinic, 
while NPs 
allocated to the 
intervention arm 
could not be 
blinded for 
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40 primary health care 
(PHC) clinics staffed by 
NPs were randomized, 
including 1,999 patients 
with cough or difficult 
breathing on 
presentation, or within 
past 6 months 
 
 
Three month study 
period, South Africa 
 
patients) 
 
Control = Usual 
NP Care, with no 
new training in 
educational 
outreach program 
20 clinics 
randomized to 
usual care 
(999/1999 
patients) 
Control 39.4% 
(394/999 ) 
OR = 1.01 
(95% CI = 0.74 
to 1.38) 
 
p = 0.95 
ICC = 0.042 
Control 10.4%, 
(20/193) 
Difference=1.8% 
Non-significant  
 
obvious reasons 
Low number of 
educational 
contacts, 
reportedly due to 
difficulties 
accommodating 
visits in small 
town / rural PHC 
clinics   
Jones, 2002 
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IPT ^^ 
 
Primary Health Care 
(PHC) 
 
222 PHC patients from 5 
general practices with 
computerized prescribing 
systems.  
 
Patients were 18 years or 
older, with non-
malignant, non-
inflammatory 
musculoskeletal pain and 
oral non-steroidal anti-
inflammatory drug 
(NSAID) prescriptions 
covering 6 or more 
weeks of the last 12 
months 
 
 
GALS screen (Gait, 
Arms, Legs & Spine) 
assessment to detect 
locomotor  abnormalities 
related to 
musculoskeletal pain  
 
 
Six month study, with all 
patients examined at 
their general practice or 
their homes, England 
 
‘Active 
Intervention’ =  
NP  assessment, 
patient-tailored 
educational 
package, with 
request that 
patients withdraw 
their NSAIDs and 
use appropriate 
alternative drug 
and non-drug 
therapies (e.g. 
strategies on 
weight reduction, 
aerobic exercise, 
use of local heat 
and cold, back and 
neck care, 
footwear, massage, 
and  relaxation 
techniques) + 
Usual GP Care 
 
(n =110) 
 
 
‘Control 
Intervention’ = 
same single NP 
provided 
assessment and 
basic education 
regarding NSAID 
use, reinforced 
with  leaflet  + 
Usual GP Care 
 
(n =112)  
 
*Self-reported 
reduction in oral 
NSAID dose by 
50% or less, at 6 
months  
 
 
Active NP 
Intervention  
 
38 % (42/110)  
 
 
Control  
13% (14/112)  
Difference 25% 
p < 0.0001 
 
  Self-reported drug 
utilization, 
alongside 
computer records 
of prescribing 
data 
 
 
 
Element of  
‘social 
desirability’ 
where active 
intervention 
provided advice 
for reduction of 
NSAID use; 
potential bias in 
same single NP 
for both 
intervention and 
control groups 
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McClellan, 2012 
63
 
RS ^ 
Equivalence Trial - 
designed to show that 
two interventions do not 
differ in either direction 
(‘zone of indifference’ 
regarding inferiority or 
superiority; the 
‘equivalence margin’) by 
more than a pre-specified 
unimportant or 
insignificant amount 
(i.e., a two-sided test)
85
 
 
 
Acute Emergency 
Department  
 
 
372 patients with 
peripheral soft tissue 
injury, older than 16 
years eligible for 
management by any of  
three professionals:  
Emergency NP (ENP), 
Extended Scope 
Physiotherapist (ESP), 
Emergency Department 
(ED) Doctor 
Eight week study period 
at a single inner city ED, 
England  
Intervention = 
patient 
management  from 
arrival to discharge 
by ENP or ESP 
ENP (n = 123)  
ESP (n = 126) 
 
 
 
 
Control = routine 
ED doctor care 
from doctors of all 
grades 
 
(n =123)  
 
Medication 
administration  
 
ESPs  
3.6% patients 
 
NPs 
23.2% patients 
 
 
Doctors  
42.2% patients 
 
 
Differences 
between groups  
 
p < 0.001 
 
 
 
NPs and ESPs 
were reported to be 
clinically  
equivalent to 
routine care 
provided by 
doctors, despite 
significant 
differences in 
prescribing 
patterns 
 
Equivalence 
margin was a 
difference of five 
calculated using 
the smallest 
minimal clinically 
important 
difference from 
all outcome  
measures 
 
Limited endpoint 
assessment related 
to no disclosure 
regarding how / 
by whom 
medication 
administration 
was measured.  
 
Incomplete raw 
data with no 
numbers for 
fractions of 
groups 
comprising 
reported 
percentages.  
 
Although main 
analysis was by 
intention-to-treat, 
a per-protocol 
(PP) analysis was 
also undertaken, 
though no PP data 
is shown  
 
Ansari, 2003 
45
 
 
Pilot RCT  
 
Two levels of individual 
randomization  
 
IPT ^^ 
 
Outpatient / Specialized 
Referral 
 
169 outpatients meeting 
Framingham criteria for 
Chronic Heart Failure 
(CHF) were individually 
randomized into 3 groups 
 
 
74 providers (internal 
Notification 
Intervention  
Beta-blocker 
advocacy 
 
Internists 10 
Cardiologists 2 
NPs 3 
(n = 64 patients) 
 
 
 
 
 
NP Facilitator 
Intervention 
Initiation, titration, 
and stabilization of 
CHF patients on 
beta-blockers 
 
*Beta blocker 
use in CHF 
outpatients  
 
 
Patients  either 
initiated or up-
titrated on beta-
blockers 
 
Notification 16% 
(10/64)  
 
NP facilitator 
67% (36/54)  
 
Control 
27% (14/51) 
 
p < 0.001  
 
 
Mean length of 
time from initiation 
to target dose  
Notification  
9.3 months 
 
 
NP facilitator  
5.9 months 
Control  
8.5 months  
p < 0.001 
 
Endpoint 
assessment based 
on an independent 
research assistant 
assessing the use 
of  beta blocker 
therapy, by 
reviewing 
pharmacy records 
and computerized 
progress notes 
 
 158 
 
medicine doctors, 
cardiologists and NPs) 
were also individually 
randomized into 3 
groups, to decrease the 
likelihood of 
contamination, i.e. 
patients receiving care 
from their regular 
providers;  
 
Median follow-up period 
= 12 months, at a single 
academically affiliated 
medical center, U.S. 
 
Internists 19 
Cardiologists 3 
NPs 3 
(n=54 patients) 
 
 
Control   
Provider education 
regarding beta 
blocker guidelines  
 
Internists 16 
Cardiologists 4 
NPs 4 
(n=51 patients) 
 
Target doses of 
beta-blocker 
medication  
Notification  
2% (1/64)  
 
NP facilitator 
43% (23/54)  
Control  
10% (5/51) 
 
p < 0.001 
Allen, 2002 
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IPT ^^ 
 
Outpatient / Specialized 
Referral 
228 coronary heart 
disease (CHD) 
outpatients who received 
coronary artery bypass 
grafting (CABG) surgery 
or percutaneous coronary 
intervention 
(angioplasty), with  
hypercholesterolemia 
(low density lipoprotein 
cholesterol level > 2.59 
mmol/L  or total 
cholesterol level > 5.18 
mmol/L) 
 
 
Intervention for one year 
post-discharge, at 
outpatient clinic of large 
tertiary hospital, U.S. 
Intervention = 
NP case 
management 
(individualized 
lifestyle and 
pharmacologic 
intervention) + 
Enhanced Usual 
Care  (n = 115) 
 
 
Control =  
Enhanced Usual 
Care (EUC) from 
primary  providers 
and/or 
cardiologists 
including full lipid 
profiles sent to 
patients and their 
physicians at 4 
weeks, 6 and 12 
months after 
discharge, 
including  
goals for levels of 
lipoproteins, diet 
and physical 
activity  
(n =113)  
 
Medication 
compliance to 
lipid-lowering 
drugs at one year 
 
NP 87% 
(100/115)  
EUC 79% 
(89/113) 
Difference 8% 
 
p = 0.10 
 
 Evaluation of 
medication use at 
admission and 
discharge based 
on admission 
history / physical 
examination,  
hospital records, 
and discharge 
summaries 
 
 
 
Among patients 
on 
pharmacotherapy, 
97% in both 
groups were 
taking a single 
statin agent: 
 
3-hydroxy-3-
methylglutaryl 
coenzyme A 
reductase inhibitor 
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Goessens, 2006 
47
 
IPT ^^ 
Outpatient / Specialized 
Referral 
 
Cardiovascular disease 
(CVD) 
Peripheral arterial 
disease  
Abdominal aortic 
aneurysm  
Cerebrovascular disease 
Coronary heart disease 
236 CVD outpatients 
with two or more 
modifiable risk factors: 
smoking, hypertension, 
dyslipidemia, diabetes, 
obesity, 
hyperhomocysteinemia.  
 
 
Intervention for one year 
after randomization at a 
risk-factor management 
clinic in the University 
Medical Center Utrecht,  
Netherlands  
Intervention =  
NP at risk factor 
management clinic  
+ usual care 
(n=119) 
 
 
 
Control = usual 
care (UC) by GP 
and  treating 
vascular specialist 
(n=117)  
 
At the time of the 
trial, an NP in the 
Netherlands was 
not formally 
allowed to 
prescribe; instead, 
a study physician 
prescribed or 
changed 
medication for 
patients in the trial 
Self-reported 
Drug Utilization 
at mean follow-
up of 14 months 
(range 10 -22 
months) 
 
 
Lipid-lowering 
drugs  
NP  89% (80/90) 
UC  73% (55/75) 
Difference 16% 
 
 
Glucose-
lowering agents 
NP 19% (17/90) 
UC 16% (12/75) 
Difference 3% 
 
Blood pressure 
lowering agents  
NP 77% (69/90) 
UC 69% (52/75)   
Difference 8% 
 
  
Angiotensin 
converting enzyme 
inhibitors 
/angiotensin II 
antagonists 
NP 76% (57/90)  
UC 53% (40/75) 
Difference 23% 
 
 
Folic acid  
NP 61% (55/90) 
UC 28% (21/75)  
Difference 33% 
 
 
Antiplatelet agents  
NP 90% (81/90)  
UC 91% (68/75)  
Difference – 1% 
 
 
Self-reported drug 
utilization not 
able to be cross-
checked with 
formal  pharmacy 
records 
 
Patients were 
randomized 
before informed 
consent was 
obtained, 
according to the 
Zelen design; 
treatment consent 
is always sought 
before actual 
intervention, 
Torgerson & 
Roland (1998) 
Attrition 31% 
(71/236) 61 
patients gave no 
informed consent 
post 
randomization:  
24 intervention 
and 37 control. 
Another 10 
patients did not 
complete study: 4 
deaths, 1 patient 
moved, and 1 
patient developed 
co-morbidity  
 
Hill, 2003 
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RS ^ 
Outpatient / Specialized 
Referral 
80 Rheumatoid Arthritis 
(RA) patients 
18 years or older, to 
rheumatology clinic on at 
least three previous 
occasions.  
Study period 12 months, 
at a traditional 
rheumatology outpatient 
clinic managed by junior 
hospital doctors (JHDs) 
within a large teaching 
hospital, England  
Intervention = 
rheumatology NP  
(RNP) care 
 
(n = 39) 
 
 
Control =  
junior hospital 
doctor (JHD)  
care 
 
( n = 41)  
Changes to 
medications for 
symptom control 
NP 24%  
(56/234)  
JHD 22% 
(50/226) 
 
Difference 2%, 
Non-significant  
 
 
 
Numbers of 
prescriptions for 
intra-articular / 
intramuscular 
corticosteroid 
injections  
 
NP 15% consults 
(36/234)   
JHD 13% consults 
(29/226) 
 
Difference 2% 
Non-significant 
  
Drug utilization 
data of limited 
quality, related to 
no disclosure 
regarding how or 
by whom all 
medication 
changes / 
administration 
were noted 
 
Per protocol, 
actual treatment 
analysis 
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Dierick-van Daele, 2009 
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RS ^ 
Primary Health Care 
(PHC) 
1,591 primary health care 
patients from 15 general 
practices. Study patients 
were 16 years and older, 
with common complaints 
regarding respiratory/ 
throat, ear/nose 
musculoskeletal/skin 
injuries, urinary/ 
gynaecological and 
geriatric problems.  
 
2 week intervention 
within a study duration 
of 6 months; patients 
who attended a general 
practice on a day when 
the NP was present were 
invited to participate in 
the trial, Netherlands 
Intervention = 
patient care from 
newly graduated 
NPs with Master 
Degree of 
Advanced Nursing 
Practice,  
experience ranging 
from 1 to 5 years; 
12 NPs 
(n = 817) 
Control = patient 
care from GP with 
an average of 16 
years’ experience; 
50 GPs (n = 684) 
 
Study practices 
were compared to 
external reference 
practices where 17 
GPs worked in 5 
general practices 
without the 
involvement of 
NPs 
 
 
Numbers of 
prescriptions 
given  
 
One prescription 
NP 55.0% 
(411/747) 
GP 54.2% 
(352/650) 
Difference 0.8%  
p = 0.75 
 
 
 
 
 
 
Two prescriptions  
NP 16.9% 
(126/747)  
GP 19.5 % 
(127/650) 
Difference 2.6% 
p = 0.20 
Three or more 
prescriptions  
 
NP 8.8% (66/747)  
GP 7.8% (51/650) 
Difference 1.0% 
p = 0.51 
Prescription data 
were extracted 
from 
the clinics’ 
computer systems 
 
 
In this study from 
the Netherlands, 
the NP had no full 
authority to 
prescribe 
medications. GPs 
therefore 
validated NPs’ 
prescriptions, 
resulting in a 
potentially 
spurious endpoint 
of comparison  
 
 
*Primary Endpoint    ^ Role Substitution (RS)    ^^ Interprofessional Team (IPT)    #Post Hoc Analysis 
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Table I-5 Resource Utilization / Cost Endpoint-Outcomes: Acute Inpatient  
Statistically significant difference in 1 RS^ study 
       Patient Wait Time in Minor Injury Emergency Department Patients, Acute RS 
 
No statistically significant differences in 2 RS^^ studies (positive results) 
Mean Length of Hospital Stay, Number of Consultations to other Services, Total Hospital 
Charges, Total Ancillary Charges in Internal Medicine Inpatients, Acute RS 
Mean Cost / Hour Patient Care, Unit ‘Cost / Patient /  Hour’ (salary / productivity), 
Average Number Patients Treated / Hour, Mean Direct Cost / Hour Patient Care, Mean  
Indirect Cost / Hour Patient Care, Number Patient Days Off Work at 8 weeks in Soft 
Tissue Injury Emergency Department Patients, Acute RS (post hoc analysis) 
 
Author, Year 
RS^ / IPT^^ 
Setting  
Study Population, 
Duration, Site 
Intervention 
 
Results 
 
(Outcome data 
analyzed by 
Intention to Treat, 
ITT, on the basis 
of all randomized 
patients, as 
randomized, 
unless otherwise 
noted) 
 
 
 
Quality of 
Endpoint 
Assessment / 
Comments 
 
Cooper, 2002 
62
 
 
RS ^ 
 
Acute Emergency 
Department  
 
 
 
 
 
204 patients over 16 
years, with minor 
injury that fell 
within the ENP 
(emergency NP) 
protocol, at a single 
Accident and 
Emergency (A & E) 
Department; 2 
month study 
duration, Scotland 
Intervention = 
ENP-led care 
(n = 102) 
 
 
Control = Senior 
House Officer 
(SHO)-led care 
(n = 102) 
 
Patient’s average 
wait time 
(minutes) 
ENP 48.6  
SHO 70.1  
95% CI 11.2–31.8  
p < 0.001 
 
Total consult time 
(minutes)  
ENP 30.0  
SHO 24.  
95% CI -1.3 - 
11.5 
p < 0.115 
 
 
Missed injuries  
ENP 1,  SHO 1 
 
 
Seeking  advice 
from senior 
medical staff 
when X-ray 
interpretation 
(ENPs were 
required to 
consult; SHOs 
were not) was 
excluded  
ENP 20.9% 
SHO 11.5% 
p < 0.21  
Numbers of X-rays 
requested  
ENP 56.6%, 
SHO 47.5%, 
p =  0.2 
 
Referral to follow-up 
clinics  
ENP 33.3 %  
SHO 27.5% 
p = 0.358 
 
Reasons for unplanned 
return regarding  6/10  
NP patients and 4/10 
SHO patients:  
 
 
New injuries  
ENP 1, SHO 1 
 
Concern about original 
injury 
ENP 2, SHO 1 
 
Problems complying 
with treatment  
ENP 2, SHO 1 
 
Problems with treatment 
ENP 1, SHO 1 
Endpoint 
assessment 
regarding wait 
time and consult 
time data, based 
on the use of the 
‘Treatment 
Record’ form 
for 
consultations 
and referrals 
 
 
Returns to the  
emergency 
department  by 
study patients 
and missed 
injuries were 
tracked by the 
hospital 
computer 
system 
 
 162 
 
Pioro, 2001 
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RS ^ 
Acute Inpatient  
 
381 heterogeneous 
internal medicine 
inpatients 
18–69 years, 
admitted for 
gastrointestinal, 
pulmonary, 
infectious, 
metabolic/ 
substance abuse, 
neurological, 
cardiovascular and 
“other” acute 
illnesses; study 
duration  from 
hospital admission 
to 6 weeks post-
discharge at single 
center teaching 
hospital, U.S. 
 
Intervention = 
NP-based care  
(n=193) 
 
 
Control=House-
staff care  
 
(n=188) 
 
 
 
 
 
 
 
 
 
 
 
 
*Mean length of 
hospital stay 
(days)  
NP 5.0  
House-staff 5.3 
Difference - 0.3 
days  
95% CI -1.2 - 0.6  
p > 0.10 
 
*Mean number of 
consultations to 
other services 
(e.g. respiratory 
therapy) 
NP 1.4  
House-staff 1.4  
Difference of  0.0 
95% CI - 0.2 - 0.3 
p > 0.10 
 
 
 
 
 
*Mean total hospital 
charges, costs (U.S.$)  
NP $8854  
House-staff  $9426  
Difference - $572  
95% CI -$2704 - $1560 
p > 0.10 
 
 
 
*Mean total ancillary 
charges, costs (U.S.$)  
NP  $4960  
House-staff  $5358  
Difference of -$399  
95% CI -$1820 - $1023 
p > 0.10 
 
  
 
 
 
Feb. 17, 2017 
$1.00 U.S =  
$1.31 Canadian 
$0.76 U.S. = 
$1.00 Canadian 
 
Incomplete 
reporting of raw 
data in Table 2. 
No fraction of 
patients was 
provided for 
derivation of 
resource 
utilization data 
 
No designated 
societal costs 
were reported. 
Costs did not 
explicitly 
consider 
differences 
in NP and 
house-staff 
salaries, costs of 
the medical 
director, nor 
costs of 
providing off-
hours coverage 
by residents 
 
#McClellan, 2013 
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Cost Minimization 
Evaluation  
 
Post hoc Analysis 
to McClellan (2012) 
 
RS ^ 
 
Acute Emergency 
Department  
 
 
372 peripheral soft 
tissue injury 
patients older than 
16 years, eligible 
for management by 
any of 3 
professionals: 
Emergency NP 
(ENP), Extended 
Scope 
Physiotherapist 
(ESP), Emergency 
Department (ED) 
Doctor. Eight week 
study period at a 
 Intervention = 
patient 
management  
from arrival to 
discharge by ENP 
or ESP 
NP group   
 
(n = 123)  
ESP group   
 
(n =126) 
Control =Routine 
ED doctor care 
( n = 123)  
 
 
Primary measures 
 
1) Mean cost per 
hour of patient 
care  
 
Doctors £80.91 
(CI £66.5 to 
£101.6)  
ESPs £89.71 
(£CI 73.0 to 
£118.7)  
ENPs £109.81 
(CI £83.0 to 
£142.1) 
(undiscounted 
values) 
 
2) Mean unit ‘cost 
per patient per 
hour,’ dividing 
the salary cost of 
different 
professional 
groups by their 
productivity: 
number of 
patients treated 
/hour)  
 
Secondary  measures 
 
1) Mean direct cost (e.g. 
crutches, medications) 
per hour of patient care  
 
Doctors £60.96 
(CI £51.1 to £73.6) 
ESPs £52.48 
(CI £44.7 to £63.9) 
ENPs £55.21  
(CI £47.0 to £66.0) 
(undiscounted values) 
 
 
2) Mean indirect cost to 
patient and society  
per hour of patient care 
(e.g. unplanned 
additional visits, 
travel/parking costs) 
 
Doctors £19.60 
(CI £11.2 to £38.6) 
ESPs £39.56  
(CI £25.6 to£ 59.0) 
ENPs £52.70 
(CI £33.0 to £81.6) 
(undiscounted values) 
 
Low quality 
measurement 
tool: accuracy 
of self-reported 
time spent with 
patients by each 
professional, 
time upon 
which cost 
calculations 
were based, was 
not verified 
 
Numbers used 
in calculations, 
including salary, 
were not 
disclosed 
 
Cost 
minimization 
evaluation is a 
controversial 
method for cost 
evaluation of 
equivalence 
trials: cost–
minimization 
analysis is 
performed when 
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single inner city 
ED, England  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Feb.17, 2017 
£ 1.00 Great Britain  
= $1.62 Canadian 
£ 0.62 Great Britain 
=  $1.00 Canadian  
 
 
 
Doctors £54.93 
(CI £37.9 to 
£73.0) 
ESPs £68.36   
(CI £50.6 to 
£91.3) 
ENPs £86.47  
(CI £62.2 to 
£122.5) 
(undiscounted 
values) 
 
 
Cost of each 
professional  = 
salary + salary ‘on 
costs’ + 
overheads + 
capital over-heads 
+ travel + contact 
times + non-
London multiplier 
 
Average number 
patients treated / 
hour 
 
Doctors 4.4  
ESPs 3  
ENPs 3.6  
 
 
 
Based on costs incurred 
within hospital-based 
secondary care alone, 
NPs were reported to be 
equivalent in cost to 
routine care while ESPs 
were reported as either 
equivalent or less 
expensive than routine 
care. Uncertainty in cost 
arose from ESPs and NPs 
potentially incurring 
greater indirect costs, 
associated with follow-
up appointments and 
subsequent primary care 
visits. 
 
Societal Costs included 
95% CIs for numbers of 
days off work at 8 weeks 
(MCID = 5 Table 3, 
McClellan, 2012, p. 7) 
 
Doctors  
(0.0 - 6.0 days)   n = 68 
ESPs  
(0.75 - 2.0 days)   n = 72 
ENPs  
(1.0 - 2.5 days)    n = 73 
 
 
 
the health 
effects of the 
alternatives are 
known or 
assumed to be 
equal. Only the 
costs need to be 
analysed, and 
the least costly 
alternative is the 
most efficient. 
However, few 
interventions 
are actually 
equally 
effective.
91
 
 
 
Although main 
analysis was by 
intention-to-
treat, a per-
protocol (PP) 
analysis was 
also undertaken, 
though no PP 
data is shown  
 
 
 
 
 
*Primary Endpoint    ^ Role Substitution (RS)    ^^ Interprofessional Team (IPT)    #Post Hoc Analysis 
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Table I-6 Resource Utilization / Cost Endpoint-Outcomes: Outpatient 
Statistically significant differences in 2 RS^ studies and 3 IPT^^ studies 
      Clinic Attendance in Acute Asthma Patients, Outpatient RS    
Total Annual Healthcare Costs per Patient (including Societal Costs) with Pediatric 
Eczema, Outpatient RS (post hoc analysis)     
Primary Health Care and Outpatient Clinic Visits by COPD Patients, Outpatient IPT 
(pilot study)   
Primary Health Care Visits by Post-operative Women with Suspected Ovarian Cancer, 
Outpatient IPT (post hoc analysis)   
Physician Office Visits by Older Adults Discharged Home, Outpatient IPT (pilot study) 
   
No statistically significant differences reported in 2 RS^ studies and 4 IPT^^ studies  
      Number Hospital Readmissions / Patient in Acute Asthma Patients, Outpatient RS    
Lab tests, X-rays, primary health care visits, referrals Rheumatoid Arthritis Patients, 
Outpatient RS  
Readmission to hospital, emergency department, specialist, primary care provider, home 
care visits by Cardiac Surgery Patients, Outpatient IPT 
Visits with primary care provider / cardiologist, emergency department visits, 
readmission to hospital by Coronary Artery Bypass Graft Patients, Outpatient IPT 
Reduction in low-density lipoprotein cholesterol in Coronary Heart Disease Patients, 
Outpatient IPT (post hoc analysis) 
Inpatient days, specialist, outpatient clinic, and primary health care visits in Type 2 
Diabetes Patients, Outpatient IPT 
 
Author, Year 
RS^ / IPT^^ 
Setting  
Study Population, 
Duration, Site 
Intervention 
 
Results 
 
(Outcome data 
analyzed by 
Intention to 
Treat, ITT, on 
the basis of all 
randomized 
patients, as 
randomized, 
unless otherwise 
noted) 
 
 
 
Quality of 
Endpoint 
Assessment 
/ Comments 
 
Nathan, 2006 
49
 
RS ^ 
Outpatient / Specialized Referral 
 
154 outpatients > 16 years of age 
recently discharged from hospital 
related to acute asthma; 6 months 
study duration post-discharge, 
Intervention =  
NP care  
 
 
 
(n= 78) 
 
 
 
 
Control = 
Respirologist care  
 
(n=76) 
Mean number 
hospital 
readmissions / 
patient (data 
also noted in 
Appendix I-1 as 
‘1st type of 
exacerbation’ ) 
 
NP 0.07  
(5 readmissions 
/68 patients)  
Mean number 
clinics not 
attended 
RR = 0.90 
 95% CI  0.54 
to 1.48   
p = 0.70 
 
No significant 
difference in 
the number of 
clinics not 
Data 
collected by 
an 
independent 
research 
assistant 
unaware 
of the group 
to which the 
patient was 
allocated 
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hospital outpatient clinic, England 
 
 
 
 
 
 
 
Respirologist 
0.18  (12 
readmissions 
/65 patients) 
 
Relative risk of 
readmission = 
0.40  
95% CI  0.14 to 
1.12,  p = 0.09 
 
 
 
Mean number  
clinics attended  
NP 1.97 
(130 clinics/66 
patients)  
Respirologist 
2.23  
(147 clinics/66 
patients)  
RR = 0.88 
95% CI 0.70 to 
1.12,  p = 0.011 
 
Patients 
attended fewer 
NP clinics than  
Respirologist 
clinics 
attended; no 
individual data 
shown 
 
Mean number 
clinics 
cancelled by 
patient  
RR = 1.65 
95% CI  1.30 
to 2.08  
p = 0.052 
Patients in the 
NP group 
were more 
likely to 
cancel 
appointment; 
no individual 
data shown  
 
Mean number 
of  clinics 
cancelled by 
practitioner  
NP 0.32 
Respirologist 
0.08   
RR = 4.20 
95% CI  1.6 to 
11.0 
p = 0.004 
More clinics 
were cancelled 
by  NP than by 
Respirologist 
 
Clinic 
attendance 
data 
gathered 
from 
hospital 
information 
system 
Berkhof, 2014 
50
  
IPT ^^ 
Outpatient / Specialized Referral 
 
Pilot study  
 
 
 
100 chronic obstructive 
pulmonary disease (COPD, a 
progressive disease)  outpatients > 
or = to 40 years, COPD GOLD 
stage > or = to 2 
(Global initiative for staging 
Obstructive Lung Disease: 1 = 
mild; 4 = very severe) smoking 
history >10 pack-years; 2 year 
study at a large teaching hospital 
in Zwolle, Netherlands 
Intervention = 
patient-initiated 
outpatient  visits 
with pulmonary NP 
upon increase of 
symptoms 
(dyspnea, cough, 
sputum, 
hemoptysis, or 
thoracic pain); NP 
followed an ‘on-
demand protocol’ 
that included  
consult with 
pulmonologist for 
urgent problems 
 
(n =49)  
 
Median (range) 
healthcare visits 
at 2 years 
Primary 
healthcare GP 
visits 
 
Intervention 4 
(0-32)  
Control 5 (0-20)  
p = 0.01 
 
 
Secondary care 
visits  
 
1) Outpatient 
Pulmonary NP  
 
Intervention  
1 (0-14)  
Control 0 (0-4)   
p = 0.003 
Mean (SD) 
total 
healthcare 
provider costs 
at 2 years 
Intervention 
€1803 (€2617)  
Control  
€2321 (€3967) 
Difference  
€ -518  
(CI - €1993, 
€788) 
 
 
Mean (SD) 
total 
healthcare 
Limited 
quality 
measure: 
GPs and 
pharmacists 
were 
contacted to 
collect 
primary 
health care 
resource-use 
data on 
themselves, 
in terms of 
GP visits 
and 
exacerbation
s.  
 
Data for 
secondary 
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Feb. 17, 2017 
€1.00 Euro = $1.53 Canadian  
€0.72 Euro = $1.00 Canadian  
Control= usual care 
(UC) of traditional 
outpatient visits 
initiated by 
pulmonologist, to 
the pulmonologist 
or the pulmonary 
NP     
(n=51)   
 
2) Outpatient 
Pulmonologist 
 
Intervention  
3 (0-17)  
Control 3 (0-13)  
p = 0.82 
insurance 
costs at 2 
years 
Intervention 
€3994 (€4669)  
Control 
€4452  
(€ 6100)  
Difference 
 -  €458  
(CI - €2700, € 
1652) 
 
Reductions in 
total costs 
were not 
significant; 
however this 
pilot study 
was not 
designed for 
cost analysis 
 
hospital-
based care 
was 
collected 
from 
hospital 
computer 
system, 
regarding  
visits to the 
pulmonologi
sts, PNPs, 
and 
exacerbation
s 
Healthcare 
provider cost 
data from 
StatLine, 
electronic 
databank of 
Statistics, 
Netherlands;
insurance 
cost data 
from “the 
Diagnosis 
Treatment 
Combination 
2013” of 
study 
hospital 
 
#McCorkle, 2011 
79
 
Healthcare Utilization  
 
Post Hoc Analysis to McCorkle 
(2009)
52
 
IPT ^^ 
 
Outpatient / Specialized Referral 
 
149 post-surgical outpatients 21 
years or older, with suspected 
primary diagnosis of ovarian 
cancer after abdominal surgery, 
prognosis of at least 6 months, 
and an order to initiate 
chemotherapy. Six month study 
duration, with patient contact 
made at private homes or by 
telephone, U.S. 
Intervention  = 18 
contacts by an 
oncology NP, 
supported by 
psychiatric NP 
(PSYNP) consults 
(32/74 intervention 
patients)  when 
warranted for high 
emotional distress = 
Distress 
Thermometer  > or 
= to 4 
 
(n=74)  
Attention Control = 
nine contacts by 
research assistant, 
supported by 
medical social 
worker (no data for 
patient contact with 
social worker) 
 
(n = 75) 
* Resource 
Utilization at 6 
months 
 
Mean (SD) 
inpatient 
admissions of  
 ‘ > than 1 
hospitalization’  
 
NP 2.43 (2.09) 
Control 1.62 
(0.71) 
p = 0.4319 
 
 
Mean (SD) 
Emergency 
Room (ER) 
visits:  
‘> than 1 visit’  
 
NP 1.85 (1.14) 
Control 1.40 
(0.74) 
Mean (SD) 
Primary 
Health Care 
visits:  
‘> than 1 visit’  
 
NP 2.75 (2.03) 
Control 3.59 
(4.66) 
p =0.0003 
The p values 
were 
evaluated with 
the Bonferroni 
correction 
(0.05/4 = 
0.0124)  
 
The outcome 
of primary 
health care 
visits, with  
p = 0.0003  
was the  only 
significantly 
Limited 
measuremen
t of 
healthcare 
utilization: 
given self-
reported 
visits had a 
95% 
agreement 
with medical 
record 
review for 
123 patients 
treated at the 
Cancer 
Center, this 
level of 
agreement 
was the 
rationale for 
including 
only self-
reported data 
on an 
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All 149 study 
patients received 
the Symptom 
Management 
Toolkit, an  
education manual 
with strategies to 
address 16 
symptoms 
commonly 
experienced 
post-surgery with 
chemotherapy 
p = 0.0852 
 
Mean (SD) 
Oncology 
outpatient visits: 
‘ > than1 visit’ 
 
NP 9.19 (5.74) 
Control 8.27 
(4.49) 
p = 0.5359 
 
different result  additional 22 
patients 
treated at 
affiliate 
hospitals, 
where self-
reported data 
could not be 
cross-
checked 
with hospital 
records 
Per protocol, 
actual 
treatment 
analysis 
 
Enguidanos, 2012 
65
 
IPT ^^ 
Outpatient / Specialized Referral 
 
Pilot study  
 
 
 
199 at-risk older adults 
discharged home from hospital 
without in-home care (e.g., home 
health or hospice) or without 
able/available caregivers; 6 month 
study set in a managed care 
medical center, or Health 
Maintenance Organization 
(HMO), with study patients 
recruited from hospital prior to 
discharge, U.S. 
Intervention = Brief 
NP Transition, a 
‘bridge’ of up to 3 
home visits, 2 
phone calls from 
primary health care 
NP, within 72 hours 
of discharge 
 
(n = 100) 
 
 
 
Control = standard 
medical care, 
including access to 
case management 
services (wait time 
2-14 days) 
(n =99) 
Resource 
Utilization at 6 
months 
 
 
 
Mean (SD) 
number of 
physician office 
visits 
NP  9.94 (8.5) 
Control 11.72 
(7.7)  
p = 0.036  
 
 
 
 
Mean (SD) 
number of 
emergency 
room  visits 
NP 0.50 (1.2) 
Control 0.99 
(2.5) 
p =0.096 
 
Mean (SD) 
Hospital Days  
NP 3.78 (8.8) 
Control 3.49 
(6.5) 
p = 0.514 
 
Mean (SD) 
home health 
care days 
NP 4.99 (8.7)  
Control 5.57 
(9.3) 
p = 0.485 
 
 
 
Hospital re-
admission rate  
NP 40%  
Control 44.4%  
p = 0.526 
 
 
 
 
 
 
 
 
Endpoint 
assessment: 
data 
collection 
from the 
Health 
Maintenance 
Organization
’s (HMO) 
electronic 
medical 
record 
database at 6 
months; did 
not include 
any medical 
service use 
that may 
have 
occurred 
outside of 
the HMO, 
accounting 
for ~ 3% of 
all service 
use 
 
Small 
sample size 
and attrition 
on follow-up 
surveys (~ a 
65% 
response 
rate) limited 
detection of 
between-
groups 
differences 
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#Schuttelaar, 2011 
78
 
 Cost-Effectiveness Analysis 
(CEA) 
Post Hoc Analysis  
to Schuttelaar (2010) 
RS ^ 
Outpatient / Specialized Referral 
160 patients < 16 years:  
80 patients aged < or = to 4 years 
and 80 patients aged 4–16 years, 
all new referrals from GPs or 
pediatricians with a diagnosis of 
atopic dermatitis (eczema);  
1 year study at an outpatient 
clinic, Netherlands 
 
 
Feb. 17, 2017 
€1.00 Euro = $1.53 Canadian  
€0.72 Euro = $1.00 Canadian 
Intervention = NP 
led care (n = 81) 
Age < or = to 4 
years (n = 40) 
 
Age 4-16 years  
(n = 41) 
Control = 
conventional care 
by dermatologist  
(n = 79) 
 
Age < or = to 4 
years (n = 40) 
 
Age 4-16 years  
(n = 39) 
 
Mean (SD) 
annual 
healthcare costs 
per patient 
(including  
family costs, 
and societal 
costs in other 
sectors)  
NP €981  
(€ 1339)  
76/81 patients  
 
Control €1409  
(€ 2289)  
71/79 patients 
 
Difference  
- €428  
95% CI  
- € 910 to €197 
 
 
For mild, 
moderate, 
severe 
eczema, mean 
total aggregate 
costs were 
consistently 
lower in the 
NP group 
 
 
Data 
gathered 
from a 
clinical 
record form, 
medical 
record and 
electronic 
hospital 
information 
system, 
including a 
cost diary, 
with 
necessity of 
parent 
documenting  
on behalf of 
the infant / 
child; 
potential 
bias related 
to patient’s 
cost diary 
 
 
 
Sawatsky, 2013 
48
 
 
IPT ^^ 
 
Outpatient / Specialized Referral 
 
 
204 postoperative cardiac surgery 
outpatients following first time 
coronary artery bypass graft 
(CABG) surgery 
 
 
Six week study intervention 
delivered offsite via telephone; 
study patients recruited from 
hospital prior to discharge. 
Patients with significant 
issues/concerns were seen at an 
NP Follow-Up (NPFU) Clinic, 
western Canada 
 
Intervention = 
Usual Care + NP 
phone contact at  
2-3 days post 
discharge for 6 
weeks, with 
recommendations 
to follow-up with 
primary care 
provider, cardiac 
surgeon, receive 
additional phone 
contact from NP, go 
to NPFU clinic, or 
to local ED 
 
(n= 97)  
 
 
Control = Usual 
Care (UC) primary 
care provider at 1 
week; return visit to  
cardiac surgeon 
scheduled for all 
patients at 6 weeks 
 
(n=107)   
Health Care 
Resources 
Utilization at 6 
weeks  
 
Total  MD visits  
 
NP 208 
UC 210 
Difference  
2 visits 
 
 
Total 
emergency 
department 
(ED) visits  
 
NP 30 
UC 37 
Difference  
7 visits 
Total  
hospitaliza- 
tions  
 
NP 15 
UC 19 
Difference  
4  hospitaliza- 
tions  
 
Reductions in 
total patient 
hospitalization
s 
/ total ED 
visits, while 
not 
statistically 
significant, 
may be 
clinically 
significant 
 
 
 
 
 
 
 
 
Limited 
quality 
measuremen
t tool: the 
‘Health Care 
Resources 
Utilization 
Questionnair
e’ was only 
pilot tested 
on 5 cardiac 
surgery 
patients.  
 
This tool 
was 
developed 
by the 
researchers 
to operation-
alize the 
outcome of 
healthcare 
costs by 
eliciting the 
self-reported 
number of 
patient  
contacts/visit
s with their 
primary care 
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provider and 
cardiologist, 
as well as 
ED visits 
and hospital 
admissions 
at the 2 and 
6-week 
interviews. 
Costs were 
not reported 
 
Tranmer, 2004 
46
 
IPT ^^ 
 
Outpatient / Specialized Referral 
 
200 postoperative cardiac surgery 
outpatients discharged from first 
cardiac surgery with no stay at 
Intensive Care Unit (ICU).  
 
Five week study intervention 
delivered offsite via telephone; 
study patients recruited from 
hospital prior to discharge, eastern 
Canada 
 
Intervention = 
Usual Care + NP 
initiated phone 
contacts for patients 
in 1
st
 5 weeks 
following hospital 
discharge 
 
(n= 102) 
 
Control = Usual 
Care (UC) 
including  
education booklet, 
home-care follow-
up as necessary, 
and NP contact 
information, with 
instruction to call 
with questions or 
concerns 
 
(n= 98) 
Self-reported 
health care 
contacts at 5 
weeks 
 
At least 1 visit 
to the ER 
NP 21 
UC 15 
p = 0.36 
 
Unexpected 
hospital 
admissions 
NP 9 
UC 8 
p = 0.85 
 
Home care on 
discharge 
NP 27 
UC 26 
p = 0.88 
Mean (SD) 
home care 
visits 
NP 11.68 (9.4)  
UC 10.07 
(8.0)  
p = 0.87 
 
Family 
physician  
NP 88 
UC 86 
p = 0.86 
 
Specialist 
NP 50 
UC 51 
p = 0.88 
 
 
Resource 
use tracked 
through 
patient self-
report, with 
no reference 
to any tool 
used, nor 
any  
reference to 
verification 
with hospital 
records 
#Paez, 2006 
83
 
Cost-Effectiveness Analysis 
(CEA) 
 
Post Hoc Analysis 
 to Allen (2002) 
 
IPT ^^ 
 
Outpatient / Specialized Referral 
 
228 coronary heart disease (CHD) 
outpatients who received coronary 
artery bypass grafting (CABG) 
surgery or percutaneous coronary 
Intervention= 
 NP case 
management 
(individualized 
lifestyle and 
pharmacologic 
intervention) + 
Enhanced Usual 
Care (EUC) for 1 
year post-discharge     
 
 (n = 115) 
 
 
 
Control =   
Enhanced Usual 
Care (EUC) from 
primary  providers 
&/or cardiologists 
including full lipid 
profiles sent to 
Total costs at 1 
year  
 
 
NP $1,573.31  
EUC $1,182.81 
 
Total 
incremental cost 
(NP - EUC) = 
$390.50  
 
 
 
Cost-
effectiveness 
ratios 1 year 
(U.S.$) 
Cost per mg/dL 
reduction in 
LDL 
cholesterol 
$26.03 
I) Cost-
effectiveness 
analysis 
(CEA) found 
the NP to be 
less cost-
effective than 
anticipated 
 
 
 
 
 
II) Less 
expenditure of  
NP time was 
offset by more 
costly drugs 
used for 
patients as the 
study 
proceeded 
Limited 
quality 
measuremen
t: self-
reported 
drug use at 6 
and 12 
months 
 
NP kept a 
daily log of 
time taken 
for each 
patient  
 
Without   
consideratio
n of societal 
costs it may 
be noted that 
costs of NP 
management 
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intervention (angioplasty), with  
hypercholesterolemia (low 
density lipoprotein cholesterol 
level > 2.59 mmol/L  or total 
cholesterol level > 5.18 mmol/L); 
intervention for one year post-
discharge, at outpatient clinic of 
large tertiary hospital, U.S. 
 
 
Feb. 17, 2017 
$1.00 U.S =  $1.31 Canadian 
$0.76 U.S. = $1.00 Canadian 
 
 
 
patients and their 
physicians at 4 
weeks, 6 and 12 
months after 
discharge, including  
goals for levels of 
lipoproteins, diet 
and physical 
activity  
 
(n =113)  
Cost per % 
reduction in 
LDL 
cholesterol 
 $39.05 
 
 
One year 
study did not 
allow for a 
comprehensiv
e CEA that 
considers 
savings 
associated 
with 
prevention of 
cardiovascular 
events by 
assuming the 
societal 
perspective 
 
 
 
 
are relatively 
nominal vs 
medical and 
disability-
related costs 
associated 
with treating 
CV 
catastrophic 
events and 
living with 
the 
consequence
s 
Ralston, 2009 
6
 
 
IPT ^^ 
 
Outpatient / Specialized Referral 
 
 
83 Type II Diabetes Mellitus 
outpatients, 18 - 75 years with 
glycosylated hemoglobin (GHb) 
in prior year > or = to 7%; at least 
2 clinic visits in prior year; 12 
month intervention period, at the 
University of Washington General 
Internal Medicine Clinic (UW 
GIMC), a teaching clinic that 
provides care to 7, 707 patients, 
staffed by 25 faculty, 48 residents, 
and an NP, for case management 
of chronic disease patients, U.S. 
(Ralston, 2009,  p. 234) 
 
 
Intervention = NP 
coordination of 
Web-based care + 
usual care 
 
(n=42) 
 
 
Control = usual  
care (UC)  from a 
physician who was 
board certified in 
internal medicine at 
the UW GIMC; all 
providers used the 
same electronic 
medical record 
 
(n=41) 
 
 
Mean (SD) 
change in total 
numbers of 
visits at 12 
months 
 
 
 
 
Primary Health 
Care Clinic  
NP 0.0 (2.9) 
UC -0.2 (2.8)  
Difference 0.2  
p = 0.76 
   
 
Outpatient 
Clinic 
NP 0.6 (10.7) 
UC -2.1 (7.0)  
Difference 2.7 
p = 0.18 
 
 
Specialty 
Physician 
Office 
NP 0.6 (9.0) 
UC -1.9 (5.9) 
Difference 2.5  
p = 0.14 
 
 
Inpatient Days 
NP 0.2 (2.6) 
UC -0.3(1.8)  
Difference 0.5  
p = 0.32 
 
Resource 
use 
measured 
from the 
electronic 
medical 
record, 
according to 
total 
numbers of 
outpatient 
visits with 
healthcare 
providers 
and inpatient 
days at the 
UW Medical 
Center and 
affiliated 
hospitals/cli
nics during 2 
years.  
 
Study not 
powered to 
detect 
differences 
in resource 
utilization 
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Hill, 2003 
55
 
RS ^ 
Outpatient / Specialized Referral 
 
80 Rheumatoid arthritis (RA) 
outpatients, 18 years or older, to 
rheumatology clinic on at least 
three previous occasions; study 
period of 12 months, at a  
traditional rheumatology 
outpatient clinic managed by 
junior hospital doctors (JHDs) 
within a large teaching hospital, 
England  
 
 
Intervention = 
Rheumatology NP 
(RNP) care 
 
(n =39)  
 
 
 
Control = Junior 
Hospital Doctor 
(JHD) 
care 
 
( n= 41)  
Lab tests 
NP 5%  
(11/234 
consultations) 
 
JHD 10% 
(23/226 
consultations)  
 
 
 
X rays 
NP 2% (4/234) 
 
JHD 3% (7/234) 
 
 
No p-values 
reported 
GP visits  
NP 1% 
(3/234) 
 
JHD 5% 
(12/226) 
 
 
 
 
 
Referrals 
NP 32% 
(75/234)  
 
JHD 12%  
(26/226) 
 
No p-values 
reported 
Limited 
quality 
measuremen
t: study 
authors 
report that 
all 
consultations 
/ referrals to 
physicians 
and other 
health 
professionals 
were noted, 
but no 
indication of 
process 
 
Per protocol, 
actual 
treatment 
analysis 
 
 
 
*Primary Endpoint    ^ Role Substitution (RS)    ^^ Interprofessional Team (IPT)    #Post Hoc Analysis 
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Table I-7 Resource Utilization / Cost Endpoint-Outcomes: Primary Health Care  
Statistically significant differences in 2 RS studies and 1 IPT study 
Consult Time and Return Visits in Patients with ‘Common Complaints’ Primary Health 
Care RS  
Direct Costs per Consult (Resource Use, Length of Consult, Follow-up Consults, Salary 
Costs); Direct Costs per Consult at Study NP Clinics versus Reference (no NP) Clinics, in 
Patients with ‘Common Complaints’ Primary Health Care RS (post hoc analysis) 
Total Healthcare Charges in Low-Income Maternal / Infant Patients, Primary Health Care 
RS 
NSAID Costs in Patients with Chronic Non-malignant, Non-inflammatory 
Musculoskeletal Pain, Primary Health Care IPT   
 
No statistically significant differences in 1 IPT study  
 Cost Effectiveness of Continence Service for Patients with Incontinence Symptoms, 
 Primary Health Care IPT (original study and post hoc analysis) 
 
Author, Year 
RS^ / IPT^^ 
Setting  
Study Population, 
Duration, Site 
Intervention 
 
Results 
 
(Outcome data 
analyzed by 
Intention to Treat, 
ITT, on the basis of 
all randomized 
patients, as 
randomized, unless 
otherwise noted) 
 
 
 
Quality of Endpoint 
Assessment / 
Comments 
 
Dierick-van Daele, 
2009 
67
 
RS ^ 
Primary Health Care 
(PHC) 
 
1,591 PHC patients 
from 15 general 
practices, 16 years and 
older, with common 
complaints regarding  
respiratory / throat, ear 
/ nose, musculoskeletal 
/ skin injuries, urinary / 
gynaecological and 
geriatric problems  
 
 
 
Two week intervention 
Intervention = 
patient care 
from newly 
graduated NP 
(Master Degree 
of Advanced 
Nursing 
Practice) 
experience 
ranging  
1 to 5 years;  
12 NPs 
 
(n = 817) 
 
 
 
 
Control = 
patient care 
from GP with 
an average of 
16 years’ 
experience;  
50 GPs  
Mean (SD)  
duration of 
consultation  
 
NP 12.22 minutes 
(5.7) 
GP 9.20 minutes 
(4.8)  
p < 0.001 
 
 
Investigations  
 
NP 2.4% (18/747)  
GP 2.9% (19/650)  
 p = 0.55  
 
 
Referrals 
 
NP 12 % (90/747)  
GP 14.2 % (92/650 
p = 0.24 
Asked to return 
NP 50.3% 
(340/676) 
GP 41.3% 
(250/604)  
p = 0.001 
 
Returned for 
same problem  
NP 23.5% 
(121/515)  
GP 18.3% 
(89/487)  
p = 0.040 
 
Mean (SD)  
length of 
absence from 
paid job due to 
illness  
NP 1.11 days 
(0.32) 
GP 1.11 days 
The research assistant 
recorded the length of 
each consultation 
from patient arrival at 
consultation room to 
departure 
 
There is no 
conclusive 
properties-
information provided 
for the three 
questionnaires used 
for patient-specific 
data collection, but 
only a justification of 
their validity 
according to the 
study authors’ 
assurance on 
discussion with 2 
GPs with research 
experience.  
Subsequent to 
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within a study duration 
of 6 months; patients 
who attended a general 
practice on a day when 
the NP was present 
were invited to 
participate in the trial, 
Netherlands 
 
 
(n = 684) 
Study practices 
were also 
compared to 
external 
reference 
practices where 
17 GPs worked 
in 5 general 
practices 
without NPs 
(0.31) discussion with the 2 
GPs, the 
questionnaires were 
next tested on a group 
of 40 patients, 
resulting in two 
textual refinements as 
well as “asking the 
name of the 
practitioner instead of 
the type of 
practitioner (NP or 
GP) consulted” 
 
Baseline differences 
in study design 
included a booking 
time set at 15 minutes 
for NPs versus 10 
minutes set for GPs 
 
#Dierick-van Daele, 
2010 
27
 
 
Cost Minimization 
Evaluation 
Post Hoc Analysis  
to Dierick-van Daele 
(2009) 
 
RS ^ 
Primary Health Care 
(PHC) 
1,591 PHC patients 
from 15 general 
practices, 16 years and 
older, with common 
complaints regarding  
respiratory / throat, ear 
/ nose, musculoskeletal 
/ skin injuries, urinary / 
gynaecological and 
geriatric problems  
 
 
Two week intervention 
within a study duration 
of 6 months; patients 
who attended a general 
practice on a day when 
the NP was present 
were invited to 
participate in the trial, 
Netherlands 
 
Intervention = 
patient care 
from newly 
graduated NP 
(Master Degree 
of Advanced 
Nursing 
Practice) 
experience 
ranging  
1 to 5 years;  
12 NPs 
 
(n = 817) 
 
 
 
 
Control = 
patient care 
from GP with 
an average of 
16 years’ 
experience;  
50 GPs  
(n = 684) 
 
Study clinics 
were also 
compared to 
reference 
clinics;17 GPs 
practiced  in 5 
reference  
clinics without 
NPs 
CONSULTS 
 
1) Mean (SD) 
direct costs within 
healthcare per 
consult 
  
Direct healthcare 
costs include 
resource use, 
length of 
consultations, costs 
of follow-up 
consultations, and 
salary costs 
NP  
€31.94 (€36.29) 
GP  
€40.15 (€49.94) 
Difference 
- €8.21 
95% CI €3.56 to 
€12.85 
p = 0.001  
 
2) Mean (SD) 
‘direct and  
productivity costs’ 
per consult 
 
NP €144.40 
(€53.18) 
GP €145.87 
(€67.15)  
Difference € –1.48  
95% CI – €4.94 to 
€7.90 
CLINICS 
continued: 
 
2) Mean (SD) 
‘direct  and  
productivity 
costs’ per 
consult 
 
Study clinics 
with NPs  
€145.08 
(€60.07) 
 
Reference 
clinics without 
NPs  
€141.09 
(€63.03) 
 
Difference  
€ 4.00  
95% CI  - €8.61 
to € 0.61 
p = 0.09 
 
“For pragmatic 
reasons, data for 
follow-up 
consultations, 
length of 
consultations, 
and number of 
days of absence 
were only 
gathered in 
study practices. 
It was assumed 
Inclusion of societal 
perspective, with 
costs outside the 
healthcare sector 
deemed productivity 
costs  (productivity 
costs = lost 
productivity while 
away from work due 
to illness on sick 
leave days; indirect 
costs related to paid 
work outside the 
healthcare sector) 
 
Without calculation 
of an equivalence 
margin, the 
intervention and 
control groups were 
assumed to be 
equivalent based on 
the erroneous 
assumption that no 
significant 
differences in 
outcome or process 
measures found 
between NP or GP 
consultations 
represented 
equivalence (Dierick-
van Daele, 2010, p. 
e33) between 
the intervention and 
control groups  
within study practices 
102
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Feb. 17, 2017 
€1.00 Euro = $1.53 
Canadian  
€0.72 Euro = $1.00 
Canadian  
 
p = 0.65   
 
CLINICS 
 
1) Mean (SD) 
direct costs  
within healthcare 
per consult 
 
 
Study clinics with 
NPs  
Cost per consult 
€35.76 (€43.35) 
 
Reference clinics 
without NPs  
Cost per consult 
€39.21 (€42.99) 
 
Difference  
– €3.45  
95% CI €0.22 to 
€6.68   
 
p = 0.04  
 
that these data 
were the same 
for the external 
reference 
group.” 
(Dierick-van 
Daele, 2010, 
p.e30). 
 
Care provided 
by NPs in 
primary health 
care (PHC) was 
measured at 
lower direct 
costs for 
consults and 
lower direct 
costs for PHC 
clinics that 
integrated NPs. 
 
Cost differences 
were mainly 
caused by 
differences in 
annual salary 
(prices indexed 
as of 2006) 
 
NP €41,160.00 
GP €94, 475.92 
 
 
Cost minimization 
evaluation is a 
controversial method 
for cost evaluation of 
equivalence trials, 
performed when the 
health effects of the 
alternatives are 
known or assumed to 
be equal. In this case, 
the decision simply 
revolves around the 
costs. Only the costs 
need to be analysed, 
and the least costly 
alternative is the most 
efficient. However, 
few interventions are 
actually equally 
effective.
91
 
Jones, 2002 
66
 
IPT ^^ 
Primary Health Care 
(PHC) 
 
222 PHC patients from 
5 general practices 
with computerized 
prescribing systems. 
Patients were 18 years 
or older, with non-
malignant, non-
inflammatory 
musculoskeletal pain 
and oral non-steroidal 
anti-inflammatory drug 
(NSAID) prescriptions 
covering 6 or more 
weeks of the last 12 
months; 6 month 
study, with all patients 
examined at their 
‘Active 
Intervention’ =  
NP  assessment 
patient-tailored 
educational 
package with 
request that 
patients 
withdraw their 
NSAIDs and 
use appropriate 
alternative drug 
and non-drug 
therapies (e.g. 
strategies on 
weight 
reduction, use 
of local heat 
and cold, back 
and neck care, 
footwear, 
massage, and 
relaxation 
techniques) + 
Usual GP Care 
(n =110) 
1) Median Change 
in NSAID Costs at 
6 months 
(interquartile  
 range) 
 
Intervention  
- £ 2.61 
(-£14.65, £3.45) 
Control  
£0.00 
(-£5.92, £11.00) 
Difference 
- £2.61 
p = 0.008 
 
2) Median change 
in all drug costs at 
6 months 
(interquartile  
 range)  
 
Intervention 
£ 24.53 
(-£ 6.94, £ 47.26) 
 
3) Mean 
healthcare 
service cost per 
patient at 6 
months 
(interquartile  
 range) 
 
Intervention 
NP educational 
package  
(excluding costs 
for telephone 
calls)  
 
£40.70  
(£34.67, £46.40) 
 
Control  no 
comparative 
cost provided 
 
4) Mean patient 
travel cost at 6 
months 
(interquartile  
 range) 
Five general practices 
represented a mix of 
rural / urban and 
fundholding / non-
fundholding practices 
Changes in health 
service use, drug and 
patient costs were 
self-reported 
 
Not inclusive of all 
(societal) costs, one 
of which was the 
patients’ additional 
purchase of drugs and 
equipment on advice 
of NP 
 
Both control and 
intervention groups 
were treated by the 
same single NP 
Time spent by NP 
(£16/hr) providing 
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general practice or 
their homes, England 
 
GALS screen (Gait, 
Arms, Legs & Spine) 
assessment to detect 
locomotor  
abnormalities related 
to musculoskeletal 
pain  
 
Feb.17, 2017 
£ 1.00 Great Britain  = 
$1.62 Canadian 
£ 0.62 Great Britain =  
$1.00 Canadian  
 
 
‘Control 
Intervention’ = 
same single NP 
provided 
assessment and 
basic education 
regarding 
NSAID use, 
reinforced with  
leaflet  + Usual 
GP Care 
(n =112)  
  
Control  
£ 10.75  
(-£ 18.98,£ 47.00) 
Difference 
 £ 13.78 
 p = 0.25 
 
 
Total drug costs 
increased more in 
the intervention 
group vs control 
 
 
Intervention  
(time & expense 
traveling to the 
practice office, 
but excluding 
purchases of 
drugs and 
equipment on 
the NP’s advice)  
 
£ 0.83 per 
patient  
(£0.00, £1.25) 
 
Control  no 
comparative 
cost provided 
 
education advice and 
checking patient 
compliance, had no 
known comparison to 
‘cost per patient for 
regular GP service’ 
 
 
 
Hannan, 2012 
69
 
RS ^ 
Primary Health Care 
(PHC) 
139  healthy first-time 
mothers, 18 years or 
older, each of whom 
delivered a healthy, 
full-term single infant; 
low-income family  
 
 
Intervention occurred 
for first 2 months post-
birth, delivered offsite 
via telephone. Study 
patients were recruited 
from hospital prior to 
discharge, U.S. 
 
 
Recognizing that 
healthcare (HC) 
charges do not equal 
actual costs (including 
societal costs), the 
study’s intent was only 
to provide a 
comparison of 
healthcare charges 
between groups. 
 
Feb. 17, 2017 
$1.00 U.S =  
$1.31 Canadian 
$0.76 U.S. = 
$1.00 Canadian  
Intervention = 
follow-up 
phone-calls  by 
NP with ‘back-
up’ pediatric 
physician 
available for 
consultation 
(n =70) 
NPs were 
Masters 
prepared 
pediatric 
NPs with a 
minimum of 10 
years’ 
experience, at a 
salary of  
$40.21/ hour, 
from the  
AHEC (Area 
Health 
Education 
Center) data 
base 
 
 
 
 
Control = 
routine hospital 
discharge and a 
pediatrician 
appointment in 
2 months 
 
(n =69) 
 
 
Infant vaccinations 
at 2 months  
NP 92.8%  
(65/70) 
Control 84.1% 
(58/69)   
p = 0.186 
 
Urgent-care-centre 
visits at 2 months  
NP 3.6%  
(5/139) 
Control 2.2% 
(3/139) 
p = 0.48  
 
Mean (SD) 
charges, Urgent-
care-centre  
NP $376 ($27) 
range $294-$482 
Control $351($15) 
range $267–$402  
p  = 0.47 
 
Emergency room 
(ER) visits at 2 
months  
NP 7.2%  
(10/139) 
Control 11.5% 
(16/139)  
p = 0.179 
 
Mean (SD) HC 
charges, ER  
NP $104 ($267) 
range $365-$ 1,080 
Control $245 
($538) 
range $298-$ 2,410 
p  = 0.13 
Hospitalizations 
at 2 months  
NP 0.7% 
(1/139) 
Control 2.2% 
(3/139) 
p = 0.30 
 
Mean (SD) HC 
charges 
hospitalizations 
 
NP $51 ($423) 
range $3,547 for 
1 hospitalization 
 
Control $764 
($3,847) 
range $9,153–
$24,012 
p = 0.29 
 
Total charges 
NP phone 
service 
$1,598  
(SD = $7.61) 
 
Average total 
charges phone-
calls per mother 
$23.83 
 
Total healthcare 
charges per 
group at 2 
months 
 
NP $14,333 
Control $70,834 
Difference  
$56, 501 
p < 0.05 
Healthcare utilization 
data derived from 
self-report and 
infants’ medical 
records obtained from 
the care facility or the 
mothers; no 
designation of 
societal cost  
 
 
Attrition: 7/70 (10%) 
intervention mothers 
were unable to be 
contacted post-
discharge due to dis-
connected telephones  
 
 
 
 
NP follow-up 
telephone calls to 
low-income first time 
mothers with healthy 
full term infants was 
an easily applied 
intervention at a 
relatively low cost, 
for management of 
maternal and infant 
health outcomes as 
per study 
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Williams, 2005 
60
 
 
IPT ^^ 
 
Primary Health Care 
(PHC) 
 
 
3746 PHC patients 
aged 40 years and over 
living in private 
households, with 
incontinence several 
times per month or 
more, or several times 
a year, and reported 
impact of symptoms on 
quality of life 
 
 
 
 
Six month intervention 
period, at patients’ 
homes in 
Leicestershire and 
Rutland, England 
 
 
 
 
 
 
Feb.17, 2017 
£ 1.00 Great Britain  = 
$1.62 Canadian 
£ 0.62 Great Britain =  
$1.00 Canadian  
Intervention = 
continence 
service 
provided by 
NPs (n = 2958) 
Control = 
existing usual 
primary care 
including GP 
and continence 
advisory 
services   
(n =788) 
 
 
4:1 ratio was  
deemed 
necessary to 
ensure 
sufficient 
intervention 
data for 
evaluation of 
detrusor muscle 
over-activity 
(wall of 
bladder)  and 
urodynamic 
stress 
incontinence 
(involuntary 
leakage of 
urine with 
increased intra-
abdominal 
pressure in the 
absence of 
detrusor 
contraction) 
Cost-effectiveness according to 
number of symptoms alleviated, at 6 
months 
 
In the 3
rd 
-  6
th
 months of study,  
costs generated by the NP service were 
similar to months 1-3,  
while the overall difference in mean 
number of symptoms alleviated 
remained the same,  
resulting in an incremental 
‘cost / additional symptom alleviated’ 
that was greater at 6 months (£488) 
than at 3 months (£242) 
 
 
No p-values reported 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Incomplete reporting  
76% of the entire 
study population 
were not included in 
the cost-effectiveness 
analysis (CEA).  
Cost data represents 
only 24% (905/3746) 
of all study patients; 
of this 24%, 19% 
(171/905) patients 
were control patients, 
and 81% (734/905) 
were intervention 
patients 
 
Inconclusive  
1) Inconsistent 
sourcing of data upon 
which CEA  was 
based, integrating 
published cost data 
for control, and only 
using data estimates 
not similarly 
verifiable, for 
intervention cost 
2)  No tabled data 
regarding type of 
resource use 
(healthcare visits / 
medications / 
appliances) with no 
associated stratified 
cost data comprising 
the CEA numbers for 
the reader to critically 
appraise 
 
No designation of 
societal cost 
 
Higher start-up costs 
/ longer consults 
limited  
cost-effectiveness  
of this study’s 
intervention service 
(designed for this 
study) versus 
standard clinic 
practice 
#Williams, 2011 
81
 
 
Post Hoc Analysis 
 
6 year follow-up to 
Williams (2005) 
Intervention = 
continence 
service 
provided by 
NPs 
Mean (SD) ‘Total 
National Health 
Service Costs + 
Own Costs’ 
collected 
retrospectively 
over 6 months 
Female  
Intervention 
£114.18 
(£29.18) 
(95% CI £56.95 
to £171.40) 
 
At long term follow-
up, cost data was 
available for 81% 
(2217/2728) cases, 
with multiple 
imputation used to 
address missing data. 
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IPT ^^ 
 
Primary Health Care 
(PHC) 
 
 
 Feb.17, 2017 
£ 1.00 Great Britain  = 
$1.62 Canadian 
£ 0.62 Great Britain = 
$1.00 Canadian 
 
 
 
The NP continence 
service was designed 
for the trial, and 
funded only for the 
duration of the 
research program. This 
NP service was not 
funded to operate 
throughout the interim 
period of 6 years 
 
 
Service expired at 
unknown time post 
original trial (that 
occurred 6 years prior) 
England  
(n = 2958) 
Control = 
existing usual 
primary care 
including GP 
and continence 
advisory 
services  
 
(n =788) 
 
4:1 ratio was  
deemed 
necessary to 
ensure 
sufficient 
intervention 
data for 
evaluation of 
detrusor muscle 
over-activity 
(wall of 
bladder)  and 
urodynamic 
stress 
incontinence 
(involuntary 
leakage of 
urine with 
increased intra-
abdominal 
pressure in the 
absence of 
detrusor 
contraction) 
 
 
 
 
prior to follow-up 
study, with study 
authors noting they 
were unable to ask 
about the whole  
5-7 year period due 
to unreliable recall 
(Williams, 2011, p. 
3) 
 
Male 
Intervention  
£93.97 (£48.17) 
(95% CI £-0.55 to 
£188.49) 
 
Male 
Control 
£65.50 (£36.43) 
(95% CI £ -5.99 to 
£136.99) 
 
p = 0.3 
 
 
Female Control 
£87.67 (£12.36) 
(95% CI £63.44 
to £111.91) 
 
p = 0.2 
 
 
  
Inconclusive, related 
to:  
 
1) Inconsistent 
sourcing of data upon 
which CEA was 
based, integrating 
published cost data 
for control, and only 
using data estimates 
not similarly 
verifiable, for 
intervention cost. 
 
2) No tabled data 
regarding type of  
resource use 
(healthcare visits / 
medications / 
appliances)  and no 
stratified cost data 
unique to each group, 
as basis for computed 
CEA values. 
 
 
No designation of 
societal cost. 
 
*Primary Endpoint     ^Role Substitution (RS)     ^^Interprofessional Team (IPT)     #Post Hoc Analysis 
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Table I-8 Overall / Global Quality of Life Endpoint-Outcomes (SF-36 or derivations) 
Statistically significant differences in 1 IPT^^ study 
 Physical and mental components of the SF-12 Questionnaire, Post-operative Women 
 with Suspected Ovarian Cancer, Outpatient IPT    
 
No statistically significant differences 2 RS studies and 6 IPT studies 
  
 Soft Tissue Injury Emergency Department Patients, Acute RS 
 Internal Medicine Inpatients, Acute RS 
 Cardiovascular Disease Patients, Outpatient IPT  
 Cardiac Surgery Patients, Outpatient IPT 
 Coronary Artery Bypass Graft (CABG) Surgery Patients, Outpatient IPT 
 COPD Patients, Outpatient IPT (pilot study) 
 Breast cancer survivors with abruptly recurred menopause, Outpatient IPT 
 Patients with Chronic Non-malignant, Non-inflammatory Musculoskeletal Pain, 
 Primary Health Care IPT 
 
Author, Year 
RS^ / IPT^^ 
Setting  
Study Population, 
Duration, Site 
Intervention 
   
Results 
 
(Outcome data analyzed by Intention to 
Treat, ITT, on the basis of all 
randomized patients, as randomized, 
unless otherwise noted) 
Quality of 
Endpoint 
Assessment 
/ Comments 
 
McCorkle, 2009
52
 
IPT ^^  
 
 
Outpatient / 
Specialized Referral  
 
 
 
 
 
149 post-surgical 
outpatients 21 years or 
older, suspected 
primary diagnosis of 
ovarian cancer after 
abdominal surgery, 
prognosis of at least 6 
months, with an order 
to initiate 
chemotherapy;  
patient contact made at  
private homes or by 
telephone, U.S.  
Intervention  = 18 
contacts by an 
oncology NP, 
supported by 
psychiatric NP 
(PSYNP) consults 
(32/74 intervention 
patients)  when 
warranted for high 
emotional distress = 
Distress Thermometer  
> or = to 4 
 
(n=74)  
 
Attention Control = 
nine contacts by 
research assistant, 
supported by medical 
social worker (no data 
for patient contact with 
social worker) 
 
(n = 75) 
 
QOL measured at baseline (24–48 
hours after surgery) 1, 3, and 6 months 
post-surgery 
 
Adjusted QOL baseline scores were 
included as covariates in 3 types of 
mixed effect regression models, built 
to estimate ‘rates of change’ in 
different QOL measures over time: 
 
(1) Oncology NP without PSYNP  
      Effect Estimates (EE) 
 
SF-12 physical component 
EE  = - 0.07599  ± se 0.02425 
p = 0.0019   
 
The rate of improvement  was 
significantly greater for control than 
intervention  
 
SF-12 mental component 
EE = 0.01776 ± se 0.01138 
p = 0.1195   
 
Non-significant rate of change in 
intervention vs control 
Endpoint 
assessment 
based on 
reliable, 
valid,  and 
standardized 
tool, the 
Short Form-
12version2 
(SF-12v2) 
Baseline 
measures 
were 
obtained 
prior to 
randomizatio
n, with 
significant 
differences 
found in 
scores on the 
SF-12 
mental 
component 
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Overall / global quality 
of life endpoints: 
 
SF-12 tool, derived 
from the Medical 
Outcomes Short-Form 
36 (SF-36) 
 
a) physical component 
 
b) mental health 
component 
 
Higher scores indicate 
better health 
 
 
(2) Oncology NP with PSYNP  
Effect Estimates (EE) 
SF-12 physical component 
Poor model fit – no EE data 
 
SF-12 mental component 
EE = 0.02300 ± se 0.00748 
p = 0.0023  
 
The rate of improvement in the SF-12 
score was significantly greater for 
intervention  vs control 
 
(3) PSYNP without Oncology NP 
Effect Estimates (EE)  
 
SF-12 physical component 
EE = 0.1948 ± se 0.03877 
p < 0.0001  
 
SF-12 mental component 
EE = 0.06558 ± se 0.01676 
p = 0.0001  
 
The PSYNP component significantly 
increased the rate of improvement over 
time in both SF-12 measures 
 
 
and lower 
baseline 
QOL in the 
intervention 
group.  
 
 
Baseline 
QOL scores 
were 
adjusted for 
model 
testing;  final 
covariates 
included 
age, marital 
status, 
number of 
comorbiditie
s, disease 
status 
(recurrence 
or not) and 
education 
level 
 
McClellan, 2012 
63
 
RS ^ 
Acute Emergency 
Department 
372 peripheral soft 
tissue injury patients 
older than 16 years 
eligible for 
management by any of 
3 professionals: 
Emergency NP (ENP), 
Extended Scope 
Physiotherapist (ESP), 
Emergency Department 
(ED) Doctor. Eight 
week study period at a 
single inner city ED, 
England  
 
Intervention = patient 
management  from 
arrival to discharge by 
ENP or ESP 
ENP group   (n = 123)  
ESP group  (n =126)  
 
Control = routine ED 
doctor care   ( n = 123)  
 
Overall Quality of Life at 8 weeks 
SF-12v2, Physical Component 
 
95% CIs 
Dr  −3.8-10.1 (3.2)  68/123 patients 
ESP 0.2-4.6 (2.4)  72/126 patients 
ENP 1.6-6.5 (4.1)  73/123 patients  
 
NPs and ESPs were reported to be 
clinically  equivalent to routine care 
provided by doctors 
 
Main 
analysis  
was by  
intention to 
treat.  
 
A per-
protocol 
analysis was 
reported to 
have also 
been 
undertaken, 
though no 
per protocol 
data is 
shown. 
 
Pioro, 2001 
71
 
RS ^ 
Acute Inpatient  
381 heterogeneous 
internal medicine 
Intervention = NP-
based care  
(n=193) 
 
Control=House-staff 
care  
Quality of Life SF-36 at 6 weeks 
following discharge 
Between group differences were not 
statistically significant  
p  > 0.1 
Endpoint 
assessed 
with the 
reliable and 
valid 
Medical 
Outcomes 
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inpatients, 18–69 years, 
from hospital 
admission to 6 weeks 
post-discharge at single 
center teaching 
hospital, U.S. 
 
 
(n=188) 
 
 
 Study Short 
Form 36 
(SF-36) 
 
Tranmer, 2004 
46
 
 
IPT ^^  
 
Outpatient / 
Specialized Referral 
200 postoperative 
cardiac surgery 
outpatients discharged 
from first cardiac 
surgery with no stay at 
Intensive Care Unit 
(ICU) 
Five week study 
intervention delivered 
offsite via telephone; 
study patients recruited 
from hospital prior to 
discharge, eastern 
Canada 
 
Intervention = Usual 
Care + NP initiated 
phone contacts for 
patients in 1
st
 5 weeks 
following hospital 
discharge 
 
(n= 102) 
 
 
Control = Usual Care 
(UC) including 
education booklet, 
home-care follow-up as 
necessary, and NP 
contact information, 
with instruction to call 
with questions or 
concerns  
 
(n= 98) 
*Mean (SD) Quality of Life 5 Weeks  
 
 
Physical component  
NP  36.3 (6.4)  (92/102 patients ) 
UC  36.2 (7.5)  (92/98 patients) 
 
Mean difference 0.04  
(95% CI –1.99 to 2.08)  
p = 0.97 
 
 
Mental component  
NP  50.4 (11.5)  (92/102 patients) 
UC  51.7 (11.9)  (92/98 patients) 
 
Mean difference –1.25  
(95% CI –4.54 to 2.04) 
 p = 0.45 
 
Endpoint 
assessed 
with reliable 
and valid 
Medical 
Outcomes 
Study Short 
Form 36 
(SF-36) 
 
Goessens, 2006 
47
 
IPT ^^ 
 
Outpatient / 
Specialized Referral 
Cardiovascular disease 
(CVD) 
Peripheral arterial 
disease 
Abdominal aortic 
aneurysm 
Cerebrovascular 
disease 
Coronary heart disease  
236 CVD outpatients 
with two or more 
modifiable risk factors: 
smoking, hypertension, 
dyslipidemia, diabetes, 
obesity, 
hyperhomocysteinemia
1 year intervention at 
risk-factor management 
clinic, Netherlands 
Intervention = NP at 
risk factor management 
clinic + Usual Care 
 
(n=119) 
 
 
Control = Usual Care  
(UC) by GP and  
treating vascular 
specialist 
 
(n=117)  
 
 
Overall quality of life at one year 
 
 
No significant differences between 
group scores on the medical outcomes 
study short form-36 (SF-36) 
 
No individual data shown 
  
 
 
 
Despite 
significant 
reduction in 
CVD risk 
factors for 
high-risk  
patients (see 
Appendix  
I-2) no 
significant 
differences 
in overall, 
global 
quality of 
life 
measures 
were found  
after one 
year of NP 
intervention, 
using the 
Medical 
Outcomes 
Study Short 
Form 36 
(SF-36) 
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Sawatsky, 2013 
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IPT ^^ 
 
Outpatient / 
Specialized Referral 
 
204 postoperative 
cardiac surgery 
outpatients following 
first time coronary 
artery bypass graft 
(CABG) surgery 
 
 
Six week study 
intervention delivered 
offsite via telephone; 
study patients recruited 
from hospital prior to 
discharge. Patients with 
significant issues / 
concerns were seen at 
an NP Follow-up 
(NPFU) Clinic, western 
Canada 
Intervention = = Usual 
Care + NP phone 
contact at 2-3 days post 
discharge for needs 
assessment, with 
recommendations to 
follow-up with primary 
care provider, cardiac 
surgeon, receive 
additional phone 
contact from NP, go to 
NPFU clinic, or to 
local Emergency 
Department     
 
(n= 97)  
 
 
 
 
Control = Usual Care 
(UC) including advice 
to make primary care 
provider appointment  
within 1 week; return 
visit to  cardiac 
surgeon was scheduled 
for all patients at 6 
weeks    
 
(n=107)   
 
 
* Mean (SD) Quality of Life  
Physical component 
 
2 weeks  
 
NP 19.0 (3.4) 
UC 18.0 (3.4) 
 p = 0.04 
6 weeks  
 
NP 22.2 (4.2) 
UC 22.0 (4.0) 
 p = 0.69 
 
Mental component 
 
2 weeks  
 
NP 21.5 (2.1) 
UC 21.5 (2.3) 
 p = 0.87 
6 weeks  
 
NP 21.3 (2.3) 
UC 21.1 (2.3) 
p = 0.67  
Endpoint 
assessed 
with reliable 
and valid 
Medical 
Outcomes 
Study Short 
Form 36 
(SF-36) 
 
 
 
Disruption 
of 
randomized 
sample: once 
intervention 
was 
established, 
several 
control 
patients 
were pulled 
from trial, 
deemed too 
ill for the 
study 
(Sawatsky, 
2013,   
p. 2085)  
  
 
Berkhof, 2014 
50
  
 
IPT ^^ 
 
Outpatient / 
Specialized Referral 
 
Pilot study 
 
100 chronic obstructive 
pulmonary disease 
(COPD, a progressive 
disease) outpatients  
> or = to 40 years, 
COPD GOLD stage > 
or = to 2 (Global 
initiative for staging 
Obstructive Lung 
Disease: 1 = mild;  
4 = very severe)  
smoking history >10 
pack-years; 2 year 
study at a large 
teaching hospital, 
Netherlands 
 
 
Intervention = patient-
initiated outpatient  
visits with pulmonary 
NP upon increase of 
symptoms (dyspnea, 
cough, sputum, 
hemoptysis, or thoracic 
pain); NP followed an 
‘on-demand protocol’ 
that included  consult 
with pulmonologist for 
urgent problems  
(n = 49)  
 
Control= usual care 
(UC) of traditional 
outpatient visits 
initiated by 
pulmonologist, to the 
pulmonologist or the 
pulmonary NP    
(n=51)   
Overall quality of life at two years 
 
No significant differences between 
groups, while 3/8 component scores on 
SF-36 met the minimal clinically 
important difference (MCID) 
Less 
deterioration 
in disease-
specific 
health status 
for 
intervention 
patients was 
not 
accompanied 
by 
significant 
differences 
in overall 
quality of 
life 
measures 
using the 
SF-36 tool 
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Ganz, 2000 
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IPT ^^ 
Outpatient / 
Specialized Referral 
 
76 breast cancer 
survivor outpatients 
with abruptly recurred 
menopause symptoms 
due to discontinued 
estrogen replacement 
therapy (ERT) related 
to breast cancer; 
intervention period of 4 
months at an outpatient 
clinic, U.S. 
Intervention = 
comprehensive 
menopausal assessment 
or CMA (targets highly 
symptomatic women 
with goal of reducing 
symptoms and 
improving quality of 
life, through education, 
counseling, and  
focused non-ERT 
interventions) delivered 
by NP    ( n=37) 
 
Control = usual care 
(UC) + 1 contact from 
research assistant at 2 
months asking of 
therapies used for 
symptom management 
( n= 39) 
 
Vitality at 4 months  
 
Vitality, a dimension of health-related 
quality of life on the SF-36 tool, 
showed no significant between-group 
differences 
p = 0 .77 
Potential 
side effects 
to clonidine 
(fatigue, 
headache) 
used to treat 
‘hot flashes’ 
in 39% of 
intervention 
patients,  
may have 
limited 
detection of 
intervention 
effect on  
SF-36 
Vitality 
Scale  
 
 
Jones, 2002 
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IPT ^  ^
 
Primary Health Care 
(PHC) 
 
222 patients 18 years or 
older, with non-
malignant, non-
inflammatory 
musculoskeletal pain 
and oral non-steroidal 
anti-inflammatory drug 
(NSAID) prescriptions 
covering 6 or more 
weeks of the last 12 
months; 6 month study, 
all patients examined at 
their general practice or 
their homes, England 
 
GALS screen (Gait, 
Arms, Legs & Spine) 
assessment to detect 
locomotor  
abnormalities related to 
musculoskeletal pain  
 
 
‘Active Intervention’ =  
NP assessment,  
patient-tailored 
educational package 
with request that 
patients withdraw their 
NSAIDs and use 
appropriate alternative 
drug and non-drug 
therapies (e.g. 
strategies on weight 
reduction, use of local 
heat and cold, back and 
neck care, footwear, 
massage, and 
relaxation techniques) 
+ Usual GP Care 
(n =110) 
 
‘Control Intervention’ 
= (same single NP 
provided assessment 
and basic education 
regarding NSAID use, 
reinforced with  leaflet)  
+ Usual GP Care 
(n =112) 
Quality of Life at 6 months on SF-36 
 
No significant differences between 
groups  
 
 
 
NSAID 
reduction: 
number of 
patients 
taking 
NSAIDs  
and dose of 
NSAID 
taken,  
may not be 
associated 
with 
deterioration 
in patients’ 
overall 
health status 
*Primary Endpoint     ^ Role Substitution (RS)     ^^ Interprofessional Team (IPT)     #Post Hoc Analysis 
 
 
 
 183 
 
Table I-9 Patient Satisfaction Endpoint-Outcomes 
Statistically significant differences in 4 RS studies & 3 IPT studies 
Communication Minor Injury Emergency Department Patients, Acute RS 
Parents of Infants / Children with Atopic Dermatitis (Eczema), Outpatient RS 
Rheumatoid Arthritis Patients, Outpatient RS  
Patients with ‘Common Complaints’ and at least One Chronic Disease, Primary Health 
Care RS  
Quality of Service and ‘Amount of Help Received’ for Coronary Artery Bypass Graft 
(CABG) Patients, Outpatient IPT 
Achieving Best Recovery Possible and Side Effect Information for Cardiac Surgery 
Patients, Outpatient IPT 
Perception of Problem in Patients with Incontinence Symptoms, Primary Health Care IPT 
(original study and post hoc analysis) 
 
No statistically significant differences in 1 IPT study  
Older Adults Discharged Home three months post-discharge, Outpatient IPT (pilot study) 
Author, Year 
RS^ / IPT^^ 
Setting  
Study Population, 
Duration, Site 
Intervention 
 
Results 
 
(Outcome data analyzed by Intention to 
Treat, ITT, on the basis of all 
randomized patients, as randomized, 
unless otherwise noted) 
 
 
Quality of 
Endpoint 
Assessment / 
Comments 
 
Cooper, 2002 
62
 
 
RS ^ 
 
Acute Emergency 
Department  
 
204 patients over 16 
years, with minor 
injury that fell within 
the ENP (emergency 
NP) protocol, at a 
single Accident and 
Emergency (A & E) 
Department; 2 month 
study duration, 
Scotland 
Intervention = 
ENP-led care 
(n = 102) 
 
 
Control = Senior 
House Officer 
(SHO)-led care 
(n = 102) 
 
 
Patient Satisfaction  
Questionnaires regarding patient-
provider communication were returned 
immediately after  treatment  
 
 
Patients reported it was easier to talk to 
ENPs  
NP 97.6 (85/102) 
SHO 84.0 (81/102) 
p = 0.009  
 
 
Patients given information on accident 
and illness prevention  
NP 75.3 (81/102) 
SHO 45.2 (73/102)  
p = 0.001 
 
 
Patients given enough information on 
their injury  
NP 95.2 (83/102) 
SHO 82.5 (80/102) 
p = 0.007 
 
Endpoint 
assessment 
based on a 
questionnaire  
modified from a 
previously 
validated 
questionnaire by 
Jenkins & 
Thomas (1996) 
 
However, 
limitations 
inherent to all 
self-completion 
questionnaires 
include: 
 
1) refusal to 
complete / 
return the 
questionnaire 
leads to bias if 
non-responders 
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Overall patient satisfaction   
NP 98.8 (85/102) 
SHO 87.7 (81/102) 
p < 0.001 
Patient felt able to ask questions 
NP 94.0 (84/102) 
SHO 83.8 (80/102)  
p = 0.123 
 
 
Patient understood advice received 
NP 94.1  (85/102)  
SHO 84.6 (78/102)  
p = 0.080 
 
 
Patient felt that the providers listened  
NP 97.7  (87/102) 
SHO 86.4  (81/102)  
p =  0.089 
 
 
Patient was given enough provider time 
NP 95.3 (86/102)  
SHO 82.5  (80/102)  
p = 0.12 
 
 
 
differ from 
responders 
 
2) Patients may 
ask other people 
to assist in 
completing the 
questionnaire, 
or even 
complete it on 
their behalf, 
prejudicing the 
sample 
 
3)Lack of ability 
to read (low 
literacy levels / 
illiteracy in 
patients) may 
contribute to 
nonresponse 
Sawatsky, 2013 
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IPT ^^ 
Outpatient / 
Specialized Referral 
 
204 postoperative 
cardiac surgery 
outpatients following 
first time coronary 
artery bypass graft 
(CABG) surgery 
 
Six week study 
intervention delivered 
offsite via telephone; 
study patients 
recruited from hospital 
prior to discharge. 
Patients with 
significant 
issues/concerns were 
seen at an NP Follow-
Up (NPFU) Clinic, 
western Canada 
Intervention =  
Usual Care + NP 
phone contact at 2-3 
days post discharge 
for needs 
assessment, with 
recommendations to 
follow-up with 
primary care 
provider, cardiac 
surgeon, receive 
additional phone 
contact from NP, go 
to NPFU clinic or to 
local ED  (n= 97)  
 
Control = Usual 
Care, including 
advice to make 
primary care 
provider 
appointment  within 
1week; return visit 
to  cardiac surgeon 
was scheduled for 
all patients at 6 
weeks (n=107)   
 
 
Patient satisfaction  
 
Intervention patients were significantly 
more satisfied with post-discharge care 
compared to usual care patients 
 
1) Quality of Service  
at 2 and 6 weeks respectively 
 
 p = 0.003 and 0.005  
 
 
2) Amount of Help Received  
at 2 and 6 weeks respectively 
 
 p = 0.001 and 0.002  
 
No individual data shown 
Endpoint 
assessment 
based on two 
questions from 
the reliable and 
valid ‘Client 
Satisfaction 
Questionnaire’ 
(CSQ-8) 
 185 
 
Tranmer, 2004 
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IPT ^  ^
 
Outpatient / 
Specialized Referral 
 
200 postoperative 
cardiac surgery 
outpatients discharged 
from first cardiac 
surgery with no stay at 
Intensive Care Unit 
(ICU) 
 
Five week study 
intervention delivered 
offsite via telephone; 
study patients 
recruited from hospital 
prior to discharge, 
eastern Canada 
Intervention = 
Usual Care + NP 
initiated phone 
contacts for patients 
in 1
st
 5 weeks 
following hospital 
discharge 
 
 
(n= 102) 
 
 
 
 
 
Control = Usual 
Care (UC) including 
education booklet, 
home-care follow-
up as necessary, and 
NP contact 
information, with 
instruction to call 
with questions or 
concerns 
 
(n= 98) 
Patient satisfaction at 5 weeks  
(scores from 5-point measurement scale 
were standardized to scores out of 100) 
 
‘Achieving best recovery possible’  
NP  71.3   UC  63.5   p = 0.03 
 
Side effect information 
NP  61.5   UC 54.0     p = 0.05 
 
Help with decisions about care  
NP  66.6   UC  59.0   p = 0.06 
  
Knowing what to expect during 
  recovery 
NP 70.3     UC 65.7     p = 0.23 
 
Complication information 
NP 63.2     UC 56.7     p = 0.11 
   
 Recognizing potential problems  
NP 59.6     UC 56.7     p = 0.48  
 
Identifying depressive feelings 
NP 51.0     UC 46.9     p = 0.32 
 
 
Overall mean (SD) ‘satisfaction with 
recovery’ 
 
NP  60.5 (20.4)   
UC  55.7 (20.8) 
p = 0.08 
 
 
 
Cronbach’s 
alphas 0.96 and 
0.95 for 
satisfaction 
scale and  heart-
specific scale 
according  to 
study conducted 
by Shortell et al. 
(2000) re post-
operative 
outcomes in 
3,045 cardiac 
procedure 
patients  
 
Schuttelaar, 2010 
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RS ^ 
Outpatient / 
Specialized Referral 
 
160 patients < 16 
years, 80 patients aged 
< or = to 4 years and 
80 patients aged 4–16 
years, all new referrals 
from GPs or 
pediatricians with a 
diagnosis of atopic 
dermatitis (eczema); 
one year study at an 
outpatient clinic, 
Netherlands 
Intervention =  
NP-led care   
(n = 81) 
Age < or = to 4 
years  (n = 40) 
Age 4-16 years 
 (n = 41) 
 
Control = 
conventional care 
by dermatologist  
(n = 79) 
 
Age < or = to 4 
years (n = 40) 
 
Age 4-16 years  
(n = 39) 
 
Mean (SD) Patient satisfaction  
 
4 months 
 
NP 27.1 (3.9) 
Control 24.4 (3.4) 
p < 0.001 
 
8 months 
 
NP 27.3 (4.0) 
Control 24.3 (3.3) 
p < 0.001 
 
 
12 months 
 
NP 26.9 (4.9) 
Control 24.8 (4.3) 
p < 0.023 
 
 
 
Endpoint 
assessment used 
the reliable and 
valid ‘Client 
Satisfaction 
Questionnaire-
8’ (CSQ-8), 
completed by 
parents at 4, 8, 
and 12 months 
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Hill, 2003 
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RS ^ 
 
Outpatient / 
Specialized Referral 
80 Rheumatoid 
arthritis (RA) 
outpatients,  
18 years or older, to 
clinic on at least 
3previous occasions; 
study period of 12 
months, at traditional 
rheumatology clinic 
managed by junior 
hospital doctors 
(JHDs) within a large 
teaching hospital, 
England 
 
Intervention = 
Rheumatology NP 
(RNP) care 
 
(n =39)  
 
 
Control = Junior 
Hospital Doctor 
(JHD) care 
 
( n= 41)  
Median (range) Patient satisfaction  
at 48 weeks 
 
 
NP total scores increased from baseline  
3.57 (2.3 – 4.9) to 4.1 (2.4 – 4.9) 
 
JHD total scores decreased from 
baseline  
3.60 (2.1 – 4.8) to 3.56 (2.4 – 4.7) 
 
p < 0.001 
  
 
 
A number of JHDs were involved in the 
study versus only one RNP, resulting in 
bias associated with the NP intervention 
(with one NP, cannot calculate 
variability through SD, for integration 
into effect estimate calculations)  
 
Endpoint 
assessment used 
the reliable and 
valid Leeds 
Satisfaction 
Questionnaire 
(Hill et al., 
1992) 
 
A rheumatology 
NP may bring 
benefit of 
enhanced 
patient 
satisfaction , 
related to 
potentially 
greater 
symptom 
control, as per 
study  
Enguidanos, 2012 
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IPT ^^ 
Outpatient / 
Specialized Referral 
Pilot study  
 
199  at-risk older 
adults discharged 
home from hospital 
without in-home care  
(e.g. home health or 
hospice) or able / 
available caregivers; 
6 month study set in a 
managed care medical 
center, or Health 
Maintenance 
Organization (HMO), 
patients recruited from 
hospital prior to 
discharge, U.S. 
Intervention = Brief 
NP Transition, a 
‘bridge’ of up to 3 
home visits, 2 
phone calls from 
primary health care 
NP, within 72 hours 
of discharge 
 
(n = 100) 
 
 
 
Control = standard 
medical care, 
including access to 
case management 
services (wait time 
2-14 days) 
(n =99) 
 
 
Patient satisfaction  at 3 months 
No significant differences between 
groups  
 
Endpoint 
assessment used 
the reliable and 
valid Home 
Care 
Satisfaction 
Measure: ‘test-
retest reliability’ 
0.68-0.88 and 
high concurrent 
validity 0.26-
0.76 
 
Small sample 
size (pilot 
study) and 
attrition on 
follow-up 
surveys (~ a 
65% response 
rate) limited 
detection of 
between-groups 
differences  
 
 
Dierick-van Daele, 
2009 
67
 
RS ^ 
 
Primary Health Care 
(PHC) 
Intervention = 
patient care from 
newly graduated NP  
(Master Degree of 
Advanced Nursing 
Practice) 
 experience ranging 
from 1 to 5 years; 
12 NPs   
 
Mean (SD) Patient perceptions of 
quality of care at 6 months 
 
NP 8.19 (1.18) 
GP 8.20 (1.26) 
 
p = 0.83 
 
No conclusive 
properties-
information 
provided for the 
questionnaires, 
but only a 
justification of 
questionnaires’ 
validity 
according to 
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1,591 PHC patients 
from 15 general 
practices, 16 years and 
older, with common 
complaints regarding 
respiratory / throat,  
ear / nose, 
musculoskeletal / skin 
injuries, urinary / 
gynaecological and 
geriatric problems 
 
 
Two week  
intervention within a 
study duration of 6 
months; patients who 
attended a general 
practice on a day when 
the NP was present 
were invited to 
participate in the trial, 
Netherlands 
 
 
(n = 817) 
 
 
 
Control = patient 
care from GP with 
an average of 16 
years’ experience; 
50 GPs   
 
(n = 684) 
 
 
 
Study practices 
were also compared 
to external reference 
practices where 17 
GPs worked in 5 
general practices 
without the 
involvement of NPs 
Statistically significant improvement in 
patient  satisfaction was only found for 
patients in NP group who reported at 
least one chronic disease  
(583/1591 patients) 
 
NP 8.35( 1.07) 
UC 8.11 (1.32) 
 
p = 0.02 
 
 
 
 
 
 
study authors’ 
assurance on 
discussion with 
2 GPs with 
research 
experience. 
 
Questionnaires 
were next tested 
on 40 patients, 
resulting in two 
textual 
refinements as 
well as asking 
the name of the 
practitioner 
instead of the 
type of 
practitioner 
(NP or GP) 
consulted 
(Dierick-van 
Daele, 2009,  
p. 394) 
Williams, 2005 
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IPT ^^ 
Primary Health Care 
(PHC) 
 
3746 PHC patients 
aged 40 years and over 
living in private 
households, with 
incontinence several 
times per month or 
more, or several times 
a year, and reported 
impact of symptoms 
on quality of life. 
 
Six month intervention 
period, at patients’ 
homes in 
Leicestershire and 
Rutland, England 
Intervention = 
continence service 
provided by NPs  
 
(n = 2958) 
Control = existing 
usual primary care 
including GP and 
continence advisory 
services   
 
(n =788) 
 
 
4:1 ratio was  
deemed necessary to 
ensure sufficient 
intervention data for 
evaluation of 
detrusor muscle 
over-activity (wall 
of bladder)  and 
urodynamic stress 
incontinence  
Patient Satisfaction  
 
3 months  
NP  52% (1294/2498)  
Control 45% (276/618)  
Difference 7%  (95% CI  3 to 12)  
p = 0.001 
 
6 months 
NP 64% (1428/2236)  
Control 53%  (289/546)  
Difference 11% (95% CI  6 to 16)  
p < 0.001 
 
 
 
 
 
Patient Perception of Problem as Mild 
or None 
 
3 months  
NP 74% (819/2468) 
Control 68% (416/614)  
Difference 6% (95% CI  2 to 10) 
p = 0.003 
 
6 months  
NP 79% (1721/2181)  
Control 70% (380/545)  
Difference 9%  (95% CI  5 to 13) 
p < 0.001 
 
 
 
Satisfaction 
with services 
was reported 
descriptively by 
patients’ answer 
to an open-
ended 
exploratory 
question, with 
no reference 
made to the 
method used for 
conversion of 
qualitative 
answers to 
quantitative 
results 
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#Williams, 2011 
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Post Hoc Analysis 
 
6 year follow-up to 
Williams (2005) 
 
IPT ^^ 
Primary Health Care 
(PHC) 
 
The NP continence 
service was designed 
for the trial, and 
funded only for the 
duration of the 
research program.  
This NP continence 
service was not funded 
to operate throughout 
the interim period of 6 
years. Service expired 
at unknown time post 
original trial, 6 years 
prior, England 
 
 
 
Intervention = 
continence service 
provided by NPs 
 
(n = 2958) 
Control = existing 
usual primary care 
including GP and 
continence advisory 
services  
  
(n =788) 
 
 
 
4:1 ratio was  
deemed necessary to 
ensure sufficient 
intervention data for 
evaluation of 
detrusor muscle 
over-activity (wall 
of bladder)  and 
urodynamic stress 
incontinence  
 
 
Patient Satisfaction; Patient Perception 
of Problem as Mild or None at 6 year 
follow-up 
Between groups differences  
diminished after 6 years, becoming 
non-significant, with results in the 
direction of the NP continence service: 
 
Patient Satisfaction  
 
NP 55% 
Control 52% 
Difference 3% 
95% CI  -2 to 7% 
 
p = 0.2 
 
Patient Perception of Problem as Mild 
or None 
 
NP 70% 
Control 69% 
Difference 1%  
95% CI  -3 to 5% 
 
p = 0.6 
 
 
 
Inconclusive: 
Measurement of 
the long term 
effect of an 
expired program 
with no 
specification as 
to the expiry 
date of the 
program leaves 
no accuracy for 
interpretation of 
its long term 
effect.  
 
Continence 
services 
available  post- 
trial for each 
group were 
identical, 
including the 
education and 
experience of 
NPs trained 
within the trial 
program, but 
without the 
continence 
program per se  
actively in place 
*Primary Endpoint     ^ Role Substitution (RS)     ^^ Interprofessional Team (IPT)     #Post Hoc Analysis 
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Table I-10 Other Endpoint-Outcomes 
Statistically significant differences in 2 RS studies and 2 IPT studies 
Perceived Maternal Health, Perceived Maternal Stress in Low-Income Mothers, Primary 
Health Care RS  
Quality of Clinical Documentation in Minor Injury Emergency Department Patients, 
Acute RS 
Knowledge and Perceived Risk of Sexually Transmitted Infection in Female College 
Students (child-bearing age), Primary Health Care IPT 
Self-Efficacy in Type 1 Diabetes Patients, Outpatient IPT (pilot study) 
 
No statistically significant differences in 2 RS studies and 2 IPT studies  
Patient Knowledge in Rheumatoid Arthritis Patients, Outpatient RS 
Family Impact in Families of Infants / Children with Atopic Dermatitis (Eczema), 
Outpatient RS 
Self-Care Efficacy in Older Adults Discharged Home, Outpatient IPT (pilot study) 
      Self-Efficacy in Management of Cardiovascular Risk Factors, Cardiovascular Disease      
Patients, Outpatient IPT (post hoc analysis)  
Author, Year 
RS^ / IPT^^ 
Setting  
Study Population, 
Duration, Site 
Intervention 
 
Results 
 
(Outcome data 
analyzed by 
Intention to Treat, 
ITT, on the basis of 
all randomized 
patients, as 
randomized, unless 
otherwise noted) 
 
Quality of 
Endpoint 
Assessment / 
Comments 
 
Hannan, 2012 
69
 
RS ^ 
 
Primary Health Care (PHC) 
 
 
139  healthy first-time mothers,  
18 years or older, each of whom 
delivered a healthy, full-term single 
infant; low-income family  
 
 
Intervention occurred for first 2 
months post-birth, delivered offsite 
via telephone. Study patients were 
recruited from hospital prior to 
discharge, U.S. 
 
Intervention = follow-up 
phone-calls  by pediatric  
NP with ‘back-up’ 
pediatric physician 
available for consultation    
 
(n =70) 
 
 
 
 
 
 
Control = routine hospital 
discharge and a 
pediatrician appointment 
at  2 months   
  
(n =69) 
Maternal / Infant 
Health at 2 months  
 
 
 
Mean (SD) 
Perceived Maternal 
Health  
 
NP 18.61 (1.74)  
Control 17.2 (2.69)  
p < 0.0004   
 
 
 
 
Mean (SD) 
Perceived Maternal 
Stress  
 
NP 14.71(3.95) 
Control 24.64(4.61) 
p < 0.0001 
 
 
 
 
Good internal 
and  test-retest 
reliability; 
good validity 
for Perceived 
Stress Scale 
(PSS), 
Multidimensio
nal Scale of 
Perceived 
Social Support 
(MSPSS) 
and  for the 
Maternal 
Perception of 
Health Rating  
Scale 
(MPHRS). 
 
Research 
assistant 
collected data 
related to 
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 Perception of Social 
Support  
 
Non-significant  
difference  
 
 
 
 
 
Infant Weight Gain 
 
Non-significant  
difference 
 
 
infant health  
from infants’ 
medical 
records or 
from  mothers  
at two months 
post-discharge.  
 
Attrition: 7/70 
intervention 
mothers 
unable to be 
contacted   
due to 
disconnected 
telephones 
 
 
 
Johnson-Mallard, 2007 
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IPT ^^ 
 
Primary Health Care (PHC) 
 
 
 
104 female college students not yet 
exposed to any formal lectures 
regarding sexually transmitted 
infections (STIs); 18 - 48 years 
(child-bearing age) presumably in 
good health at baseline; study 
duration of two weeks, set at two 
different universities, U.S. 
 
  
  
Intervention = a brief 30 
minute educational  / 
behavioral intervention 
delivered by an NP at one 
week 
 
(n =51) 
 
Control = no educational 
/ behavioral intervention 
 
(n = 53) 
 
A one-time educational / 
behavioural intervention 
was delivered to the 
experimental group one 
week after the pretest was 
given to both groups; 
post-test for both groups 
two weeks after pretest 
 
Mean (SD) 
STI knowledge 
survey (higher 
scores indicate 
greater knowledge) 
at 2 weeks 
 
NP  26.1 (2.6) 
Control  21.0 (2.3) 
 
p < 0.0001 
 
 
 
 
Mean (SD) 
perceived risk of 
STI survey (lower 
scores indicate 
lower perceived 
risk) at 2 weeks  
 
NP 4.0 (1.0)  
Control 7.9 (2.3)  
 
 
p < 0.0001 
 
‘STI 
Knowledge 
Survey’ 
(STIKS, 
1998): 
content 
validity at 0.93 
and reliability 
at 0.76 
 
 
 
 
Findings may 
assist NPs in  
reducing 
knowledge 
gaps related to 
STI morbidity 
associated 
with 
reproductive 
health: pelvic 
inflammatory 
disease, 
chronic pelvic 
pain, 
infertility, 
ectopic 
pregnancy, 
compromised 
birth outcomes 
(premature  
delivery, 
stillbirths, 
neonatal deaths,  
and infant 
disorders), and 
cervical cancer  
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RS ^ 
Outpatient / Specialized Referral 
 
 
80 Rheumatoid arthritis outpatients, 
18 years or older, to rheumatology 
clinic on at least three previous 
occasions; study period of 12 months, 
at a traditional rheumatology 
outpatient clinic managed by  junior 
hospital doctors (JHDs), within a 
large teaching hospital, England  
 
Intervention = 
rheumatology NP (RNP) 
care 
 
(n =39)  
 
 
Control = junior hospital 
doctor (JHD) 
care 
 
( n= 41)  
Median (range) 
Patient Knowledge  
at 48 weeks 
 
 
NP total scores 
increased from 
baseline  
17 (9-28) to    
21 (11–30) 
 
JHD total scores 
increased from 
baseline  
  
21 (8–29) to  
22 (12–30) 
 
No significant 
differences  
 
Endpoint 
assessment  
based on the 
reliable and 
valid ‘Patient 
Knowledge 
Questionnaire’  
a multiple-
choice tool  
designed for 
use with 
rheumatoid 
arthritis 
patients (Hill 
et al., 1991) 
 
 
Cooper, 2002 
62
 
RS ^ 
Acute Emergency Department 
 
204 patients over 16 years, with 
minor injury that fell within the ENP 
(emergency NP) protocol, at a single 
Accident and Emergency (A & E) 
Department; 2 month study duration, 
Scotland 
Intervention = ENP-led 
care 
(n = 102) 
 
Control = Senior House 
Officer (SHO)-led care 
(n = 102) 
 
Quality of  Clinical 
Documentation, 
scored out of 30, 
audited 4 months 
after the trial ended 
 
 
ENP 28.0/30.0 
(94/102)  
 
SHO 26.6/30.0 
(92/102)  
 
p < 0.001 
‘Documentatio
n Audit Tool,’ 
reliable and 
previously 
validated  
using an expert 
panel and a 
consensus 
methodology, 
scored out of 
30 points 
(Cooper et al., 
2000, double 
blind peer 
reviewed)  
  
 
McCarrier, 2009 
7
 
 
IPT ^  ^
 
Outpatient / Specialized Referral 
Pilot study 
  
78 Type 1 Diabetes Mellitus 
outpatients randomized, 21 -49 years 
with at least one A1c test > or = to 
7% in previous 12 months; one year 
intervention period at the Diabetes 
Care Center (DCC multidisciplinary 
practice team includes physicians, 
NPs, on-site pharmacists, nurse 
educators, nutritionists, and mental 
health professionals) affiliated with 
the University of Washington 
Medical Center, U.S. 
 
 
Intervention = NP 
coordination of Web-
based care  + usual care 
 
(n =42)   
 
 
Control = usual care (UC) 
from team at Diabetes 
Care Center (DCC)  
(n = 36) 
Diabetes-Specific 
Self-Efficacy at 1 
year 
NP + 0.14 (0.62) 
 
UC - 0.16 (0.62) 
 
Effect size = 0.30 
 
(95% CI 0.01 to 
0.59) 
 
p= 0.044 
 
 
 
 
‘Diabetes 
Empowerment 
Scale,’  a 
measure of 
psychosocial 
self-efficacy, 
reliable and 
valid 
(Anderson et 
al., 2000) 
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Enguidanos, 2012 
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IPT ^^ 
 
 
Outpatient / Specialized Referral 
 
 
Pilot study  
199 at-risk older adults discharged 
home from hospital without in-home 
care (e.g. home health or hospice) or 
able /available caregivers; 6 month 
study set in a managed care medical 
center, or Health Maintenance 
Organization (HMO), patients 
recruited from hospital prior to 
discharge, U.S. 
Intervention = Brief NP 
Transition, a ‘bridge’ of 
up to 3 home visits, 2 
phone calls from primary 
health care NP, within 72 
hours of discharge 
 
(n = 100) 
 
 
Control = standard 
medical care, including 
access to case 
management services 
(wait time 2-14 days) 
(n =99) 
 
Efficacy in Self-
Care at 6 months 
No significant 
differences between 
groups  
 
‘Efficacy in 
Self-Care 
Survey’ with 
test-retest 
reliability at 
0.82 - 0.89 and 
internal 
consistency at 
0.77- 0.92 
Attrition on 
follow-up self-
efficacy 
surveys (66%; 
131/199 
outpatients) 
limited 
detection of 
between  
groups 
differences  
 
#Sol, 2008 
75
 
 
Post Hoc Analysis to  
Goessens (2006)   IPT ^^ 
Outpatient / Specialized Referral 
Cardiovascular disease (CVD) 
Peripheral arterial disease 
Abdominal aortic aneurysm 
Cerebrovascular disease 
Coronary heart disease 
236 CVD outpatients with two or 
more modifiable risk factors: 
smoking, hypertension, dyslipidemia, 
diabetes, obesity, hyper-
homocysteinemia 
 
One year intervention at a risk-factor 
management clinic in the University 
Medical Center Utrecht,  Netherlands 
CVD is globally the most common 
cause of morbidity and mortality, 
influenced by multiple risk factors. 
 
New strategies are needed to reduce 
vascular risk; this post hoc study 
investigated whether changes in self-
efficacy were related to changes in 
vascular risk factors 
 
Intervention = NP at risk 
factor management clinic  
+ Usual Care  (n=119)  
 
 
 
Self-efficacy, a person’s 
confidence to carry out 
the behaviour necessary 
to reach a desired goal, is 
theoretically, an 
important pre-condition 
for successful self-
management and 
behavioural change. 
 
Goals for lifestyle change 
were monitored in 
context of self-efficacy 
promotion: encouraging 
feedback on self-
management and 
performance attainment 
 
 
 
Control = Usual Care by 
GP and  treating vascular 
specialist   (n=117) 
Self-Efficacy  in 
Management  of 
CVD risk factors  
No significant 
differences  
 
 
Self-efficacy was 
not associated with 
achievement  of 
treatment goals  
 
 
 
Limited 
quality 
measurement 
tool, adapted 
from a self-
efficacy scale 
designed for 
Type II 
Diabetes 
Mellitus 
patients, not 
used before 
with CVD  
patients  
 
Study  
population was 
diverse and 
intervention 
focused on a 
variety of 
universal self-
management  
tasks; wide 
scope may 
clarify non-
significant 
differences in 
self-efficacy 
 
 193 
 
Schuttelaar, 2010 
59
 
RS ^ 
 
Outpatient / Specialized Referral 
 
160 patients < 16 years,  
80 patients aged < or = to 4 years and 
80 patients aged 4–16 years, all new 
referrals from GPs or pediatricians 
with a diagnosis of atopic dermatitis 
(eczema); one year study at an 
outpatient clinic, Netherlands 
Intervention = NP-led 
care (n = 81) 
Age < or = to 4 years  
(n = 40) 
 
Age 4-16 years  
(n = 41) 
 
Control = conventional 
care by dermatologist  
(n = 79) 
 
Age < or = to 4 years  
(n = 40) 
 
Age 4-16 years  
(n = 39) 
 
Family Impact  
Between groups 
differences were not 
statistically 
significant at 
baseline, 4, 8, or 12 
months, nor for the 
separate age groups 
of children. 
 
 
 
 
‘Dermatitis 
Family 
Impact’ 
questionnaire 
reliable and  
valid 
 
 
The impact of 
pediatric 
eczema on 
family may be 
similarly 
managed by 
NP as by 
dermatologist 
in a population 
representative 
of normal 
referrals from 
GP to 
specialist care 
 
*Primary Endpoint     ^ Role Substitution (RS)     ^^ Interprofessional Team (IPT)     #Post Hoc Analysis
  
1
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Appendix J Results of NP Interventions on All Quantitative Patient Endpoint-Outcomes in Each of 29 RCTs 
 
Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
Pioro, 2001
71
 
 
 
U.S. 
 
To compare care 
delivered by NPs and 
house-staff, for 
general medical 
inpatients from 
admission to 
discharge 
 
 
Tertiary Prevention 
reducing risks / 
threats to health in 
long-term chronic 
illness / permanent 
impairment
13
 
 
 
Feb. 17, 2017 
$1.00 U.S =  
$1.31 Canadian 
$0.76 U.S. = 
$1.00 Canadian 
RS^ 
 
 
 
 
Hospital 
admission  to 6 
weeks post-
discharge; RCT 
conducted for 1.5 
years  
 
 
 
Acute Care 
Inpatient   
 
 
 
Internal medicine 
wards at single 
center teaching 
hospital, 
Cleveland, Ohio, 
affiliated with 
Case Western 
Reserve 
University 
381 unselected  
inpatients, 18–
69 years, 
admitted for 
gastrointestinal, 
pulmonary, 
infectious, 
metabolic/ 
substance 
abuse, 
neurological, 
cardiovascular 
and  “other” 
acute illnesses 
 
 
Intervention = 
NP-based care   
(n=193) 
 
Control=House-
staff care   
 
(n=188) 
 
Diagnosis 
 
Prescribing 
 
Clinical 
Procedures 
 
Education 
 
1) *Adverse  
Events 
 
2) *Resource &  
 Cost 
 
3)**Functional 
Status 
 
4) **Global 
Quality of  Life             
 
     
 
1)  *Overall Adverse Events (transfers to ICUs,  
hospital-acquired complications, and in-hospital 
mortality) 
 
NP  7.5%   House-staff  11.8%  
Difference  - 4.3% (95% CI -10.2, 1.6) 
p > 0.10 
 
2) *Resource & Cost 
a. Mean length of hospital stay  
NP 5.0 days   House-staff  5.3 days   
Difference -0.3 (95% CI -1.2, 0.6 days)  
p > 0.10 
 
b. Mean number of consultations to other 
services (e.g. respiratory therapy) 
NP 1.4  House-staff 1.4   
Difference -0.0 (95% CI -0.2, 0.3) 
p > 0.10 
 
c. Mean total hospital charges, costs (U.S.$)  
NP $8854   House-staff  $9426  
Difference -$572 (95% CI -$2704, $1560)   
p > 0.10 
 
d. Mean total ancillary charges, costs (U.S.$)  
NP  $4960   House-staff  $5358  
Difference -$399 (95% CI -$1820, $1023)  
    p > 0.10 
 
Post-randomization 
breach (crossover of 
89 NP patients to 
house-staff ward) in 
assignment of 
patients to groups, 
leading to possible 
selection bias  
(see Appendix G) 
  
It is unclear as to 
whether patient 
assignment post-
randomization, truly 
represents selection 
bias: a systematic 
error that over or 
underestimates the 
intervention effect. 
An Unclear 
judgement may not 
be penalized with a 
No judgement
15
 
 
 
Incomplete reporting 
of raw data in Table 
2: no fraction of 
patients comprising 
 1
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
 3) **Mean Change Functional Status  
a. Activities of daily living (ADL) 
       NP 0.1 (76/193); House-staff 0.2 (86/188)  
       Difference -0.1 (95% CI -0.5, 0.3) 
       p < 0.10 
 
b. Independent activities of daily living (IADL)  
NP 1.4 (76/193); House-staff 2.1 (86/188)  
Difference -0.7 (95% CI -1.4, 0.1) 
0.05 < p < 0.10 
 
4)**Global Quality of Life, SF-36 scores             
    Differences not statistically significant p > 0.1 
percentages reported  
 
 
No societal costs 
were reported, nor 
differences 
in salaries, costs of 
the medical director, 
or costs of off-hour 
coverage by residents 
Allen, 2002 
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U. S.  
 
 
To test the 
effectiveness of a 
nurse case 
management program 
to lower blood lipids 
in patients with 
coronary heart 
disease (CHD) 
 
 
IPT ^^ 
Intervention for 
one year  
post-discharge 
 
Outpatient / 
Specialized 
Referral  
 
 
Outpatient clinic 
of Johns Hopkins 
Hospital, a large 
tertiary hospital, 
Baltimore, 
Maryland 
228 coronary 
heart disease 
outpatients who 
received 
coronary artery 
bypass graft 
(CABG) 
surgery or 
percutaneous 
coronary 
intervention, 
with  
hypercholestero
lemia (low 
density 
lipoprotein 
cholesterol level 
>2.59 mmol/L  
Diagnosis    
 
Prescribing 
 
Strategies for 
Behaviour 
Change  
 
Care 
coordination 
2) 1) *Lipid 
Goals: 
 
Total 
cholesterol  
 
Low density 
lipoprotein 
cholesterol 
(LDL-C, “bad” 
cholesterol)  
 
Triglyceride 
levels 
 
High density 
lipoprotein 
cholesterol 
1) *Mean (SD) Lipid Levels at 1 year  
a. Total Cholesterol  
NP 4.1mmol/L (0.7)  EUC 4.6mmol/L (0.6) 
Difference = 0.5 mmol/L,  p < 0.0001 
 
b. Low-density lipoprotein cholesterol (LDL-C) 
NP 2.2mmol/L (0.57)  EUC 2.67mmol/L 
(0.57) 
Difference = 0.47 mmol/L, p < 0.0001 
 
c. Triglycerides  
NP 3.57 mmol/L (1.53)  EUC  4.25 mmol/L 
(1.79) 
Difference = 0.68 mmol/L, p = 0.002 
 
d. High-density lipoprotein cholesterol (HDL-C) 
increased modestly in both groups 
 
Attrition  
31% with 69% 
(158/228) outpatients 
completing 12 month 
follow-up (77% NP 
patients; 62% UC 
patients) 
 
 
 
Incomplete reporting 
of raw data in Table 
II: no fraction of 
patients comprising 
percentages of dietary 
intake was reported  
 
 
 1
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
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Post hoc analysis, 
Paez (2006)  
Cost-effectiveness of 
nurse practitioner 
management of 
hypercholesterolemia 
following coronary 
revascularization 
Appendix I-6 
 
Feb. 17, 2017 
$1.00 U.S =  
$1.31 Canadian 
$0.76 U.S. = 
$1.00 Canadian 
 or total 
cholesterol level 
> 5.18 mmol/L) 
Intervention= 
NP case 
management 
(individualized 
lifestyle and 
pharmacologic 
intervention) + 
Enhanced Usual 
Care (EUC)  
 (n = 115) 
 
Control =  
Enhanced Usual 
Care (EUC) 
from primary  
providers &/or 
cardiologists 
including full 
lipid profiles at 
4 weeks, 6 and 
12 months after 
discharge, and  
goals for  
lipoprotein 
levels, diet and 
physical activity 
(n =113)  
(HDL-C, 
“good” 
cholesterol) 
 
2) **Drug 
Compliance  
 
3) **Diet and 
Exercise 
e. Achieved LDL-C goal < 2.59 mmol/L 
NP 65%   EUC 35% 
Difference = 30% 
p = 0.0001 
Hypercholesterolemia  defined as  
LDL  cholesterol level > 2.59 mmol/L  or  
total cholesterol level > 5.18 mmol/L 
 
2)**Medication compliance to lipid-lowering drugs at 
one  year:  NP 87% (100/115); EUC 79% (89/113) 
                  Difference 8% p = 0.10 
   
3) **Diet and Exercise at 1 year 
    Mean dietary intake (SD) in calories 
a. Total Fat 
NP 33.2% (+ or - 6.7%); EUC 34.6%  
(+ or - 6.5%) 
       Difference 1.4%   p = 0.009  
 
b. Saturated Fat 
NP 10.1% (+ or - 2.2%); EUC 11.0%  
(+ or - 2.3%) 
Difference 1.1%   p = 0.004 
 
c. Dietary Cholesterol  
NP 254.2mg (+ or - 99.8 mg); EUC 292.0mg 
(+ or - 104.9 mg) 
Difference 37.8 mg   p = 0.006 
  
d. Dietary fiber 
NP 22.2 (+ or - 7.2);  EUC 21.3 (+ or - 5.7) 
Difference 0.9   p = 0.28 
Among patients on 
pharmacotherapy, 
97% in both groups 
were taking a single 
statin agent:  
3-hydroxy-3-
methylglutaryl 
coenzyme A 
reductase inhibitor 
 
 
Control of 
hypercholesterolemia 
in patients who have 
undergone coronary 
revascularization can 
be improved by NP 
case management as 
per study 
 1
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
 e. Exercise at 6 MET (metabolic  equivalent) 
hours per week or more:  
   NP 40% (46/115); EUC 26% (29/113)  
   Difference 14%   p = 0.02 
 
Jones, 2002
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England 
 
To find out whether 
an NP-delivered 
educational package 
can reduce chronic 
oral non-steroidal 
anti-inflammatory 
drug (NSAID) usage 
in general practice 
 
 
 
 
GALS screen (Gait, 
Arms, Legs & Spine) 
assessment to detect 
locomotor  
abnormalities related 
to musculoskeletal 
pain  
 
IPT^^  
 
Six month study 
duration  
 
 
 
Primary Health 
Care 
Five general 
practices with 
computerized 
prescribing 
systems 
 
 
 
 
 
 
 
All patients 
examined at their 
general practice 
or their homes in 
Nottinghamshire 
 
222 patients 18 
years or older, 
with non-
malignant, non-
inflammatory 
musculoskeletal 
pain and oral 
non-steroidal 
anti-
inflammatory 
drug (NSAID) 
prescriptions 
covering 6 or 
more weeks of 
the last year  
‘Active 
Intervention’ = 
NP assessment, 
patient-tailored 
educational 
package with 
request that 
patients 
withdraw their 
NSAIDs and 
use appropriate 
Diagnosis 
Prescribing 
Education 
 
 
 
 
 
 
 
 
 
 
1) *Self-
reported 
reduction in 
oral NSAID 
dose at six 
months  
 
 
2) **Changes 
in total 
prescription 
data, partially 
self-reported, 
alongside 
computer 
records of 
prescribing data 
 
3) **NSAID 
costs; health 
service costs 
 
4)**Global 
Quality of Life 
1) *Self-reported reduction in oral NSAID dose by   
50% or less, at 6 months  
 
Active NP Intervention 38 % (42/110) patients 
Control 13% (14/112) patients  
Difference = 25%, p < 0.0001 
 
2) **Total prescriptions (median values and 
interquartile  range) reported in terms of ‘change in 
costs’ at 6 months 
 
Active NP Intervention £ 24.53 (-6.94, 47.26) 
Control  £ 10.75 (-18.98, 47.00) 
Difference= £ 13.78  p = 0.25 
 
 
 
3)**Median change in NSAID cost at 6 months 
(interquartile  range) 
 
Intervention  -£ 2.61(-£14.65, £3.45) 
Control £0.00 (-£5.92, £11.00) 
Difference  -£2.61, p = 0.008 
 
 
Oral NSAIDS are one 
of the most widely 
used classes of drugs 
in the United 
Kingdom, 
particularly in older 
adults with 
osteoarthritis; 
significant 
inappropriate 
prescription 
or over-prescription 
of  NSAIDs may 
contribute to 
morbidity (ulcer 
bleeding / ulcer 
perforation, NSAID 
toxicity), mortality 
and costs to health 
services and the 
patient 
 
Limitations:  
same single NP for 
both intervention and 
control groups, 
resulting in potential 
 1
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
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Feb.17, 2017 
£ 1.00 Great Britain  
= $1.62 Canadian 
£ 0.62 Great Britain =  
$1.00 Canadian  
 
 
 
 
Five general 
practices 
represented a mix 
of rural/urban and 
fundholding/non-
fundholding 
practices  
 
alternative drug 
and non-drug 
therapies (e.g. 
strategies for 
weight loss, use 
of local heat  
and cold,  
relaxation 
techniques) + 
Usual GP Care  
(n =110)  
 
‘Control 
Intervention’ =  
NP assessment 
and basic 
education 
regarding 
NSAIDs + 
Usual GP Care 
(n =112) 
 
 
 
 Mean (interquartile  range) healthcare service costs       
per patient at 6 months 
 
Intervention Education Service 
(excluding phone calls)  
 
£40.70 (£34.67, £46.40) 
Control  no comparative cost provided 
 
        Patient travel costs  
(including time and expense traveling to the 
practice office; excluding purchases of drugs 
and equipment on the NP’s advice)  
 
Intervention £ 0.83 (£0.00, £1.25) 
Control  no comparative cost provided 
 
 
 4)**Overall quality of life at 6 months on SF-36 
     No significant differences between groups  
bias;  ‘social 
desirability’ where 
active intervention 
provided advice for 
reduction of  NSAID 
use 
 
 
Not inclusive of all 
(societal) costs, one 
of which was the 
patients’ additional 
purchase of drugs and 
equipment on advice 
of NP 
 
 
Ansari, 2003 
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U.S. 
 
Pilot RCT  
  IPT ^^ 
Two levels of 
individual 
randomization  
 
74 providers 
(internal medicine 
doctors, 
169 CHF 
outpatients 
individually 
randomized into 
three groups 
 
 
 
 
Diagnosis 
Prescribing 
Education 
1) *Target beta 
blocker use: 
proportion of 
patients who 
were initiated or 
up-titrated on 
beta-blockers, 
proportion of 
patients that 
1) *Beta Blocker Use 
 
a. Patients initiated or up-titrated on beta-
blockers 
Notification group 16% (10/64)  
NP facilitator 67% (36/54)  
Control group 27% (14/51) 
 p < 0.001 
 
An independent 
research assistant 
assessed the use of 
beta blocker  
therapy by reviewing 
pharmacy records and 
computerized 
progress notes in 
conjunction with 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
To evaluate NP 
facilitator and  
combination of 
patient – specific 
computer reminders 
and patient letters, on 
utilization of beta 
blocker medications 
in chronic heart 
failure (CHF)  
outpatients, compared 
to a usual provider 
education program 
alone 
 
 
 
 
Tertiary Prevention 
reducing risks / 
threats to health in 
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illness / permanent 
impairment 
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cardiologists and 
NPs) were also 
individually 
randomized into 3 
groups, to 
decrease the 
likelihood of 
contamination, 
i.e. patients 
receiving care 
from their regular 
providers; median 
follow-up period 
= 12 months 
Outpatient / 
Specialized 
Referral  
 
Academic 
Medical Centre, 
San Francisco, 
California 
Notification 
Intervention  
Internists 10 
Cardiologists 2 
NPs 3 
(n = 64 patients) 
 
 
NP Facilitator 
Intervention  
Internists 19 
Cardiologists 3 
NPs 3 
(n=54 patients) 
 
 
Control   
Internists 16 
Cardiologists 4 
NPs 4 
(n=51 patients) 
reached target 
dose and were 
maintained on 
beta-blockers 
 
2) 
**Hospitalizatio
ns / emergency 
room visits 
 
 
3)**Mortality 
b. Percent patients to target guideline dose  
Notification group 2% (1/64)  
NP facilitator 43% (23/54)  
Control group 10% (5/51) 
p < 0.001 
c. Mean length of time from initiation to target 
dose (months)  
Notification 9.3 
NP facilitator 5.9 
Control 8.5 
p < 0.001 
 
2) **Hospitalizations / emergency room visits 
Notification 45% (29/64 patients)  
NP Facilitator 43% (23/54 patients)  
Control 49% (25/51 patients), p=0.81 
 
3) **Mortality 
Notification 2% (1/64 patients) 
NP Facilitator 9% (5/54 patients) 
Control 14% (7/51 patients), p=0.05  
 
Only 1 death recorded in the notification group 
eliminates ability to statistically infer impact  
 
patient self-report at 
3-month intervals  
 
 
 
 
Information on 
adverse events  was 
collected in this pilot 
study as an indicator 
of safety not efficacy 
(e.g. to confirm no 
increase in adverse 
events, versus an 
efficacious reduction 
in adverse events) 
 
Hill, 2003 
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England 
 
RS ^ 
 
12 month study 
period 
 
80 outpatients, 
18 years or 
older, to 
rheumatology 
clinic on at least 
three previous 
occasions  
 
Diagnosis 
Prescribing 
Clinical 
Procedures 
 
Strategies for 
1) *Disease 
Activity Score 
results at 24 and 
48 weeks past 
baseline, 
measured using 
the DAWN 
Visual DAS28 
 1) *Disease Activity Score (DAS28)  
 
Week 24: NP 35/39, JHD 34/41 
Patients Scores Unchanged: NP 19  JHD 25 
Patients Scores Worsened: NP 6    JHD 5  
Patients Scores Improved: NP 10   JHD 4  
no p-value reported 
 
Per protocol, actual 
treatment analysis 
 
A number of 
physicians were 
involved in the study 
versus only one RNP, 
resulting in bias 
 2
0
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
To compare the 
outcome of patients 
with rheumatoid 
arthritis (RA) 
attending a 
rheumatology NP  
(RNP) clinic to 
patients attending the 
traditional junior 
hospital doctor’s  
(JHD) clinic 
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Outpatient / 
Specialized 
Referral  
 
Traditional 
rheumatology 
outpatient clinic 
managed by  
junior hospital 
doctors (JHDs) 
within a large 
teaching hospital, 
affiliated with the 
University of 
Leeds 
Intervention = 
Rheumatology 
NP (RNP) care 
 
(n =39)  
 
 
 
Control = 
Junior Hospital 
Doctor (JHD) 
care 
 
( n= 41) 
Behaviour 
Change 
calculator 
2) **Plasma 
Viscosity  
3) **Pain, 
physical 
function  and 
psychological 
status  
4)**Changes to 
medications, 
administration 
of steroid to 
intra-articular or 
intra-muscular 
steroids 
5) **Lab tests, 
investigations 
6)**Patient 
Satisfaction 
7) **Patient 
Knowledge 
Week 48: NP 36/39, JHD 35/41 
Patients Scores Unchanged: NP 19   JHD 22  
Patients Scores Worsened: NP 6   JHD 7  
Patients Scores Improved: NP 11  JHD 6  
no p-value reported 
2) **Plasma Viscosity at 48 weeks 
Median value (range)  
RNP 1.62 mPa (1.49– 1.85 mPa)  
JHD 1.63 mPa (1.50–1.97 mPa)  
  Difference nonsignificant  
3) **Pain, physical function, and psychological status 
 
a. Week 48 Pain, Median (range)  
NP 5.7 (2.0 - 9.0); JHD 6.0 (1.5 – 9.5) 
Difference non-significant 
 
b. Week 48 Physical Function Median (range)  
NP 3.0 (0.8 –8.2); JHD 3.8 (0.4 -7.6)  
Difference nonsignificant 
 
c. Week 48 Length of morning stiffness 
(minutes), Median (range) 
NP 60 (0–600); JHD 37.5 (0–270) 
Difference 22.5 minutes, nonsignificant 
 
d. Week 48 Fatigue (minutes) Median value 
(range)  
NP 60 (0–600); JHD 270 (0–600)  p=0.02 
 
e. Week 48 Psychological status Median (range)  
associated with the 
NP intervention (with 
one NP, cannot 
calculate variability 
through SD, for 
integration into effect 
estimate calculations) 
   
 
 
RNP care may bring 
benefit to patient for 
symptom control as 
per study 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
              NP 2.7 (0.7 – 7.5); JHD 2.5 (0.2 – 6.7) 
              Difference nonsignificant  
4) **Changes to medications for symptom control 
a. NP 24% (56/234); JHD 22% (50/226) 
Difference 2%  non-significant  
 
b. Prescriptions for intra-articular / intramuscular 
corticosteroid injections  
NP 15% consults (36/234); JHD 13% consults 
(29/226)  Difference 2%  non-significant 
 
5) **Lab tests, investigations 
a. Lab tests 
NP 5% (11/234 consultations) 
JHD 10% (23/226 consultations)  
b. X rays NP 2% (4/234); JHD 3% (7/234) 
c. GP visits NP 1% (3/234); JHD 5% (12/226) 
d. Referrals NP 32% (75/234); JHD 12% 
(26/226) 
               No p-values reported 
 
6) **Patient satisfaction outpatient care at 48 weeks 
NP scores: baseline 3.57 to 4.1  
JHD scores: baseline of 3.60 to 3.56  p < 0.001 
 
7) **Patient knowledge at 48 Weeks 
No significant differences 
 
Tranmer, 2004 
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Canada 
IPT ^^ 
Five week study 
intervention 
delivered offsite 
200 
postoperative 
cardiac surgery 
outpatients 
discharged from 
first cardiac 
Diagnosis  
 
Education  
 
Care 
Coordination 
1)*Global 
Quality of Life, 
using the MOS 
SF-36 (Medical 
Outcomes Study 
Short Form 36)  
1) *Mean (SD) Quality of Life at 5 weeks 
      NP 92/102      UC 92/98 patients   
 
Physical: NP  36.3 (6.4)  UC 36.2 (7.5)    
Mean difference 0.04 (95% CI -1.99  to 2.08)  p = 0.97  
Mental : NP  50.4 (11.5)   UC  51.7 (11.9)  
A disease-specific 
quality of life tool 
sensitive to nursing 
interventions may 
facilitate detection  of 
statistically 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
 
To determine the 
effectiveness of NP 
support on cardiac 
surgery outpatients 
during the first five 
weeks following 
hospital discharge 
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via telephone; 
study patients 
recruited from 
hospital prior to 
discharge 
 
 
 
Outpatient / 
Specialized 
Referral  
 
Study patients 
recruited prior to 
discharge, from 
teaching hospital 
affiliated with 
Queen’s 
University, 
Kingston, Ontario   
surgery with no 
stay at Intensive 
Care Unit  
Intervention = 
Usual Care + 
NP initiated 
phone contacts 
for patients in 
1
st
 5 weeks 
following 
hospital 
discharge 
(n= 102) 
 
Control = Usual 
Care (UC) 
including 
education 
booklet, home-
care follow-up 
as necessary, 
and NP contact 
information, 
with instruction 
to call with 
questions or 
concerns (n= 
98) 
 
2) 
**Postoperative 
symptom 
distress 
 
3) **Healthcare 
Utilization  
 
 
4) **Patient 
satisfaction  
 Mean difference -1.25 (95% CI –4.54 to 2.04) p = 0.45 
 
2) **Mean number (SD) symptoms at 5 weeks  
 
Physical    NP 3.5 (2.6)   UC 3.8 (2.9)  p = 0.39 
Psychological   NP 2.4 (2.1)   UC 2.3 (2.2)  p = 0.64 
Cardiac    NP 1.5 (1.1)    UC 1.7 (1.1)  p = 0.29 
Total     NP 8.1 (5.0)    UC 8.5 (5.5)  p = 0.74 
 
3) **Number of self-reported health care contacts at 5 
weeks     NP 92/102      UC 92/98 patients   
a. At least one Emergency Room (ER) visit 
NP 21    UC 15    p = 0.36 
b. Unexpected hospital admissions 
NP 9      UC 8      p = 0.85 
c. Home care on discharge 
NP 27    UC 26    p = 0.88 
d. Mean (SD) home care visits 
NP 11.68 (9.4)  UC 10.07 (8.0)  p = 0.87 
e. Family physician  
NP 88    UC 86    p = 0.86 
f. Specialist 
NP 50    UC 51    p = 0.88 
 
4) **Patient satisfaction at 5 weeks (scores from a  
5-point measurement scale were standardized to 
scores out of 100) 
a. Achieving best recovery possible  
NP  71.3    UC  63.5    p = 0.03 
b. Side effect information  
NP 61.5     UC 54.0     p = 0.05 
c. Help with decisions about care  
significant 
differences during 
early post-operative 
recovery 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
 NP  66.6    UC  59.0    p = 0.06 
d. Knowing what to expect during recovery 
NP 70.3     UC 65.7     p = 0.23 
e. Complication information 
NP 63.2     UC 56.7     p = 0.11 
f. Recognizing potential problems  
NP 59.6     UC 56.7     p = 0.48  
g. Identifying depressive feelings 
NP 51.0     UC 46.9     p = 0.32 
h. Overall Mean (SD) satisfaction with recovery 
NP 60.5 (20.4)    UC  55.7 (20.8)    p = 0.08 
Fairall, 2005 
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South Africa 
 
To implement an 
educational outreach 
programme for case 
management of 
priority respiratory 
diseases (Practical 
Approach to Lung 
Health in South 
Africa, or PALSA) 
among adults 
attending primary 
care clinics staffed by 
NPs 
IPT ^^ 
 
Pragmatic cluster 
RCT with the 
primary health 
care clinic the 
unit of random 
allocation  
Three month 
study period  
 
Primary Health 
Care 
 
40 primary health 
care clinics in the 
Free State 
province 
 
1,999 patients 
with cough or 
difficult 
breathing on 
presentation  or 
within past 6 
months 
 
Intervention = 
an educational 
outreach 
program 
(expanded 
prescribing 
provisions with 
locally tailored 
guidelines) 
implemented  
by NPs 
 
Diagnosis  
 
Prescribing  
 
Strategies for 
Behaviour 
Change 
1) *Case 
detection of 
tuberculosis by 
sputum 
microscopy or 
culture for 
tuberculosis  
 
 
2) 
*Prescriptions 
for inhaled 
corticosteroids 
to treat asthma; 
antibiotic 
prescriptions for 
upper and lower 
respiratory tract 
infections  
 
1) *Case detection of tuberculosis (TB) at 3 months 
 
Outreach Intervention 6.4% (57/892)   
Control 3.8% (34/890) 
OR = 1.72 (95% CI 1.04-2.85) 
p = 0.04, ICC = 0.007 
2) *Prescriptions at 3 months 
a. Inhaled corticosteroids for asthma 
 
Outreach Intervention 13.7% (137/1000)  
Control 7.7% (77/999) 
OR = 1.90 (95% CI 1.14 to 3.18) 
p = 0.006, ICC = 0.019  
 
b. Antibiotics for upper and lower respiratory 
tract infections  
 
Outreach Intervention 39.7% (397/1000 ) vs 
Control 39.4% (394/999 ) 
OR = 1.01 (95% CI 0.74 to 1.38) 
p = 0.95, ICC = 0.042 
Patients and 
fieldworkers were 
blind to intervention 
status of each clinic; 
data from patient-
held records and 
records of dispensed 
drugs, was collected 
by blinded  
fieldworkers, with 
intervention NPs not 
blinded for obvious 
reasons 
While challenges 
occurred scheduling 
educational outreach  
for clinics in small 
towns and rural areas,  
educational outreach 
with integrated case 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
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Respiratory 
Diseases: 
1. Tuberculosis  
2. Tuberculosis / 
HIV co-infection 
3. Asthma 
4. Chronic    
Obstructive 
Pulmonary 
disease (COPD) 
 5. Upper / lower  
respiratory tract 
infection  
20 clinics; 
1000/1999 
patients 
Control = Usual 
Care, no 
educational 
outreach 
program 
 
20 clinics; 
999/1999 
patients 
 
3) **Number of 
HIV patients 
receiving 
prescriptions for 
cotrimoxazole 
prophylaxis  
 
3) **HIV patients diagnosed with tuberculosis and 
receiving cotrimoxazole prescription 
 
Outreach Intervention 7.8% (13/167) 
Control 7.5% (11/147)  
Difference = 0.3% 
Non-significant 
management can 
improve case 
detection of TB 
without extra staff, in 
resource poor settings 
as per study 
 
Goessens, 2006 
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Netherlands 
 
To determine whether 
the extra care of an 
NP could be 
beneficial to the 
cardiovascular risk 
profile of  high–risk 
patients with manifest 
vascular disease, at 
high risk for a new 
vascular event or 
death 
IPT ^^ 
Intervention for 
one year after 
randomization  
 
Outpatient / 
Specialized 
Referral  
 
 
Risk-factor 
management 
clinic in the 
University 
Medical Center 
Utrecht 
Cardiovascular 
disease (CVD) 
outpatients: 
Peripheral 
arterial disease,  
Abdominal 
aortic 
aneurysm,  
Cerebrovascular 
disease 
Coronary heart 
disease 
 
236 outpatients 
with two or 
more 
Diagnosis 
Education 
 
 
At the time of 
the trial, an 
NP in the 
Netherlands 
was not 
formally 
allowed to 
prescribe; 
instead, a 
study 
1) *Treatment 
goals: blood 
pressure, blood 
glucose, lipid, 
homocysteine, 
BMI (body 
mass index), 
and smoking 
 
 
2) **Self-
reported drug 
utilization 
 
1)*Percentage of  patients who achieved treatment 
goals; mean follow-up of 14 months  (range 10-22) 
 
a. Low-density lipoprotein (LDL) cholesterol 
treatment goal  < or equal to 3.1 mmol/L 
NP 88; UC 67 
OR = 3.5 (95% CI 1.5–8.6) 
 
b. Total cholesterol (mmol/L) treatment goal < 
5.0 mmol/L 
NP 79; UC 61 
OR = 3.3 (95% CI 1.5–7.3)  
 
c. Systolic blood pressure (mm Hg) treatment 
goal < 140 mmHg 
NP 63; UC 37 
OR = 2.7 (95% CI 1.3–5.4) 
d. Body mass index (kg/m2) treatment goal < 25 
Patients were 
randomized before 
informed consent was 
obtained, according 
to the Zelen design; 
treatment consent is 
always sought before 
actual intervention, 
Torgerson & Roland 
(1998)  
 
Attrition 31% 
(71/236) patients: 61 
patients gave no 
informed consent 
post randomization, 
including 24 patients 
randomized to 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
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Post hoc analysis  
Sol (2008)  
The role of self-
efficacy in vascular 
risk factor 
management: a 
randomized 
controlled trial 
Appendix I-10 
 
 
 
modifiable risk 
factors: 
smoking, 
hypertension, 
dyslipidemia, 
diabetes, 
obesity, 
hyperhomocyste
inemia. 
 
 
 
 Intervention = 
NP at risk factor 
management 
clinic  + usual 
care 
 
(n=119) 
 
Control = usual 
care (UC) by 
GP & treating 
vascular 
specialist 
 
(n=117)  
 
physician 
prescribed or 
changed 
medication for 
patients in the 
trial 
3) **Overall 
quality of life at 
one year 
measured by the 
medical 
outcomes 
study short form 
36 (SF-36) 
 
kg/m
2
  
NP 38; UC 24 
OR = 4.0 (95% CI 1.2–13.1) 
 
e. Differences non-significant:  Diastolic BP, 
HDL-C, Triglycerides, Fasting Blood 
Glucose, Homocysteine, Waist 
Circumference, Smoking  
 
2) **Self-reported drug utilization at mean follow-up 
of 14 months (range 10 -22 months); no p-values 
reported 
a. Lipid-lowering drugs  
NP  89% (80/90); UC  73% (55/75) 
b. Glucose-lowering agents 
NP 19% (17/90); UC 16% (12/75) 
c. Blood pressure lowering agents  
NP 77% (69/90); UC 69% (52/75)    
d. Angiotensin converting enzyme 
inhibitor/angiotensin II receptor antagonist  
NP 76% (57/90); UC 53% (40/75) 
e. Folic acid  
NP 61% (55/90); UC 28% (21/75)  
f. Antiplatelet agents  
NP 90% (81/90); UC 91% (68/75)  
 
 
3) **Overall quality of life at 1 year 
    Nonsignificant differences between groups 
intervention and 37 
randomized to 
control. Another 10 
patients did not 
complete study: 4 
patients in each group 
died during trial, 1 
patient moved, and 1 
patient developed co-
morbidity 
 
 
Management by NP 
can improve CVD 
risk factors as per 
study  
 
 
CVD is globally, the 
most common cause 
of morbidity and 
mortality, influenced 
by multiple risk 
factors, such as 
smoking, obesity, 
physical inactivity, 
hypertension, 
dyslipidemia, and 
diabetes 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
Nathan, 2006 
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England 
 
 
To evaluate whether 
follow-up of patients 
recently discharged 
from the hospital as a 
result of acute 
asthma, can be 
adequately provided 
by a respiratory NP 
compared to a 
respiratory doctor 
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RS ^ 
 
6 months study 
duration post-
hospital discharge 
 
 
 
Outpatient / 
Specialized 
Referral  
 
West Suffolk 
hospital 
outpatient clinic 
 
 
 
154 outpatients 
> 16 years of 
age recently 
discharged from 
the hospital as a 
result of acute 
asthma  
 
 
 
 
 
Intervention = 
NP care  
 
(n= 78) 
 
 
 
Control = 
Respirologist 
care  
 
(n=76) 
 
 
Diagnosis 
Prescribing 
Education 
1) *Number of 
acute asthma 
exacerbations 
within six 
months of 
hospital 
discharge 
 
2) **Peak flow 
 
3) **Disease-
specific quality 
of life (QoL) 
 
i) St. George 
Respiratory 
Questionnaire 
(SGRQ) and 
  
ii) Asthma 
Questionnaire 
20 (AQ20) 
 
4) **Resource 
utilization 
i) hospital 
readmission  
 
ii) outpatient 
clinic 
attendance            
 
1) *Number acute asthma exacerbations at 6 months 
NP 98/174 exacerbations 
Respirologist 76/174 exacerbations 
Difference 22 exacerbations 
p = 0.368  
 
4 types exacerbations  
i) Mean number hospital readmissions per patient  
NP 0.07     Respirologist 0.18  
RR of readmission = 0.40  
(95% CI, 0.14 to 1.12)  p = 0.09 
 
ii) Emergency nebulization  
NP 35 times (17 different patients) 
 Respirologist 16 times (10 different patients) 
no p-value reported 
 
iii) Mean number of exacerbations 
    per patient requiring any emergency treatment  
NP  0.59 
Respirologist  0.43 
RR= 1.37 (95% CI 0.84 to 2.21)  no significant 
difference (CI contains the null value of 1) 
 
iv) IV or oral steroids during exacerbation  
NP 51.9%  (27/52patients)  
Respirologist  48.1%  (25/52 patients) 
Difference 3.8%   p = 0.572  
2) **Mean percentage drop (SD) peak flow at 6    
months 
NP 3.92% (12.4) Respirologist 2.53% (11.5) 
Difference 1.39% (95% CI  – 3.84 to 6.63)  p= 0.122 
 
Data was collected by 
an independent 
research assistant 
who was unaware of 
the group to which 
the patient was 
allocated 
 
 
 
No inconsistencies 
were found between 
data sources: patient 
diary card, 
emergency 
department 
attendance records, 
and general practice 
records  
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
  3) **Disease-specific quality of life at 6 months  
i. St. George’s Respiratory  Questionnaire (SGRQ) 
  (higher score indicates greater limitations) 
   Mean (SD) percentage reduction, SGRQ score  
NP 3.94% (14.34)  (49/78 patients) 
Respirologist 5.02% (16.43)  (52/76 patients)  
Difference = 1.08% (95% CI  -5.0 to 7.2)  p=0.727 
ii. Airways Questionnaire 20 (AQ20) 
  (AQ20 high score indicates poor quality of life) 
Mean (SD) change, AQ20 score  
NP 0.47 reduction  (3.73)  (49/70 patients) 
Respirologist 0.31 increase (3.53)  (52/66 patients) 
Difference 0.78 (95% CI  – 0.64 to 2.19)  p = 0.285 
 
4) **Resource Utilization 
i. Mean number hospital readmissions / patient 
NP 0.07 (5 re-admissions/68 patients)  
Respirologist 0.18 (12 readmissions/65 patients) 
RR of readmission = 0.40 (95% CI  0.14 to 1.12)   
p = 0.09  
 ii.  Mean number follow-up clinics attended  
NP 1.97 (130 clinics / 66 patients)  
Respirologist 2.23 (147 clinics / 66 patients)  
RR = 0.88 (95% CI 0.70 to 1.12)  p = 0.011 
McCarrier, 2009 
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U.S. 
 
Pilot RCT to assess 
whether a Web-based 
IPT ^^ 
 
One year 
intervention 
period 
 
Outpatient / 
Specialized 
78 Type 1 
Diabetes 
Mellitus 
outpatients,  
21 -49 years 
with at least one 
A1C test  
Diagnosis 
Education 
Care 
Coordination 
1) *Difference 
in mean 
Hemoglobin 
A1c between 
baseline and 
one year 
 
1) *Mean (SD) change hemoglobin A1c at 1 year 
 
NP - 0.37 (1.3) 
UC: + 0.11 (1.4) 
Absolute difference = 0.48 (95% CI -1.2 2 to 0.27)  
 
p = 0.160 
Pilot study with small 
sample size 
 
Attrition at 17% 
(13/78 patients:    
7 patients from UC 
group, and 6 patients 
from NP group)  
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
diabetes case 
management program 
based in an electronic 
medical record 
accessible to both 
patient and provider, 
can improve glycemic 
control and diabetes-
specific self-efficacy 
in adults with Type I 
Diabetes Mellitus 
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Referral  
 
Diabetes Care 
Center (DCC: 
team includes 
physicians, NPs, 
on-site 
pharmacists, 
nurse educators, 
nutritionists, and 
mental health 
professionals) 
affiliated with the 
University of 
Washington 
Medical Centre, 
Seattle, 
Washington 
> or = to 7% in 
previous 12 
months 
Intervention = 
NP coordination 
of Web-based 
care + usual 
care 
 
(n =42)   
 
Control = usual 
care (UC) from 
team at 
Diabetes Care 
Center (DCC)  
(n = 36) 
2) **Diabetes-
specific self-
efficacy 
2) **Diabetes-Specific Self-Efficacy at 1 year 
NP +0.14 (0.62) 
UC -0.16 (0.62) 
Effect size = 0.30 (95% CI 0.01 to 0.59) 
 
p = 0.044 
 
This study’s Web-
based case 
management program 
is associated with a 
beneficial treatment 
effect on self-
efficacy, which may 
improve effectiveness 
of patients’ self-care 
behaviors 
Mitchell, 2009 
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U.S. 
 
To determine the 
effect of a NP-
delivered 
psychosocial-
IPT ^^ 
 
8 week 
intervention 
within a 24 month 
study period, with 
follow-ups at  
9 & 21 weeks 
post-entry, and  
12 & 24 months 
post-stroke   
 
101 patients 
within 4 months 
of an ischemic 
stroke and 
diagnosis of 
clinical 
depression 
Intervention =  
Brief psycho-
social/behaviour
al intervention 
Diagnosis  
 
Strategies for 
Behaviour 
Change 
1) *Post-stroke 
depressive 
symptomology 
(reduction in 
depressive 
symptoms) 
 
 
 
 
1) *Mean change (SD) Hamilton Rating Scale for 
Depression (HRSD) at 12   months 
 
NP  - 9.2 (5.7) 44/48 patients 
UC: - 6.2 (6.4) 48/53 patients 
Difference -2.9 (CI -5.4 to -0.4) 
 p=0.023 
 
 Remission (defined as HRSD < or = 9) at 
9weeks 
NP 47% (45/48) 
UC 19% (53/53) 
Family participation 
(patient support) was 
not a consistent factor 
between groups  
 
Per protocol analysis 
 
Attrition 9% (9/101) 
of patients were lost 
to one year follow-up 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
behavioural 
intervention on 
depression in 
community dwelling 
post-stroke patients 
 
 
 
 
 
Tertiary Prevention 
reducing risks / 
threats to health in 
long-term chronic 
illness / permanent 
impairment
13
 
Outpatient / 
Specialized 
Referral  
 
Outpatient clinic 
affiliated with the 
University of 
Washington 
Seattle, 
Washington; 
follow-up contact 
included patients’ 
private homes 
(9 in-person 
sessions with 
NP over 8 
weeks) + usual 
care, including 
antidepressant 
medication  
(n=48) 
 
Control = usual 
care (UC) 
scheduled by 
stroke care 
provider 
including 
antidepressant 
medication  
(n=53)  
2) 
**Limitations in 
ability (physical 
function), 
participation 
and overall 
stroke impact 
Difference 28 % OR = 4.8  
(CI 1.8 to 12.9) p = 0.001 
 Remission at 21weeks 
NP 46% (46/48) 
UC 22% (50/53) 
Difference 24% OR=3.4  
(CI 1.3 to 8.7) p = 0.008 
 Remission at 12 months 
NP 48% (44/48); UC 27% (48/53) 
Difference21%  OR=2.7  
(CI 1.1 to 6.6) p = 0.031 
 Remission at 24 months  
NP 65% (44/48) 
UC 46% (48/53) 
               Difference 19% OR =2.3  
               (CI 0.8  to 6.7) p = 0.130 
 
2) **Measures of overall stroke impact, limitations in 
physical function, social  participation at 12 months, 
were non-significant 
 
 
Ralston, 2009 
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U.S. 
 
To test Web-based 
management of 
glycemic control in 
Type II Diabetes 
IPT ^^ 
 
12 month 
intervention 
period 
 
 
Outpatient / 
Specialized 
Referral  
83 Type II 
Diabetes 
Mellitus 
outpatients,  
18 - 75 years, 
glycosylated 
hemoglobin 
(GHb) in prior 
year  > or = 7%, 
at least 2 clinic 
Diagnosis 
Prescribing 
Strategies for 
Behaviour 
Change 
Care 
Coordination 
1) *Absolute 
change in 
glycated 
hemoglobin 
between 
baseline and 
end of 12 month 
study period 
 
1) *Absolute change in glycated hemoglobin at 12           
months; target for glycated hemoglobin is < 7% A1C       
(corresponding to an average blood glucose 
concentration of less than 8.6 mmol/L)  
 
NP 33% at target 
UC 11% at target 
Difference = 22%   p = 0.03 
 
 
Incomplete reporting 
of raw data in Table 
3: no fraction of 
patients comprising 
percentages reported 
 
Patient / provider 
Web access to same 
Electronic Medical 
Record (EMR) can 
 2
1
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
Mellitus outpatients, 
via one NP providing 
case management 
services, using a 
shared electronic 
medical record 
 
 
 
 
 
Tertiary Prevention 
reducing risks / 
threats to health in 
long-term chronic 
illness / permanent 
impairment 
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University of 
Washington 
General Internal 
Medicine Clinic 
(UW GIMC), a 
teaching clinic 
that provides care 
to 7, 707 patients, 
staffed by 25 
faculty, 48 
residents, and an 
NP, for case 
management of 
chronic disease 
patients; Seattle, 
Washington 
(Ralston, 2009,  
p. 234) 
 
visits in prior 
year 
 
 
 
Intervention = 
NP coordination 
of Web-based 
care + usual 
care    
 
(n=42) 
 
 
 
 
Control = usual  
 care (UC)  
from an internal 
medicine 
physician  
 
(n=41) 
 
 2) **Blood 
pressure, total 
plasma 
cholesterol  
 
 
3) **Healthcare 
utilization  
 
 
2) **Mean group difference for change  in risk factors  
 Systolic BP reduction -0.9 mmHg   p = 0.84 
 Diastolic BP +0.1 mmHg   p = 0.96 
 Total Cholesterol +0.20 mmol/L   p = 0.38 
 
3) **Healthcare Utilization Mean (SD) change in total 
numbers of visits at 12 months 
 Outpatient Clinic 
NP 0.6 (10.7)  UC -2.1 (7.0) 
Difference 2.7  p= 0.18 
 
 Primary Health Care Clinic   
NP 0.0 (2.9)  UC -0.2 (2.8) 
Difference 0.20  p= 0.76 
 
 Specialty Physician Office 
NP 0.6 (9.0)  UC -1.9 (5.9)  
Difference 2.5  p= 0.14 
 
 Inpatient Days 
NP 0.2 (2.6)  UC -0.3(1.8) 
Difference 0.5  p= 0.32 
improve glycemic 
control in type 2 
diabetes patients as 
per study, while 
single case manager 
and small sample size 
limits generalizability 
 
 
Huizinga, 2010 
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U.S. 
 
IPT ^^ 
 
Two year study 
intervention 
delivered offsite 
via telephone 
165  Type II 
Diabetes 
Mellitus  
outpatients,  
18-75 years, 
with recent  
glycemic 
control  
 
Diagnosis 
 
Prescribing 
 
Strategies for 
Behaviour 
Change  
 
Care 
Coordination 
1)*Glycemic 
relapse 
 
 
 
1)*Glycemic  relapse, defined as an increase in HbA1c 
of  > or = to 1% over baseline, at 2 years 
 
 Quarterly contact 21% (10/48) patients 
relapsed  
 
 Monthly contact 29% (15/52) patients 
relapsed 
Test was performed 
in a study population 
already motivated 
with previous 
successful glycemic 
control.   
Study protocol did 
not contain care 
 2
1
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
To determine the 
optimal frequency of 
telephone contact by 
NPs necessary to 
prevent glycaemic 
relapse in Type II 
Diabetes Mellitus  
outpatients who had 
recently  achieved  
glycemic control  
( ≥ 1% decline A1c) 
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Outpatient / 
Specialized 
Referral  
 
Academic 
Medical Centre 
for Diabetes 
Improvement 
Program (DIP), 
offered by a 
physician-led 
team, including a 
NP, registered 
dietician, and a 
diabetes nurse; 
outpatient clinic 
of Johns Hopkins 
Hospital, 
Baltimore, 
Maryland 
 
2 Intervention 
Groups   
 
NP phone 
contact + Usual 
Care  (UC) : 
1) Quarterly 
contact, every 3 
months   
(n = 55) 
2) Monthly 
contact   
(n = 55) 
 
 
Control =  UC  
in Diabetes 
Improvement 
Program  
(n = 55)  
 
 
 
 
 
 
 
 
 UC  25% (12/48) patients relapsed  
 
               p=0.83  
 
Prevalence of relapse did not differ between groups 
over follow-up time, nor did the cumulative incidence 
of relapse differ between treatment groups (p = 0.72) 
strategies for patients 
who relapsed, and 
was not powered for 
sub-group analysis 
between its 3 groups 
Kim, 2013 
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South Korea 
 
To test the 
effectiveness of 
standardized 
IPT ^^ 
Intervention 
period of 1 week  
 
Outpatient / 
Specialized 
Referral  
108 advanced 
cancer 
outpatients,  
20 - 80 years 
diagnosed with 
a stage IV solid 
tumor, moderate 
level of cancer-
related pain 
(Visual Analog 
Scale score ≥4 
Diagnosis 
 
Prescribing 
 
Strategies for 
Behaviour 
Change  
 
Care 
Coordination 
1) *Reduction 
in  average pain 
levels at 1 week 
2) 
**Performance 
status / 
functional 
impairment; 
anxiety/ 
depression, 
 1)* Reduction in average pain ratings on Brief Pain 
Inventory at 1 week 
(0 = no pain; > or = to 4= average pain; 10 = ‘pain as 
bad  as you can imagine’)  
 
Number patients experiencing average pain intensity at 
1 week 
 
NP  19% (10/54)    
UC  35% (19/54) 
Difference 16% 
All calculations used 
actual per protocol 
data; no adjustments 
were made for 
missing data  
 
 
 2
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
education and tele-
monitoring (phone 
contact) for 
improving pain, 
distress, anxiety, 
depression, quality of 
life, and performance 
in outpatients with 
advanced cancer 
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Severance 
Hospital Pain 
Clinic of the 
Yonsei University 
Health System, 
Seoul 
 
out of 10 over 
last 24 h), and 
life expectancy 
> 1 month 
  
Intervention = 
usual care + 
daily phone 
monitoring by 
NP  
 
(n = 54) 
 
Control = usual 
care (UC) of 
standardized 
pain education 
by NP in both 
study arms at 
first visit 
 
(n = 54) 
distress at 1 
week 
3) **Cancer 
specific 
symptoms 
measured by the 
European 
Organization for 
Research and 
Treatment 
of Cancer 
Quality of Life 
Questionnaire 
(EORTC 
QLQC30) 
p = 0.02 
 
 
2) **Functional impairment, mean (SD) (Karnofsky 
performance score 100 = ‘perfect’ health; 0 = death) 
NP 66 (8.0); UC 65 (9.2) Difference 1  p = 0.68 
 
Percent patients with score ≥ 11, Hospital Anxiety 
Depression Scale (0 -7=normal, 8-10=borderline 
abnormal,11-21=abnormal) 
NP 57% (31/54 )  UC 54% (29/54) 
Difference 3%   p=0.34 
 
Percent patients ≥ score of 4 on Distress Thermometer 
(0 = not distressed to 10 = extremely distressed) 
NP 83% (45/54)  UC 91 % (49/54) 
Difference 8 %  p = 0.09 
  
3) **Cancer-specific symptoms (EORTC QLQC30) 
Physical function, mean (SD) at 1 week 
(higher scores represent higher levels of functioning) 
 
NP 56 (23) UC 55 (21)  
p = 0.03 
 
Differences in all other component scores were non-
significant  
 
 2
1
3
 
 
Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
Sawatsky, 2013 
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Canada 
 
To compare patient 
outcomes between 
NP-managed follow-
up care and  usual 
follow-up care, for 
coronary artery 
bypass graft (CABG) 
surgery outpatients 
 
 
 
 
 
 
Tertiary Prevention 
reducing risks / 
threats to health in 
long-term chronic 
illness / permanent 
impairment
13
 
 
IPT ^^ 
 
Six week study 
intervention 
delivered offsite 
via telephone 
 
 
 
 
Outpatient / 
Specialized 
Referral  
 
 
 
 
 
 
Study patients 
recruited prior to 
discharge, from  
St. Boniface 
Hospital, 
affiliated with the 
University of 
Manitoba, 
Winnipeg, 
Manitoba 
204 
postoperative 
cardiac surgery 
outpatients 
following first 
time coronary 
artery bypass 
graft (CABG) 
surgery 
 
 
 
Intervention =  
Usual Care + 
NP phone 
contact at 2-3 
days post 
discharge for 
needs 
assessment and 
recommendatio
ns: additional 
NP phone 
contact, follow-
up with primary 
care provider or 
cardiac surgeon, 
NP Follow-Up 
(NPFU) clinic, 
or local ED   
(n= 97)  
All 5 domains: 
  
Diagnosis 
 
 
Prescribing 
 
 
Clinical 
Procedures  
 
 
Education 
 
 
Care 
Coordination 
1)*Global 
quality of life 
 
 
2) **Symptoms 
in cardiac 
surgery 
recovery 
 
 
3) **Health 
resource use 
 
 
 
4) **Patient 
satisfaction 
 
1)* Mean (SD) Global Quality of Life at 2 and  6 
weeks post-discharge, SF-36  
 
Physical component  
2 weeks NP 19.0 (3.4)  UC 18.0 (3.4)   p = 0.04 
6 weeks  NP 22.2 (4.2)  UC 22.0 (4.0)  p = 0.69 
 
Mental component  
2 weeks NP 21.5 (2.1)  UC 21.5 (2.3)   p = 0.87 
6 weeks NP 21.3 (2.3)  UC 21.1 (2.3)   p = 0.67 
2)** Mean (SD) summary symptom-score (including 
number and frequency of symptoms)   
2 weeks 
NP 45.2 (10.2)    UC 50.4 (12.6)  
Difference 5.2     p = 0.002    
 
6 weeks 
NP 41.2 (11.1)    UC 43.2 (11.1) 
Difference 2.0     p = 0.23 
 
Palpitations and leg pain were  reported with less 
frequency in NP group vs UC at 6 weeks post-
discharge (p < 0.05) no individual data shown 
 
3)** Health care resources utilization at 6 weeks 
 
a. Total emergency department (ED) visits  
 NP 30      UC 37    Difference  7  visits 
 
b. Total  medical doctor (MD) visits  
Disruption of 
randomized sample: 
once intervention was 
established, several 
control patients were 
pulled from the trial, 
deemed too ill for the 
study (Sawatsky, 
2013, p. 2085) 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
 
 
 
 
  
 
 
 
 
 
 
 
Control =  
Usual Care 
(UC) including 
advice to make 
primary care 
provider 
appointment  
within 1 week; 
return visit to  
cardiac surgeon 
was scheduled 
for all patients 
at 6 weeks 
(n=107)   
 
 NP 208     UC 210    Difference  2 visits 
 
c. Total  hospitalizations  
 NP 15      UC 19     
Difference  4  hospitalizations 
 
4)**Patient satisfaction  
NP intervention patients were significantly more 
satisfied 
 
a. Quality of Service at 2 and 6 weeks 
respectively: p = 0.003 and 0.005  
 
b. Amount of Help Received at 2 and 6 weeks 
respectively: p = 0.001 and 0.002  
              (no individual data shown) 
Berkhof, 2014 
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Netherlands 
 
Pilot RCT to assess 
the effect of an on-
demand system of 
patient-initiated 
outpatient visits on 
health status for 
patients with Chronic 
Obstructive 
Pulmonary Disease 
IPT ^^ 
 
2 year study 
 
 
Outpatient / 
Specialized 
Referral  
 
 
 
Large teaching 
hospital, Zwolle 
100 Chronic 
Obstructive 
Pulmonary 
Disease 
(COPD) 
outpatients > or 
= to 40 years, 
COPD GOLD 
stage > or = to 2  
(Global 
initiative for 
staging 
Obstructive 
Lung Disease:  
1 = mild;  
Diagnosis 
Prescribing 
Education 
1) *Mean 
change in 
Clinical COPD 
Questionnaire, 
or CCQ (an 
increase in total 
score indicates a 
decline in health 
status)  
 
2) **Time to 
first 
exacerbation 
COPD  
1) *Mean (SE) change COPD (Chronic Obstructive 
Pulmonary Disease) status at 2 years 
 
Lower score on Clinical COPD Questionnaire 
(CCQ) = less deterioration / better health status 
 
Minimal clinically important difference (MCID) of 
CCQ total score is 0.4 
 
Symptom domain of the CCQ 
NP  0.14 (+ or - 0.14)  in 40/49 patients 
UC 0.58 (+ or - 0.16)  in 29/51 patients 
Difference = - 0.44 (+ or -  0.21)   
95% CI -0.87 to -0.023, p = 0.04 
Absolute difference between groups of 0.44 met 
the MCID for a clinically relevant effect 
Results of this pilot 
study are exploratory:  
the on-demand 
system of patient 
scheduling had not 
been investigated 
before in COPD  
patients  
 
Less deterioration in 
COPD health status 
for intervention 
patients was not 
accompanied by 
significant 
 2
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
(COPD) a progressive 
disease 
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Feb. 17, 2017 
€1.00 Euro = $1.53 
Canadian  
€0.72 Euro = $1.00 
Canadian  
 
 
 
4 = very severe)  
smoking history 
>10 pack-years 
 
 
 
Intervention = 
patient-initiated 
outpatient  
visits with 
pulmonary NP 
upon increase of 
symptoms 
(dyspnea, 
cough, sputum, 
hemoptysis, or 
thoracic pain); 
NP followed an 
‘on-demand 
protocol’ that 
included  
consult with 
pulmonologist 
for urgent 
problems 
 (n =49)  
Control= usual 
care (UC) of 
traditional 
outpatient visits 
initiated by 
pulmonologist, 
3) **Visits to 
general practice 
physicians, 
pulmonologists, 
and pulmonary 
NPs  
 
 4) **Total 
treatment costs 
from provider 
and insurance 
perspectives 
 
5) **Disease-
specific quality 
of life measured 
by St. George’s 
Respiratory 
Questionnaire  
 
 
6) **Global 
quality of life 
measured by the 
Short Form-36 
(SF-36) 
2) **Median time to 1st exacerbation COPD at 2 years  
  
NP 307 days  + or - 61.6 days (95% CI 186.3 to 427.7) 
UC 335 days + or - 60.2 days (95% CI 217.0 to 453.0) 
Difference 28 days  p=0.40 
 
 3)**Healthcare Visits median scores (range) at 2 years 
 Primary Health Care  GP  
Intervention 4 (0-32); Control 5 (0-20)  
p = 0.01 
 
 Outpatient Pulmonary NP  
Intervention  1 (0-14); Control 0 (0-4)   
p = 0.003 
 
 Pulmonologist 
Intervention 3 (0-17); Control 3 (0-13),  
p = 0.82 
 
4 ) **Total HC provider costs at 2 years,  mean (SD) 
Intervention €1803 (€2617); Control €2321 (€3967) 
Difference € -518 (CI -€1993; €788), nonsignificant 
Total HC insurance costs at 2 years, mean (SD) 
Intervention €3994 (€4669); Control €4452 (€ 6100)  
Difference -€458 (CI -€2700,€ 1652), nonsignificant 
5) **St. George’s Respiratory Questionnaire (SGRQ) 
mean (SE) symptom domain  at 2 years  
(higher score = worse health status; minimal clinically 
important difference (MCID) of SGRQ total score is 4) 
differences in 
overall/global quality 
of life measures  
(SF-36)  
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
to the 
pulmonologist 
or the 
pulmonary NP 
(n=51)   
 
NP 2.6 (3.0)  38/49 patients 
UC 10.3 (3.4) 30/51patients 
Difference 7.7 (4.6) 95% CI  -16.8 to 1.4  p = 0.10, 
meeting MCID for a clinically relevant effect 
 
6) **Overall quality of life at two years 
No significant differences between groups; 3/8 
component scores on SF-36 met the minimal clinically 
important difference (MCID) 
 
Mertens, 2014 
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South Africa 
To assess the 
effectiveness of a 
brief motivational 
interviewing 
intervention for 
alcohol & drug use in 
young adult primary 
care patients of low 
socioeconomic status 
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IPT ^^ 
Study period 3 
months 
 
 
 
Primary Health 
Care 
 
 
Large public 
sector primary 
healthcare clinic 
in Delft, a 
township in the 
Western Cape  
403 primary 
health care 
clinic patients 
18–24 years 
who screened 
for high-risk 
alcohol and / or 
drug use 
 
Intervention = 
single session 
of Brief 
Motivational 
Interviewing 
(average session 
10 minutes) 
delivered by NP 
+ referral list of 
resources 
(n=206)   
 
Only 1domain: 
 
Strategies for 
Behaviour 
Change 
1)*Rates of at-
risk alcohol use 
and drug use at 
three month 
follow-up 
 
1) *Mean %  reduction in ASSIST scores at 3 months  
(ASSIST - Alcohol, Smoking and Substance 
Involvement Screening Test) 
 
 Alcohol  
NP  38.3 % 
Control 20.9% 
p = 0.0293 
 
 
 Cannabis  
NP 28.3% 
Control 9.8% 
p = 0.1119 
 
 
 Methamphetamine 
              NP 57.2% 
              Control 76.9% 
               p = 0.2264 
Raw data in Table 2 
incomplete: no 
fraction of patients 
comprising 
percentages was 
reported 
Attrition 40/403 = 
10% 
 
A brief motivational 
interviewing 
intervention delivered 
by NPs may reduce 
at-risk (medium to 
high risk scores on 
the ASSIST 
instrument) alcohol 
use, the most 
prevalent substance 
used,  in the short 
term among 
 2
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
Control = 
minimally 
enhanced usual 
care &  referral 
list of resources 
(n=197) 
 
 economically 
disadvantaged young 
adults, as per study 
Ganz, 2000  
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U.S. 
 
To test the effect of a 
comprehensive 
menopausal 
assessment 
intervention program 
in breast cancer 
survivors, for their 
achievement of relief 
in abruptly recurred 
menopausal 
symptoms, 
improvement in 
quality of life, and 
sexual functioning at 
four months  
 
 
IPT ^^ 
Intervention 
period of 4 
months 
 
Outpatient / 
Specialized 
Referral  
 
 
 
 
Outpatient clinic 
at the Jonsson 
Comprehensive 
Cancer Center, 
University of 
California, Los 
Angeles, 
California 
76 surviving 
breast cancer 
outpatients with 
abruptly 
recurred 
menopause 
symptoms due 
to discontinued 
estrogen 
replacement 
therapy (ERT) 
related to breast 
cancer  
 
Intervention = 
comprehensive 
menopausal 
assessment or 
CMA (targets 
highly 
symptomatic 
women with 
goal of reducing 
Diagnosis 
Prescribing  
Strategies for 
Behaviour 
Change 
1) *Composite 
menopausal 
symptom scale 
for abruptly 
recurred 
menopause 
symptoms due 
to discontinued 
estrogen 
replacement 
therapy, related 
to breast cancer 
 
2) **Vitality, 
from Medical 
Outcomes Study 
Short Form 36 
(SF-36)  
 
3) **Cancer 
Rehabilitation 
1) *Menopause  symptom-scale score, mean change 
(reduction) from baseline to 4 months   
 
NP 0.61 (95% CI 0.40–0.82), 33/37 patients 
UC 0.19 (95% CI −0.06 to 0.44) 39/39 patients  
 
p = 0.0004 
 
 
 
 
 
 
 
 
2) **Vitality, at baseline and 4 months  
Vitality, a dimension of health-related quality of life on 
the SF-36 tool 
 p = 0 .77 
 
3) **Sexual functioning scale (Cancer Rehabilitation 
Potential side effects 
to clonidine (fatigue, 
headache) used to 
treat ‘hot flashes’ in 
39% of the 
intervention patients,  
may have limited 
detection of 
intervention effect on 
SF-36 Vitality Scale  
 
 
 
 
Instead of using 
intention to treat 
analysis, estimation 
of intervention 
efficacy was made 
according to methods 
described by Angrist 
JD, Imbens GW, 
Rubin DB. 
Identification of 
causal effects using 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
 
 
 
 
 
 
 
Secondary 
Prevention  
reducing risks / 
threats to health in a 
condition that has 
already occurred to 
halt or slow 
progress
13
 
 
symptoms)  
delivered by NP    
( n=37) 
 
Control = usual 
care (UC) +1 
contact from 
research 
assistant at 2 
months asking 
of therapies 
used for 
symptom 
management  
( n= 39) 
Evaluation 
System 
(CARES) 
Sexual 
Functioning 
Scale 
Evaluation System, CARES) mean change from 
baseline to 4 months 
 
NP 0.38 (95% CI 0.05–0.71)  33/37 patients 
UC 0.015 (95% CI −0.37 to 0.40) 39/39 patients 
  
p = 0.04 
 
instrumental 
variables. J Am Stat 
Assoc 1996, (p. 
1056) 
Cooper, 2002 
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Scotland 
 
 
To develop methods 
and tools that could 
be easily used in 
different emergency 
departments, for 
evaluation of 
emergency NP care 
 
RS ^ 
 
2 month study 
duration 
 
 
 
Acute Care 
Emergency 
Department 
 
 
 
 
204 patients 
over 16 years, 
with minor 
injury that fell 
within the 
emergency NP 
(ENP) protocol 
 
Intervention = 
ENP-led care  
(n = 102) 
 
 
Diagnosis 
 
Prescribing 
 
Clinical 
Procedures 
 
Education 
 
1) Resource 
Utilization: 
consultation 
time and 
referral to 
follow-up 
clinics  
 
2) Unplanned 
Follow-up 
 
3) Missed 
Injuries  
Endpoints not pre-specified as primary / secondary 
 
1) Resource Utilization 
     
Patient’s average wait time  
ENP 48.6 minutes  SHO 70.1 minutes   
95% CI 11.2–31.8 minutes, p < 0.001 
 
Total consult time (including treatment time) 
ENP 30.0 minutes  SHO 24.9  minutes   
95% CI  -1.3 to 11.5 minutes, p < 0.115 
 
Seeking  advice from senior medical staff  
(when X-ray interpretation was excluded: ENPs were 
required to consult while SHOs were not required to 
consult)  ENP 20.9%   SHO 11.5%, p < 0.21  
Wait time and consult 
time data were based 
on  use of the 
‘Treatment Record’ 
form for 
consultations and 
referrals; returns to 
the  emergency 
department  by study 
patients and missed 
injuries, were tracked 
by the hospital 
computer system 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
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Single Accident 
and Emergency 
(A & E) 
Department of 
Glasgow Royal 
Infirmary, 
Glasgow 
 
 
Control = 
Senior House 
Officer  
(SHOs)-led care  
(n = 102) 
 
4) Patient 
Satisfaction 
 
5) Quality of  
Clinical 
Documentation 
 
 
6) Recovery at 
one month 
 
Numbers of X-rays requested   
ENP 56.6%  SHO 47.5%, p =  0.2 
 
Referral to follow-up clinics  
ENP 33.3 %   SHO 27.5%, p = 0.358 
 
2) Reasons for unplanned return regarding  6/10  NP 
patients and 4/10 SHO patients:  
 New injuries  ENP 1  SHO 1 
 Concern about original injury ENP 2  SHO 1 
 Problems complying with treatment  
ENP 2 SHO 1 
 Problems with treatment ENP 1  SHO 1 
 
3) Missed injuries  ENP 1  SHO 1 
 
4) Patient Satisfaction  
a. Patients reported it was easier to talk to ENPs 
NP 97.6 (85/102) 
SHO 84.0 (81/102) 
p = 0.009  
b. Patients were given information on accident 
and illness prevention  
NP 75.3 (81/102) 
SHO 45.2 (73/102)  
p =0.001 
c. Patients were given enough information on 
their injury  
NP 95.2 (83/102) 
SHO 82.5 (80/102) 
Inherent to all self-
completion 
questionnaires: 
 
1) Refusal to 
complete/return the 
questionnaire, leading 
to bias if non-
responders differ 
from responders 
 
2) Patients may ask 
other people to assist 
in completing the 
questionnaire, or 
even complete it on 
their behalf, 
prejudicing the 
sample 
 
3) Lack of ability to 
read (low literacy 
levels / illiteracy in 
patients) may 
contribute to non-
response 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
p = 0.007 
d. Overall patient satisfaction   
NP 98.8 (85/102) 
SHO 87.7 (81/102), p < 0.001 
 
e. Between-group differences in remaining 4 
satisfaction statements were non-significant 
(see Appendix I-9) 
5) Quality of  Clinical Documentation, scored out of      
30, audited 4 months after the trial ended 
ENP 28.0/30 (94/102) 
SHO 26.6 /30 (92/102)  p < 0.001 
 
6) Recovery at one month: symptoms and ‘level of 
activity’ all non-significant (no individual data shown) 
 
Williams, 2005 
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England 
 
 
To evaluate the 
impact of a service 
led by a continence 
NP (designed for this 
IPT ^^ 
Six month 
intervention 
period 
 
 
Primary Health 
Care 
 
 
Patients’ homes 
in Leicestershire 
and Rutland 
 
3746 patients 
aged 40 years 
and over living 
in private 
households, 
with 
incontinence 
several times 
per month or 
more, or several 
times a year,  
and reported 
impact of 
symptoms on 
quality of life 
Diagnosis 
Prescribing 
Education 
 
 
 
 
 
1) 
*Improvement 
in one or more 
symptoms 
(incontinence, 
urgency, 
frequency, and  
nocturia), of 
which cure (no 
symptoms) is a 
subset  
 
 
 
 
1) *Improvement in 1 or more symptoms  
3 months       
NP 60% (1417/ 2378 responders)  
Control 48% (281/584 responders) 
Difference 12% (95% CI  7 to 16)  p < 0.001 
 
6 months  
NP 62% (1369/2201 responders) 
Control 52% (277/536 responders) 
Difference 10% (95% CI  6 to 15) p < 0.001 
 
Cure = 0 symptoms 
3 months 
NP 25% (591/2378) 
Control 15% (88/584)  
Incomplete reporting:  
 
Cost data represents 
only 24% (905/3746) 
of all study patients; 
19% (171/905) 
control patients; 81% 
intervention patients 
734/905. Seventy-six 
percent of the entire 
study population 
were not included in 
the cost-effectiveness 
analysis (CEA) 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
study) compared to 
existing primary / 
secondary care for 
people with urinary 
incontinence and 
storage symptoms 
 
 
Secondary 
Prevention  
reducing risks / 
threats to health in a 
condition that has 
already occurred to 
halt or slow 
progress
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Post hoc analysis  
Williams (2011) 
Long term follow-up 
of a randomised 
controlled 
trial of services for 
urinary symptoms 
Appendices I-3, I-7 
 
 
 
 
Intervention = 
continence 
service 
provided by 
NPs (n = 2958) 
Control = 
existing usual 
primary care 
including GP 
and continence 
advisory 
services  
(n = 788) 
  
 
4:1 ratio was  
deemed 
necessary to 
ensure 
sufficient 
intervention 
data for 
evaluation of 
detrusor muscle 
over-activity 
(bladder wall)  
and urodynamic 
stress 
incontinence  
 
 
2)**Number of  
symptoms 
alleviated  
 
 
 
 
 
 
 
 
 
3) **Resources 
measured 
healthcare 
professional 
contacts, 
investigations; 
Cost-
effectiveness 
 
 
 
 
 
4) **Patient 
satisfaction and 
patient 
perception of 
problem 
Difference 10%  (95% CI  6 to 13) p < 0.001 
 
6 months 
NP 28% (624/ 2201) 
Control 19% (104/536) 
Difference 9% (95% CI  5 to 13) p < 0.001 
 
2)**Number of  symptoms alleviated  
 
 At 3 and 6 month time points, the percentage of 
responders reporting each of all four symptoms /events 
were statistically significantly  less in the intervention 
group than control, with the exception of one 
borderline result at p=0.066 
 
Differences ranged from 11% p < 0.001  to 4% 
p = 0.066  
  
3) **Cost-effectiveness according to number of 
symptoms alleviated, at 6 months 
 
In the 3
rd
- 6
th
 months of study, costs 
generated by the NP service were similar to months 1-
3, while the overall difference in mean number of 
symptoms alleviated remained the same, resulting in an 
incremental cost / additional symptom alleviated that 
was greater at 6 months (£488) than at 3 months 
(£242), no p-values reported 
 
Higher start-up costs/longer consults limited cost-
effectiveness of intervention  
 
Inconclusive, related 
to:  
 
1) Inconsistent 
sourcing of data upon 
which CEA was 
based, integrating 
published cost data 
for control, and only 
using data estimates 
not similarly 
verifiable, for 
intervention cost 
 
 2)  No comparative 
resource data or 
associated stratified 
cost comprising the 
CEA numbers for the 
reader to critically 
appraise 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
 
 
 
 
 
 
 
 
Feb.17, 2017 
£ 1.00 Great Britain  
= $1.62 Canadian 
£ 0.62 Great Britain =  
$1.00 Canadian 
4) **Patient Satisfaction  
a. 3 months  
NP  52% (1294/2498)  
Control 45% (276/618)  
Difference 7% (95% CI 3 to 12) p = 0.001 
 
b. 6 months 
NP 64% (1428/2236)  
Control 53%  (289/546)  
Difference 11% (95% CI 6 to 16) p <0.001 
Patient Perception of Problem as Mild or None 
a. 3 months  
NP 74% (819/2468) 
Control 68% (416/614)  
Difference 6% (95% CI  2 to 10) p = 0.003 
 
b. 6 months  
NP 79% (1721/2181)  
Control 70% (380/545)  
Difference 9% (95% CI  5 to 13) p <0.001 
 
Krichbaum, 2007 
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U.S. 
 
Pilot RCT to test the 
effectiveness of a 
nursing intervention 
IPT ^^ 
Six  month  
intervention in a 
12 month study 
period 
 
Outpatient / 
Specialized 
33 hip fracture 
surgery 
outpatients at 
least 65 years, 
admitted from 
home or 
assisted living 
facilities, and 
ambulatory 
prior to 
Diagnosis 
 
Prescribing 
(medication 
reconciliation) 
 
Strategies for 
Behaviour 
Change 
1) Self-rated 
health 
2) Level of 
geriatric 
depression  
3) Activities of 
daily living or 
ADLs: basic 
Endpoints not pre-specified as primary / secondary 
 
Mean (SD) symptoms / function  at 12 months 
 
1) Self-rated health (Global Health (GH) self-ratings - 
higher scores better) 
 
NP 4.1 (0.95) Control 4.0 (0.71)  
Difference non-significant 
 
Findings provide 
effect sizes that may 
be useful in designing 
larger studies for 
further tests of the 
Post-Acute Care 
Coordination (PACC) 
model on older adults 
recovering from hip 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
model: the Post-
Acute Care 
Coordination (PACC) 
model, for 
improvement in 
health, function, and 
return-home 
outcomes in elders 
with hip fracture 
 
 
 
Secondary 
Prevention  
reducing risks / 
threats to health in a 
condition that has 
already occurred to 
halt or slow 
progress
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Referral  
 
Patients were 
recruited from 
two hospitals in 
St. Paul, 
Minnesota  
 
 
Mobile NP 
followed the 
patient to all 
discharge 
locations, 
including 
subacute care 
facilities, long 
term care 
facilities, 
rehabilitation 
agencies, and 
private homes 
hip fracture 
Intervention = 
usual care + 
post-acute care 
coordination by 
gerontologic NP 
with experience 
in orthopedics   
(n=17) 
 
 
Control = usual 
care according 
to hospital and 
individual 
surgeon’s 
protocols for the 
post-acute care 
period (n=16) 
 
self-care tasks, 
skills usually 
learned in early 
childhood, and 
instrumental 
activities of 
daily living or 
IADLs: 
complex skills 
needed to 
successfully live 
independently, 
usually learned 
during teenage 
years, measured 
by the  
Functional 
Status Index 
2) Depression (Geriatric Depression Scale - higher 
scores worse)  
 
NP 2.2 (2.4) Control 1.7 (1.7) 
Difference non-significant 
 
 
3) Activities of daily living (ADLs higher scores 
worse) 
 Mobility 
NP 1.42 (0.48) Control 1.24 (0.34)  
 Personal care 
NP 1.22 (0.32) Control 1.41 (0.53)  
Differences non-significant 
 
 
Instrumental ADLs (IADL) (higher scores worse) 
 Home chores 
NP 1.44 (0.19) Control 1.48 (0.51)  
 Social 
NP 1.54 (0.61) Control 1.39 (0.49) 
Differences non-significant 
 
fracture surgery 
 
High attrition (30%; 
10/33) on a very 
small sample:   
4 patients withdrew: 
3 control 
and 1 intervention 
 
6 patients died:  
3 from each group - 
3 to cancer,  
1 from myocardial 
infarction,  
1 from stroke, and  
1 from post-operative  
complication 
 
Dierick-van Daele, 
2009 
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Netherlands 
To evaluate process 
and outcomes of care 
provided to patients 
RS ^ 
 
Two week 
intervention 
within a study 
duration of 6 
months  
1,591 primary 
health care 
(PHC) patients 
16 years and 
older, with 
common 
complaints 
regarding 
Diagnosis 
Prescribing  
 
Education 
1) Duration of 
consultation  
2) Medical 
resource use 
3) Number of 
prescriptions 
Endpoints not pre-specified as primary / secondary 
 
1) Mean (SD) duration of consultation (minutes) 
NP 12.22 (5.7 minutes)    GP 9.20 (4.8 minutes) 
p < 0.001 
 
1) 2) Medical resource use 
 Investigations 
No psychometric 
properties 
information for study 
questionnaires, but 
only a justification of 
validity according to 
study authors’ 
assurance on 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
with common 
complaints by GPs or 
specially trained NPs 
as first point of 
contact in primary 
health care clinics in 
the Netherlands 
 
 
Secondary 
Prevention  
reducing risks / 
threats to health in a 
condition that has 
already occurred to 
halt or slow 
progress
13
 
 
 
 
 
 
Post hoc analysis 
Dierick-van Daele 
(2010) 
Economic evaluation 
of nurse 
practitioners vs GPs 
in treating common 
conditions 
Appendix I-7 
 
Primary Health 
Care  
 
 
Trial affiliated 
with the School 
of Primary Care 
and  Public 
Health, 
University of 
Maastricht; 
Foundation for 
Development of 
Quality 
Care in General 
Practice, 
Eindhoven 
 
 
Patients who 
attended a general 
practice on a day 
when the NP was 
present were 
invited to 
participate in the 
trial that ran in 15 
general practices 
Study practices 
were also 
respiratory/ 
throat, ear/nose 
musculoskeletal
/skin injuries, 
urinary/ 
gynaecological 
and geriatric 
problems 
 
Intervention = 
patient care 
from newly 
graduated NP 
(Master Degree 
of Advanced 
Nursing 
Practice), 
experience 
ranging from 1 
to 5 years 
 
12 NPs 
(n = 817) 
 
Control = 
patient care 
from GP with 
an average of 
16 years’ 
experience  
 
given 
4) Patient 
satisfaction and 
patient 
perceptions of 
quality of care 
NP 2.4% (18/747)  GP 2.9% (19/650) 
p = 0.55  
 Referrals 
NP 12 % (90/747) GP 14.2 % (92/650) 
p =0.24 
 Asked to return 
NP 50.3% (340/676)  GP 41.3% (250/604) 
p = 0.001 
 Returned for same continuing problem  
NP 23.5% (121/515)  GP 18.3% (89/487) 
p = 0.040 
 Mean (SD) length of absence from paid job 
due to illness (days) 
     NP 1.11 (0.32)  GP 1.11 (0.31) 
 
3) Numbers of prescriptions given  
 
 One prescription  
NP 55.0% (411/747)  GP 54.2% (352/650) 
Difference 0.8%,  p = 0.75 
 Two prescriptions 
NP 16.9% (126/747)  GP 19.5 % (127/650) 
Difference 2.6%,  p = 0.20 
 Three or more prescriptions  
NP 8.8% (66/747)  GP 7.8% (51/650) 
Difference 1.0%, p = 0.51 
 
4) Mean (SD) patient satisfaction and patient 
perceptions of quality of care 
 
 Patient satisfaction for patients in NP group  
who reported at least one chronic disease 
discussion with 2 
GPs with research 
experience. 
The questionnaires 
were next tested on a 
group of 40 patients, 
resulting in two 
textual refinements as 
well as “asking the 
name of the 
practitioner instead of 
type of practitioner 
(NP or GP) 
consulted.” 
 
Baseline differences 
in study design 
included a booking 
time set at 15 minutes 
for NPs versus 10 
minutes set for GPs 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
 
 
Feb. 17, 2017 
€1.00 Euro = $1.53 
Canadian  
€0.72 Euro = $1.00 
Canadian   
 
compared to 
external reference 
practices where 
17 GPs worked in 
5 general 
practices without 
involvement of 
NPs 
 
50 GPs 
(n = 684) 
 
(583/1591patients) 
NP 8.35 (1.07)   UC 8.11 (1.32)   p = 0.02 
 
All other patient satisfaction measures were 
non-significant  
 
 Patient perceptions of quality of care at 6 
months 
NP 8.19 (1.18)   GP 8.20 (1.26)   p= 0.83 
 
McCorkle, 2009
52
  
 
U.S. 
 
To evaluate the 
effectiveness of an 
intervention provided 
by an oncology NP 
and a psychiatric 
liaison NP on women 
post-surgery for 
suspected diagnosis 
of ovarian cancer, for  
cancer-specific and 
global quality of life 
(QOL) outcomes, 
compared to an 
attention control   
IPT ^^ 
 
 
Six month study 
duration 
 
 
Outpatient / 
Specialized 
Referral  
 
 
Patient contact 
made at private 
homes or by 
telephone, 
northeast 
Connecticut 
 
Trial approved by 
Yale University, 
New Haven, 
Connecticut 
149 female 
outpatients with 
suspected 
primary 
diagnosis of 
ovarian cancer 
after abdominal 
surgery; 
21 years or 
older, with 
prognosis of at 
least 6 months 
and an order to 
initiate 
chemotherapy   
 
Intervention  = 
18 contacts by 
an oncology 
NP, supported 
by psychiatric 
Diagnosis 
Prescribing 
  
Strategies for 
Behaviour 
Change 
 
Care 
Coordination 
 
 
 
 
 
*Quality of Life 
(QOL) 
1. Cancer 
specific 
a) Center for 
Epidemiological 
Studies-
Depression 
(CES-D) 
(total score 
range 0 to 60; 
score > or = to 
16 indicates 
impairment) 
b) Ambiguity 
subscale of the 
Mishel 
‘Uncertainty in 
*QOL was measured at baseline (24–48 hours after 
surgery) 1, 3, and 6 months post-surgery 
 
Adjusted QOL baseline scores were included as 
covariates in 3 types of mixed effect regression 
models, built to estimate ‘rates of change’ (effect 
estimates) in different QOL measures over time: 
(1) Oncology NP intervention without PSYNP  
- Rate of reduction in MUIS score was significantly    
greater for intervention vs control 
              Uncertainty of Illness (MUIS)  
effect estimate = - 0.04847 ± se 0.01394,  p = 0.0006  
- Rate of change in CES-D, SDS and SF-12 physical 
scores was significantly greater for control vs  
intervention 
              CES-Depression (CES-D) 
effect estimate = 0.06566 ± se 0.02190,  p = 0.0030  
              Symptom Distress Scale (SDS) 
effect estimate = 0.05092 ± se 0.01638,  p = 0.0021  
              SF-12 physical component 
Baseline measures 
were obtained prior 
to randomization, 
with significant 
differences found in 
three out of five QOL 
scores, and lower 
baseline QOL in the 
NP intervention 
group 
 
Baseline QOL scores 
were adjusted for 
model testing, with 
final covariates 
including age, marital 
status, number of 
comorbidities, 
disease status 
(recurrence or not), 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
 
 
Secondary 
Prevention  
reducing risks / 
threats to health in a 
condition that has 
already occurred to 
halt or slow  
progress;
13
 without a 
definitive diagnosis 
of ovarian cancer 
(only suspected), this 
study is classified as 
secondary prevention 
with regards to 
ovarian cancer, the 
study’s target disease 
 
 
 
Post hoc analysis 
McCorkle (2011) 
Healthcare utilization 
in women after 
abdominal surgery 
for ovarian cancer 
Appendix I-6 
 
 
 
Variable within 
intervention = use 
of  psychiatric NP 
(PSYNP) when 
high emotional 
distress (Distress 
Thermometer  > 
or = to 4)  
 
NP (PSYNP) 
consults (32/74 
intervention 
patients)  when 
warranted for 
high emotional 
distress = 
Distress 
Thermometer  > 
or = to 4 
 
(n=74)  
 
Attention 
Control = nine 
contacts by 
research 
assistant, 
supported by 
medical social 
worker (no data 
for patient 
contact with 
social worker) 
 
(n = 75) 
 
 
 
Illness’ Scale 
(MUIS) (scores 
range 13 to 65; 
higher scores, 
more 
uncertainty) 
c) Symptom 
Distress Scale 
(SDS) (rated 
from 1to 5; :1 
indicates 
absence/low 
symptoms & 5 
indicates high 
symptom 
severity ) 
2. Overall / 
Global (non-
cancer specific) 
Quality of Life 
(QOL) 
a) SF-12 
physical 
component  
b) SF-12 mental 
component  
effect estimate = - 0.07599 ± se 0.02425,  p = 0.0019  
- Non-significant rate of increase in global, mental 
QOL for intervention vs control 
                   SF-12 mental component  
effect estimate = 0.01776 ± se 0.01138,  p = 0.1195   
 (2) Oncology NP intervention with PSYNP 
 Rate of reduction in MUIS score & rate of 
improvement in the SF-12 score was 
significantly greater for intervention vs 
control 
Uncertainty of Illness (MUIS)  
effect estimate = - 0.03917 ± se 0.00915,  p < 0.0001  
SF-12 mental component 
effect estimate = 0.02300 ± se 0.00748,  p = 0.0023  
 
 Rate of change in CES-D scores was 
significantly greater for control vs 
intervention  
CES-Depression (CES-D) 
effect estimate = 0.03594 ± se 0.01213,  p = 0.0033  
 Poor model fit - no effect estimate data for 
SDS or SF-12 physical  
Symptom Distress Scale (SDS) 
                      SF-12 physical component 
 
(3) PSYNP separate from Oncology NP  
The PSYNP component significantly increased the 
rate of improvement over time in all QOL 
measures except for the CES-D 
and education level 
 
Cancer care that 
addresses both 
physical and 
emotional QOL in 
synchrony, may 
contribute to 
enhanced rate of 
improvement in QOL 
as per study  
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
 
 
 
 
 
 
Uncertainty of Illness (MUIS) 
effect estimate = - 0.04978 ± se 0.02094, p = 0.0181  
Symptom Distress Scale (SDS) 
effect estimate = - 0.1164 ± se 0.01284, p < 0.0001  
SF-12-mental component 
effect estimate = 0.06558 ± se 0.01676, p = 0.0001  
SF-12-physical component 
effect estimate = 0.1948 ± se 0.03877, p < 0.0001  
-Non-significant rate of change greater for control 
vs intervention 
CES-Depression (CES-D) 
effect estimate = 0.01662 ± se 0.03549,  p = 0.6400  
ter Bogt, 2009 
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Netherlands 
 
To investigate the 
long-term effects of 
lifestyle counseling 
by NPs, and its 
potential contribution 
to counteracting 
rising trends of 
overweight/obesity 
Hypothesis -an early 
RS ^ 
 
One year duration 
to the Groningen 
Overweight and 
Lifestyle (GOAL) 
study, Groningen 
 
Primary Health 
Care 
 
 
 
 
457 Primary 
Health Care 
patients with 
BMI 25- 40, 
and either 
hypertension, 
dyslipidemia or 
both 
 
Intervention = 
low-intensity 
(for prevention 
of additional 
weight gain) 
lifestyle 
counseling by 
NPs over one 
Diagnosis 
Prescribing 
  
Strategies for 
Behaviour 
Change 
 
Care 
Coordination 
1) *Changes in 
body weight 
after one year of 
intervention 
 
 
2) **Waist 
circumference  
 
 
 
1) *Percentage change in body weight at 1 year 
 
   NP -1.9% (95% CI -2.5, -1.2) 200/225 patients 
         UC -0.9% (95% CI -1.5, -0.2) 214/232 patients 
         Difference 1.0%, p < 0.05 
 
Weight losers (successful) and stabilizers 
(percentage of subjects who gained less than 1% 
body weight by end of study) at 1 year 
 Women 
NP 72.8% (75/103) patients  
GP 64.0% (73/114) patients  
Difference 8.8% non-significant  
 Men 
NP 80.6% (79/98) patients  
GP 65.3% (66/101) patients  
Difference 15.3%, p <0.05  
 
Attrition 9% 
(41/457); 24 
intervention patients 
+ 17 control patients  
 
General linear model 
showed that gender is 
an effect modifier; 
data thus reported 
separately for men & 
women  
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
focus on preventing 
progression of 
overweight 
/comorbidities 
through weight 
stabilization, versus 
weight loss, may be 
more successful in the 
long term. 
 
 
 
 
 
 
 
Secondary 
Prevention  
reducing risks / 
threats to health in a 
condition that has 
already occurred to 
halt or slow 
progress;
13
 although 
obesity is now 
considered a chronic 
disease, it is 
reversible, thus 
secondary prevention 
 
 
11 general 
practice locations 
(1-7 GPs and 1-3 
NPs per location), 
Groningen, 
northern 
Netherlands 
 
 
 
 
 
 
 
 
 
 
 
 
 
Obesity: Body 
Mass Index 
(BMI)  > or =  
30 kg/m
2
 
 
 
Moderately 
Overweight:  
BMI = 25 - 30 
kg/m
2
 
 
 
year: 4 
individual visits 
and 1 feedback 
session by 
telephone 
 
(n =225)  
 
 
 
Control = usual 
primary health 
care (PHC) 
from GPs 
 
(n = 232)  
 
 
 
 
 
 
 
 
 
3) **Blood 
pressure, total 
cholesterol, and 
fasting glucose 
one year after 
intervention 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2) **Mean (SD) waist circumference at 1 year  
 
 Women 
NP -2.0 cm (7.8) on 103/225 female patients 
GP -1.5 cm (6.8) on 114/232 female patients  
Difference 0.5 cm  non-significant 
 Men 
NP -2.8 cm (6.2) on 98/225 male patients 
GP -0.9 cm (4.5) on 101/232 male patients   
Difference 1.9 cm,  p < 0.05 
 
3) **Blood pressure, total cholesterol, and fasting 
glucose one year after intervention 
 
a. Systolic blood pressure (SBP) reduction in 
obese men (BMI > or = 30 kg/m
2
) 
NP -14 mmHg; UC -5 mmHg  
Difference = 9 mmHg reduction  
p < 0.05 
 
b. Systolic blood pressure (SBP), mean 
reduction (SD)  
 Men  (BMI 25 - 40 kg/m2)  
NP -8.5 (16.8) mmHg  
UC -5.3 (12.7) mmHg  
Difference = 3.2 mmHg reduction 
non-significant  
 Women (BMI 25 -40 kg/m2)  
NP -5.3 (20.1) mmHg   
UC -2.2(16.5) mmHg  
Difference = 3.1 mmHg reduction 
non-significant  
 2
2
9
 
 
Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
Post hoc analysis 
ter Bogt (2011) 
Preventing Weight 
Gain by Lifestyle 
Intervention 
in a General Practice 
Setting 
Three-Year Results of 
a Randomized 
Controlled Trial, 
American Medical 
Association 
Appendices I-2, I-3 
Post hoc analysis 
ter Bogt (2011) 
Changes in 
lifestyle habits 
after counselling 
by nurse 
practitioners: 1-
year results of the 
Groningen 
Overweight 
and Lifestyle 
study, 
Public Health 
Nutrition  
Appendix I-3 
Post hoc 
analysis 
Driehuis (2012) 
Maintenance of 
lifestyle 
changes: 3-Year 
results of the 
Groningen 
Overweight and 
Lifestyle study, 
Patient 
Education and 
Counselling 
Appendix I-3 
 
 
 
 
 
 
 
 
c. Total cholesterol, mean change (SD)  
  
Women & Men (BMI 25 -40 kg/m
2
)  
Between group differences non-significant 
 
d. Fasting Glucose, mean reduction (SD) 
 
Women & Men (BMI 25 -40 kg/m
2
) 
Between group differences non-significant 
 
Schuttelaar, 2010 
59
 
Netherlands 
To compare the level 
of care by NPs with 
that by dermatologists 
in children with 
atopic dermatitis 
(eczema) 
Secondary 
Prevention  
reducing risks / 
threats to health in a 
condition that has 
RS ^ 
1 year study 
Outpatient / 
Specialized 
Referral  
 
 
 
Dermatology 
outpatient clinic 
of the University 
Medical Center in 
Groningen 
160 patients  < 
16 years:  
80 patients < or 
= to 4 years & 
80 patients  
4–16 years, 
all new referrals 
from GPs or 
pediatricians 
with a diagnosis 
of eczema  
 
Intervention = 
NP-led care 
(n=81) 
Diagnosis 
Prescribing 
  
Strategies for 
Behaviour 
Change 
 
 
1) *Change in 
quality of life of 
the child  at 12 
months 
measured by the 
Infants’ 
Dermatitis 
Quality of Life 
Index for 
children aged < 
or = to 4 years 
or by the 
illustrated 
version of the 
Children’s 
1) *Eczema-specific Quality of Life (higher scores 
representing a poor quality of life) at 12 months 
 
 Infants’ Dermatitis Quality of Life Index, 
mean (SD) 
NP 5.7 (5.4); Dermatologist 5.6 (3.9), p= 0.26 
 
 Children’s Dermatology Life Quality Index, 
mean (SD)  
NP 4.9 (3.5), Dermatologist 5.6 (4.2), p= 0.55 
 
2) **Eczema severity at 12 months, mean (SD)  
 
NP 13.2 (16.6) (73/81) 
Dermatologist  13.1 (17.1) (70/79) 
Intervention 
treatment  
primarily carried out 
by one NP in single 
dermatology 
outpatient clinic 
 
The impact of 
pediatric eczema on 
family may be 
similarly managed by 
NP care as by 
dermatologist care as 
per study, in a patient  
population that was 
 2
3
0
 
 
Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
already occurred to 
halt or slow 
progress
13
 
 
Post hoc analysis 
Schuttelaar (2011) 
Costs and cost-
effectiveness analysis 
of treatment in 
children with eczema 
by NP vs 
dermatologist: results 
of a randomized, 
controlled trial 
and a review of 
international costs 
Appendix I-6 
 
 
 
 
 
 
 
 
 
Feb. 17, 2017 
€1.00 Euro = 
$1.53 Canadian  
€0.72 Euro = 
$1.00 Canadian   
 
Age < or = to 4 
years    (n=40) 
 
Age 4-16 years 
(n=41) 
 
Control = 
conventional 
care by 
dermatologist  
(n =79) 
 
Age < or = to 4 
years   (n=40) 
 
Age 4-16 years 
(n=39) 
Dermatology of 
Life Quality 
Index for 
children aged 
4–16 years 
2) **Eczema 
severity 
3) **Family 
impact of 
childhood 
eczema 
4) **Patient 
satisfaction at 4, 
8, and 12 
months 
Difference was reported as 0.2  
(95% CI 5.4 to 5.7)  p = 0.9 
3) **Family Impact of childhood eczema 
Between groups differences were not statistically 
significant at baseline, 4, 8, or 12 months, nor for 
groups stratified by age of children 
 
4) **Patient satisfaction at 4, 8, and 12 months,  mean 
scores (SD)   
 4 months 
NP 27.1 (3.9); Control 24.4 (3.4), p < 0.001 
 8 months 
NP 27.3 (4.0); Control 24.3 (3.3), p < 0.001 
 12 months 
NP 26.9 (4.9); Control 24.8 (4.3), p < 0.023 
representative of 
normal referrals from 
GP to specialist care 
 
Enguidanos, 2012
65
 
U.S. 
Pilot RCT to assess 
whether a ‘Brief NP 
Transition’ (BNPT) 
intervention could 
improve patient self-
efficacy and patient  
satisfaction, as well 
as reduce medical 
service use among 
IPT ^^ 
6 month study 
duration 
 
 
Outpatient / 
Specialized 
Referral 
 
 
Set in a managed 
199 at-risk 
hospitalized 
older adults 
discharged 
home without 
in-home care 
(e.g. home 
health/hospice) 
or caregivers; 
recruited from 
hospital prior to 
discharge 
Intervention = 
Diagnosis 
Prescribing 
(medication 
reconciliation) 
  
Education 
Care 
Coordination 
1) Efficacy in 
Self-Care  
 
 
 
 
2) Home Care 
Patient 
Satisfaction 
Measure 
 
 
Endpoints not pre-specified as primary / secondary 
 
1) Efficacy in Self-Care at 6 months 
 
No significant differences between groups  
 
 
 
2) Patient satisfaction at 3 months 
 
No significant differences between groups  
 
 
Attrition on follow-
up surveys resulted in 
a 65% response rate, 
limiting detection of 
between-groups 
differences  
 
 
NP support on 
transition from 
hospital to home, 
during a high-risk 
period for older 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
hospitalized older 
adults discharged to 
home,  who do not 
qualify for home 
health care services, 
hospice, or palliative 
care 
 
 
Secondary 
Prevention  
reducing risks / 
threats to health in a 
condition that has 
already occurred to 
halt or slow 
progress
13
 
care medical 
center, or Health 
Maintenance 
Organization 
(HMO), Los 
Angeles County, 
California 
 
 
Brief NP 
Transition, a 
‘bridge’ of up to 
3 home visits, 2 
phone calls 
from primary 
health care NP, 
within 72 hours 
of discharge 
(n = 100) 
 
Control = 
standard 
medical care, 
including access 
to case 
management 
services (wait 
time 2-14 days) 
(n =99) 
3) Emergency 
room visits, 
hospital re-
admission, days 
re-hospitalized, 
number of 
physician office 
visits, and home 
health care days 
3) Mean (SD) Resource Utilization at 6 months 
 
Emergency room  visits 
NP 0.50 (1.2)  Control 0.99 (2.5)  p =0.096 
 
Hospital re-admission rate  
NP 40%  Control 44.4%  p = 0.526 
 
Days re-hospitalized 
NP 3.78 (8.8)  Control 3.49 (6.5)  p = 0.514 
 
Physician office visits 
NP  9.94 (8.5)  Control 11.72 (7.7)  p = 0.036  
 
Home health care days  
NP 4.99 (8.7)  Control 5.57 (9.3)  p = 0.485 
 
adults, can reduce 
primary health care 
visits as per study 
 
McClellan, 2012 
63
 
 
England 
 
To evaluate the 
clinical effectiveness 
of soft tissue injury 
RS ^ 
Equivalence 
Trial: designed to 
show that two 
interventions do 
not differ in either 
direction by more 
than a pre-
specified 
372 patients 
with peripheral 
soft tissue 
injury,  older 
than 16 years, 
were eligible for 
management by 
any of  three 
professionals:  
 
 
Diagnosis  
 
Prescribing  
 
Clinical 
Procedures  
 
Education 
1) *Functional 
recovery to 
upper / lower 
extremity  
 
2) 
**Preference-
based health 
utility scores 
using the 
1) *Functional recovery to upper / lower extremity  
at 8 weeks  
 
 Percentage return to normal function;  MCID (minimal 
clinically important difference) of 9  
  
95% CIs  
Dr    45 to 80 (63.3%), (68/123) 
ESP 52.5 to 65.0 (59.2%), (72/126) 
ENP 55.0 to 66.3 (60.0%), (73/123)  
 
Equivalence margin 
was set at five, 
calculated using the 
smallest minimal 
clinically important 
difference (MCID) 
from all outcome  
measures 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
management by 
emergency NPs and 
extended scope 
physiotherapists 
compared to routine 
care provided by 
doctors in an 
emergency 
department (ED) 
Secondary 
Prevention  
reducing risks / 
threats to health in a 
condition that has 
already occurred to 
halt or slow 
progress
13
 
Post hoc analysis 
McClellan (2013)  
A randomised trial 
comparing the cost 
effectiveness of 
different emergency 
department 
healthcare 
professionals 
in soft tissue injury 
management 
Appendix I-5 
unimportant or 
insignificant 
amount, the 
equivalence 
margin  
(i.e. a two-sided 
statistical test)
85
    
 
Eight week study 
period 
 
Acute Care 
Emergency 
Department 
 
 
A single, inner 
city, adult ED 
of University 
Hospitals 
Bristol NHS 
Foundation Trust 
 
Feb.17, 2017 
£ 1.00 Great 
Britain  = $1.62 
Canadian 
£ 0.62 Great 
Britain =  $1.00 
Canadian 
Emergency NPs 
(ENPs), 
Extended Scope 
Physiotherapists 
(ESPs),  
ED Doctor  
 
Intervention = 
patient 
management  
from arrival to 
discharge by 
ENP or ESP 
ENP (n = 123)  
ESP (n = 126) 
 
 
 
 
 
Control = 
routine ED 
Doctor care 
from arrival to 
discharge 
 
( n =123) 
Short Form-6D 
(SF-6D) 
 
3)**Medication 
administration  
 
4) **Global 
quality of life 
(SF-36) 
 
 
5) **Number of 
days unable to 
work 
 
2) **Preference-based health utility scores at 8 weeks 
for percentage recovery; MCID of 5 
95% CIs  
Dr    86.2-105.8 (92.2%) (68/123)  
ESP 93.2-100 (94.3%) (72/126)  
ENP 87.8 to 99.5 (92.2%) (73/123) 
 
3) **Medication administration 
 
Dr    42.2% patients  
ESP  3.6% patients 
ENP 23.2% patients 
Differences between groups p < 0.001  
4) **Overall Quality of Life at 8 weeks  
95% CIs to the Physical Component of SF-12v2 
 
Dr    −3.8-10.1 (3.2) on 68/123 patients 
ESP  0.2-4.6 (2.4) on 72/126 patients 
ENP 1.6-6.5 (4.1) on 73/123 patients 
 
5) **Numbers of days off work at 8 weeks; MCID of 5 
 
95% CIs 
Dr    (0.0 days - 6.0 days) n=68 
ESP  (0.75 days - 2.0 days) n=72 
ENP (1.0 days - 2.5 days) n=73 
 
ENPs and ESPs were 
reported to be 
clinically equivalent 
to routine care 
provided by doctors 
as per study  
 
 
Main analysis was by 
intention-to-treat; a 
per-protocol analysis 
was also undertaken 
(McClellan, 2012, 
p.3), though no per-
protocol data is 
shown 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
Johnson-Mallard,  
2007 
70
 
 
 
U.S. 
 
To test the effects of 
an educational / 
behavioural 
intervention on 
knowledge and 
perceived risk of 
sexually transmitted 
infections (STIs) in 
women of 
childbearing age, 
presumably in good 
health at baseline    
 
 
Primary 
Prevention: 
preventing disease or 
injury before it ever 
occurs
13
 
IPT ^^ 
 
Study duration 
two weeks 
 
 
Primary Health 
Care 
 
 
 
Set at two 
different 
American 
universities; study 
authors affiliated 
with the 
University of 
South Florida, 
Tampa, Florida 
 
104 female 
college 
students, 18 - 
48 years  in 
presumably 
good health, 
and not yet 
exposed to 
lectures on 
sexually 
transmitted 
infections 
(STIs) 
  
Intervention = a 
brief, 30 minute 
educational / 
behavioral 
intervention 
delivered by an 
NP at one week 
(n =51) 
 
 
Control = no 
educational / 
behavioral 
intervention 
(n = 53) 
 
Only 1domain: 
 
Education 
 
 
6) 1) Knowledge 
of sexually 
transmitted 
infections 
(STIs), 
including 
knowledge of 
pre and post-
natal morbidity 
/ mortality 
 
 
 
7) 2) Perceived 
risk of sexually 
transmitted 
infections 
(STIs) 
Endpoints not pre-specified as primary / secondary 
 
1) Mean (SD) STI knowledge two weeks following 
pre-test (higher scores indicate greater knowledge) 
one week post-intervention 
 
NP  26.1 (2.6) 
Control  21.0 (2.3) 
 
p < 0.0001 
 
 
 
2) Mean (SD) perceived risk of STI (lower scores 
indicate lower perceived risk) at 2 weeks 
 
NP 4.0 (1.0)  
Control 7.9 (2.3)  
 
p < 0.0001 
 
 
 
Findings may assist 
NPs in reducing 
knowledge gaps 
related to STI 
morbidity associated 
with reproductive 
health: pelvic 
inflammatory disease,  
chronic pelvic pain, 
infertility, ectopic  
pregnancy, 
compromised birth 
outcomes (premature 
delivery, stillbirths, 
neonatal deaths, 
and infant disorders), 
and cervical cancer  
 
 
 
 
 
At the time of this 
trial, women were 
being diagnosed 
with two-thirds of the 
estimated annual 12 
million new cases of 
STIs in the U.S. 
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
Hannan, 2012 
69
 
 
 
 
 
U.S.   
 
 
To examine the 
effects of a low cost 
telephone 
intervention provided 
by a pediatric NP, for 
the first two months 
post-birth in low-
income families of 
healthy, first time 
mothers who 
delivered a healthy, 
full-term single infant 
 
 
Primary 
Prevention: 
preventing disease or 
injury before it ever 
occurs
13
  
RS ^ 
 
 
 
Primary Health 
Care 
 
 
 
Intervention 
occurred for first 
2 months post-
birth, delivered 
offsite via 
telephone. Study 
patients were 
recruited prior to 
discharge from 
Jackson 
Memorial 
Hospital, in the 
inner city of 
Miami, South 
Florida  
 
 
 
 
139  healthy 
first-time 
mothers,  
18 years or 
older, each of 
whom delivered 
a healthy, full-
term single 
infant; low-
income family  
Intervention = 
follow-up 
phone-calls  by 
pediatric NP 
with ‘back-up’ 
pediatric 
physician 
available for 
consultation   
  
(n =70) 
 
Control = 
routine hospital 
discharge and a 
pediatrician 
appointment in 
2 months     
 
(n =69) 
Diagnosis 
 
Education 
 
Care 
Coordination 
 
 
 
 
NPs were 
Masters 
prepared 
pediatric 
NPs with a 
minimum of 
10 years’ 
experience; 
salary of 
$40.21/ hour, 
from  
Area Health 
Education 
Center 
(AHEC) data 
base 
 
1) Maternal 
health: 
perceived stress, 
social support, 
physical health 
  
 
 
2) Infant health: 
routine medical 
visits for 
immunizations, 
weight gain 
measurements 
 
 
 
3) Infant 
morbidity: 
urgent care 
visits, 
Emergency 
Room (ER) 
visits, re-
hospitalizations  
Endpoints not pre-specified as primary / secondary 
 
1) Maternal Health Outcomes at 2 months Post Birth  
 Mean (SD) Perceived Maternal Health  
NP 18.61 (1.74); Control 17.2 (2.69) 
p < 0.0004   
 Mean (SD) Perceived Stress  
NP 14.71(3.95); Control 24.64(4.61) 
p < 0.0001 
 Perception of Social Support 
Differences non-significant 
2) Infant Health Outcomes at 2 months Post Birth 
 Infant vaccinations  
NP 92.8% (65/70); Control 84.1% (58/69) 
p = 0.186 
 Weight Gain 
Differences non-significant 
 
3) Infant Morbidity at 2 months Post Birth 
 Urgent-care-centre visits  
NP 3.6% (5/139); Control 2.2% (3/139) 
p = 0.48 
 Emergency room visits  
NP 7.2% (10/139); Control 11.5% (16/139) 
p = 0.179 
 Hospitalizations  
NP 0.7% (1/139); Control 2.2% (3/139) 
p = 0.30 
 
 4) Mean (SD) healthcare charges (not total costs) at 2        
months 
Attrition: 7/70 (10%) 
intervention mothers 
were unable to be 
contacted post-
discharge due to dis-
connected telephones  
 
 
 
 
As per study, follow-
up phone calls by a 
pediatric NP to low-
income first-time 
mothers in good 
health, with healthy 
full term infants, can 
be an effective, safe, 
and relatively  low 
cost intervention that 
may improve 
maternal and infant 
health outcomes  
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Author, Year 
Country 
Purpose 
  
Level of     
Prevention 
 
Design, Duration 
Setting                
 Patients (N)                   NP 
Intervention 
Domains 
 
Endpoints 
  
Outcomes 
Outcome data analyzed by Intention to Treat, on the 
basis of all randomized patients, as randomized, unless 
otherwise noted 
 
Comments 
 
Feb. 17, 2017 
$1.00 U.S =  
$1.31 Canadian 
$0.76 U.S. = 
$1.00 Canadian  
 4)Associated 
health care 
charges: urgent 
care visits, 
Emergency 
Room (ER) 
visits, re-
hospitalizations, 
and NP phone 
service 
 
 Urgent-Care-Centre 
NP $376 ($27) range $294-$482 
Control $351($15)  range $267–$402 
p = 0.47 
 Emergency Room  
NP $104 ($267) range $365-$1,080 
Control $245 ($538) range $298–$2,410 
p  = 0.13 
 Hospitalizations 
NP $51 ($423) range $3,547 (only 1 
hospitalization);  
Control $764 ($3,847) range $9,153–$24,012 
p = 0.29 
 NP phone service  
Average total phone-calls $23.83 / mother  
     Total NP group phone-calls $1,598.00 ($7.61)   
     Control N/A 
 
Total Healthcare charges  
NP $14,333   Control $70,834  
 Difference $56, 501, p < 0.05 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Primary Endpoint     **Secondary Endpoint    ^ Role Substitution (RS)      ^^ Interprofessional Team (IPT) 
 
17   Tertiary (3
0
) Prevention
13
 RCTs   
Pioro (2001),
71
 Allen (2002),
44
 Jones (2002),
66
 Ansari (2003),
45
 Hill (2003),
55
 Tranmer (2004),
46
 Fairall (2005),
8
 Goessens (2006), 
47
 Nathan (2006),
49
 McCarrier (2009),
7
 
Mitchell (2009),
54
 Ralston (2009),
6
 Huizinga (2010),
51
 Kim (2013),
53
 Sawatsky (2013),
48
 Berkhoff (2014),
50
 Mertens (2014)
68
 
10   Secondary (2
0
)
 
Prevention
13
 RCTs  
Ganz (2000),
61
 Cooper (2002),
62
 Williams (2005),
60
 Krichbaum (2007),
64
 Dierick-van Daele (2009),
67
 ter Bogt (2009),
56
 Schuttelaar (2010),
59
 McCorkle (2009),
52
 Enguidanos 
(2012),
65
 McClellan (2012)
63
      
2 Primary (1
0
)
 
Prevention
13
 RCTs   Johnson-Mallard (2007),
70
  Hannan (2012)
69
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Appendix K Landmark RCTs Conducted upon the Formal Origin of the NP Role 
Author, Year 
Country 
 
Setting & Site 
 
Duration & 
Design 
 
Intervention 
 
Endpoint-Outcomes 
 
 
 
Comments 
 
Spitzer
29
 1974 
Burlington, 
Ontario, Canada 
 
 
Primary Health 
Care  
Single family 
practice clinic, not 
associated with 
university or 
hospital 
 
 
One year study 
from July 01, 1971- 
July 01, 1972 
 
RS^ Cluster RCT  
 
Unit of random 
allocation =  family 
Definition of 
‘family:’ person or 
group sharing a 
common provincial 
health insurance 
number 
 
 
Non-Inferiority 
Trial: to assess the 
effects of NP care 
compared to GP 
care on patient 
outcomes   in a 
single family 
practice clinic, with 
the non-inferiority 
margin set at 5%. 
Five% worse = 
greatest degree of 
worse functional 
outcomes tolerated 
from NP care 
before declared 
“inferior”97  
 
  
Intervention = NP 
care; families 
equally divided 
between 2 NPs 
 
n = 540 families, 
including 
1529/4325 patients  
 
Control = GP care; 
families equally 
divided between 2 
GPs 
n = 1058 families, 
including 
2796/4325 patients 
 
2:1 Ratio of 
Random Allocation 
of 1598 families, 
since one half of the 
family physician 
case load was 
considered 
appropriate for 
newly trained NPs 
 
 
Study Practitioners 
2 GPs with 9 & 14 
years’ experience 
2 Nurses with 11 & 
22 years’ 
experience, trained 
by  an inter-
professional 1 year, 
part-time program 
(from colleges of 
Nursing & 
Medicine at 
McMaster 
University, prior to 
start of trial) for the 
‘co-practitioner’ 
role of NP 
I. Patient Health Status at 
1 year 
1. Physical status of NP 
patients was at best, the 
same or 1-2 % lower 
than that in GP patients 
2. Emotional function was 
0.4% lower in the NP 
group, & social function  
was 0.7% higher in the 
NP group, compared to 
the GP group 
 
II. Clinician Activities  
Two methods to measure 
‘quality of care:’  
 
1. NP and GP management 
of 10 ‘indicator 
conditions’(select types 
of diseases, symptoms, 
states or injuries, not 
known to the GPs / NPs) 
Percent of episodes 
rated as ‘adequate 
management’ 
NP 69% of episodes 
GP 66% of episodes 
 
2. Prescribing for 13 
common drugs 
Percent of prescriptions 
rated as ‘adequate 
management’ 
NP 71% of prescriptions 
GP 75% of prescriptions 
 
III. Clinic Activities 
Intervention effect on 
clinic profits: 
5% drop in gross 
revenue, related to no 
billing for NP services. 
The  22% increase in 
families served, would 
have created a 9% 
increase in income for 
the clinic had regulations 
permitted billing for NP 
services 
Benefits 
experienced by 
new clinic 
families were 
not 
accompanied 
by a new 
model of care. 
 
Without 
changes made 
to address both 
types of 
clinicians’ 
services, by 
regulatory 
bodies 
governing 
reimbursement 
for services, 
the positive 
gains 
experienced by 
new clinic 
families were 
not sustained 
over the long 
term. 
 
Non-Inferiority 
Trial  One-
sided analysis 
showed a 
probability of 
NPs’ patients 
being ‘worse 
off’ by 5% or 
more,’ equal to  
0.008, or a 
likelihood of 1 
chance out of 
125 chances
97
 
 
At end of trial  
22% net 
increase to   
1952 clinic 
families, from  
original 1598 
clinic families  
At one year 
follow-up,  
June 30, 
1973 “New 
Plateau of 
Saturation”  
2256 clinic 
families, a 
41% net 
increase in 
families 
receiving 
care 
 
Post-
randomizati
on consent 
(Zelen 
design) for 
family’s 
clinical 
allocation, 
with option 
to decline 
 
Attrition 
7 families 
refused 
their 
assignment: 
2 from the 
GP group, 2 
from the NP 
group; 3 
families had 
a member 
under care 
by a GP for 
a long term 
condition 
Drop-out 
rate  
NP 0.9% 
GP 0.7%  
No 
individual 
data shown 
 Deaths 
NP 4 
GP 18 
 237 
 
Author, Year 
Country 
 
Setting & Site 
 
Duration & 
Design 
Intervention 
 
Endpoint-Outcomes 
 
 
 
Comments 
Spitzer
96
 1973 
southern Ontario, 
Canada 
 
Primary Health 
Care  
14 private  family 
practices not 
associated with 
university or 
hospital, located 
within 50 miles of 
Hamilton, 
excluding 
metropolitan 
Toronto 
 
 
Study period 12 
months; April 1971 
to March 1972 
 
IPT^^  RCT 
 
Unit of random 
allocation = nurse 
 
Seven nurses were 
randomly assigned 
to receive NP 
training; the 
corresponding 
practices became 
intervention 
practices  
 
Purpose: to assess 
the effect of the one 
year, part-time 
education program 
from the Colleges 
of Nursing and 
Medicine, 
McMaster 
University, on the 
roles of primary 
care NPs and GPs 
 
Intervention = care 
from ‘GP + NP’ 
 
n = 7 family 
practices; 7 RNs 
newly trained as 
NPs 
 
 
Control = usual care 
from ‘GP + RN’ 
n = 7 family 
practices  
 
Administration of 
questionnaires, time 
and motion studies, 
and observation of 
practices were 
undertaken by 
trained interviewers 
and observers from 
the Health Sciences 
Field Survey Unit of 
McMaster 
University 
 
Logistic difficulties 
prevented a true set 
of   “before” 
measurements, prior 
to start date of the 
trial. Obtaining the 
“before” 
measurements 
would have required 
an unacceptable 
postponement of the 
NP educational 
program. Instead 
‘Time 1’ values 
were measured in 
April & May 1971, 
as soon as possible 
after the onset of the 
trial; Time 2 was 
March 1972 
 
Research Questions 
1. What were the financial 
effects on practices, GPs and 
NPs?  
 
Intervention Practices 
Net earnings increased in 3 
practices, remained 
unchanged in 2, and 
decreased in 1 practice, 
without reimbursement for 
unsupervised NP services
98
 
 
Control Practices 
Net earnings increased in 1 
practice, remained unchanged 
in 4, and decreased in 1 
practice
98
 
 
 
2. a) What was the effect on 
job satisfaction for GPs, NPs 
and RNs?  
 
GPs’ satisfaction scores at 
intervention practices were 
reported to be 71% satisfied 
and above, for all aspects 
measured. The largest 
reduction in satisfaction 
scores was measured 
regarding ‘salary,’ with a 
25% difference between 96% 
of GPs at control practices to 
only 71% of GPs at 
intervention practices 
satisfied with salary. 
 
Except for ‘relationship with 
colleagues,’ all aspects of job 
satisfaction remained similar 
or improved for NPs 
compared to RNs. 
 
 
b) What was the effect on 
views of each professional 
role, reported from the 
perspective of GPs?  
  
2. Clinical 
activities 
identified by 
GPs as 
“exclusively 
GP 
activities” 
were lowered 
at all time 
points in the 
intervention 
group; at end 
of trial, 
activities that 
were viewed 
as 
interchangea
ble increased 
in all 
categories 
3.   
4. c) How are 
activities of 
GPs & NPs 
altered? (i.e. 
change in the 
proportion of 
clinical & 
non-clinical 
activities) 
5.  
NPs spent  
~ 50% more 
time in 
clinical work 
than RNs & ~ 
½ the time in 
non-clinical 
work.  
 
GPs’ time in 
clinical & 
non-clinical  
work, differed 
between 
groups by 
only 1-2%  
 
Attrition 
2 practices 
dropped-out 
before the 
end of the 
trial: 1 
control 
practice 
became 
university-
affiliated 
and 1 
intervention 
practice 
experienced   
financial 
and 
professional 
dis-
satisfaction.  
 
Clinical 
activity data 
presented in 
Figures 4 & 
5  was only 
physician-
reported 
without 
presentation  
of  NP-
reported 
data 
*Primary Endpoint     ^ Role Substitution (RS)     ^^ Interprofessional Team (IPT) 
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